<SEC-DOCUMENT>0001213900-25-095847.txt : 20251003
<SEC-HEADER>0001213900-25-095847.hdr.sgml : 20251003
<ACCEPTANCE-DATETIME>20251003081613
ACCESSION NUMBER:		0001213900-25-095847
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20251001
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251003
DATE AS OF CHANGE:		20251003

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Onconetix, Inc.
		CENTRAL INDEX KEY:			0001782107
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41294
		FILM NUMBER:		251372128

	BUSINESS ADDRESS:	
		STREET 1:		201 E. FIFTH STREET
		STREET 2:		SUITE 1900
		CITY:			CINCINNATI
		STATE:			OH
		ZIP:			45202
		BUSINESS PHONE:		513-620-4101

	MAIL ADDRESS:	
		STREET 1:		201 E. FIFTH STREET
		STREET 2:		SUITE 1900
		CITY:			CINCINNATI
		STATE:			OH
		ZIP:			45202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Blue Water Biotech, Inc.
		DATE OF NAME CHANGE:	20230424

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Blue Water Vaccines Inc.
		DATE OF NAME CHANGE:	20190710
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0259860-8k_onconetix.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ONCO="http://onconetix.com/20251001">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_ONCO_onconetix.com_20251001 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20251001_20251001 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001782107 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000004" name="dei:EntityCentralIndexKey">0001782107</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="onco-20251001.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-10-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001782107</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-01</xbrli:startDate>
        <xbrli:endDate>2025-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>FORM <span id="xdx_90D_edei--DocumentType_c20251001__20251001_zkTgpBZYFtri"><ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Date of Report (Date of
earliest event reported): <b>October 3, 2025 (<span id="xdx_90E_edei--DocumentPeriodEndDate_c20251001__20251001_zylAUtusWJ52"><ix:nonNumeric contextRef="AsOf2025-10-01" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">October 1, 2025</ix:nonNumeric></span>)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><span id="xdx_90F_edei--EntityRegistrantName_c20251001__20251001_zC8D8ayF6i89"><ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000011" name="dei:EntityRegistrantName">Onconetix, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">(Exact name of registrant
as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20251001__20251001_zzxGH4trqLd9"><ix:nonNumeric contextRef="AsOf2025-10-01" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_907_edei--EntityFileNumber_c20251001__20251001_zr3jq50Kzsrk"><ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000013" name="dei:EntityFileNumber">001-41294</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_901_edei--EntityTaxIdentificationNumber_c20251001__20251001_z9eJ5HQQwiP4"><ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000014" name="dei:EntityTaxIdentificationNumber">83-2262816</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(State or other Jurisdiction<br/>
of Incorporation)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Commission File Number)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(IRS Employer<br/>
Identification No.)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 49%"><b><span id="xdx_906_edei--EntityAddressAddressLine1_c20251001__20251001_zOHmGJNNjdIi"><ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000015" name="dei:EntityAddressAddressLine1">201 E. Fifth Street</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressAddressLine2_c20251001__20251001_zgDmxNyrCWyb"><ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 1900</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressCityOrTown_c20251001__20251001_zYoRp0dkiR4k"><ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000017" name="dei:EntityAddressCityOrTown">Cincinnati</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressStateOrProvince_c20251001__20251001_zWSsDhjMySl6"><ix:nonNumeric contextRef="AsOf2025-10-01" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Ohio</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 49%"><b><span id="xdx_902_edei--EntityAddressPostalZipCode_c20251001__20251001_z5zeEr4uuBXa"><ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000019" name="dei:EntityAddressPostalZipCode">45202</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(Address of Principal Executive Offices)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Zip Code)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Registrant&#8217;s telephone
number, including area code: <b>(<span id="xdx_900_edei--CityAreaCode_c20251001__20251001_zZjNT1fXvBJl"><ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000020" name="dei:CityAreaCode">513</ix:nonNumeric></span>) <span id="xdx_904_edei--LocalPhoneNumber_c20251001__20251001_zfIOERXTNLp1"><ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000021" name="dei:LocalPhoneNumber">620-4101</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">(Former name or former
address, if changed since last report.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_edei--WrittenCommunications_c20251001__20251001_zHHGLzsibNdg"><ix:nonNumeric contextRef="AsOf2025-10-01" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_edei--SolicitingMaterial_c20251001__20251001_zkk6sJKfXBp2"><ix:nonNumeric contextRef="AsOf2025-10-01" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_edei--PreCommencementTenderOffer_c20251001__20251001_zqXta3yNewf1"><ix:nonNumeric contextRef="AsOf2025-10-01" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20251001__20251001_zyCDSIW32Hsd"><ix:nonNumeric contextRef="AsOf2025-10-01" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b>Title of Each Class</b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b>Trading Symbol(s)</b></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b>Name&#160;of&#160;Each&#160;Exchange&#160;on&#160;Which&#160;Registered</b></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: center"><span id="xdx_901_edei--Security12bTitle_c20251001__20251001_zoK1QFnIXtba"><ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000026" name="dei:Security12bTitle">Common Stock, par value $0.00001 per share</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_907_edei--TradingSymbol_c20251001__20251001_zBXTpwhivJy8"><ix:nonNumeric contextRef="AsOf2025-10-01" id="Fact000027" name="dei:TradingSymbol">ONCO</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">The <span id="xdx_90C_edei--SecurityExchangeName_c20251001__20251001_zPQWv23yYAa9"><ix:nonNumeric contextRef="AsOf2025-10-01" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20251001__20251001_z9rmyxQaefnl"><ix:nonNumeric contextRef="AsOf2025-10-01" format="ixt:booleantrue" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--EntityExTransitionPeriod_c20251001__20251001_z7KqYtQbWCgi"><ix:nonNumeric contextRef="AsOf2025-10-01" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 1.01. Entry into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>PIPE Financing</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">On
October 1, 2025, Onconetix, Inc., a Delaware corporation (the &#8220;<b>Company</b>&#8221;), entered into, and sold to institutional investor(s)
(collectively, the &#8220;<b>PIPE Investors</b>&#8221;), pursuant to a securities purchase agreement (the &#8220;<b>Securities Purchase
Agreement</b>&#8221;) an aggregate of 7,813 shares of Series E convertible preferred stock, par value $0.00001 per share (&#8220;<b>Series
E Preferred Stock</b>&#8221;), which are convertible into common stock of the Company, $0.00001 par value per share (the &#8220;<b>Common
Stock</b>&#8221;) and warrants to purchase 2,025,223 shares of Common Stock (the &#8220;<b>Warrants</b>&#8221; and, together with the
Series E Preferred Stock, the &#8220;<b>PIPE Securities</b>&#8221;), for an aggregate purchase price of approximately $6.25 million. Such
investment is referred to as the &#8220;<b>PIPE Financing</b>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">Concurrently
with entering into the Securities Purchase Agreement, the Company also entered into a registration rights agreement with the PIPE Investors,
pursuant to which it has agreed to provide the PIPE Investors with certain registration rights related to the shares of Common Stock underlying
the shares of Series E Preferred Stock (the &#8220;<b>Preferred Shares</b>&#8221;) and Warrants, as described below. The following description
of the terms of the Securities Purchase Agreement and the Certificate of Designations of Preferences, Rights and Limitations of the Series
E Preferred Stock (the &#8220;<b>Certificate of Designations</b>&#8221;), Warrants and Registration Rights Agreement are only summaries
and do not purport to be complete and are qualified in their entirety by reference to the full text of each of those transaction documents,
copies of which are filed as Exhibits 10.1, 3.1, 4.1 and 10.2, respectively, to this Current Report on Form 8-K, and are incorporated
by reference herein. Capitalized terms used but not defined herein will have the meanings assigned to them in the Securities Purchase
Agreement, Certificate of Designations, Warrants or Registration Rights Agreement, as the case may be.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Series E Preferred Stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Certificate of Designations</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>General<b>.
</b></i>Pursuant to the Certificate of Designations, the Company has authorized the issuance of up to 10,000 shares of Series E Preferred
Stock, each having a stated value of $1,000 per share (the &#8220;<b>Stated Value</b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Ranking.
</i>Except (i) for the Series C Preferred Stock of the Company and the Series D Preferred Stock of the Company, which shall be of pari
passu rank to the Preferred Shares (the &#8220;<b>Parity Stock</b>&#8221;), and (ii) to the extent that the Required Holders (as defined
in the Securities Purchase Agreement) expressly consent to the creation of Parity Stock or Senior Preferred Stock, all shares of capital
stock of the Company will be junior in rank to all Preferred Shares with respect to the preferences as to dividends, distributions and
payments upon the liquidation, dissolution and winding up of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Dividends.
</i>The holders of Series E Preferred Stock are entitled to dividends (the &#8220;<b>Dividends</b>&#8221;), when and as declared by the
Company&#8217;s Board of Directors (the &#8220;<b>Board</b>&#8221;), from time to time, in its sole discretion, which Dividends shall
be paid by the Company out of funds legally available therefor, payable, subject to the conditions and other terms hereof, in cash, in
securities of the Company or any other entity, or using assets as determined by the Board on the Stated Value of such Preferred Share.
In addition, from and after the occurrence and during the continuance of any Triggering Event, dividends (&#8220;<b>Default Dividends</b>&#8221;)
will accrue on the Stated Value of each Preferred Share at a rate of fifteen percent (15.0%) (the &#8220;<b>Default Rate</b>&#8221;) per
annum. Default Dividends are payable by way of inclusion of Default Dividends in the Conversion Amount (as defined below) on each conversion
date. In the event that such Triggering Event is subsequently cured (and no other Triggering Event then exists), the accrual of Default
Dividends will cease to be effective as of the calendar day immediately following the date of such cure; provided that Default Dividends
as calculated and unpaid during the continuance of such Triggering Event will continue to apply to the extent relating to the days after
the occurrence of such Triggering Event through and including the date of such cure of such Triggering Event.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;<i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Conversion Rights</i>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Conversion
at Option of Holder. </i>Each holder is entitled to convert any portion of the outstanding Preferred Shares held by such holder into validly
issued, fully paid and non-assessable Conversion Shares at the Conversion Rate (as defined below). Except as otherwise provided in the
Certificate of Designations, the number of Conversion Shares issuable upon conversion of any Preferred Share will be determined by dividing
(x) the Conversion Amount (as defined below) of such Preferred Share by (y) the Conversion Price (the &#8220;<b>Conversion Rate</b>&#8221;).
As used herein, the term &#8220;<b>Conversion Amount</b>&#8221; means, with respect to each Preferred Share, as of the applicable date
of determination, the sum of (1) the Stated Value thereof <span style="text-decoration: underline">plus</span> (2) any Default Dividends thereon as of such date of determination
<span style="text-decoration: underline">plus</span> (3) any other amounts owed to such PIPE Investor pursuant to the terms of the Certificate of Designations or any other Transaction
Document; and the term &#8220;<b>Conversion Price</b>&#8221; means, with respect to each Preferred Share, as of any Conversion Date or
other date of determination, $3.8576, subject to adjustment as provided in the Certificate of Designations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Conversion
at the Option of the Holder Upon the Occurrence of a Triggering Event</i>. After the Stockholder Approval Date (as defined in the Securities
Purchase Agreement), if a Triggering Event occurs and is continuing, at any time after the earlier of a holder&#8217;s receipt of a Triggering
Event Notice (as defined below) and such holder becoming aware of such Triggering Event (such earlier date, the &#8220;<b>Alternate Conversion
Right Commencement Date</b>&#8221;) and ending on the twentieth (20<span style="font-size: 10pt"><sup>th</sup></span>) Trading Day (as
defined in the Securities Purchase Agreement) after the later of (x) the date such Triggering Event is cured and (y) such holder&#8217;s
receipt of a Triggering Event Notice (such ending date, the &#8220;<b>Alternate Conversion Right Expiration Date</b>&#8221;, and each
such period, an &#8220;<b>Alternate Conversion Right Period</b>&#8221;), such holder may, at such holder&#8217;s option, by delivery of
a Conversion Notice to the Company (the date of any such Conversion Notice, each an &#8220;<b>Alternate Conversion Date</b>&#8221;), convert
all, or any number of Preferred Shares held by such holder into shares of Common Stock at the Alternate Conversion Price (each, an &#8220;<b>Alternate
Conversion</b>&#8221;). Additionally, at any time after the Stockholder Approval Date, the Holder may convert any number of Preferred
Shares held by such Holder at the Alternate Optional Conversion Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>As used herein:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#8220;<b><i>Alternate
Conversion Price</i></b>&#8221; means, with respect to any Alternate Conversion that price which will be the lowest of (i) the applicable
Conversion Price as in effect on the applicable Conversion Date of the applicable Alternate Conversion, and (ii) the greater of (x) the
Floor Price (as defined below) and (y) 90% of the lowest VWAP of the Common Stock during the five (5) consecutive Trading Day period ending
and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice (such period,
the &#8220;<b><i>Alternate Conversion Measuring Period</i></b>&#8221;). All such determinations to be appropriately adjusted for any stock
dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the Common
Stock during such Alternate Conversion Measuring Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#8220;<b><i>Alternate
Conversion Floor Amount</i></b>&#8221; means an amount equal to the product obtained by multiplying (A) the higher of (i) the highest
price that the Common Stock trades at on the Trading Day immediately preceding the relevant Alternate Conversion Date and (ii) the applicable
Alternate Conversion Price and (B) the difference obtained by subtracting (i) the number of shares of Common Stock delivered (or to be
delivered) to such holder on the applicable Share Delivery Deadline (as defined in the Certificate of Designations) with respect to such
Alternate Conversion from (ii) the quotient obtained by dividing (x) the applicable Conversion Amount that such holder has elected to
be the subject of the applicable Alternate Conversion, by (y) the applicable Alternate Conversion Price, without giving effect to the
Floor Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#8220;<b><i>Alternate
Optional Conversion Price</i></b>&#8221; means, with respect to any Alternate Conversion that price which will be the lowest of (i) the
applicable Conversion Price as in effect on the applicable Conversion Date of the applicable Alternate Conversion, and (ii) the greater
of (x) the Floor Price and (y) 95% of the lowest VWAP of the Common Stock during the five (5) consecutive Trading Day period ending and
including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice (such period, the
&#8220;<b><i>Alternate Optional Conversion Measuring Period</i></b>&#8221;). All such determinations to be appropriately adjusted for
any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases
the Common Stock during such Alternate Optional Conversion Measuring Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#8220;<b><i>Floor
Price</i></b>&#8221; means $0.7715 (as adjusted for stock splits, stock dividends, stock combinations, recapitalizations and similar events),
or, subject to the rules and regulations of the Principal Market (as defined in the Certificate of Designations), such lower price as
the Company and the Required Holders may agree, from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#8220;<b><i>Triggering
Event Notice</i></b>&#8221; means written notice from the Company delivered to each holder within two Business Days (as defined in the
Securities Purchase Agreement) after the occurrence of a Triggering Event) that includes (i) a reasonable description of the applicable
Triggering Event, (ii) a certification as to whether, in the reasonable opinion of the Company, such Triggering Event is capable of being
cured and, if applicable, a reasonable description of any existing plans of the Company to cure such Triggering Event and (iii) a certification
as to the date the Triggering Event occurred and, if cured on or prior to the date of such Triggering Event Notice, the applicable Alternate
Conversion Right Expiration Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#8220;<b><i>Triggering
Event</i></b>&#8221; includes, but is not limited to, the following, subject to certain cure periods as set forth in the Certificate of
Designations:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(i) the failure
to file a registration statement for the resale of the shares of Common Stock underlying the Preferred Shares and the Warrants, or the
failure of the applicable registration statement to be declared effective by the SEC, ten (10) days after the applicable deadline;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(ii) the failure
to maintain the effectiveness of a registration statement pursuant to the terms of the Registration Rights Agreement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(iii) the suspension
from trading or the failure of the Common Stock to be trading or listed (as applicable) on an Eligible Market for a period of five (5)
consecutive Trading Days;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(iv) failure to
cure a Conversion Failure or a Delivery Failure (as defined in the Warrants) by delivery of the required number of shares of Common Stock
within the requisite time frame;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(v) failure to
maintain authorized, but unissued shares equal to 150% of the shares underlying the Preferred Shares and the Warrants;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(vi) failure to
remove any restrictive legend on any certificate or any shares of Common Stock issued to the applicable Holder upon conversion or exercise
(as the case may be) of any Securities (as defined in the Securities Purchase Agreement) acquired by such Holder under the Transaction
Documents as and when required by such Securities or the Securities Purchase Agreement, as applicable, unless otherwise then prohibited
by applicable federal securities laws, and any such failure remains uncured for at least five (5) days;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(vii) the occurrence
of any default under, redemption of or acceleration prior to maturity of at least an aggregate of $500,000 of Indebtedness of the Company
or any of its Subsidiaries (as defined in the Securities Purchase Agreement);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(viii) the institution,
commencement, court order or decree by or against the Company or any Subsidiary of certain bankruptcy, insolvency, reorganization or liquidation
proceedings or other proceedings for the relief of debtors;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(ix) the commencement
by the Company or any Subsidiary of a voluntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency,
reorganization or other similar law or of any other case or proceeding to be adjudicated a bankrupt or insolvent, or the consent by it
to the entry of a decree, order, judgment or other similar document in respect of the Company or any Subsidiary in an involuntary case
or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or to the commencement
of any bankruptcy or insolvency case or proceeding against it, or the filing by it of a petition or answer or consent seeking reorganization
or relief under any applicable federal, state or foreign law, or the consent by it to the filing of such petition or to the appointment
of or taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company
or any Subsidiary or of any substantial part of its property, or the making by it of an assignment for the benefit of creditors, or the
execution of a composition of debts, or the occurrence of any other similar federal, state or foreign proceeding, or the admission by
it in writing of its inability to pay its debts generally as they become due, the taking of corporate action by the Company or any Subsidiary
in furtherance of any such action or the taking of any action by any Person to commence a Uniform Commercial Code foreclosure sale or
any other similar action under federal, state or foreign law;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#160;</p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(x) the entry by
a court of (i) a decree, order, judgment or other similar document in respect of the Company or any Subsidiary of a voluntary or involuntary
case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or (ii)
a decree, order, judgment or other similar document adjudging the Company or any Subsidiary as bankrupt or insolvent, or approving as
properly filed a petition seeking liquidation, reorganization, arrangement, adjustment or composition of or in respect of the Company
or any Subsidiary under any applicable federal, state or foreign law or (iii) a decree, order, judgment or other similar document appointing
a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any Subsidiary or of any
substantial part of its property, or ordering the winding up or liquidation of its affairs, and the continuance of any such decree, order,
judgment or other similar document or any such other decree, order, judgment or other similar document unstayed and in effect for a period
of forty-five (45) consecutive days;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(xi) a final judgment
or judgments for the payment of money aggregating in excess of $500,000 are rendered against the Company and/or any of its Subsidiaries
and which judgments are not, within forty-five (45) days after the entry thereof, bonded, discharged, settled or stayed pending appeal,
or are not discharged within forty-five (45) days after the expiration of such stay; provided, however, any judgment which is covered
by insurance or an indemnity from a credit worthy party shall not be included in calculating the $500,000 amount set forth above so long
as the Company provides each Holder a written statement from such insurer or indemnity provider (which written statement shall be reasonably
satisfactory to each Holder) to the effect that such judgment is covered by insurance or an indemnity and the Company or such Subsidiary
(as the case may be) will receive the proceeds of such insurance or indemnity within forty-five (45) days of the issuance of such judgment;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(xii) the Company
and/or any Subsidiary, individually or in the aggregate, either (i) fails to pay, when due, or within any applicable grace period, any
payment with respect to any Indebtedness in excess of $500,000 due to any third party (other than, with respect to unsecured Indebtedness
only, payments contested by the Company and/or such Subsidiary (as the case may be) in good faith by proper proceedings and with respect
to which adequate reserves have been set aside for the payment thereof in accordance with GAAP) or is otherwise in breach or violation
of any agreement for monies owed or owing in an amount in excess of $500,000, which breach or violation permits the other party thereto
to declare a default or otherwise accelerate amounts due thereunder, or (ii) suffer to exist any other circumstance or event that would,
with or without the passage of time or the giving of notice, result in a default or event of default under any agreement binding the Company
or any Subsidiary, which default or event of default would or is likely to have a material adverse effect on the business, assets, operations
(including results thereof), liabilities, properties, condition (including financial condition) or prospects of the Company or any of
its Subsidiaries, individually or in the aggregate;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(xiii) the Company
or any Subsidiary breaches any representation or warranty in any material respect (other than representations or warranties subject to
Material Adverse Effect or materiality, which may not be breached in any respect) or any covenant or other term or condition of any Transaction
Document, except, in the case of a breach of a covenant or other term or condition that is curable, only if such breach remains uncured
for a period of five (5) consecutive Trading Days;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(xiv) a false or
inaccurate certification (including a false or inaccurate deemed certification) by the Company that either (A) the Equity Conditions are
satisfied, (B) there has been no Equity Conditions Failure, or (C) as to whether any Triggering Event has occurred;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(xv) any
breach or failure in any respect by the Company or any Subsidiary to comply with any provision of the covenants listed in the Certificate
of Designations;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(xvi) any Preferred
Shares remain outstanding on or after April 2, 2027;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(xvii) any Change
of Control occurs without the prior written consent of the Required Holders, which consent will not be unreasonably withheld, conditioned
or delayed;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(xviii) any Material
Adverse Effect occurs; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&#160;</p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">(xix) any provision
of any Transaction Document will at any time for any reason (other than pursuant to the express terms thereof) cease to be valid and binding
on or enforceable against the Company, or the validity or enforceability thereof is contested.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Stock Combination Event
Adjustment<b>.</b></i> In addition to the adjustments set forth above, if at any time and from time to time on or after Stockholder Approval,
there occurs any share split, share dividend, stock combination recapitalization or other similar transaction involving the Common Stock
(each, a &#8220;<b>Stock Combination Event</b>&#8221;, and such date thereof, the &#8220;<b>Stock Combination Event Date</b>&#8221;) and
the lowest VWAP during the ten consecutive (10) Trading Day period ending and including the fifth (5) Trading Day immediately preceding
the Stock Combination Event Date (the &#8220;<b>Event Market Price</b>&#8221;) (provided if the Stock Combination Event is effective after
close of trading on the primary Trading Market, then commencing on the next Trading Day which period will be the &#8220;<b>Stock Combination
Adjustment Period</b>&#8221;) is less than the Conversion Price then in effect, then at the close of trading on the primary Trading Market
on the last day of the Stock Combination Adjustment Period, the Conversion Price then in effect on such fifth (5th) Trading Day will be
reduced (but in no event increased) to the Event Market Price, but not less than the Floor Price. Notwithstanding the foregoing, if one
or more Stock Combination Events occur prior to Stockholder Approval being obtained and a reduction of the Conversion Price did not occur,
once Stockholder Approval is obtained, the Conversion Price will automatically be reduced to equal the lowest Event Market Price with
respect to any Stock Combination Event that occurred prior to Stockholder Approval being obtained, but not less than the Floor Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Adjustments for Variable
Price Security Issuances</i>. If the Company in any manner issues or sells or enters into any agreement to issue or sell, any Common Stock,
Options or Convertible Securities (other than with respect to a Permitted Equity Line (as defined in the Securities Purchase Agreement))
(any such securities, &#8220;<b>Variable Price Securities</b>&#8221;) after the Subscription Date (as defined in the Certificate of Designations)
that are issuable pursuant to such agreement or convertible into or exchangeable or exercisable for shares of Common Stock at a price
which varies or may vary with the market price of the shares of Common Stock, including by way of one or more reset(s) to a fixed price,
but exclusive of such formulations reflecting share splits, share combinations and share dividends (each of the formulations for such
variable price being herein referred to as, the &#8220;<b>Variable Price</b>&#8221;), the Company shall provide written notice thereof
via electronic mail and overnight courier to each Holder on the date of such agreement and/or the issuance of such shares of Common Stock,
Convertible Securities or Options, as applicable. From and after the date the Company enters into such agreement or issues any such Variable
Price Securities, each Holder shall have the right, but not the obligation, in its sole discretion to substitute the Variable Price for
the Conversion Price upon conversion of the Preferred Shares by designating in the Conversion Notice delivered upon any conversion of
Preferred Shares that solely for purposes of such conversion such Holder is relying on the Variable Price rather than the Conversion Price
then in effect. A Holder&#8217;s election to rely on a Variable Price for a particular conversion of Preferred Shares shall not obligate
such Holder to rely on a Variable Price for any future conversions of Preferred Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Adjustments
for Dilutive Issuances</i>. If and whenever the Company grants, issues or sells (or enters into any agreement to grant, issue or sell),
or pursuant to the provisions of the Certificate of Designations is deemed to have done any of the foregoing, but excluding any Excluded
Securities (as defined in the Certificate of Designations) granted, issued or sold or deemed to have been granted, issued or sold, any
shares of Common Stock for a consideration per share (the &#8220;<b>New Issuance Price</b>&#8221;) less than a price equal to the Conversion
Price in effect immediately prior to such granting, issuance or sale (such Conversion Price then in effect is referred to herein as the
&#8220;<b>Applicable Price</b>&#8221;) (the foregoing a &#8220;<b>Dilutive Issuance</b>&#8221;), then, immediately after such Dilutive
Issuance, the Conversion Price then in effect will be reduced to an amount equal to the New Issuance Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Voluntary
Adjustment Right. </i>Subject to the rules and regulations of the Principal Market, the Company has the right, at any time, with the written
consent of the Required Holders, to lower the fixed conversion price to any amount and for any period of time deemed appropriate by the
Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Change
of Control Exchange.</i> Upon a change of control of the Company, each holder may require the Company to exchange the holder&#8217;s shares
of Series E Preferred Stock for consideration equal to the change of Control Election Price, to be satisfied at the Company&#8217;s election
in either (x) cash or (y) rights convertible into such securities or other assets to which such holder would have been entitled with respect
to such shares of Common Stock had such shares of Common Stock been held by such holder upon consummation of such corporate event.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Fundamental
Transactions. </i>The Certificate of Designations prohibits the Company from entering specified fundamental transactions (including, without
limitation, mergers, business combinations and similar transactions) unless the Company (or the Company&#8217;s successor) assumes in
writing all of the Company&#8217;s obligations under the of Common Stock, except as provided in the transaction documents in the PIPE
Financing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Redemption
Rights:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Optional
Redemption by the Company. </i>At any time, the Company shall have the right to redeem all, or any part pro rata based on the number of
the Preferred Shares then held by the Holders, of the Preferred Shares then outstanding (the &#8220;<b>Company Optional Redemption Amount</b>&#8221;)
on the Company Optional Redemption Date (a &#8220;<b>Company Optional Redemption</b>&#8221;). The Preferred Shares subject to redemption
shall be redeemed by the Company in cash at a price (the &#8220;<b>Company Optional Redemption Price</b>&#8221;) equal to 25% premium
on the greater of (i) the Conversion Amount being redeemed as of the Company Optional Redemption Date and (ii) the product of (1) the
Conversion Rate with respect to the Conversion Amount being redeemed as of the Company Optional Redemption Date (as defined in the Certificate
of Designations) multiplied by (2) the greatest Closing Sale Price of the Common Stock on any Trading Day during the period commencing
on the date immediately preceding such Company Optional Redemption Notice Date (as defined in the Certificate of Designations) and ending
on the Trading Day immediately prior to the date the Company makes the entire payment required to be made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Voting
Rights</i>. The holders of the Series E Preferred Stock have no voting power and no right to vote on any matter at any time, either as
a separate series or class or together with any other series or class of share of capital stock, and are not entitled to call a meeting
of such holders for any purpose nor are they entitled to participate in any meeting of the holders of Common Stock, except as provided
in the Certificate of Designations (or as otherwise required by applicable law).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Covenants</i>.
The Certificate of Designations contains a variety of obligations on the Company&#8217;s part not to engage in specified activities, which
are typical for transactions of this type. In particular, the Company will not, and will cause the Company&#8217;s subsidiaries to not,
redeem, repurchase or declare any dividend or distribution on any of its capital stock (other than as required under the Certificate of
Designations). In addition, the Company will not issue any preferred stock or issue any other securities that would cause a breach or
default under the Certificate of Designations or Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Ownership
Limitation. </i>In no event may any Preferred Shares be converted (or Warrants be exercised) and shares of Common Stock be issued to any
holder if after giving effect to the issuance of shares of Common Stock upon such conversion of the Preferred Shares (or exercise of the
Warrants), the holder (together with its affiliates, if any) would beneficially own more than 4.99% of the outstanding shares of Common
Stock, which we refer to herein as the &#8220;<b>PIPE Blocker</b>&#8221;. The PIPE Blocker may be raised or lowered to any other percentage
not in excess of 9.99% at the option of the applicable holder of the Preferred Shares (or Warrants), except that any raise will only be
effective upon 61-days&#8217; prior notice to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Exchange
Right. </i>If the Company or any of its Subsidiaries consummates any Subsequent Placement (as defined in the Securities Purchase Agreement)
(other than with respect to Excluded Securities ), and a holder elects in writing to the Company to participate in such Subsequent Placement,
each such holder may, at the option of such holder as elected in writing to the Company, exchange all, or any part, of the Preferred Shares
of such holder into the securities in such Subsequent Placement (with the aggregate amount of such securities to be issued in such exchange
equal to such aggregate amount of such securities with a purchase price valued at a 20% premium on the Conversion Amount of the Preferred
Shares delivered by such holder in exchange therefor); provided that any such exchange will be subject to all applicable Nasdaq restrictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>&#160;&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Reservation
Requirements. </i>So long as any Series E Preferred Stock remains outstanding, the Company will at all times reserve at least 150% of
the number of shares of Common Stock as will from time to time be necessary to effect the conversion of all Preferred Shares then outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Conditions
Precedent to Closing</i>: As set forth in the Securities Purchase Agreement, the obligations of each party to consummate the PIPE Financing
are conditioned upon, among other things, customary closing conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Exercise
Price</i>. The initial exercise price of the Warrants is $3.8576. The exercise price is subject to adjustment for stock splits, combinations
and similar events, and, in the event of stock dividends and splits, the number of shares of Common Stock issuable upon the exercise of
the Warrant also will be adjusted so that the aggregate exercise price will be the same immediately before and immediately after any such
adjustment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Exercise
Price Adjustments</i>. If on an Adjustment Date (as defined in the Warrants), the exercise price then in effect is greater than the Market
Price then in effect (the &#8220;<b>Warrant Adjustment Price</b>&#8221;), the exercise price will automatically lower to the Warrant Adjustment
Price. As used herein, &#8220;<b>Market Price</b>&#8221; means, with respect to any Adjustment Date, the greater of (x) the Floor Price
and (y) the lowest closing price of the Common Stock on the Principal Market on any Trading Day during the five (5) Trading Day period
ended on, and including, the Trading Day ended immediately prior to such applicable Adjustment Date (each, a &#8220;<b>Market Price Measuring
Period</b>&#8221;). All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification
or similar transaction that proportionately decreases or increases the Common Stock during such applicable Market Price Measuring Period.
Only downward adjustments will be made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Adjustments
for Dilutive Issuances or Variable Price Securities</i>. If and whenever the Company grants, issues or sells (or enters into any agreement
to grant, issue or sell), or pursuant to the provisions of the Warrant is deemed to have done any of the foregoing, but excluding any
Excluded Securities granted, issued or sold or deemed to have been granted, issued or sold any shares of Common Stock for a consideration
price per share (the &#8220;<b>Warrant New Issuance Price</b>&#8221;) less than a price equal to the exercise price in effect immediately
prior to such granting, issuance or sale (the foregoing a &#8220;<b>Warrant Dilutive Issuance</b>&#8221;), then, immediately after such
Warrant Dilutive Issuance, the exercise price then in effect will be reduced to an amount equal to the Warrant New Issuance Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">Additionally,
if the Company grants, issues or sells (or enters into any agreement to grant, issue or sell) securities at a Variable Price (as defined
in the Warrants), the warrant holder shall have the right, but not the obligation, in its sole discretion to exercise the Warrants at
the Variable Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Exercise
Period</i>. The Warrants are exercisable beginning on the issuance date (the &#8220;<b>Initial Exercisability Date</b>&#8221;) and expiring
on the third anniversary of the Initial Exercisability Date. The Warrants require &#8220;buy-in&#8221; payments to be made by us for failure
to deliver any shares of Common Stock issuable upon exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Cashless
Exercise</i>. If at the time of exercise of the Warrants on or after six months and one day from issuance, there is no effective registration
statement registering the shares of the Common Stock underlying the Warrants, such Warrants may be exercised on a cashless basis pursuant
to their terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Purchase
Rights; Participation Rights</i>. If the Company issues options, convertible securities, warrants, shares, or similar securities to holders
of the Company shares of the Company Common Stock, each Warrant holder has the right to acquire the same as if the holder had exercised
its Warrant. The holders of the Warrants are entitled to receive any dividends paid or distributions made to the holders of the Company&#8217;s
shares of Common Stock on an &#8220;as if converted&#8221; basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><i>Fundamental
Transactions</i>. The Warrants prohibit the Company from entering into specified fundamental transactions unless the successor entity
assumes all of the Company obligations under the Warrants under a written agreement before the transaction is completed. Upon specified
corporate events, a Warrant holder will thereafter have the right to receive upon an exercise such shares, securities, cash, assets or
any other property whatsoever which the holder would have been entitled to receive upon the happening of the applicable corporate event
had the Warrant been exercised immediately prior to the applicable corporate event. When there is a transaction involving specified changes
of control, a Warrant holder will have the right to force the Company to repurchase the holder&#8217;s Warrant for a purchase price in
cash equal to the Black Scholes value, as calculated under the Warrants, of the then unexercised portion of the Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Registration Rights
Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">The
PIPE Investors have been granted certain customary registration rights in connection with the PIPE Financing with respect to the shares
of Common Stock underlying the Series E Preferred Stock and Warrant pursuant to a registration rights statement, in the form annexed hereto
as Exhibit 10.2 (the &#8220;<b>Registration Rights Agreement</b>&#8221;). Pursuant to the Registration Rights Agreement, the Company has
agreed to file a registration statement to register the shares of Common Stock underlying the Series E Preferred Stock and Warrants within
45 days after the closing of the Securities Purchase Agreement and to have such registration statement effective within 120 days of such
closing (or 90 days of such closing if the Company is notified by the Securities and Exchange Commission that such registration statement
will not be reviewed or subject to further review).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 3.02. Unregistered
Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">The
information provided in Item 1.01 with respect to the issuances of the PIPE Securities pursuant to the Securities Purchase Agreement is
incorporated herein by reference. The issuance of all such PIPE Securities will not be registered under the Securities Act in reliance
on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder,
or under any state securities laws. The Company relied on this exemption from registration in entering into the Securities Purchase Agreement
and will rely upon this exemption from registration in issuing such securities based in part on representations made by the PIPE Investors.
The securities may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
Neither this Current Report on Form 8-K, nor the exhibits attached hereto, is an offer to sell or the solicitation of an offer to buy
the securities described herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 9.01 Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; text-align: left; vertical-align: top; width: 9%"><b>Exhibit <br/>
    Number</b></td>
    <td style="vertical-align: top; padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: justify; vertical-align: bottom; width: 90%"><b>Description</b></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">3.1</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom"><a href="ea025986001ex3-1_onconetix.htm">Certificate of Designations authorizing the issuance of the Series E Preferred Stock,</a></td></tr>
  <tr style="background-color: White">
    <td style="text-align: left; vertical-align: top">4.1</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: bottom"><a href="ea025986001ex4-1_onconetix.htm">Form of Warrant</a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">10.1+</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: top"><a href="ea025986001ex10-1_onconetix.htm">Form of Securities Purchase Agreement dated October 1, 2025 relating to the sale of the Series E Preferred Stock and Warrants</a></td></tr>
  <tr style="background-color: White">
    <td style="text-align: left; vertical-align: top">10.2+</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="text-align: justify; vertical-align: top"><a href="ea025986001ex10-2_onconetix.htm">Form of Registration Rights Agreement dated as of October 1, 2025 relating to the resale of the shares of Common Stock underlying the Series E Preferred Stock and Warrants</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">104</td>
    <td>&#160;</td>
    <td style="text-align: justify">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">+</td><td style="text-align: justify">Certain schedules, exhibits and similar attachments have been
omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company will provide a copy of such omitted materials to the Securities and
Exchange Commission or its staff upon request.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td colspan="2" style="text-align: left; vertical-align: top"><b>Onconetix, Inc.</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left; width: 60%; vertical-align: top">&#160;</td>
    <td style="text-align: left; width: 4%; vertical-align: top">&#160;</td>
    <td style="text-align: left; width: 36%; vertical-align: top">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left; vertical-align: top">Date: October 3, 2025</td>
    <td style="text-align: left; vertical-align: top">By:</td>
    <td style="border-bottom: black 1.5pt solid; text-align: left; white-space: nowrap; vertical-align: top">/s/ Karina M. Fedasz</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; white-space: nowrap; vertical-align: top">Karina M. Fedasz</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td style="text-align: left; vertical-align: top">Interim Chief Executive Officer and Interim Chief Financial Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6PVxX1ItdOnSIU2QM8ba4KMWtGWn9eyTf0rohhkBIzvlOhIhFQSvTIsNxUZVQY9e32iNUeEZGe8LgyNebDMKs8GKcZ239sP7AnAKDgZlPlA73wXk3DpsMUpnINFEzkPNsqmC/FdFXz8meTYPWG92Ctg3smXo26DW/xoRaP8lS9xo+HZCdIRviJnKU36BkqmBHd/0gvjooy1xE8VCRKJhufXAtnx7tl4Rli11450b639EHx59KVg== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ea025986001ex3-1_onconetix.htm
<DESCRIPTION>CERTIFICATE OF DESIGNATIONS AUTHORIZING THE ISSUANCE OF THE SERIES E PREFERRED STOCK
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE OF DESIGNATIONS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF RIGHTS AND PREFERENCES OF<BR>
SERIES E CONVERTIBLE PREFERRED STOCK OF<BR>
ONCONETIX, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I, Karina M. Fedasz, hereby
certify that I am the Interim Chief Executive Officer of Onconetix, Inc. (the &ldquo;<B>Company</B>&rdquo;), a corporation organized and
existing under the Delaware General Corporation Law (the &ldquo;<B>DGCL</B>&rdquo;), and further do hereby certify:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">That pursuant to the authority
expressly conferred upon the Board of Directors of the Company (the &ldquo;<B>Board</B>&rdquo;) by the Company&rsquo;s Certificate of
Incorporation, as amended (the &ldquo;<B>Certificate of Incorporation</B>&rdquo;), and Section 151(g) of the DGCL, the Board on September
29, 2025 adopted the following resolution determining it desirable and in the best interests of the Company and its stockholders for the
Company to create a series of Ten Thousand (10,000) shares of preferred stock designated as &ldquo;<B>Series E Convertible Preferred Stock</B>&rdquo;,
none of which shares have been issued, to be issued pursuant to the Securities Purchase Agreement (as defined below), in accordance with
the terms of the Securities Purchase Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RESOLVED, that pursuant to
the authority vested in the Board, in accordance with the provisions of the Certificate of Incorporation, a series of preferred stock,
par value $0.00001 per share, of the Company be and hereby is created pursuant to this certificate of designations (this &ldquo;<B>Certificate
of Designations</B>&rdquo;), and that the designation and number of shares established pursuant hereto and the voting and other powers,
preferences and relative, participating, optional or other rights of the shares of such series and the qualifications, limitations and
restrictions thereof are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>TERMS OF SERIES E CONVERTIBLE PREFERRED STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;<U>Designation
and Number of Shares</U>. There shall hereby be created and established a series of preferred stock of the Company designated as &ldquo;Series
E Convertible Preferred Stock&rdquo; (the &ldquo;<B>Preferred Shares</B>&rdquo;). The authorized number of Preferred Shares shall be Ten
Thousand (10,000) shares. Each Preferred Share shall have a par value of $0.00001. Capitalized terms not defined herein shall have the
meaning as set forth in Section 32 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;<U>Ranking</U>.
Except (i) for the Series C Preferred Stock of the Company and the Series D Preferred Stock of the Company (in each case, as issued pursuant
to the applicable certificate of designations with respect thereto as in effect as of the Initial Issuance Date (as defined below)), which
shall be Parity Stock (as defined below) or (ii) to the extent that the Required Holders (as defined in the Securities Purchase Agreement)
expressly consent to the creation of Parity Stock or Senior Preferred Stock (as defined below) in accordance with Section 16, all shares
of capital stock of the Company shall be junior in rank to all Preferred Shares with respect to the preferences as to dividends, distributions
and payments upon the liquidation, dissolution and winding up of the Company (such junior stock is referred to herein collectively as
&ldquo;<B>Junior Stock</B>&rdquo;). For the avoidance of doubt, the Preferred Shares will, with respect to dividend rights and rights
on liquidation, winding-up and dissolution, rank (A) junior to the Senior Preferred Stock, (B) on parity with the Parity Stock and (C)
senior to the Junior Stock. The rights of all such shares of capital stock of the Company shall be subject to the rights, powers, preferences
and privileges of the Preferred Shares. Without limiting any other provision of this Certificate of Designations, without the prior express
consent of the Required Holders, voting separately as a single class, the Company shall not hereafter authorize or issue any additional
or other shares of capital stock that is (i) of senior rank to the Preferred Shares in respect of the preferences as to dividends, distributions
and payments upon the liquidation, dissolution and winding up of the Company (collectively, the &ldquo;<B>Senior Preferred Stock</B>&rdquo;),
(ii) of pari passu rank to the Preferred Shares in respect of the preferences as to dividends, distributions and payments upon the liquidation,
dissolution and winding up of the Company (collectively, the &ldquo;<B>Parity Stock</B>&rdquo;) or (iii) any Junior Stock having a maturity
date or any other date requiring redemption or repayment of such shares of Junior Stock that is prior to the eighteen month anniversary
of the Initial Issuance Date. In the event of the merger or consolidation of the Company with or into another corporation, the Preferred
Shares shall maintain their relative rights, powers, designations, privileges and preferences provided for herein and no such merger or
consolidation shall result inconsistent therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;<U>Dividends</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;In
addition to Section 7, Section 8 and/or Section 15 below, as applicable, subject to the senior rights of the Senior Preferred Stock, and
pari passu with the holders of shares of Parity Stock, from and after the first date of issuance of any Preferred Shares (the &ldquo;<B>Initial
Issuance Date</B>&rdquo;), each holder of a Preferred Share (each, a &ldquo;<B>Holder</B>&rdquo; and collectively, the &ldquo;<B>Holders</B>&rdquo;)
shall be entitled to receive dividends (&ldquo;<B>Dividends</B>&rdquo;) when and as declared by the Board, from time to time, in its sole
discretion, which Dividends shall be paid by the Company out of funds legally available therefor, payable, subject to the conditions and
other terms hereof, in cash, in securities of the Company or any other entity, or using assets as determined by the Board on the Stated
Value of such Preferred Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;Notwithstanding
the foregoing, from and after the occurrence and during the continuance of any Triggering Event, dividends ( &ldquo;<B>Default Dividends</B>&rdquo;)
shall accrue on the Stated Value of each Preferred Share at a rate of fifteen percent (15.0%) (the &ldquo;<B>Default Rate</B>&rdquo;)
per annum computed on the basis of a 360-day year and twelve 30-day months. Default Dividends shall be payable by way of inclusion of
Default Dividends in the Conversion Amount (as defined below) on each Conversion Date (as defined below) in accordance with Section 4(b)
or upon any redemption in accordance with Section 9 or as otherwise provided herein. In the event that such Triggering Event is subsequently
cured (and no other Triggering Event then exists), the accrual of Default Dividends referred to in the preceding sentence shall cease
to be effective as of the calendar day immediately following the date of such cure; provided that Default Dividends as calculated and
unpaid during the continuance of such Triggering Event shall continue to apply to the extent relating to the days after the occurrence
of such Triggering Event through and including the date of such cure of such Triggering Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;<U>Conversion</U>.
At any time after the Initial Issuance Date, each Preferred Share shall be convertible into validly issued, fully paid and non-assessable
shares of Common Stock (the &ldquo;<B>Conversion Shares</B>&rdquo;), on the terms and conditions set forth in this Section 4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Holder&rsquo;s
Conversion Right</U>. Subject to the provisions of Section 4(d), at any time or times on or after the Initial Issuance Date, each Holder
shall be entitled to convert any portion of the outstanding Preferred Shares held by such Holder into validly issued, fully paid and non-assessable
Conversion Shares in accordance with Section 4(c) at the Conversion Rate (as defined below). The Company shall not issue any fraction
of a share of Common Stock upon any conversion. If the issuance would result in the issuance of a fraction of a share of Common Stock,
the Company shall round such fraction of a share of Common Stock up to the nearest whole share. The Company shall pay any and all transfer,
stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees and expenses of the Company&rsquo;s transfer
agent (the &ldquo;<B>Transfer Agent</B>&rdquo;) that may be payable with respect to the issuance and delivery of Common Stock upon conversion
of any Preferred Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Conversion
Rate</U>. Except as otherwise provided herein, the number of Conversion Shares issuable upon conversion of any Preferred Share pursuant
to this Section 4 shall be determined by dividing (x) the Conversion Amount of such Preferred Share by (y) the Conversion Price (as defined
below) (the &ldquo;<B>Conversion Rate</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;For
purposes of this Certificate of Designations, the term &ldquo;<B>Conversion Amount</B>&rdquo; means, with respect to each Preferred Share,
as of the applicable date of determination, the sum of (1) the Stated Value thereof <U>plus</U> (2) any Additional Amount thereon as of
such date of determination <U>plus</U> (3) any other amounts owed to such Holder pursuant to this Certificate of Designations or any other
Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;For
purposes of this Certificate of Designations, the term &ldquo;<B>Conversion Price</B>&rdquo; means, with respect to each Preferred Share,
as of any Conversion Date or other date of determination, $3.8576, subject to adjustment as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Mechanics
of Conversion</U>. The conversion of each Preferred Share shall be conducted in the following manner:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Optional
Conversion</U>. To convert one or more Preferred Shares into Conversion Shares on any date (a &ldquo;<B>Conversion Date</B>&rdquo;), a
Holder shall deliver (whether via electronic mail or otherwise), for receipt on or prior to 11:59 p.m., New York time, on such date, a
copy of an executed notice of conversion of the Preferred Share(s) subject to such conversion in the form attached hereto as <B><U>Exhibit
I</U></B> (the &ldquo;<B>Conversion Notice</B>&rdquo;) to the Company. If required by Section 4(c)(iii), within one (1) Trading Day following
a conversion of any such Preferred Shares as aforesaid, such Holder shall surrender to a nationally recognized overnight delivery service
for delivery to the Company the original certificates, if any, representing the Preferred Shares (the &ldquo;<B>Preferred Share Certificates</B>&rdquo;)
so converted as aforesaid (or an indemnification undertaking with respect to the Preferred Shares in the case of its loss, theft or destruction
as contemplated by Section 18(b)). On the date of receipt of a Conversion Notice, the Company shall transmit by electronic mail an acknowledgment
of confirmation and representation as to whether such shares of Common Stock may then be resold pursuant to Rule 144 (as defined in the
Securities Purchase Agreement) or an effective and available Registration Statement (as defined in the Registration Rights Agreement),
in the form attached hereto as <B><U>Exhibit II</U></B>, of receipt of such Conversion Notice to such Holder and the Transfer Agent, which
confirmation shall constitute an instruction to the Transfer Agent to process such Conversion Notice in accordance with the terms set
forth herein. On or before the first (1<SUP>st</SUP>) Trading Day following each date on which the Company has received a Conversion Notice
(or such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the settlement of a trade initiated
on the applicable Conversion Date of such Conversion Shares issuable pursuant to such Conversion Notice) (the &ldquo;<B>Share Delivery
Deadline</B>&rdquo;), the Company shall (1) provided that the Transfer Agent is participating in Fast Automated Securities Transfer Program
(&ldquo;<B>FAST</B>&rdquo;) and such shares of Common Stock (i) (A) may then be sold by the applicable Holder pursuant to an available
and effective registration statement and (B) such Holder provides such documentation or other information evidencing the sale of the shares
of Common Stock as the Company, the Transfer Agent or legal counsel to the Company shall reasonably request (which, for the avoidance
of doubt, shall not include the requirement of a medallion guarantee or a legal opinion) or (ii) may be sold by such Holder pursuant to
Rule 144 of the 1933 Act, as applicable (the &ldquo;<B>Resale Eligibility Conditions</B>&rdquo;), credit such aggregate number of Conversion
Shares to which such Holder shall be entitled pursuant to such conversion to such Holder&rsquo;s or its designee&rsquo;s balance account
with is participating in the Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) through its Deposit/Withdrawal at Custodian system, or
(2) if the Transfer Agent is not participating in FAST or the Resale Eligibility Conditions are not satisfied, upon the request of such
Holder, issue and deliver (via reputable overnight courier) to the address as specified in such Conversion Notice, a certificate, registered
in the name of such Holder or its designee, for the number of Conversion Shares to which such Holder shall be entitled. If the number
of Preferred Shares represented by the Preferred Share Certificate(s) submitted for conversion pursuant to Section 4(c)(iii) is greater
than the number of Preferred Shares being converted, then the Company shall, as soon as practicable and in no event later than one (1)
Trading Day after receipt of the Preferred Share Certificate(s) and at its own expense, issue and deliver to such Holder (or its designee)
by overnight courier service a new Preferred Share Certificate or a new Book-Entry (in either case, in accordance with Section 18(d))
representing the number of Preferred Shares not converted. The Person or Persons entitled to receive the Conversion Shares issuable upon
a conversion of Preferred Shares shall be treated for all purposes as the record holder or holders of such Conversion Shares on the Conversion
Date; provided, that such Person shall be deemed to have waived any voting rights of any such Conversion Shares during the period commencing
on such Conversion Date, through, and including, such applicable Share Delivery Deadline (each, a &ldquo;<B>Conversion Period</B>&rdquo;),
as necessary, such that the aggregate voting rights of any shares of Common Stock (including such Conversion Shares) beneficially owned
by such Person and/or any of its Attribution Parties, collectively, on any such date of determination shall not exceed the Maximum Percentage
(as defined below) as a result of any such conversion of such applicable Preferred Shares. Notwithstanding the foregoing, if a Holder
delivers a Conversion Notice to the Company prior to the date of issuance of Preferred Shares to such Holder, whereby such Holder elects
to convert such Preferred Shares pursuant to such Conversion Notice, the Share Delivery Deadline with respect to any such Conversion Notice
shall be the later of (x) the date of issuance of such Preferred Shares and (y) the first (1st) Trading Day after the date of such Conversion
Notice. Notwithstanding anything to the contrary contained in this Certificate of Designations or the Registration Rights Agreement, after
the effective date of a Registration Statement and prior to a Holder&rsquo;s receipt of the notice of a Grace Period (as defined in the
Registration Rights Agreement), the Company shall cause the Transfer Agent to deliver unlegended shares of Common Stock to such Holder
(or its designee) in connection with any sale of Registrable Securities (as defined in the Registration Rights Agreement) with respect
to which such Holder has entered into a contract for sale, and delivered a copy of the prospectus included as part of the particular Registration
Statement to the extent applicable, and for which such Holder has not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Company&rsquo;s
Failure to Timely Convert</U>. If the Company shall fail, for any reason or for no reason, on or prior to the applicable Share Delivery
Deadline, either (I) if the Transfer Agent is not participating in FAST or the Resale Eligibility Conditions are not satisfied, to issue
and deliver to such Holder (or its designee) a certificate for the number of Conversion Shares to which such Holder is entitled and register
such Conversion Shares on the Company&rsquo;s share register or, if the Transfer Agent is participating in FAST and the Resale Eligibility
Conditions are satisfied, to credit such Holder&rsquo;s or its designee&rsquo;s balance account with DTC for such number of Conversion
Shares to which such Holder is entitled upon such Holder&rsquo;s conversion of any Conversion Amount (as the case may be) or (II) if the
Registration Statement covering the resale of the Conversion Shares that are the subject of the Conversion Notice (the &ldquo;<B>Unavailable
Conversion Shares</B>&rdquo;) is not available for the resale of such Unavailable Conversion Shares and the Company fails to promptly,
but in no event later than as required pursuant to the Registration Rights Agreement (x) notify such Holder and (y) deliver the shares
of Common Stock electronically without any restrictive legend by crediting such aggregate number of shares of Common Stock to which such
Holder is entitled pursuant to such conversion to such Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit/Withdrawal
At Custodian system (the event described in the immediately foregoing clause (II) is hereinafter referred to as a &ldquo;<B>Notice Failure</B>&rdquo;
and together with the event described in clause (I) above, a &ldquo;<B>Conversion Failure</B>&rdquo;), and if on or after such Share Delivery
Deadline such Holder acquires (in an open market transaction, stock loan or otherwise) shares of Common Stock corresponding to all or
any portion of the number of Conversion Shares issuable upon such conversion that such Holder is entitled to receive from the Company
and has not received from the Company in connection with such Conversion Failure or Notice Failure, as applicable (a &ldquo;<B>Buy-In</B>&rdquo;),
then, in addition to all other remedies available to such Holder, the Company shall, within two (2) Business Days after receipt of such
Holder&rsquo;s request and in such Holder&rsquo;s discretion, either: (I) pay cash to such Holder in an amount equal to such Holder&rsquo;s
total purchase price (including brokerage commissions, stock loan costs and other out-of-pocket expenses, if any) for the shares of Common
Stock so acquired (including, without limitation, by any other Person in respect, or on behalf, of such Holder) (the &ldquo;<B>Buy-In
Price</B>&rdquo;), at which point the Company&rsquo;s obligation to so issue and deliver such certificate (and to issue such Conversion
Shares) or credit to the balance account of such Holder or such Holder&rsquo;s designee, as applicable, with DTC for the number of Conversion
Shares to which such Holder is entitled upon such Holder&rsquo;s conversion hereunder (as the case may be) (and to issue such Conversion
Shares) shall terminate, or (II) promptly honor its obligation to so issue and deliver to such Holder a certificate or certificates representing
such Conversion Shares or credit the balance account of such Holder or such Holder&rsquo;s designee, as applicable, with DTC for the number
of Conversion Shares to which such Holder is entitled upon such Holder&rsquo;s conversion hereunder (as the case may be) and pay cash
to such Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (x) such number of shares of Common Stock
multiplied by (y) the lowest Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date of the
applicable Conversion Notice and ending on the date of such issuance and payment under this clause (II) (each, a &ldquo;<B>Buy-In Payment
Amount</B>&rdquo;). In addition to the foregoing, if on or prior to the Share Delivery Deadline either (A) the Transfer Agent is not participating
in FAST or the Resale Eligibility Conditions are not satisfied, the Company shall fail to issue and deliver to such Holder (or its designee)
a certificate and register such Conversion Shares on the Company&rsquo;s share register or, if the Transfer Agent is participating in
the FAST and the Resale Eligibility Conditions are satisfied, the Transfer Agent shall fail to credit the balance account of such Holder
or such Holder&rsquo;s designee, as applicable, with DTC for the number of Conversion Shares to which such Holder is entitled upon such
Holder&rsquo;s conversion hereunder or pursuant to the Company&rsquo;s obligation pursuant to clause (ii) below or (B) a Notice Failure
occurs, then, in addition to all other remedies available to such Holder, (X) the Company shall pay in cash to such Holder on each day
after the Share Delivery Deadline that the issuance of such Conversion Shares is not timely effected an amount equal to 2% of the product
of (A) the sum of the number of Conversion Shares not issued to such Holder on or prior to the Share Delivery Deadline and to which such
Holder is entitled, multiplied by (B) any trading price of the Common Stock selected by such Holder in writing as in effect at any time
during the period beginning on the applicable Conversion Date and ending on the applicable Share Delivery Deadline and (Y) such Holder,
upon written notice to the Company, may void its Conversion Notice with respect to, and retain or have returned, as the case may be, all,
or any portion, of such Preferred Shares that has not been converted pursuant to such Conversion Notice; provided that the voiding of
a Conversion Notice shall not affect the Company&rsquo;s obligations to make any payments which have accrued prior to the date of such
notice pursuant to this Section 4(c)(ii) or otherwise. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies
available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief
with respect to the Company&rsquo;s failure to timely deliver certificates representing Conversion Shares (or to electronically deliver
such Conversion Shares) upon the conversion of the Preferred Shares as required pursuant to the terms hereof. Notwithstanding anything
herein to the contrary, with respect to any given Notice Failure and/or Conversion Failure, as applicable, this Section 4(c)(ii) shall
not apply to a Holder to the extent the Company has already paid such amounts in full to such Holder with respect to such Notice Failure
and/or Conversion Failure, as applicable, pursuant to the analogous sections of the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;<U>Registration;
Book-Entry</U>. At the time of issuance of any Preferred Shares hereunder, the applicable Holder may, by written request (including by
electronic-mail) to the Company, elect to receive such Preferred Shares in the form of one or more Preferred Share Certificates or in
Book-Entry form. The Company (or the Transfer Agent, as custodian for the Preferred Shares) shall maintain a register (the &ldquo;<B>Register</B>&rdquo;)
for the recordation of the names and addresses of the Holders of each Preferred Share and the Stated Value of the Preferred Shares and
whether the Preferred Shares are held by such Holder in Preferred Share Certificates or in Book-Entry form (the &ldquo;<B>Registered Preferred
Shares</B>&rdquo;). The entries in the Register shall be conclusive and binding for all purposes absent manifest error. The Company and
each Holder of the Preferred Shares shall treat each Person whose name is recorded in the Register as the owner of a Preferred Share for
all purposes (including, without limitation, the right to receive payments and Dividends hereunder) notwithstanding notice to the contrary.
A Registered Preferred Share may be assigned, transferred or sold only by registration of such assignment or sale on the Register. Upon
its receipt of a written request to assign, transfer or sell one or more Registered Preferred Shares by such Holder thereof, the Company
shall record the information contained therein in the Register and issue one or more new Registered Preferred Shares in the same aggregate
Stated Value as the Stated Value of the surrendered Registered Preferred Shares to the designated assignee or transferee pursuant to Section&nbsp;18,
provided that if the Company does not so record an assignment, transfer or sale (as the case may be) of such Registered Preferred Shares
within two (2) Business Days of such a request, then the Register shall be automatically deemed updated to reflect such assignment, transfer
or sale (as the case may be). Notwithstanding anything to the contrary set forth in this Section&nbsp;4, following conversion of any Preferred
Shares in accordance with the terms hereof, the applicable Holder shall not be required to physically surrender such Preferred Shares
held in the form of a Preferred Share Certificate to the Company unless (A) the full or remaining number of Preferred Shares represented
by the applicable Preferred Share Certificate are being converted (in which event such certificate(s) shall be delivered to the Company
as contemplated by this Section 4(c)(iii)) or (B) such Holder has provided the Company with prior written notice (which notice may be
included in a Conversion Notice) requesting reissuance of Preferred Shares upon physical surrender of the applicable Preferred Share Certificate.
Each Holder and the Company shall maintain records showing the Stated Value and Dividends converted and/or paid (as the case may be) and
the dates of such conversions and/or payments (as the case may be) or shall use such other method, reasonably satisfactory to such Holder
and the Company, so as not to require physical surrender of a Preferred Share Certificate upon conversion. If the Company does not update
the Register to record such Stated Value and Dividends converted and/or paid (as the case may be) and the dates of such conversions and/or
payments (as the case may be) within one (1) Business Day of such occurrence, then the Register shall be automatically deemed updated
to reflect such occurrence. In the event of any dispute or discrepancy, the records of the Company establishing the number of Preferred
Shares to which the record holder is entitled shall be controlling and determinative in the absence of manifest error. A Holder and any
transferee or assignee, by acceptance of a certificate, acknowledge and agree that, by reason of the provisions of this paragraph, following
conversion of any Preferred Shares, the number of Preferred Shares represented by such certificate may be less than the number of Preferred
Shares stated on the face thereof. Each Preferred Share Certificate shall bear the following legend:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in 0pt 2in; text-align: justify">ANY TRANSFEREE OR ASSIGNEE OF THIS CERTIFICATE
SHOULD CAREFULLY REVIEW THE TERMS OF THE CORPORATION&rsquo;S CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES E CONVERTIBLE
PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE, INCLUDING SECTION 4(c)(iii) THEREOF. THE NUMBER OF SHARES OF SERIES E CONVERTIBLE PREFERRED
STOCK REPRESENTED BY THIS CERTIFICATE MAY BE LESS THAN THE NUMBER OF SHARES OF SERIES E CONVERTIBLE PREFERRED STOCK STATED ON THE FACE
HEREOF PURSUANT TO SECTION 4(c)(iii) OF THE CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES E CONVERTIBLE PREFERRED STOCK
REPRESENTED BY THIS CERTIFICATE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;<U>Pro
Rata Conversion; Disputes</U>. In the event that the Company receives a Conversion Notice from more than one Holder for the same Conversion
Date and the Company can convert some, but not all, of such Preferred Shares submitted for conversion, the Company shall convert from
each Holder electing to have Preferred Shares converted on such date a pro rata amount of such Holder&rsquo;s Preferred Shares submitted
for conversion on such date based on the number of Preferred Shares submitted for conversion on such date by such Holder relative to the
aggregate number of Preferred Shares submitted for conversion on such date. In the event of a dispute as to the number of Conversion Shares
issuable to a Holder in connection with a conversion of Preferred Shares, the Company shall issue to such Holder the number of Conversion
Shares not in dispute and resolve such dispute in accordance with Section 23. If a Conversion Notice delivered to the Company would result
in a breach of Section 4(d) below, and the applicable Holder does not elect in writing to withdraw, in whole, such Conversion Notice,
the Company shall hold such Conversion Notice in abeyance until such time as such Conversion Notice may be satisfied without violating
Section 4(d) below (with such calculations thereunder made as of the date such Conversion Notice was initially delivered to the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Limitation
on Beneficial Ownership</U>. The Company shall not effect the conversion of any of the Preferred Shares held by a Holder, and such Holder
shall not have the right to convert any of the Preferred Shares held by such Holder pursuant to the terms and conditions of this Certificate
of Designations and any such conversion shall be null and void and treated as if never made, to the extent that after giving effect to
such conversion, such Holder together with the other Attribution Parties collectively would beneficially own in excess of 4.99% (the &ldquo;<B>Maximum
Percentage</B>&rdquo;) of the shares of Common Stock outstanding immediately after giving effect to such conversion. For purposes of the
foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such Holder and the other Attribution Parties
shall include the number of shares of Common Stock held by such Holder and all other Attribution Parties <U>plus</U> the number of shares
of Common Stock issuable upon conversion of the Preferred Shares with respect to which the determination of such sentence is being made,
but shall exclude shares of Common Stock which would be issuable upon (A) conversion of the remaining, nonconverted Preferred Shares beneficially
owned by such Holder or any of the other Attribution Parties and (B) exercise or conversion of the unexercised or nonconverted portion
of any other securities of the Company (including, without limitation, any convertible notes, convertible preferred stock or warrants,
including the Preferred Shares and the Warrants) beneficially owned by such Holder or any other Attribution Party subject to a limitation
on conversion or exercise analogous to the limitation contained in this Section 4(d). For purposes of this Section 4(d), beneficial ownership
shall be calculated in accordance with Section 13(d) of the 1934 Act. For the avoidance of doubt, the calculation of the Maximum Percentage
shall take into account the concurrent exercise and/or conversion, as applicable, of the unexercised or unconverted portion of any other
securities of the Company beneficially owned by such Holder and/or any other Attribution Party, as applicable. For purposes of determining
the number of outstanding shares of Common Stock a Holder may acquire upon the conversion of such Preferred Shares without exceeding the
Maximum Percentage, such Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company&rsquo;s most
recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as the
case may be, (y) a more recent public announcement by the Company or (z) any other written notice by the Company or the Transfer Agent,
if any, setting forth the number of shares of Common Stock outstanding (the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). If
the Company receives a Conversion Notice from a Holder at a time when the actual number of outstanding shares of Common Stock is less
than the Reported Outstanding Share Number, the Company shall notify such Holder in writing of the number of shares of Common Stock then
outstanding and, to the extent that such Conversion Notice would otherwise cause such Holder&rsquo;s beneficial ownership, as determined
pursuant to this Section 4(d), to exceed the Maximum Percentage, such Holder must notify the Company of a reduced number of shares of
Common Stock to be purchased pursuant to such Conversion Notice. For any reason at any time, upon the written or oral request of any Holder,
the Company shall within one (1) Business Day confirm orally and in writing or by electronic mail to such Holder the number of shares
of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect
to the conversion or exercise of securities of the Company, including such Preferred Shares, by such Holder and any other Attribution
Party since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of shares of Common
Stock to a Holder upon conversion of such Preferred Shares results in such Holder and the other Attribution Parties being deemed to beneficially
own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section
13(d) of the 1934 Act), the number of shares so issued by which such Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate
beneficial ownership exceeds the Maximum Percentage (the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall be
cancelled ab initio, and such Holder shall not have the power to vote or to transfer the Excess Shares. Upon delivery of a written notice
to the Company, any Holder may from time to time increase (with such increase not effective until the sixty-first (61<SUP>st</SUP>) day
after delivery of such notice) or decrease the Maximum Percentage of such Holder to any other percentage not in excess of 9.99% as specified
in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61<SUP>st</SUP>)
day after such notice is delivered to the Company and (ii) any such increase or decrease will apply only to such Holder and the other
Attribution Parties and not to any other Holder that is not an Attribution Party of such Holder. For purposes of clarity, the shares of
Common Stock issuable to a Holder pursuant to the terms of this Certificate of Designations in excess of the Maximum Percentage shall
not be deemed to be beneficially owned by such Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the
1934 Act. No prior inability to convert such Preferred Shares pursuant to this paragraph shall have any effect on the applicability of
the provisions of this paragraph with respect to any subsequent determination of convertibility. The provisions of this paragraph shall
not be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 4(d) to the extent necessary
to correct this paragraph (or any portion of this paragraph) which may be defective or inconsistent with the intended beneficial ownership
limitation contained in this Section 4(d) or to make changes or supplements necessary or desirable to properly give effect to such limitation.
The limitation contained in this paragraph may not be amended, modified or waived and shall apply to a successor holder of such Preferred
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Right
of Alternate Conversion</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>General</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 1in">(1) <U>Alternate Optional
Conversion</U>. Subject to Section 4(d), after the Stockholder Approval Date (as defined in the Securities Purchase Agreement), at any
time, at the option of the Holder, the Holder may convert (each, an &ldquo;<B>Alternate Optional Conversion</B>&rdquo;, and the date of
such Alternate Optional Conversion, an &ldquo;<B>Alternate Optional Conversion Date</B>&rdquo;) all, or any number of Preferred Shares
held by such Holder into shares of Common Stock (such aggregate Conversion Amount of the Preferred Shares subject to such Alternate Optional
Conversion, the &ldquo;<B>Alternate Optional Conversion Amount</B>&rdquo;) at the Alternate Optional Conversion Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 1in">(2) <U>Alternate Triggering
Event Conversion</U>. Subject to Section 4(d), after the Stockholder Approval Date, at any time after the earlier of a Holder&rsquo;s
receipt of a Triggering Event Notice (as defined below) and such Holder becoming aware of a Triggering Event (as defined below) (such
earlier date, the &ldquo;<B>Alternate Conversion Right Commencement Date</B>&rdquo;) and ending (such ending date, the &ldquo;<B>Alternate
Conversion Right Expiration Date</B>&rdquo;, and each such period, an &ldquo;<B>Alternate Conversion Right Period</B>&rdquo;) on the twentieth
(20<SUP>th</SUP>) Trading Day after the later of (x) the date such Triggering Event is cured and (y) such Holder&rsquo;s receipt of a
Triggering Event Notice that includes (I) a reasonable description of the applicable Triggering Event, (II) a certification as to whether,
in the reasonable opinion of the Company, such Triggering Event is capable of being cured and, if applicable, a reasonable description
of any existing plans of the Company to cure such Triggering Event and (III) a certification as to the date the Triggering Event occurred
and, if cured on or prior to the date of such Triggering Event Notice, the applicable Alternate Conversion Right Expiration Date, such
Holder may, at such Holder&rsquo;s option, by delivery of a Conversion Notice to the Company (the date of any such Conversion Notice,
each an &ldquo;<B>Alternate Triggering Event Conversion Date</B>&rdquo; and together with each Alternate Optional Conversion Date, each,
an &ldquo;<B>Alternate Conversion Date</B>&rdquo;), convert (each an &ldquo;<B>Alternate Triggering Event Conversion</B>&rdquo;, and together
with each Alternate Optional Conversion, each an &ldquo;<B>Alternate Conversion</B>&rdquo;) all, or any number of Preferred Shares held
by such Holder (such Conversion Amount of the Preferred Shares to be converted pursuant to this Section 4(e)(i)(2), the &ldquo;<B>Alternate
Triggering Event Conversion Amount</B>&rdquo; and together with each Alternate Optional Conversion Amount, each, an &ldquo;<B>Alternate
Conversion Amount</B>&rdquo;) into shares of Common Stock at the Alternate Triggering Event Conversion Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Mechanics
of Alternate Conversion</U>. On any Alternate Conversion Date, a Holder may voluntarily convert any number of Preferred Shares held by
such Holder pursuant to Section 4(c) (with the applicable &ldquo;Alternate Conversion Price&rdquo; replacing &ldquo;Conversion Price&rdquo;
for all purposes hereunder with respect to such Alternate Conversion and, solely with respect to the calculation of the number of shares
of Common Stock issuable upon conversion of any Conversion Amount in an Alternate Triggering Event Conversion, with &ldquo;the applicable
Required Premium multiplied by the Conversion Amount&rdquo; replacing &ldquo;Conversion Amount&rdquo; in clause (x) of the definition
of Conversion Rate in Section 4(b) above with respect to such Alternate Conversion) by designating in the Conversion Notice delivered
pursuant to this Section 4(e)(ii) of this Certificate of Designations that such Holder is electing to use the Alternate Conversion Price
for such conversion; provided that in the event of the Conversion Floor Price Condition, on the applicable Alternate Conversion Date the
Stated Value of the remaining Preferred Shares of such Holder shall automatically increase, pro rata, by the applicable Alternate Conversion
Floor Amount or, at the Company&rsquo;s option, the Company shall deliver the applicable Alternate Conversion Floor Amount to such applicable
Holder on the applicable Alternate Conversion Date. Notwithstanding anything to the contrary in this Section 4(e)(ii), but subject to
Section 4(d), until the Company delivers to such Holder the shares of Common Stock to which such Holder is entitled pursuant to the applicable
Alternate Conversion of such Holder&rsquo;s Preferred Shares, such Preferred Shares may be converted by such Holder into shares of Common
Stock pursuant to Section 4(c) without regard to this Section 4(e)(ii). In the event of an Alternate Conversion pursuant to this Section
4(e)(ii) of all, or any portion, of any Preferred Shares of a Holder, such Holder&rsquo;s damages would be uncertain and difficult to
estimate because of the parties&rsquo; inability to predict future interest rates and the uncertainty of the availability of a suitable
substitute investment opportunity for such Holder. Accordingly, any redemption premium due under this Section 4(e)(ii), together the Alternate
Conversion Price used in such Alternate Conversion, as applicable, is intended by the parties to be, and shall be deemed, a reasonable
estimate of, such Holder&rsquo;s actual loss of its investment opportunity and not as a penalty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;<U>Triggering
Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>General</U>.
Each of the following events shall constitute a &ldquo;<B>Triggering Event</B>&rdquo;:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;the
failure of the applicable Registration Statement to be filed with the SEC on or prior to the date that is ten (10) days after the applicable
Filing Deadline (as defined in the Registration Rights Agreement) or the failure of the applicable Registration Statement to be declared
effective by the SEC on or prior to the date that is ten (10) days after the applicable Effectiveness Deadline (as defined in the Registration
Rights Agreement);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;while
the applicable Registration Statement is required to be maintained effective pursuant to the terms of the Registration Rights Agreement,
the effectiveness of the applicable Registration Statement lapses for any reason (including, without limitation, the issuance of a stop
order) or such Registration Statement (or the prospectus contained therein) is unavailable to any holder of Registrable Securities (as
defined in the Registration Rights Agreement) for sale of all of such holder&rsquo;s Registrable Securities in accordance with the terms
of the Registration Rights Agreement, and such lapse or unavailability continues for a period of ten (10) consecutive days or for more
than an aggregate of twenty (20) days in any 365-day period (excluding days during an Allowable Grace Period (as defined in the Registration
Rights Agreement));</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;the
suspension from trading or the failure of the Common Stock to be trading or listed (as applicable) on an Eligible Market for a period
of five (5) consecutive Trading Days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;the
Company&rsquo;s (A) failure to cure a Conversion Failure or a Delivery Failure (as defined in the Warrants) by delivery of the required
number of shares of Common Stock within three (3) Trading Days after the applicable Conversion Date or exercise date (as the case may
be) or (B) notice, written or oral, to any holder of Preferred Shares or Warrants, including, without limitation, by way of public announcement
or through any of its agents, at any time, of its intention not to comply, as required, with a request for exercise of any Warrants for
Warrant Shares in accordance with the provisions of the Warrants or a request for conversion of any Preferred Shares into shares of Common
Stock that is requested in accordance with the provisions of this Certificate of Designations, other than pursuant to Section 4(d) hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;except
to the extent the Company is in compliance with Section 11(b) below, at any time following the tenth (10<SUP>th</SUP>) consecutive day
that a Holder&rsquo;s Authorized Share Allocation (as defined in Section 11(a) below) is less than the sum of (A) 150% of the number of
shares of Common Stock that such Holder would be entitled to receive upon a conversion, in full, of all of the Preferred Shares then held
by such Holder (assuming conversions at the Floor Price then in effect without regard to any limitations on conversion set forth in this
Certificate of Designations) and (B) 150% of the number of shares of Common Stock that such Holder would then be entitled to receive upon
exercise in full of such Holder&rsquo;s Warrants (without regard to any limitations on exercise set forth in the Warrants);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;the
Company fails to remove any restrictive legend on any certificate or any shares of Common Stock issued to the applicable Holder upon conversion
or exercise (as the case may be) of any Securities (as defined in the Securities Purchase Agreement) acquired by such Holder under the
Transaction Documents as and when required by such Securities or the Securities Purchase Agreement, as applicable, unless otherwise then
prohibited by applicable federal securities laws, and any such failure remains uncured for at least five (5) days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii)&nbsp;the
occurrence of any default under, redemption of or acceleration prior to maturity of at least an aggregate of $500,000 of Indebtedness
of the Company or any of its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(viii)&nbsp;bankruptcy,
insolvency, reorganization or liquidation proceedings or other proceedings for the relief of debtors shall be instituted by or against
the Company or any Subsidiary and, if instituted against the Company or any Subsidiary by a third party, shall not be dismissed within
forty-five (45) days of their initiation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ix)&nbsp;the
commencement by the Company or any Subsidiary of a voluntary case or proceeding under any applicable federal, state or foreign bankruptcy,
insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated a bankrupt or insolvent, or the consent
by it to the entry of a decree, order, judgment or other similar document in respect of the Company or any Subsidiary in an involuntary
case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or to the
commencement of any bankruptcy or insolvency case or proceeding against it, or the filing by it of a petition or answer or consent seeking
reorganization or relief under any applicable federal, state or foreign law, or the consent by it to the filing of such petition or to
the appointment of or taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official
of the Company or any Subsidiary or of any substantial part of its property, or the making by it of an assignment for the benefit of creditors,
or the execution of a composition of debts, or the occurrence of any other similar federal, state or foreign proceeding, or the admission
by it in writing of its inability to pay its debts generally as they become due, the taking of corporate action by the Company or any
Subsidiary in furtherance of any such action or the taking of any action by any Person to commence a Uniform Commercial Code foreclosure
sale or any other similar action under federal, state or foreign law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(x)&nbsp;the
entry by a court of (i) a decree, order, judgment or other similar document in respect of the Company or any Subsidiary of a voluntary
or involuntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar
law or (ii) a decree, order, judgment or other similar document adjudging the Company or any Subsidiary as bankrupt or insolvent, or approving
as properly filed a petition seeking liquidation, reorganization, arrangement, adjustment or composition of or in respect of the Company
or any Subsidiary under any applicable federal, state or foreign law or (iii) a decree, order, judgment or other similar document appointing
a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any Subsidiary or of any
substantial part of its property, or ordering the winding up or liquidation of its affairs, and the continuance of any such decree, order,
judgment or other similar document or any such other decree, order, judgment or other similar document unstayed and in effect for a period
of forty-five (45) consecutive days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xi)&nbsp;a
final judgment or judgments for the payment of money aggregating in excess of $500,000 are rendered against the Company and/or any of
its Subsidiaries and which judgments are not, within forty-five (45) days after the entry thereof, bonded, discharged, settled or stayed
pending appeal, or are not discharged within forty-five (45) days after the expiration of such stay; provided, however, any judgment which
is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the $500,000 amount set forth
above so long as the Company provides each Holder a written statement from such insurer or indemnity provider (which written statement
shall be reasonably satisfactory to each Holder) to the effect that such judgment is covered by insurance or an indemnity and the Company
or such Subsidiary (as the case may be) will receive the proceeds of such insurance or indemnity within forty-five (45) days of the issuance
of such judgment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xii)&nbsp;the
Company and/or any Subsidiary, individually or in the aggregate, either (i) fails to pay, when due, or within any applicable grace period,
any payment with respect to any Indebtedness in excess of $500,000 due to any third party (other than, with respect to unsecured Indebtedness
only, payments contested by the Company and/or such Subsidiary (as the case may be) in good faith by proper proceedings and with respect
to which adequate reserves have been set aside for the payment thereof in accordance with GAAP) or is otherwise in breach or violation
of any agreement for monies owed or owing in an amount in excess of $500,000, which breach or violation permits the other party thereto
to declare a default or otherwise accelerate amounts due thereunder, or (ii) suffer to exist any other circumstance or event that would,
with or without the passage of time or the giving of notice, result in a default or event of default under any agreement binding the Company
or any Subsidiary, which default or event of default would or is likely to have a material adverse effect on the business, assets, operations
(including results thereof), liabilities, properties, condition (including financial condition) or prospects of the Company or any of
its Subsidiaries, individually or in the aggregate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xiii)&nbsp;other
than as specifically set forth in another clause of this Section 5(a), the Company or any Subsidiary breaches any representation or warranty
in any material respect (other than representations or warranties subject to Material Adverse Effect or materiality, which may not be
breached in any respect) or any covenant or other term or condition of any Transaction Document, except, in the case of a breach of a
covenant or other term or condition that is curable, only if such breach remains uncured for a period of five (5) consecutive Trading
Days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xiv)&nbsp;a
false or inaccurate certification (including a false or inaccurate deemed certification) by the Company that either (A) the Equity Conditions
are satisfied, (B) there has been no Equity Conditions Failure, or (C) as to whether any Triggering Event has occurred;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xv)&nbsp;any
breach or failure in any respect by the Company or any Subsidiary to comply with any provision of Section 13 of this Certificate of Designations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xvi)&nbsp;any
Preferred Shares remain outstanding on or after April 2, 2027;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xvii)&nbsp;any
Change of Control occurs without the prior written consent of the Required Holders, which consent shall not be unreasonably withheld,
conditioned or delayed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xviii)&nbsp;any
Material Adverse Effect occurs; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xix)&nbsp;any
provision of any Transaction Document shall at any time for any reason (other than pursuant to the express terms thereof) cease to be
valid and binding on or enforceable against the Company, or the validity or enforceability thereof shall be contested, directly or indirectly,
by the Company or any Subsidiary, or a proceeding shall be commenced by the Company or any Subsidiary or any Governmental Authority having
jurisdiction over any of them, seeking to establish the invalidity or unenforceability thereof or the Company or any of its Subsidiaries
shall deny in writing that it has any liability or obligation purported to be created under one or more Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Notice
of a Triggering Event</U>. Upon the occurrence of a Triggering Event with respect to the Preferred Shares, the Company shall within two
(2) Business Days deliver written notice thereof via electronic mail and overnight courier (with next day delivery specified) (a &ldquo;<B>Triggering
Event Notice</B>&rdquo;) to each Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;<U>Rights
Upon Fundamental Transactions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Assumption</U>.
The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity assumes in writing all of the
obligations of the Company under this Certificate of Designations and the other Transaction Documents in accordance with the provisions
of this Section 6(a) pursuant to written agreements in form and substance satisfactory to the Required Holders and approved by the Required
Holders prior to such Fundamental Transaction, including agreements to deliver to each holder of Preferred Shares in exchange for such
Preferred Shares a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
Certificate of Designations, including, without limitation, having a stated value and dividend rate equal to the stated value and dividend
rate of the Preferred Shares held by the Holders and having similar ranking to the Preferred Shares, and satisfactory to the Required
Holders and (ii) the Successor Entity (including its Parent Entity) is a publicly traded corporation whose shares of common stock are
quoted on or listed for trading on an Eligible Market. Upon the occurrence of any Fundamental Transaction, the Successor Entity shall
succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Certificate
of Designations and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Certificate of
Designations and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein
and therein. In addition to the foregoing, upon consummation of a Fundamental Transaction, the Successor Entity shall deliver to each
Holder confirmation that there shall be issued upon conversion or redemption of the Preferred Shares at any time after the consummation
of such Fundamental Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property (except such
items still issuable under Sections 7 and 15, which shall continue to be receivable thereafter)) issuable upon the conversion or redemption
of the Preferred Shares prior to such Fundamental Transaction, such shares of the publicly traded common stock (or their equivalent) of
the Successor Entity (including its Parent Entity) which each Holder would have been entitled to receive upon the happening of such Fundamental
Transaction had all the Preferred Shares held by each Holder been converted immediately prior to such Fundamental Transaction (without
regard to any limitations on the conversion of the Preferred Shares contained in this Certificate of Designations), as adjusted in accordance
with the provisions of this Certificate of Designations. Notwithstanding the foregoing, such Holder may elect, at its sole option, by
delivery of written notice to the Company to waive this Section 6(a) to permit the Fundamental Transaction without the assumption of the
Preferred Shares. The provisions of this Section 6(a) shall apply similarly and equally to successive Fundamental Transactions and shall
be applied without regard to any limitations on the conversion or redemption of the Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Notice
of a Change of Control; Change of Control Election Notice</U>. No sooner than the earlier of (x) twenty (20) Trading Days prior to the
consummation of a Change of Control or (y) the public announcement of the entry into an agreement with respect to a Change of Control,
nor later than ten (10) Trading Days prior to the consummation of a Change of Control (the &ldquo;<B>Change of Control Date</B>&rdquo;),
the Company shall deliver written notice thereof via electronic mail and overnight courier to each Holder (a &ldquo;<B>Change of Control
Notice</B>&rdquo;). At any time during the period beginning after a Holder&rsquo;s receipt of a Change of Control Notice or such Holder
becoming aware of a Change of Control if a Change of Control Notice is not delivered to such Holder in accordance with the immediately
preceding sentence (as applicable) and ending on twenty (20) Trading Days after the later of (A) the date of consummation of such Change
of Control or (B) the date of receipt of such Change of Control Notice or (C) the date of the announcement of such Change of Control,
such Holder may require, by delivering written notice thereof (&ldquo;<B>Change of Control Election Notice</B>&rdquo;) to the Company
(which Change of Control Election Notice shall indicate the number of Preferred Shares subject to such election), to have the Company
exchange such Holder&rsquo;s Preferred Shares designated in such Change of Control Election Notice for consideration equal to the Change
of Control Election Price, to be satisfied at the Company&rsquo;s election (such election to pay in cash or by delivery of the Rights
(as defined below), a &ldquo;<B>Consideration Election</B>&rdquo;), in either (I) rights (with a beneficial ownership limitation in the
form of Section 4(d) hereof, <I>mutatis mutandis</I>) (collectively, the &ldquo;<B>Rights</B>&rdquo;), convertible in whole, or in part,
at any time, without the requirement to pay any additional consideration, at the option of the Required Holders, into such Corporate Event
Consideration (as defined below) applicable to such Change of Control equal in value to the Change of Control Election Price (as determined
with the fair market value of the aggregate number of Successor Shares (as defined below) issuable upon conversion of the Rights to be
determined in increments of 10% (or such greater percentage as the applicable Holder may notify the Company from time to time) of the
portion of the Change of Control Election Price attributable to such Successor Shares (the &ldquo;<B>Successor Share Value Increment</B>&rdquo;),
with the aggregate number of Successor Shares issuable upon exercise of the Rights with respect to the first Successor Share Value Increment
determined based on 70% of the VWAP of the Successor Shares on the date the Rights are issued and on each of the nine (9) subsequent Trading
Days, in each case, the aggregate number of additional Successor Shares issuable upon exercise of the Rights shall be determined based
upon a Successor Share Value Increment at 70% of the VWAP of the Successor Shares in effect for such corresponding Trading Day (such ten
(10) Trading Day period commencing on, and including, the date the Rights are issued, the &ldquo;<B>Rights Measuring Period</B>&rdquo;)),
or (II) in cash; provided, that the Company shall not consummate a Change of Control if the Corporate Event Consideration includes capital
stock or other equity interest (the &ldquo;<B>Successor Shares</B>&rdquo;) either in an entity that is not listed on an Eligible Market
or an entity in which the daily share volume for the applicable Successor Shares for each of the twenty (20) Trading Days prior to the
date of consummation of such Change of Control is less than the aggregate number of Successor Shares issuable to all Holders upon conversion
in full of the applicable Rights (without regard to any limitations on conversion therein, assuming the exercise in full of the Rights
on the date of issuance of the Rights and assuming the VWAP of the Successor Shares for each Trading Day in the Rights Measuring Period
is the VWAP on the Trading Day ended immediately prior to the time of consummation of the Change of Control). The Company shall give each
Holder written notice of each Consideration Election at least twenty (20) Trading Days prior to the time of consummation of such Change
of Control. Payment of such amounts or delivery of the Rights, as applicable, shall be made by the Company (or at the Company&rsquo;s
direction) to each Holder on the later of (x) the second (2nd) Trading Day after the date of such request and (y) the date of consummation
of such Change of Control (or, with respect to any Right, if applicable, such later time that holders of shares of Common Stock are initially
entitled to receive Corporate Event Consideration with respect to the shares of Common Stock of such holder). Any Corporate Event Consideration
included in the Rights, if any, pursuant to this Section 6(b) is <I>pari passu</I> with the Corporate Event Consideration to be paid to
holders of shares of Common Stock and the Company shall not permit a payment of any Corporate Event Consideration to the holders of shares
of Common Stock without on or prior to such time delivering the Right to the Holders in accordance herewith. Cash payments, if any, required
by this Section 6(b) shall have priority to payments to all other stockholders of the Company in connection with such Change of Control.
Notwithstanding anything to the contrary in this Section 6(b), but subject to Section 4(d), until the applicable Change of Control Election
Price is paid in full to the applicable Holder in cash or Corporate Event Consideration in accordance herewith, the Preferred Shares submitted
by such Holder for exchange or payment, as applicable, under this Section 6(b) may be converted, in whole or in part, by such Holder into
Common Stock pursuant to Section 4 or in the event the Conversion Date is after the consummation of such Change of Control, stock or equity
interests of the Successor Entity substantially equivalent to the Company&rsquo;s shares of Common Stock pursuant to Section 6. In the
event of the Company&rsquo;s repayment or exchange, as applicable, of any of the Preferred Shares under this Section 6(b), such Holder&rsquo;s
damages would be uncertain and difficult to estimate because of the parties&rsquo; inability to predict future interest rates and the
uncertainty of the availability of a suitable substitute investment opportunity for a Holder. Accordingly, any Required Premium due under
this Section 6(b) is intended by the parties to be, and shall be deemed, a reasonable estimate of such Holder&rsquo;s actual loss of its
investment opportunity and not as a penalty. Notwithstanding anything herein to the contrary, in connection with any redemption hereunder
at a time a Holder is entitled to receive a cash payment under any of the other Transaction Documents, at the option of such Holder delivered
in writing to the Company, the applicable redemption price hereunder shall be increased by the amount of such cash payment owed to such
Holder under such other Transaction Document and, upon payment in full or conversion in accordance herewith, shall satisfy the Company&rsquo;s
payment obligation under such other Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&nbsp;<U>Rights
Upon Issuance of Purchase Rights and Other Corporate Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Purchase
Rights</U>. In addition to any adjustments pursuant to Section 8 and Section 15 below, if at any time the Company grants, issues or sells
any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to all or substantially
all of the record holders of any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then each Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such
Holder had held the number of shares of Common Stock acquirable upon complete conversion of all the Preferred Shares (without taking into
account any limitations or restrictions on the convertibility of the Preferred Shares and assuming for such purpose that all the Preferred
Shares were converted at the Alternate Conversion Price as of the applicable record date) held by such Holder immediately prior to the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of
which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights; provided,
however, to the extent that such Holder&rsquo;s right to participate in any such Purchase Right would result in such Holder and the other
Attribution Parties exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Purchase Right to
such extent of the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of
such Purchase Right (and beneficial ownership) to such extent of any such excess) and such Purchase Right to such extent shall be held
in abeyance (and, if such Purchase Right has an expiration date, maturity date or other similar provision, such term shall be extended
by such number of days held in abeyance, if applicable) for the benefit of such Holder until such time or times, if ever, as its right
thereto would not result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times such
Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent
Purchase Right held similarly in abeyance (and, if such Purchase Right has an expiration date, maturity date or other similar provision,
such term shall be extended by such number of days held in abeyance, if applicable)) to the same extent as if there had been no such limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Other
Corporate Events</U>. In addition to and not in substitution for any other rights hereunder, prior to the consummation of any Fundamental
Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to or
in exchange for shares of Common Stock (a &ldquo;<B>Corporate Event</B>&rdquo;), the Company shall make appropriate provision to ensure
that each Holder will thereafter have the right, at such Holder&rsquo;s option, to receive upon a conversion of all the Preferred Shares
held by such Holder (i) such securities or other assets (the &ldquo;<B>Corporate Event Consideration</B>&rdquo;) to which such Holder
would have been entitled with respect to such shares of Common Stock had such shares of Common Stock been held by such Holder upon the
consummation of such Corporate Event (without taking into account any limitations or restrictions on the convertibility of the Preferred
Shares set forth in this Certificate of Designations) or (ii) in lieu of the shares of Common Stock otherwise receivable upon such conversion,
such securities or other assets received by the holders of shares of Common Stock in connection with the consummation of such Corporate
Event in such amounts as such Holder would have been entitled to receive had the Preferred Shares held by such Holder initially been issued
with conversion rights for the form of such consideration (as opposed to shares of Common Stock) at a conversion rate for such consideration
commensurate with the Conversion Rate of an Alternate Conversion. Provision made pursuant the preceding sentence shall be in a form and
substance satisfactory to the Required Holders. The provisions of this Section 7 shall apply similarly and equally to successive Corporate
Events and shall be applied without regard to any limitations on the conversion or redemption of the Preferred Shares set forth in this
Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&nbsp;<U>Rights
Upon Issuance of Other Securities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Adjustment
of Conversion Price upon Issuance of Common Stock</U>. If and whenever on or after the Subscription Date the Company grants, issues or
sells (or enters into any agreement to grant, issue or sell), or in accordance with this Section 8(a) is deemed to have granted, issued
or sold, any shares of Common Stock (including the granting, issuance or sale of shares of Common Stock owned or held by or for the account
of the Company, but excluding any Excluded Securities granted, issued or sold or deemed to have been granted, issued or sold) for a consideration
per share (the &ldquo;<B>New Issuance Price</B>&rdquo;) less than a price equal to the Conversion Price in effect immediately prior to
such granting, issuance or sale or deemed granting, issuance or sale (such Conversion Price then in effect is referred to herein as the
&ldquo;<B>Applicable Price</B>&rdquo;) (the foregoing a &ldquo;<B>Dilutive Issuance</B>&rdquo;), then, immediately after such Dilutive
Issuance, the Conversion Price then in effect shall be reduced to an amount equal to the New Issuance Price. For all purposes of the foregoing
(including, without limitation, determining the adjusted Conversion Price and the New Issuance Price under this Section 8(a)), the following
shall be applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Issuance
of Options</U>. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell) any Options
and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or upon
conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the
terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued
and sold by the Company at the time of the granting, issuance or sale of such Option for such price per share. For purposes of this Section
8(a)(i), the &ldquo;lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option
or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant
to the terms thereof&rdquo; shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or
receivable by the Company with respect to any one share of Common Stock upon the granting, issuance or sale of such Option, upon exercise
of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option or otherwise
pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option for which one share of Common Stock is issuable
(or may become issuable assuming all possible market conditions) upon the exercise of any such Options or upon conversion, exercise or
exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof, minus (2)
the sum of all amounts paid or payable to the holder of such Option (or any other Person) with respect to any one share of Common Stock
upon the granting, issuance or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible
Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof plus the value of any other consideration (including,
without limitation, consideration consisting of cash, debt forgiveness, assets or any other property) received or receivable by, or benefit
conferred on, the holder of such Option (or any other Person). Except as contemplated below, no further adjustment of the Conversion Price
shall be made upon the actual issuance of such share of Common Stock or of such Convertible Securities upon the exercise of such Options
or otherwise pursuant to the terms thereof or upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange
of such Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Issuance
of Convertible Securities</U>. If the Company in any manner issues or sells (or enters into any agreement to issue or sell) any Convertible
Securities and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise or
exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be
deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale (or the time of execution
of such agreement to issue or sell, as applicable) of such Convertible Securities for such price per share. For the purposes of this Section
8(a)(ii), the &ldquo;lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise
or exchange thereof or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1) the lower of (x) the sum of the lowest amounts
of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon the issuance or sale (or
pursuant to the agreement to issue or sell, as applicable) of the Convertible Security and upon conversion, exercise or exchange of such
Convertible Security or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth in such Convertible Security
for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion, exercise
or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder of such
Convertible Security (or any other Person) with respect to any one share of Common Stock upon the issuance or sale (or the agreement to
issue or sell, as applicable) of such Convertible Security plus the value of any other consideration received or receivable (including,
without limitation, any consideration consisting of cash, debt forgiveness, assets or other property) by, or benefit conferred on, the
holder of such Convertible Security (or any other Person). Except as contemplated below, no further adjustment of the Conversion Price
shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities
or otherwise pursuant to the terms thereof, and if any such issuance or sale of such Convertible Securities is made upon exercise of any
Options for which adjustment of the Conversion Price has been or is to be made pursuant to other provisions of this Section 8(a), except
as contemplated below, no further adjustment of the Conversion Price shall be made by reason of such issuance or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;<U>Change
in Option Price or Rate of Conversion</U>. If the purchase or exercise price provided for in any Options, the additional consideration,
if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities
are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases at any time (other than proportional
changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section 8(b) below), the Conversion
Price in effect at the time of such increase or decrease shall be adjusted to the Conversion Price which would have been in effect at
such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration
or increased or decreased conversion rate (as the case may be) at the time initially granted, issued or sold. For purposes of this Section
8(a)(iii), if the terms of any Option or Convertible Security (including, without limitation, any Option or Convertible Security that
was outstanding as of the Subscription Date) are increased or decreased in the manner described in the immediately preceding sentence,
then such Option or Convertible Security and the shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof
shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 8(a) shall be
made if such adjustment would result in an increase of the Conversion Price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;<U>Calculation
of Consideration Received</U>. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection with the issuance
or sale or deemed issuance or sale of any other securities of the Company (as determined by the Required Holders, the &ldquo;<B>Primary
Security</B>&rdquo;, and such Option and/or Convertible Security and/or Adjustment Right, the &ldquo;<B>Secondary Securities</B>&rdquo;),
together comprising one integrated transaction (or one or more transactions if such issuances or sales or deemed issuances or sales of
securities of the Company either (A) have at least one investor or purchaser in common, (B) are consummated in reasonable proximity to
each other and/or (C) are consummated under the same plan of financing), the aggregate consideration per share of Common Stock with respect
to such Primary Security shall be deemed to be equal to the difference of (x) the lowest price per share for which one share of Common
Stock was issued (or was deemed to be issued pursuant to Section 8(a)(i) or 8(a)(ii) above, as applicable) in such integrated transaction
solely with respect to such Primary Security, minus (y) with respect to such Secondary Securities, the sum of (I) the Black Scholes Consideration
Value of each such Option, if any, (II) the fair market value (as determined by the Required Holders in good faith) or the Black Scholes
Consideration Value, as applicable, of such Adjustment Right, if any, and (III) the fair market value (as determined by the Required Holders)
of such Convertible Security, if any, in each case, as determined on a per share basis in accordance with this Section 8(a)(iv). If any
shares of Common Stock, Options or Convertible Securities are issued or sold or deemed to have been issued or sold for cash, the consideration
received therefor (for the purpose of determining the consideration paid for such Common Stock, Option or Convertible Security, but not
for the purpose of the calculation of the Black Scholes Consideration Value) will be deemed to be the net amount of consideration received
by the Company therefor. If any shares of Common Stock, Options or Convertible Securities are issued or sold for a consideration other
than cash, the amount of such consideration received by the Company (for the purpose of determining the consideration paid for such Common
Stock, Option or Convertible Security, but not for the purpose of the calculation of the Black Scholes Consideration Value) will be the
fair value of such consideration, except where such consideration consists of publicly traded securities, in which case the amount of
consideration received by the Company for such securities will be the arithmetic average of the VWAPs of such security for each of the
five (5) Trading Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Convertible Securities are
issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount
of consideration therefor (for the purpose of determining the consideration paid for such Common Stock, Option or Convertible Security,
but not for the purpose of the calculation of the Black Scholes Consideration Value) will be deemed to be the fair value of such portion
of the net assets and business of the non-surviving entity as is attributable to such shares of Common Stock, Options or Convertible Securities
(as the case may be). The fair value of any consideration other than cash or publicly traded securities will be determined jointly by
the Company and the Required Holders. If such parties are unable to reach agreement within ten (10) days after the occurrence of an event
requiring valuation (the &ldquo;<B>Valuation Event</B>&rdquo;), the fair value of such consideration will be determined within five (5)
Trading Days after the tenth (10<SUP>th</SUP>) day following such Valuation Event by an independent, reputable appraiser jointly selected
by the Company and the Required Holders. The determination of such appraiser shall be final and binding upon all parties absent manifest
error and the fees and expenses of such appraiser shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Record
Date</U>. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A) to receive a dividend
or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase shares
of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale of the
shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution
or the date of the granting of such right of subscription or purchase (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Adjustment
of Conversion Price upon Subdivision or Combination of Common Stock</U>. Without limiting any provision of Section 7 or Section 15, if
the Company at any time on or after the Subscription Date subdivides (by any stock split, stock dividend, stock combination, recapitalization
or other similar transaction) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Conversion
Price in effect immediately prior to such subdivision will be proportionately reduced. Without limiting any provision of Section 7 or
Section 15, if the Company at any time on or after the Subscription Date combines (by any stock split, stock dividend, stock combination,
recapitalization or other similar transaction) one or more classes of its outstanding shares of Common Stock into a smaller number of
shares, the Conversion Price in effect immediately prior to such combination will be proportionately increased. Any adjustment pursuant
to this Section 8(b) shall become effective immediately after the effective date of such subdivision or combination. If any event requiring
an adjustment under this Section 8(b) occurs during the period that a Conversion Price is calculated hereunder, then the calculation of
such Conversion Price shall be adjusted appropriately to reflect such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Holder&rsquo;s
Right of Adjusted Conversion Price</U>. In addition to and not in limitation of the other provisions of this Section 8(c), <FONT STYLE="font-weight: normal">if
the Company</FONT> in any manner issues or sells or enters into any agreement to issue or sell, any Common Stock, Options or Convertible
Securities (other than with respect to a Permitted Equity Line (as defined in the Securities Purchase Agreement)) (any such securities,
&ldquo;<B>Variable Price Securities</B>&rdquo;) after the Subscription Date that are issuable pursuant to such agreement or convertible
into or exchangeable or exercisable for shares of Common Stock at a price which varies or may vary with the market price of the shares
of Common Stock, including by way of one or more reset(s) to a fixed price, but exclusive of such formulations reflecting share splits,
share combinations and share dividends (each of the formulations for such variable price being herein referred to as, the &ldquo;<B>Variable
Price</B>&rdquo;), the Company shall provide written notice thereof via electronic mail and overnight courier to each Holder on the date
of such agreement and/or the issuance of such shares of Common Stock, Convertible Securities or Options, as applicable. From and after
the date the Company enters into such agreement or issues any such Variable Price Securities, each Holder shall have the right, but not
the obligation, in its sole discretion to substitute the Variable Price for the Conversion Price upon conversion of the Preferred Shares
by designating in the Conversion Notice delivered upon any conversion of Preferred Shares that solely for purposes of such conversion
such Holder is relying on the Variable Price rather than the Conversion Price then in effect. A Holder&rsquo;s election to rely on a Variable
Price for a particular conversion of Preferred Shares shall not obligate such Holder to rely on a Variable Price for any future conversions
of Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Stock
Combination Event Adjustments</U>. If at any time and from time to time on or after the Subscription Date there occurs any stock split,
stock dividend, stock combination recapitalization or other similar transaction involving the Common Stock (each, a &ldquo;<B>Stock Combination
Event</B>&rdquo;, and such date thereof, the &ldquo;<B>Stock Combination Event Date</B>&rdquo;) and the Event Market Price is less than
the Conversion Price then in effect (after giving effect to the adjustment in Section 8(b) above), then on the sixteenth (16th) Trading
Day immediately following such Stock Combination Event Date (each, a &ldquo;<B>Stock Combination Adjustment Date</B>&rdquo;), the Conversion
Price then in effect on such sixteenth (16th) Trading Day (after giving effect to the adjustment in Section 8(b) above) shall be reduced
(but in no event increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in the immediately preceding sentence
would otherwise result in an increase in the Conversion Price hereunder, no adjustment shall be made. Notwithstanding the foregoing, if
a Holder requests to convert any Preferred Shares in whole or in part on any given date during a Stock Combination Measuring Period, solely
with respect to such Preferred Shares being converted on such applicable Conversion Date, (a) such applicable Stock Combination Adjustment
Date shall be deemed to mean such Conversion Date, (b) such applicable Stock Combination Measuring Period shall be deemed to have ended
on the Trading Day immediately prior to such Conversion Date and (c) the applicable Event Market Price for such converted Preferred Shares
shall be calculated pursuant to this Section 8(d). For the avoidance of doubt, following the calculation of the Event Market Price pursuant
to this Section 8(d), the Company&rsquo;s obligations with regard to such con-verted Preferred Shares shall be deemed satisfied and no
additional Event Market Price shall apply to such converted Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Other
Events</U>. In the event that the Company (or any Subsidiary) shall take any action to which the provisions hereof are not strictly applicable,
or, if applicable, would not operate to protect any Holder from dilution or if any event occurs of the type con-templated by the provisions
of this Section 8 but not expressly provided for by such pro-visions (including, without limitation, the granting of stock appreciation
rights, phantom stock rights or other rights with equity features), then the Board shall in good faith determine and implement an appropriate
adjustment in the Conversion Price so as to protect the rights of such Holder, provided that no such adjustment pursuant to this Section
8(e) will increase the Conversion Price as otherwise determined pursuant to this Section 8, provided further that if such Holder does
not accept such adjustments as appropriately protecting its interests hereunder against such dilution, then the Board and such Holder
shall agree, in good faith, upon an independent investment bank of nationally recognized standing to make such appropriate adjustments,
whose determination shall be final and binding absent manifest error and whose fees and expenses shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Calculations</U>.
All calculations under this Section 8 shall be made by rounding to the nearest cent or the nearest 1/100th of a share, as applicable.
The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the
Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Voluntary
Adjustment by Company</U>. Subject to the rules and regulations of the Principal Market, the Company may at any time any Preferred Shares
remain outstanding, with the prior written consent of the Required Holders, reduce the then current Conversion Price to any amount and
for any period of time deemed appropriate by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Exchange
Right</U>. Notwithstanding anything herein to the contrary, if the Company or any of its Subsidiaries consummates any Subsequent Placement
(other than with respect to Excluded Securities), and a Holder elects in writing to the Company to participate in such Subsequent Placement,
each such Holder may, at the option of such Holder as elected in writing to the Company, exchange all, or any part, of the Preferred Shares
of such Holder into the securities in such Subsequent Placement (with the aggregate amount of such securities to be issued in such exchange
equal to such aggregate amount of such securities with a purchase price valued at 120% of the Conversion Amount of the Preferred Shares
delivered by such Holder in exchange therefor).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Conversion
Floor Price</U>. Prior to the Stockholder Approval Date, no adjustment pursuant to this Section 8 shall cause the Conversion Price to
be less than $3.8576 (as adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction occurring
after the date of the Securities Purchase Agreement) (the &ldquo;<B>Conversion Floor Price</B>&rdquo;). As of the Stockholder Approval
Date, any Dilutive Issuances or other events that would have resulted in an adjustment to the Conversion Price prior to the Stockholder
Approval Date, but for the application of this Section 8(i), shall adjust the Conversion Price hereunder as if such Dilutive Issuances
and/or other events, as applicable, occurred on the Stockholder Approval Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&nbsp;<U>Redemption
at the Company&rsquo;s Election</U>. At any time, the Company shall have the right to redeem all, or any part pro rata based on the number
of the Preferred Shares then held by the Holders, of the Preferred Shares then outstanding (the &ldquo;<B>Company Optional Redemption
Amount</B>&rdquo;) on the Company Optional Redemption Date (as defined below) (a &ldquo;<B>Company Optional Redemption</B>&rdquo;). The
Preferred Shares subject to redemption pursuant to this Section 9 shall be redeemed by the Company in cash at a price (the &ldquo;<B>Company
Optional Redemption Price</B>&rdquo;) equal to 125% of the greater of (i) the Conversion Amount being redeemed as of the Company Optional
Redemption Date and (ii) the product of (1) the Conversion Rate with respect to the Conversion Amount being redeemed as of the Company
Optional Redemption Date multiplied by (2) the greatest Closing Sale Price of the Common Stock on any Trading Day during the period commencing
on the date immediately preceding such Company Optional Redemption Notice Date (as defined below) and ending on the Trading Day immediately
prior to the date the Company makes the entire payment required to be made under this Section 9. The Company may exercise its right to
require redemption under this Section 9 by delivering a written notice thereof by electronic mail and overnight courier to all, but not
less than all, of the Holders (the &ldquo;<B>Company Optional Redemption Notice</B>&rdquo; and the date all of the Holders received such
notice is referred to as the &ldquo;<B>Company Optional Redemption Notice Date</B>&rdquo;). Such Company Optional Redemption Notice shall
be irrevocable; provided that the Company Optional Redemption Notice may be conditioned upon the consummation of a refinancing transaction
or a Going Private Transaction. The Company Optional Redemption Notice shall (x) state the date on which the Company Optional Redemption
shall occur (the &ldquo;<B>Company Optional Redemption Date</B>&rdquo;) which date shall not be less than ten (10) Trading Days nor more
than twenty (20) Trading Days following the Company Optional Redemption Notice Date, and (y) state the aggregate Conversion Amount of
the Preferred Shares which is being redeemed in such Company Optional Redemption from such Holder and all of the other Holders of the
Preferred Shares pursuant to this Section 9 on the Company Optional Redemption Date. The Company shall deliver the applicable Company
Optional Redemption Price to each Holder in cash on the applicable Company Optional Redemption Date. Notwithstanding anything herein to
the contrary, at any time prior to the date the Company Optional Redemption Price is paid, in full, the Company Optional Redemption Amount
may be converted, in whole or in part, by any Holder into shares of Common Stock pursuant to Section 4. All Conversion Amounts converted
by a Holder after the Company Optional Redemption Notice Date shall reduce the Company Optional Redemption Amount of the Preferred Shares
of such Holder required to be redeemed on the Company Optional Redemption Date. In the event of the Company&rsquo;s redemption of any
of the Preferred Shares under this Section 9, a Holder&rsquo;s damages would be uncertain and difficult to estimate because of the parties&rsquo;
inability to predict future interest rates and the uncertainty of the availability of a suitable substitute investment opportunity for
such Holder. Accordingly, any redemption premium due under this Section 9 is intended by the parties to be, and shall be deemed, a reasonable
estimate of such Holder&rsquo;s actual loss of its investment opportunity and not as a penalty. For the avoidance of doubt, the Company
shall have no right to effect a Company Optional Redemption if any Triggering Event has occurred and continuing, but any Triggering Event
shall have no effect upon any Holder&rsquo;s right to convert Preferred Shares in its discretion. Notwithstanding the foregoing, with
respect to a Going Private Transaction, the Company may effect a Company Optional Redemption under this Section 9, but with &ldquo;Change
of Control Election Price&rdquo; replacing &ldquo;Company Optional Redemption Price&rdquo; for all purposes in this Section 9 in connection
therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&nbsp;<U>Noncircumvention</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws (as defined
below) or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of
securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Certificate
of Designations, and will at all times in good faith carry out all the provisions of this Certificate of Designations and take all action
as may be required to protect the rights of the Holders hereunder. Without limiting the generality of the foregoing or any other provision
of this Certificate of Designations or the other Transaction Documents, the Company (a) shall not increase the par value of any shares
of Common Stock receivable upon the conversion of any Preferred Shares above the Conversion Price then in effect, (b) shall take all such
actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable shares
of Common Stock upon the conversion of Preferred Shares and (c) shall, so long as any Preferred Shares are outstanding, take all action
necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting
the conversion of the Preferred Shares, the maximum number of shares of Common Stock as shall from time to time be necessary to effect
the conversion of the Preferred Shares then outstanding (without regard to any limitations on conversion contained herein). Notwithstanding
anything herein to the contrary, if after the sixty (60) calendar day anniversary of the Initial Issuance Date, each Holder is not permitted
to convert such Holder&rsquo;s Preferred Shares in full for any reason (other than pursuant to restrictions set forth in Section 4(d)
hereof), the Company shall use its best efforts to promptly remedy such failure, including, without limitation, obtaining such consents
or approvals as necessary to effect such conversion into shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&nbsp;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Reservation</U>.
So long as any Preferred Shares remain outstanding, the Company shall at all times reserve at least 150% of the number of shares of Common
Stock as shall from time to time be necessary to effect the conversion, including without limitation, Alternate Conversions, of all of
the Preferred Shares then outstanding at the Alternate Conversion Price then in effect (without regard to any limitations on conversions)
(the &ldquo;<B>Required Reserve Amount</B>&rdquo;). The Required Reserve Amount (including, without limitation, each increase in the number
of shares so reserved) shall be allocated pro rata among the Holders based on the number of the Preferred Shares held by each Holder on
the Initial Issuance Date or increase in the number of reserved shares, as the case may be (the &ldquo;<B>Authorized Share Allocation</B>&rdquo;).
In the event that a Holder shall sell or otherwise transfer any of such Holder&rsquo;s Preferred Shares, each transferee shall be allocated
a pro rata portion of such Holder&rsquo;s Authorized Share Allocation. Any shares of Common Stock reserved and allocated to any Person
which ceases to hold any Preferred Shares shall be allocated to the remaining Holders of Preferred Shares, pro rata based on the number
of the Preferred Shares then held by the Holders. Notwithstanding the foregoing, a Holder may allocate its Authorized Share Allocation
to any other of the securities of the Company held by such Holder (or any of its designees) by delivery of a written notice to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Insufficient
Authorized Shares</U>. If, notwithstanding Section 11 (a) and not in limitation thereof, at any time while any of the Preferred Shares
remain outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation
to reserve for issuance upon conversion of the Preferred Shares at least a number of shares of Common Stock equal to the Required Reserve
Amount (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company shall immediately take all action necessary to increase the
Company&rsquo;s authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount
for the Preferred Shares then outstanding. Without limiting the generality of the foregoing sentence, as soon as practicable after the
date of the occurrence of an Authorized Share Failure, but in no event later than ninety (90) days after the occurrence of such Authorized
Share Failure, the Company shall hold a meeting of its stockholders for the approval of an increase in the number of authorized shares
of Common Stock. In connection with such meeting, the Company shall provide each stockholder with a proxy statement and shall use its
best efforts to solicit its stockholders&rsquo; approval of such increase in authorized shares of Common Stock and to cause its board
of directors to recommend to the stockholders that they approve such proposal (or, if a majority of the voting power then in effect of
the capital stock of the Company consents to such increase, in lieu of such proxy statement, deliver to the stockholders of the Company
an information statement that has been filed with (and either approved by or not subject to comments from) the SEC with respect thereto).
Notwithstanding the foregoing, if at any such time of an Authorized Share Failure, the Company is able to obtain the written consent of
a majority of the shares of its issued and outstanding shares of Common Stock to approve the increase in the number of authorized shares
of Common Stock, the Company may satisfy this obligation by obtaining such consent and submitting for filing with the SEC an Information
Statement on Schedule 14C. In the event that the Company is prohibited from issuing shares of Common Stock to a Holder upon any conversion
due to the failure by the Company to have sufficient shares of Common Stock available out of the authorized but unissued shares of Common
Stock (such unavailable number of shares of Common Stock, the &ldquo;<B>Authorized Failure Shares</B>&rdquo;), in lieu of delivering such
Authorized Failure Shares to such Holder, the Company shall pay cash in exchange for the redemption of such portion of the Conversion
Amount of the Preferred Shares convertible into such Authorized Failure Shares at a price equal to the sum of (i) the product of (x) such
number of Authorized Failure Shares and (y) the greatest Closing Sale Price of the Common Stock on any Trading Day during the period commencing
on the date such Holder delivers the applicable Conversion Notice with respect to such Authorized Failure Shares to the Company and ending
on the date of such issuance and payment under this Section 11(b); and (ii) to the extent such Holder purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Holder of Authorized Failure Shares, any brokerage commissions
and other out-of-pocket expenses, if any, of such Holder incurred in connection therewith. Nothing contained in Section 11(a) or this
Section 11(b) shall limit any obligations of the Company under any provision of the Securities Purchase Agreement or Registration Rights
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&nbsp;<U>Voting
Rights</U>. The holders of the Preferred Shares shall have no voting rights, except as required by law (including without limitation,
the DGCL) and as expressly provided in this Certificate of Designations. To the extent that under the DGCL the vote of the holders of
the Preferred Shares, voting separately as a class or series, as applicable, is required to authorize a given action of the Company, the
affirmative vote or consent of the Required Holders of the Preferred Shares, voting together in the aggregate and not in separate series
unless required under the DGCL, represented at a duly held meeting at which a quorum is presented or by written consent of the Required
Holders (except as otherwise may be required under the DGCL), voting together in the aggregate and not in separate series unless required
under the DGCL, shall constitute the approval of such action by both the class or the series, as applicable. Subject to Section 4(d),
to the extent that under the DGCL holders of the Preferred Shares are entitled to vote on a matter with holders of shares of Common Stock,
voting together as one class, each Preferred Share shall entitle the holder thereof to cast that number of votes per share as is equal
to the number of shares of Common Stock into which it is then convertible (subject to the ownership limitations specified in Section 4(d)
hereof) using the record date for determining the stockholders of the Company eligible to vote on such matters as the date as of which
the Conversion Price is calculated. Holders of the Preferred Shares shall be entitled to written notice of all stockholder meetings or
written consents (and copies of proxy materials and other information sent to stockholders) with respect to which they would be entitled
to vote, which notice would be provided pursuant to the Company&rsquo;s bylaws (the &ldquo;<B>Bylaws</B>&rdquo;) and the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&nbsp;<U>Covenants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Incurrence
of Indebtedness</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, incur
or guarantee, assume or suffer to exist any Indebtedness (other than Permitted Indebtedness).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Existence
of Liens</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, allow or suffer
to exist any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property or assets (including accounts
and contract rights) owned by the Company or any of its Subsidiaries (collectively, &ldquo;<B>Liens</B>&rdquo;) other than Permitted Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Restricted
Payments and Investments</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,
redeem, defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in whole or in part,
whether by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any Indebtedness (other
than pursuant to this Certificate of Designations) whether by way of payment in respect of principal of (or premium, if any) or interest
on, such Indebtedness or make any Investment, as applicable, if at the time such payment with respect to such Indebtedness and/or Investment,
as applicable, is due or is otherwise made or, after giving effect to such payment, (i) an event constituting a Triggering Event has occurred
and is continuing or (ii) an event that with the passage of time and without being cured would constitute a Triggering Event has occurred
and is continuing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Restriction
on Redemption and Cash Dividends</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or
indirectly, redeem, repurchase or declare or pay any cash dividend or distribution on any of its capital stock (other than as required
by this Certificate of Designations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Restriction
on Transfer of Assets</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,
sell, lease, license, assign, transfer, spin-off, split-off, close, convey or otherwise dispose of any assets or rights of the Company
or any Subsidiary owned or hereafter acquired whether in a single transaction or a series of related transactions, other than (i) sales,
leases, licenses, assignments, transfers, conveyances and other dispositions of such assets or rights by the Company and its Subsidiaries
in the ordinary course of business consistent with its past practice and (ii) sales of inventory and product in the ordinary course of
business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Change
in Nature of Business</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,
engage in any material line of business substantially different from those lines of business conducted by or publicly contemplated to
be conducted by the Company and each of its Subsidiaries on the Subscription Date or any business substantially related or incidental
thereto. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, modify its or their
corporate structure or purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Preservation
of Existence, Etc</U>. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, its existence,
rights and privileges, and become or remain, and cause each of its Subsidiaries to become or remain, duly qualified and in good standing
in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction of its business makes
such qualification necessary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Maintenance
of Properties, Etc</U>. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, all of its
properties which are necessary or useful in the proper conduct of its business in good working order and condition, ordinary wear and
tear excepted, and comply, and cause each of its Subsidiaries to comply, at all times with the provisions of all leases to which it is
a party as lessee or under which it occupies property, so as to prevent any loss or forfeiture thereof or thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Maintenance
of Intellectual Property</U>. The Company will, and will cause each of its Subsidiaries to, take all action necessary or advisable to
maintain all of the Intellectual Property Rights of the Company and/or any of its Subsidiaries that are necessary or material to the conduct
of its business in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Maintenance
of Insurance</U>. The Company shall maintain, and cause each of its Subsidiaries to maintain, insurance with responsible and reputable
insurance companies or associations (including, without limitation, comprehensive general liability, hazard, rent and business interruption
insurance) with respect to its properties (including all real properties leased or owned by it) and business, in such amounts and covering
such risks as is required by any Governmental Authority having jurisdiction with respect thereto or as is carried generally in accordance
with sound business practice by companies in similar businesses similarly situated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Transactions
with Affiliates</U>. The Company shall not, nor shall it permit any of its Subsidiaries to, enter into, renew, extend or be a party to,
any transaction or series of related transactions (including, without limitation, the purchase, sale, lease, transfer or exchange of property
or assets of any kind or the rendering of services of any kind) with any affiliate, except transactions in the ordinary course of business
in a manner and to an extent consistent with past practice and necessary or desirable for the prudent operation of its business, for fair
consideration and on terms no less favorable to it or its Subsidiaries than would be obtainable in a comparable arm&rsquo;s length transaction
with a Person that is not an affiliate thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Restricted
Issuances</U>. The Company shall not, directly or indirectly, without the prior written consent of the Required Holders, (i) issue any
Preferred Shares (other than as contemplated by the Securities Purchase Agreement and this Certificate of Designations), or (ii) issue
any other securities that would cause a breach or default under this Certificate of Designations or the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Stay,
Extension and Usury Laws</U>. To the extent that it may lawfully do so, the Company (A) agrees that it will not at any time insist upon,
plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law (wherever or whenever enacted
or in force) that may affect the covenants or the performance of this Certificate of Designations; and (B) expressly waives all benefits
or advantages of any such law and agrees that it will not, by resort to any such law, hinder, delay or impede the execution of any power
granted to the Holders by this Certificate of Designations, but will suffer and permit the execution of every such power as though no
such law has been enacted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Taxes</U>.
The Company and its Subsidiaries shall pay when due all taxes, fees or other charges of any nature whatsoever (together with any related
interest or penalties) now or hereafter imposed or assessed against the Company and its Subsidiaries or their respective assets or upon
their ownership, possession, use, operation or disposition thereof or upon their rents, receipts or earnings arising therefrom (except
where the failure to pay would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries).
The Company and its Subsidiaries shall file on or before the due date therefor all personal property tax returns (except where the failure
to file would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries). Notwithstanding
the foregoing, the Company and its Subsidiaries may contest, in good faith and by appropriate proceedings, taxes for which they maintain
adequate reserves therefor in accordance with GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>PCAOB
Registered Auditor</U>. At all times any Preferred Shares remain outstanding, the Company shall have engaged an independent auditor to
audit its financial statements that is registered with (and in compliance with the rules and regulations of) the Public Company Accounting
Oversight Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Independent
Investigation</U>. At the request of the Required Holders either (x) at any time when a Triggering Event has occurred and is continuing,
(y) upon the occurrence of an event that with the passage of time or giving of notice would constitute a Triggering Event or (z) at any
time such Required Holders reasonably believe a Triggering Event may have occurred or be continuing, the Company shall hire an independent,
reputable investment bank selected by the Company and approved by such Holder (such approval not to be unreasonably withheld, conditioned
or delayed) to investigate as to whether any breach of this Certificate of Designations has occurred (the &ldquo;<B>Independent Investigator</B>&rdquo;).
If the Independent Investigator determines that such breach of this Certificate of Designations has occurred, the Independent Investigator
shall notify the Company of such breach and the Company shall deliver written notice to each Holder of such breach. In connection with
such investigation, the Independent Investigator may, during normal business hours, inspect all contracts, books, records, personnel,
offices and other facilities and properties of the Company and its Subsidiaries and, to the extent available to the Company after the
Company uses reasonable efforts to obtain them, the records of its legal advisors and accountants and any books of account, records, reports
and other papers not contractually required of the Company to be confidential or secret, or subject to attorney-client or other evidentiary
privilege, and the Independent Investigator may make such copies and inspections thereof as the Independent Investigator may reasonably
request. The Company shall furnish the Independent Investigator with such financial and operating data and other information with respect
to the business and properties of the Company as the Independent Investigator may reasonably request. The Company shall permit the Independent
Investigator to discuss the affairs, finances and accounts of the Company with, and to make proposals and furnish advice with respect
thereto to, the Company&rsquo;s officers, directors, key employees and independent public accountants or any of them (and by this provision
the Company authorizes said accountants to discuss with such Independent Investigator the finances and affairs of the Company and any
Subsidiaries), all at such reasonable times, upon reasonable notice, and as often as may be reasonably requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.&nbsp;<U>Liquidation,
Dissolution, Winding-Up</U>. In the event of a Liquidation Event, the Holders shall be entitled to receive in cash out of the assets of
the Company, whether from capital or from earnings available for distribution to its stockholders (the &ldquo;<B>Liquidation Funds</B>&rdquo;),
before any amount shall be paid to the holders of any of shares of Junior Stock, but pari passu with any Parity Stock then outstanding,
an amount per Preferred Share equal to the sum of (i) the Black Scholes Value (as defined in the Warrants) with respect to the outstanding
portion of all Warrants held by such Holder (without regard to any limitations on the exercise thereof) as of the date of such event and
(ii) the greater of (A) 125% of the Conversion Amount of such Preferred Share on the date of such payment and (B) the amount per share
such Holder would receive if such Holder converted such Preferred Share into Common Stock immediately prior to the date of such payment,
provided that if the Liquidation Funds are insufficient to pay the full amount due to the Holders and holders of shares of Parity Stock,
then each Holder and each holder of Parity Stock shall receive a percentage of the Liquidation Funds equal to the full amount of Liquidation
Funds payable to such Holder and such holder of Parity Stock as a liquidation preference, in accordance with their respective certificate
of designations (or equivalent), as a percentage of the full amount of Liquidation Funds payable to all holders of Preferred Shares and
all holders of shares of Parity Stock. To the extent necessary, the Company shall cause such actions to be taken by each of its Subsidiaries
so as to enable, to the maximum extent permitted by law, the proceeds of a Liquidation Event to be distributed to the Holders in accordance
with this Section 14. All the preferential amounts to be paid to the Holders under this Section 14 shall be paid or set apart for payment
before the payment or setting apart for payment of any amount for, or the distribution of any Liquidation Funds of the Company to the
holders of shares of Junior Stock in connection with a Liquidation Event as to which this Section 14 applies. Upon payment in full of
the Black Scholes Value (as defined in the Warrants) of such Warrants pursuant to this Section 14, such Warrants shall be deemed repurchased
by the Company and no longer exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&nbsp;<U>Distribution
of Assets</U>. In addition to any adjustments pursuant to Section 7 and Section 8, if the Company shall declare or make any dividend or
other distributions of its assets (or rights to acquire its assets) to any or all holders of shares of Common Stock, by way of return
of capital or otherwise (including without limitation, any distribution of cash, stock or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (the &ldquo;<B>Distributions</B>&rdquo;),
then each Holder, as holders of Preferred Shares, will be entitled to such Distributions as if such Holder had held the number of shares
of Common Stock acquirable upon complete conversion of the Preferred Shares (without taking into account any limitations or restrictions
on the convertibility of the Preferred Shares and assuming for such purpose that the Preferred Share was converted at the Alternate Conversion
Price as of the applicable record date) immediately prior to the date on which a record is taken for such Distribution or, if no such
record is taken, the date as of which the record holders of Common Stock are to be determined for such Distributions (<U>provided</U>,
<U>however</U>, that to the extent that such Holder&rsquo;s right to participate in any such Distribution would result in such Holder
and the other Attribution Parties exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Distribution
to such extent of the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result
of such Distribution (and beneficial ownership) to such extent of any such excess) and the portion of such Distribution shall be held
in abeyance for the benefit of such Holder until such time or times as its right thereto would not result in such Holder and the other
Attribution Parties exceeding the Maximum Percentage, at which time or times, if any, such Holder shall be granted such Distribution (and
any Distributions declared or made on such initial Distribution or on any subsequent Distribution held similarly in abeyance) to the same
extent as if there had been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.&nbsp;<U>Vote
to Change the Terms of or Issue Preferred Shares</U>. In addition to any other rights provided by law, except where the vote or written
consent of the holders of a greater number of shares is required by law or by another provision of the Certificate of Incorporation, without
first obtaining the affirmative vote at a meeting duly called for such purpose or the written consent without a meeting of the Required
Holders, voting together as a single class, the Company shall not: (a) amend or repeal any provision of, or add any provision to, its
Certificate of Incorporation or Bylaws, or file any certificate of designations or articles of amendment of any series of shares of preferred
stock, if such action would adversely alter or change in any respect the preferences, rights, privileges or powers, or restrictions provided
for the benefit of the Preferred Shares hereunder, regardless of whether any such action shall be by means of amendment to the Certificate
of Incorporation or by merger, consolidation or otherwise; (b) increase or decrease (other than by conversion) the authorized number of
shares of Series E Convertible Preferred Stock; (c) without limiting any provision of Section 2, create or authorize (by reclassification
or otherwise) any new class or series of Senior Preferred Stock or Parity Stock; (d) purchase, repurchase or redeem any shares of Junior
Stock (other than pursuant to the terms of the Company&rsquo;s equity incentive plans and options and other equity awards granted under
such plans (that have in good faith been approved by the Board)); (e) without limiting any provision of Section 2, pay dividends or make
any other distribution on any shares of any Junior Stock; (f) issue any Preferred Shares other than as contemplated hereby or pursuant
to the Securities Purchase Agreement; or (g) without limiting any provision of Section 10, whether or not prohibited by the terms of the
Preferred Shares, circumvent a right of the Preferred Shares hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.&nbsp;<U>Transfer
of Preferred Shares</U>. A Holder may offer, sell or transfer some or all of its Preferred Shares without the consent of the Company subject
only to the provisions of Section 5 of the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18.&nbsp;<U>Reissuance
of Preferred Share Certificates and Book Entries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Transfer</U>.
If any Preferred Shares are to be transferred, the applicable Holder shall surrender the applicable Preferred Share Certificate to the
Company (or, if the Preferred Shares are held in Book-Entry form, a written instruction letter to the Company), whereupon the Company
will forthwith issue and deliver upon the order of such Holder a new Preferred Share Certificate (in accordance with Section 18(d)) (or
evidence of the transfer of such Book-Entry), registered as such Holder may request, representing the outstanding number of Preferred
Shares being transferred by such Holder and, if less than the entire outstanding number of Preferred Shares is being transferred, a new
Preferred Share Certificate (in accordance with Section 18(d)) to such Holder representing the outstanding number of Preferred Shares
not being transferred (or evidence of such remaining Preferred Shares in a Book-Entry for such Holder). Such Holder and any assignee,
by acceptance of the Preferred Share Certificate or evidence of Book-Entry issuance, as applicable, acknowledge and agree that, by reason
of the provisions of Section 4(c)(i) following conversion or redemption of any of the Preferred Shares, the outstanding number of Preferred
Shares represented by the Preferred Shares may be less than the number of Preferred Shares stated on the face of the Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Lost,
Stolen or Mutilated Preferred Share Certificate</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of
the loss, theft, destruction or mutilation of a Preferred Share Certificate (as to which a written certification and the indemnification
contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking
by the applicable Holder to the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation
of such Preferred Share Certificate, the Company shall execute and deliver to such Holder a new Preferred Share Certificate (in accordance
with Section 18(d)) representing the applicable outstanding number of Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Preferred
Share Certificate and Book-Entries Exchangeable for Different Denominations and Forms</U>. Each Preferred Share Certificate is exchangeable,
upon the surrender hereof by the applicable Holder at the principal office of the Company, for a new Preferred Share Certificate or Preferred
Share Certificate(s) or new Book-Entry (in accordance with Section 18(d)) representing, in the aggregate, the outstanding number of the
Preferred Shares in the original Preferred Share Certificate, and each such new Preferred Share Certificate and/or new Book-Entry, as
applicable, will represent such portion of such outstanding number of Preferred Shares from the original Preferred Share Certificate as
is designated in writing by such Holder at the time of such surrender. Each Book-Entry may be exchanged into one or more new Preferred
Share Certificates or split by the applicable Holder by delivery of a written notice to the Company into two or more new Book-Entries
(in accordance with Section 18(d)) representing, in the aggregate, the outstanding number of the Preferred Shares in the original Book-Entry,
and each such new Book-Entry and/or new Preferred Share Certificate, as applicable, will represent such portion of such outstanding number
of Preferred Shares from the original Book-Entry as is designated in writing by such Holder at the time of such surrender.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Issuance
of New Preferred Share Certificate or Book-Entry</U>. Whenever the Company is required to issue a new Preferred Share Certificate or a
new Book-Entry pursuant to the terms of this Certificate of Designations, such new Preferred Share Certificate or new Book-Entry (i) shall
represent, as indicated on the face of such Preferred Share Certificate or in such Book-Entry, as applicable, the number of Preferred
Shares remaining outstanding (or in the case of a new Preferred Share Certificate or new Book-Entry being issued pursuant to Section 18(a)
or Section 18(c), the number of Preferred Shares designated by such Holder) which, when added to the number of Preferred Shares represented
by the other new Preferred Share Certificates or other new Book-Entry, as applicable, issued in connection with such issuance, does not
exceed the number of Preferred Shares remaining outstanding under the original Preferred Share Certificate or original Book-Entry, as
applicable, immediately prior to such issuance of new Preferred Share Certificate or new Book-Entry, as applicable, and (ii) shall have
an issuance date, as indicated on the face of such new Preferred Share Certificate or in such new Book-Entry, as applicable, which is
the same as the issuance date of the original Preferred Share Certificate or in such original Book-Entry, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19.&nbsp;<U>Remedies,
Characterizations, Other Obligations, Breaches and Injunctive Relief. </U>The remedies provided in this Certificate of Designations shall
be cumulative and in addition to all other remedies available under this Certificate of Designations and any of the other Transaction
Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit
any Holder&rsquo;s right to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Certificate
of Designations. No failure on the part of a Holder to exercise, and no delay in exercising, any right, power or remedy hereunder shall
operate as a waiver thereof; nor shall any single or partial exercise by such Holder of any right, power or remedy preclude any other
or further exercise thereof or the exercise of any other right, power or remedy. In addition, the exercise of any right or remedy of a
Holder at law or equity or under this Certificate of Designations or any of the documents shall not be deemed to be an election of such
Holder&rsquo;s rights or remedies under such documents or at law or equity. The Company covenants to each Holder that there shall be no
characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect
to payments, conversion and the like (and the computation thereof) shall be the amounts to be received by a Holder and shall not, except
as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). No failure on the part of
a Holder to exercise, and no delay in exercising, any right, power or remedy hereunder shall operate as a waiver thereof; nor shall any
single or partial exercise by such Holder of any right, power or remedy preclude any other or further exercise thereof or the exercise
of any other right, power or remedy. In addition, the exercise of any right or remedy of any Holder at law or equity or under Preferred
Shares or any of the documents shall not be deemed to be an election of such Holder&rsquo;s rights or remedies under such documents or
at law or equity. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holders
and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or
threatened breach, each Holder shall be entitled, in addition to all other available remedies, to specific performance and/or temporary,
preliminary and permanent injunctive or other equitable relief from any court of competent jurisdiction in any such case without the necessity
of proving actual damages and without posting a bond or other security. The Company shall provide all information and documentation to
a Holder that is requested by such Holder to enable such Holder to confirm the Company&rsquo;s compliance with the terms and conditions
of this Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">20.&nbsp;<U>Payment
of Collection, Enforcement and Other Costs</U>. If (a) any Preferred Shares are placed in the hands of an attorney for collection or enforcement
or is collected or enforced through any legal proceeding or a Holder otherwise takes action to collect amounts due under this Certificate
of Designations with respect to the Preferred Shares or to enforce the provisions of this Certificate of Designations or (b) there occurs
any bankruptcy, reorganization, receivership of the Company or other proceedings affecting Company creditors&rsquo; rights and involving
a claim under this Certificate of Designations, then the Company shall pay the costs reasonably incurred by such Holder for such collection,
enforcement or action or in connection with such bankruptcy, reorganization, receivership or other proceeding, including, without limitation,
attorneys&rsquo; fees and disbursements. The Company expressly acknowledges and agrees that no amounts due under this Certificate of Designations
with respect to any Preferred Shares shall be affected, or limited, by the fact that the purchase price paid for each Preferred Share
was less than the original Stated Value thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">21.&nbsp;<U>Construction;
Headings</U>. This Certificate of Designations shall be deemed to be jointly drafted by the Company and the Holders and shall not be construed
against any such Person as the drafter hereof. The headings of this Certificate of Designations are for convenience of reference and shall
not form part of, or affect the interpretation of, this Certificate of Designations. Unless the context clearly indicates otherwise, each
pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms &ldquo;including,&rdquo;
&ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall be construed broadly as if followed by the words &ldquo;without
limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo; &ldquo;hereof&rdquo; and words of like import refer to this
entire Certificate of Designations instead of just the provision in which they are found. Unless expressly indicated otherwise, all section
references are to sections of this Certificate of Designations. Terms used in this Certificate of Designations and not otherwise defined
herein, but defined in the other Transaction Documents, shall have the meanings ascribed to such terms on the Initial Issuance Date in
such other Transaction Documents unless otherwise consented to in writing by the Required Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">22.&nbsp;<U>Failure
or Indulgence Not Waiver</U>. No failure or delay on the part of a Holder in the exercise of any power, right or privilege hereunder shall
operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further
exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it is in writing and signed by an authorized
representative of the waiving party. This Certificate of Designations shall be deemed to be jointly drafted by the Company and all Holders
and shall not be construed against any Person as the drafter hereof. Notwithstanding the foregoing, nothing contained in this Section
22 shall permit any waiver of any provision of Section 4(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">23.&nbsp;<U>Dispute
Resolution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Submission
to Dispute Resolution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) &nbsp;In
the case of a dispute relating to a Closing Bid Price, a Closing Sale Price, a Conversion Price, an Alternate Conversion Price, a VWAP
or a fair market value or the arithmetic calculation of a Conversion Rate, or the applicable redemption price (as the case may be) (including,
without limitation, a dispute relating to the determination of any of the foregoing), the Company or the applicable Holder (as the case
may be) shall submit the dispute to the other party via electronic mail (A) if by the Company, within two (2) Business Days after the
occurrence of the circumstances giving rise to such dispute or (B) if by such Holder at any time after such Holder learned of the circumstances
giving rise to such dispute. If such Holder and the Company are unable to promptly resolve such dispute relating to such Closing Bid Price,
such Closing Sale Price, such Conversion Price, such Alternate Conversion Price, such VWAP or such fair market value, or the arithmetic
calculation of such Conversion Rate or such applicable redemption price (as the case may be), at any time after the second (2<SUP>nd</SUP>)
Business Day following such initial notice by the Company or such Holder (as the case may be) of such dispute to the Company or such Holder
(as the case may be), then such Holder may, with the consent of the Company (not to be unreasonably withheld, conditioned or delayed),
select an independent, reputable investment bank to resolve such dispute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) Such Holder and
the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in accordance with the
first sentence of this Section 23 and (B) written documentation supporting its position with respect to such dispute, in each case, no
later than 5:00 p.m. (New York time) by the fifth (5<SUP>th</SUP>) Business Day immediately following the date on which such Holder selected
such investment bank (the &ldquo;<B>Dispute Submission Deadline</B>&rdquo;) (the documents referred to in the immediately preceding clauses
(A) and (B) are collectively referred to herein as the &ldquo;<B>Required Dispute Documentation</B>&rdquo;) (it being understood and agreed
that if either such Holder or the Company fails to so deliver all of the Required Dispute Documentation by the Dispute Submission Deadline,
then the party who fails to so submit all of the Required Dispute Documentation shall no longer be entitled to (and hereby waives its
right to) deliver or submit any written documentation or other support to such investment bank with respect to such dispute and such investment
bank shall resolve such dispute based solely on the Required Dispute Documentation that was delivered to such investment bank prior to
the Dispute Submission Deadline). Unless otherwise agreed to in writing by both the Company and such Holder or otherwise requested by
such investment bank, neither the Company nor such Holder shall be entitled to deliver or submit any written documentation or other support
to such investment bank in connection with such dispute (other than the Required Dispute Documentation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) The Company
and such Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company and such Holder of
such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees and expenses of such
investment bank shall be borne by the party in whose favor the investment bank decides such dispute or, in the event that the investment
bank determines that the applicable calculation is in between the amounts submitted by the Company and such Holder, then half of such
fees and expenses shall be borne by the Company and half of such fees and expenses shall be borne by the Holder, and such investment bank&rsquo;s
resolution of such dispute shall be final and binding upon all parties absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Miscellaneous</U>.
The Company expressly acknowledges and agrees that (i) this Section 23 constitutes an agreement to arbitrate between the Company and each
Holder (and constitutes an arbitration agreement) under the rules then in effect under Delaware Rapid Arbitration Act, as amended, (ii)
the terms of this Certificate of Designations and each other applicable Transaction Document shall serve as the basis for the selected
investment bank&rsquo;s resolution of the applicable dispute, such investment bank shall be entitled (and is hereby expressly authorized)
to make all findings, determinations and the like that such investment bank determines are required to be made by such investment bank
in connection with its resolution of such dispute and in resolving such dispute such investment bank shall apply such findings, determinations
and the like to the terms of this Certificate of Designations and any other applicable Transaction Documents, (iii) the applicable Holder
(and only such Holder with respect to disputes solely relating to such Holder), in its sole discretion, shall have the right to submit
any dispute described in this Section 23 to any state or federal court sitting in Wilmington Delaware, in lieu of utilizing the procedures
set forth in this Section 23 and (iv) nothing in this Section 23 shall limit such Holder from obtaining any injunctive relief or other
equitable remedies (including, without limitation, with respect to any matters described in this Section 23).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">24.&nbsp;<U>Notices;
Currency; Payments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Notices</U>.
The Company shall provide each Holder of Preferred Shares with prompt written notice of all actions taken pursuant to the terms of this
Certificate of Designations, including in reasonable detail a description of such action and the reason therefor. Whenever notice is required
to be given under this Certificate of Designations, unless otherwise provided herein, such notice must be in writing and shall be given
in accordance with Section 9(f) of the Securities Purchase Agreement. The Company shall provide each Holder with prompt written notice
of all actions taken pursuant to this Certificate of Designations, including in reasonable detail a description of such action and the
reason therefore. Without limiting the generality of the foregoing, the Company shall give written notice to each Holder (i) immediately
upon any adjustment of the Conversion Price, setting forth in reasonable detail, and certifying, the calculation of such adjustment and
(ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend
or distribution upon the Common Stock, (B) with respect to any grant, issuances, or sales of any Options, Convertible Securities or rights
to purchase stock, warrants, securities or other property to holders of shares of Common Stock or (C) for determining rights to vote with
respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall be made known to
the public prior to or in conjunction with such notice being provided to such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Currency</U>.
All dollar amounts referred to in this Certificate of Designations are in United States Dollars (&ldquo;<B>U.S. Dollars</B>&rdquo;), and
all amounts owing under this Certificate of Designations shall be paid in U.S. Dollars. All amounts denominated in other currencies (if
any) shall be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate (as defined below) on the date of
calculation. &ldquo;<B>Exchange Rate</B>&rdquo; means, in relation to any amount of currency to be converted into U.S. Dollars pursuant
to this Certificate of Designations, the U.S. Dollar exchange rate as published in the Wall Street Journal on the relevant date of calculation
(it being understood and agreed that where an amount is calculated with reference to, or over, a period of time, the date of calculation
shall be the final date of such period of time).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Payments</U>.
Whenever any payment of cash is to be made by the Company to any Person pursuant to this Certificate of Designations, unless otherwise
expressly set forth herein, such payment shall be made in lawful money of the United States of America by wire transfer of immediately
available funds pursuant to wire transfer instructions that Holder shall provide to the Company in writing from time to time. Whenever
any amount expressed to be due by the terms of this Certificate of Designations is due on any day which is not a Business Day, the same
shall instead be due on the next succeeding day which is a Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">25.&nbsp;<U>Waiver
of Notice</U>. To the extent permitted by law, the Company hereby irrevocably waives demand, notice, presentment, protest and all other
demands and notices in connection with the delivery, acceptance, performance, default or enforcement of this Certificate of Designations
and the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">26.&nbsp;<U>Governing
Law</U>. This Certificate of Designations shall be construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Certificate of Designations shall be governed by, the internal laws of the State of Delaware,
without giving effect to any provision of law or rule (whether of the State of Delaware or any other jurisdictions) that would cause the
application of the laws of any jurisdictions other than the State of Delaware. Except as otherwise required by Section 23 above, the Company
hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in Wilmington, Delaware, for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein
(i) shall be deemed or operate to preclude any Holder from bringing suit or taking other legal action against the Company in any other
jurisdiction to collect on the Company&rsquo;s obligations to such Holder, to realize on any collateral or any other security for such
obligations, or to enforce a judgment or other court ruling in favor of such Holder or (ii) shall limit, or shall be deemed or construed
to limit, any provision of Section 23 above. <B>THE COMPANY AND EACH HOLDER HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES
NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS CERTIFICATE OF
DESIGNATIONS OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">27.&nbsp;<U>Judgment
Currency</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;If
for the purpose of obtaining or enforcing judgment against the Company in any court in any jurisdiction it becomes necessary to convert
into any other currency (such other currency being hereinafter in this Section 27 referred to as the &ldquo;<B>Judgment Currency</B>&rdquo;)
an amount due in U.S. Dollars under this Certificate of Designations, the conversion shall be made at the Exchange Rate prevailing on
the Trading Day immediately preceding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;the
date actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction
that will give effect to such conversion being made on such date: or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;the
date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of which
such conversion is made pursuant to this Section 27(a)(ii) being hereinafter referred to as the &ldquo;<B>Judgment Conversion Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;If
in the case of any proceeding in the court of any jurisdiction referred to in Section 27(a)(ii) above, there is a change in the Exchange
Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable party shall pay
such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange Rate
prevailing on the date of payment, will produce the amount of US dollars which could have been purchased with the amount of Judgment Currency
stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;Any
amount due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained
for any other amounts due under or in respect of this Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">28.&nbsp;<U>Taxes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;All
payments made by the Company hereunder or under any other Transaction Document shall be made in accordance with the terms of the respective
Transaction Document and shall be made without set-off, counterclaim, withholding, deduction or other defense. Without limiting the foregoing,
all such payments shall be made free and clear of and without deduction or withholding for any present or future taxes, levies, imposts,
deductions, charges or withholdings, and all liabilities with respect thereto, excluding (i) taxes imposed on the net income of a Holder
by the jurisdiction in which such Holder is organized or where it has its principal lending office, (ii) with respect to any payments
made by the Company hereunder, taxes (including, but not limited to, backup withholding) to the extent such taxes are imposed due to the
failure of the applicable recipient of such payment to provide the Company with whichever (if any) is applicable of valid and properly
completed and executed IRS Forms W-9, W-8BEN, W-8BEN-E, W-8ECI, and/or W-8IMY, when requested in writing by the Company, and (iii) with
respect to any payments made by the Company, taxes to the extent such taxes are imposed due to the failure of the applicable recipient
of such payment to comply with FATCA (all such nonexcluded taxes, levies, imposts, deductions, charges, withholdings and liabilities,
collectively or individually, &ldquo;<B>Taxes</B>&rdquo;). If the Company shall be required to deduct or to withhold any Taxes from or
in respect of any amount payable hereunder or under any other Transaction Document:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;the
amount so payable shall be increased to the extent necessary so that after making all required deductions and withholdings (including
Taxes on amounts payable to a Holder pursuant to this sentence) such Holder receives an amount equal to the sum it would have received
had no such deduction or withholding been made,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;the
Company shall make such deduction or withholding,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;the
Company shall pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable law, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;as
promptly as possible thereafter, the Company shall send such Holder an official receipt (or, if an official receipt is not available,
such other documentation as shall be satisfactory to such Holder, as the case may be) showing payment. In addition, the Company agrees
to pay any present or future stamp or documentary taxes or any other excise or property taxes, charges or similar levies that arise from
any payment made hereunder or from the execution, delivery, registration or enforcement of, or otherwise with respect to, this Preferred
Shares or any other Transaction Document (collectively, &ldquo;<B>Other Taxes</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;The
Company hereby indemnifies and agrees to hold each Holder and each of their affiliates and their respective officers, directors, employees,
agents and advisors (each, an &ldquo;<B>Indemnified Party</B>&rdquo;) each Indemnified Party harmless from and against Taxes or Other
Taxes (including, without limitation, any Taxes or Other Taxes imposed by any jurisdiction on amounts payable under this Section 28) paid
by any Indemnified Party as a result of any payment made hereunder or from the execution, delivery, registration or enforcement of, or
otherwise with respect to, this Preferred Shares or any other Transaction Document, and any liability (including penalties, interest and
expenses for nonpayment, late payment or otherwise) arising therefrom or with respect thereto, whether or not such Taxes or Other Taxes
were correctly or legally asserted. This indemnification shall be paid within thirty (30) days from the date on which such Holder makes
written demand therefor, which demand shall identify the nature and amount of such Taxes or Other Taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;If
the Company fails to perform any of its obligations under this Section 28, the Company shall indemnify such Holder for any taxes, interest
or penalties that may become payable as a result of any such failure. The obligations of the Company under this Section 28 shall survive
the repayment and/or conversion, as applicable, in full of the Preferred Shares and all other amounts payable with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;If
any Indemnified Party determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which
it has been indemnified pursuant to this Section 28 (including by the payment of additional amounts pursuant to this Section 28), it shall
pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this Section 28
with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including taxes) of such Indemnified Party and
without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund). Such indemnifying
party, upon the request of such Indemnified Party, shall repay to such Indemnified Party the amount paid over pursuant to this paragraph
(d) (plus any penalties, interest, or other charges imposed by the relevant Governmental Authority) in the event that such Indemnified
Party is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this paragraph (d),
in no event will the Indemnified Party be required to pay any amount to an indemnifying party pursuant to this paragraph (d) the payment
of which would place the Indemnified Party in a less favorable net after-Tax position than the Indemnified Party would have been in if
the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification
payments or additional amounts with respect to such Tax had never been paid. This paragraph (d) shall not be construed to require any
Indemnified Party to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to the
indemnifying party or any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">29.&nbsp;<U>Severability</U>.
If any provision of this Certificate of Designations is prohibited by law or otherwise determined to be invalid or unenforceable by a
court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to
apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not
affect the validity of the remaining provisions of this Certificate of Designations so long as this Certificate of Designations as so
modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the
prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations
or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties.
The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s),
the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">30.&nbsp;<U>Maximum
Payments</U>. Without limiting Section 9(d) of the Securities Purchase Agreement, nothing contained herein shall be deemed to establish
or require the payment of a rate of interest or other charges in excess of the maximum permitted by applicable law. In the event that
the rate of interest required to be paid or other charges hereunder exceed the maximum permitted by such law, any payments in excess of
such maximum shall be credited against amounts owed by the Company to the applicable Holder and thus refunded to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">31.&nbsp;<U>Stockholder
Matters; Amendment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Stockholder
Matters</U>. Any stockholder action, approval or consent required, desired or otherwise sought by the Company pursuant to the DGCL, the
Certificate of Incorporation, this Certificate of Designations or otherwise with respect to the issuance of Preferred Shares may be effected
by written consent of the Company&rsquo;s stockholders or at a duly called meeting of the Company&rsquo;s stockholders, all in accordance
with the applicable rules and regulations of the DGCL. This provision is intended to comply with the applicable sections of the DGCL permitting
stockholder action, approval and consent affected by written consent in lieu of a meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Amendment</U>.
Except for Section 4(d) and this Section 31(b), which may not be amended, modified or waived hereunder, this Certificate of Designations
or any provision hereof may be amended by obtaining the affirmative vote at a meeting duly called for such purpose, or written consent
without a meeting in accordance with the DGCL, of the Required Holders, voting separate as a single class, and with such other stockholder
approval, if any, as may then be required pursuant to the DGCL and the Certificate of Incorporation. <FONT STYLE="background-color: white">Except
(a)&nbsp;to the extent otherwise expressly provided in this Certificate of Designations or the Certificate of Incorporation with respect
to voting or approval rights of a particular class or series of capital stock or (b)&nbsp;to the extent otherwise provided pursuant to
the DGCL, the holders of each outstanding class or series of shares of the Company shall not be entitled to vote as a separate voting
group on any amendment to the terms of this Certificate of Designations with respect to which such class or series would otherwise be
entitled under the DGCL&nbsp;to vote as a separate voting group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="background-color: white"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">32.&nbsp;<U>Certain
Defined Terms</U>. For purposes of this Certificate of Designations, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;&ldquo;<B>1933
Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;
&ldquo;<B>1934 Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;&ldquo;<B>Additional
Amount</B>&rdquo; means, as of the applicable date of determination, with respect to each Preferred Share, all declared and unpaid Dividends
on such Preferred Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;&ldquo;<B>Adjusted
Floor Price</B>&rdquo; means, as determined on each six month anniversary of the Initial Issuance Date (each, an &ldquo;<B>Floor Adjustment
Date</B>&rdquo;), the lower of (i) the Floor Price then in effect and (ii) 20% of the lower of (x) the Nasdaq closing price of the Common
Stock as of the Trading Day ended immediately prior to such applicable Floor Adjustment Date and (y) the quotient of (I) the sum of each
Nasdaq closing price of the Common Stock on each Trading Day of the five (5) Trading Day period ended on, and including, the Trading Day
ended immediately prior to such applicable Floor Adjustment Date, divided by (II) five (5). All such determinations to be appropriately
adjusted for any stock split, stock dividend, stock combination or other similar transaction during any such measuring period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;&ldquo;<B>Adjustment
Right</B>&rdquo; means any right granted with respect to any securities issued in connection with, or with respect to, any issuance or
sale (or deemed issuance or sale in accordance with Section 8(a)) of shares of Common Stock (other than rights of the type described in
Section 7(a) hereof) that could result in a decrease in the net consideration received by the Company in connection with, or with respect
to, such securities (including, without limitation, any cash settlement rights, cash adjustment or other similar rights).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;&ldquo;<B>Affiliate</B>&rdquo;
or &ldquo;<B>Affiliated</B>&rdquo; means, with respect to any Person, any other Person that directly or indirectly controls, is controlled
by, or is under common control with, such Person, it being understood for purposes of this definition that &ldquo;control&rdquo; of a
Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of
directors of such Person or direct or cause the direction of the management and policies of such Person whether by contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;&ldquo;<B>Alternate
Conversion Floor Amount</B>&rdquo; means an amount equal to the product obtained by multiplying (A) the higher of (I) the highest price
that the Common Stock trades at on the Trading Day immediately preceding the relevant Alternate Conversion Date and (II) the applicable
Alternate Conversion Price and (B) the difference obtained by subtracting (I) the number of shares of Common Stock delivered (or to be
delivered) to such Holder on the applicable Share Delivery Deadline with respect to such Alternate Conversion from (II) the quotient obtained
by dividing (x) the applicable Conversion Amount that such Holder has elected to be the subject of the applicable Alternate Conversion,
by (y) the applicable Alternate Conversion Price without giving effect to clause (x) of such definition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;&ldquo;<B>Alternate
Conversion Price</B>&rdquo; means, with respect to any Alternate Conversion, the Alternate Optional Conversion Price or the Alternate
Triggering Event Conversion Price, as applicable, with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&ldquo;<B>Alternate
Optional Conversion Price</B>&rdquo; means, with respect to any Alternate Optional Conversion, that price which shall be the lower of
(i) the applicable Conversion Price as in effect on the applicable Conversion Date of the applicable Alternate Optional Conversion, and
(ii) the greater of (x) the Floor Price and (y) 95% of the lowest VWAP of the Common Stock during the five (5) consecutive Trading Day
period ending and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice
(such period, the &ldquo;<B>Alternate Optional Conversion Measuring Period</B>&rdquo;). All such determinations to be appropriately adjusted
for any share dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases
the shares of Common Stock during such Alternate Optional Conversion Measuring Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;&ldquo;<B>Alternate
Triggering Event Conversion Price</B>&rdquo; means, with respect to any Alternate Triggering Event Conversion, that price which shall
be the lower of (i) the applicable Conversion Price as in effect on the applicable Conversion Date of the applicable Alternate Triggering
Event Conversion, and (ii) the greater of (x) the Floor Price and (y) 90% of the lowest VWAP of the Common Stock during the five (5) consecutive
Trading Day period ending and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion
Notice (such period, the &ldquo;<B>Alternate Triggering Event Conversion Measuring Period</B>&rdquo;). All such determinations to be appropriately
adjusted for any stock dividend, stock split, share combination, reclassification or similar transaction that proportionately decreases
or increases the shares of Common Stock during such Alternate Triggering Event Conversion Measuring Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&nbsp;&ldquo;<B>Approved
Stock Plan</B>&rdquo; means any employee benefit plan or agreement which has been approved by the Board prior to or subsequent to the
Subscription Date pursuant to which shares of Common Stock, restricted stock units, and standard options to purchase Common Stock may
be issued to any employee, officer, consultant or director for services provided to the Company in their capacity as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&nbsp;
&ldquo;<B>Attribution Parties</B>&rdquo; means, collectively, the following Persons and entities: (i) any investment vehicle, including,
any funds, feeder funds or managed accounts, currently, or from time to time after the Initial Issuance Date, directly or indirectly managed
or advised by a Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of such
Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with such Holder or any
of the foregoing and (iv) any other Persons whose beneficial ownership of the Company&rsquo;s Common Stock would or could be aggregated
with such Holder&rsquo;s and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of
the foregoing is to subject collectively such Holder and all other Attribution Parties to the Maximum Percentage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&nbsp;&ldquo;<B>Black
Scholes Consideration Value</B>&rdquo; means the value of the applicable Option, Convertible Security or Adjustment Right (as the case
may be) as of the date of issuance thereof calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg utilizing (i) an underlying price per share equal to the Closing Sale Price of the Common Stock on the Trading Day
immediately preceding the public announcement of the execution of definitive documents with respect to the issuance of such Option, Convertible
Security or Adjustment Right (as the case may be), (ii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period
equal to the remaining term of such Option, Convertible Security or Adjustment Right (as the case may be) as of the date of issuance of
such Option, Convertible Security or Adjustment Right (as the case may be), (iii) a zero cost of borrow and (iv) an expected volatility
equal to the greater of 100% and the 100 day volatility obtained from the &ldquo;HVT&rdquo; function on Bloomberg (determined utilizing
a 365 day annualization factor) as of the Trading Day immediately following the date of issuance of such Option, Convertible Security
or Adjustment Right (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)&nbsp;&ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)&nbsp;&ldquo;<B>Book-Entry</B>&rdquo;
means each entry on the Register evidencing one or more Preferred Shares held by a Holder in lieu of a Preferred Share Certificate issuable
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p)&nbsp;&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>, <U>however</U>, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo;&nbsp; or any other similar orders or restrictions or the closure of any physical branch locations
at the direction of any Governmental Authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="background-color: white"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(q)&nbsp;&ldquo;<B>Change
of Control</B>&rdquo; means any Fundamental Transaction other than (i) any merger of the Company or any of its, direct or indirect, wholly-owned
Subsidiaries with or into any of the foregoing Persons, (ii) any reorganization, recapitalization or reclassification of the shares of
Common Stock in which holders of the Company&rsquo;s voting power immediately prior to such reorganization, recapitalization or reclassification
continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and, directly or indirectly,
are, in all material respects, the holders of the voting power of the surviving entity (or entities with the authority or voting power&nbsp;to
elect the members of the board of directors (or their equivalent if other than a corporation) of such entity or entities) after such reorganization,
recapitalization or reclassification, or (iii) pursuant to a migratory merger effected solely for the purpose of changing the jurisdiction
of incorporation of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(r)&nbsp;&ldquo;<B>Change
of Control Election Price</B>&rdquo; means, with respect to any given Change of Control, such price equal to the greatest of (i) the product
of (A) the Required Premium multiplied by (B) the Conversion Amount of the Preferred Shares subject to the applicable election, as applicable,
(ii) the product of (A) the Conversion Amount of the Preferred Shares being redeemed or exchanged, as applicable, multiplied by (B) the
quotient determined by dividing (I) the greatest Closing Sale Price of the shares of Common Stock during the period beginning on the date
immediately preceding the earlier to occur of (1) the consummation of the applicable Change of Control and (2) the public announcement
of such Change of Control and ending on the date such Holder delivers the Change of Control Election Notice by (II) the Alternate Conversion
Price then in effect, and (iii) the product of (A) the Conversion Amount of the Preferred Shares being redeemed multiplied by (B) the
quotient of (I) the aggregate cash consideration and the aggregate cash value of any non-cash consideration per share of Common Stock
to be paid to such holders of the shares of Common Stock upon consummation of such Change of Control (any such non-cash consideration
constituting publicly-traded securities shall be valued at the highest of the Closing Sale Price of such securities as of the Trading
Day immediately prior to the consummation of such Change of Control, the Closing Sale Price of such securities on the Trading Day immediately
following the public announcement of such proposed Change of Control and the Closing Sale Price of such securities on the Trading Day
immediately prior to the public announcement of such proposed Change of Control) divided by (II) the Conversion Price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(s)&nbsp;&ldquo;<B>Closing
Bid Price</B>&rdquo; and &ldquo;<B>Closing Sale Price</B>&rdquo; means, for any security as of any date, the last closing bid price and
last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market
begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade price (as the case may
be) then the last bid price or last trade price, respectively, of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg,
or, if the Principal Market is not the principal securities exchange or trading market for such security, the last closing bid price or
last trade price, respectively, of such security on the principal securities exchange or trading market where such security is listed
or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade price, respectively, of
such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no closing
bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the ask prices,
respectively, of any market makers for such security as reported in The Pink Open Market (or a similar organization or agency succeeding
to its functions of reporting prices). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular
date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price (as the case may be) of such security on such date
shall be the fair market value as mutually determined by the Company and the Required Holders. If the Company and the Required Holders
are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures
in Section 23. All such determinations shall be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations
or other similar transactions during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(t)&nbsp;&ldquo;<B>Closing
Date</B>&rdquo; shall have the meaning set forth in the Securities Purchase Agreement, which date is the date the Company initially issued
the Preferred Shares and the Warrants pursuant to the terms of the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(u)&nbsp;&ldquo;<B>Code</B>&rdquo;
means the Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;&ldquo;<B>Common
Stock</B>&rdquo; means (i)&nbsp;the Company&rsquo;s shares of common stock, $0.00001 par value per share, and (ii) any capital stock into
which such common stock shall have been changed or any share capital resulting from a reclassification of such common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(w)&nbsp;&ldquo;<B>Contingent
Obligation</B>&rdquo; means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect
to any Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such
liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or
discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in
whole or in part) against loss with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)&nbsp;&ldquo;<B>Conversion
Floor Price Condition</B>&rdquo; means that the relevant Alternate Conversion Price is being determined based on clause (x) of such definitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(y)&nbsp;&ldquo;<B>Convertible
Securities</B>&rdquo; means any stock or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares
of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(z)&nbsp;&ldquo;<B>Eligible
Market</B>&rdquo; means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market or the
Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aa)&nbsp;&ldquo;<B>Equity
Conditions</B>&rdquo; means, with respect to an given date of determination: (i) on each day during the period beginning thirty calendar
days prior to such applicable date of determination and ending on and including such applicable date of determination either (x) one or
more Registration Statements filed pursuant to the Registration Rights Agreement shall be effective and the prospectus contained therein
shall be available on such applicable date of determination (with, for the avoidance of doubt, any shares of Common Stock previously sold
pursuant to such prospectus deemed unavailable) for the resale of all shares of Common Stock to be issued in connection with the event
requiring this determination, as applicable, in the event requiring this determination at the Alternate Conversion Price then in effect
(without regard to any limitations on conversion set forth herein) (each, a &ldquo;<B>Required Minimum Securities Amount</B>&rdquo;),
in each case, in accordance with the terms of the Registration Rights Agreement and there shall not have been during such period any Grace
Periods or (y) all Registrable Securities shall be eligible for sale pursuant to Rule 144 without the need for registration under any
applicable federal or state securities laws (in each case, disregarding any limitation on conversion of the Preferred Shares, other issuance
of securities with respect to the Preferred Shares and exercise of the Warrants) and no Current Information Failure (as defined in the
Registration Rights Agreement) exists or is continuing; (ii) on each day during the period beginning thirty calendar days prior to the
applicable date of determination and ending on and including the applicable date of determination (the &ldquo;<B>Equity Conditions Measuring
Period</B>&rdquo;), the Common Stock (including all shares of Common Stock issued or issuable upon conversion of the Preferred Shares
and exercise of the Warrants) is listed or designated for quotation (as applicable) on an Eligible Market and shall not have been suspended
from trading on an Eligible Market (other than suspensions of not more than two (2) days and occurring prior to the applicable date of
determination due to business announcements by the Company) nor shall delisting or suspension by an Eligible Market have been threatened
(with a reasonable prospect of delisting occurring after giving effect to all applicable notice, appeal, compliance and hearing periods)
or reasonably likely to occur or pending as evidenced by (A) a writing by such Eligible Market or (B) the Company falling below the minimum
listing maintenance requirements of the Eligible Market on which the Common Stock is then listed or designated for quotation, as applicable;
(iii) during the Equity Conditions Measuring Period, the Company shall have delivered all shares of Common Stock issuable upon conversion
of the Preferred Shares on a timely basis as set forth in Section 4 hereof and all other shares of capital stock required to be delivered
by the Company on a timely basis as set forth in the other Transaction Documents; (iv) any shares of Common Stock to be issued in connection
with the event requiring determination may be issued in full without violating Section 4(d) hereof; (v) any shares of Common Stock to
be issued in connection with the event requiring determination may be issued in full without violating the rules or regulations of the
Eligible Market on which the Common Stock is then listed or designated for quotation (as applicable); (vi) on each day during the Equity
Conditions Measuring Period, no public announcement of a pending, proposed or intended Fundamental Transaction shall have occurred which
has not been abandoned, terminated or consummated; (vii) the Company shall have no knowledge of any fact that would reasonably be expected
to cause (1) any Registration Statement required to be filed pursuant to the Registration Rights Agreement to not be effective or the
prospectus contained therein to not be available for the resale of the applicable Required Minimum Securities Amount of Registrable Securities
in accordance with the terms of the Registration Rights Agreement or (2) any Registrable Securities to not be eligible for sale pursuant
to Rule 144 without the need for registration under any applicable federal or state securities laws (in each case, disregarding any limitation
on conversion of the Preferred Shares, other issuance of securities with respect to the Preferred Shares and exercise of the Warrants)
and no Current Information Failure exists or is continuing, (viii) none of the Holders shall be in possession of any material, non-public
information provided to any of them by the Company, any of its Subsidiaries or any of their respective affiliates, employees, officers,
representatives, agents or the like; (ix) on each day during the Equity Conditions Measuring Period, the Company otherwise shall have
been in compliance with each, and shall not have breached any representation or warranty in any material respect (other than representations
or warranties subject to Material Adverse Effect or materiality, which may not be breached in any respect) or any covenant or other term
or condition of any Transaction Document, including, without limitation, the Company shall not have failed to timely make any payment
pursuant to any Transaction Document; (x) there shall not have occurred any Volume Failure or Price Failure as of such applicable date
of determination; (xi) on the applicable date of determination (A) no Authorized Share Failure shall exist or be continuing and the applicable
Required Minimum Securities Amount of shares of Common Stock are available under the certificate of incorporation of the Company and reserved
by the Company to be issued pursuant to this Certificate of Designations and the Warrants and (B) all shares of Common Stock to be issued
in connection with the event requiring this determination may be issued in full without resulting in an Authorized Share Failure; (xii)
on each day during the Equity Conditions Measuring Period, there shall not have occurred and there shall not exist a Triggering Event
or an event that with the passage of time or giving of notice would constitute a Triggering Event; (xiii) the shares of Common Stock issuable
pursuant to the event requiring the satisfaction of the Equity Conditions are duly authorized and listed and eligible for trading without
restriction on an Eligible Market or (xiv) the Company shall have obtained the Stockholder Approval (as defined in the Securities Purchase
Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bb)&nbsp;&ldquo;<B>Equity
Conditions Failure</B>&rdquo; means that on any day during the period commencing twenty (20) Trading Days prior to the applicable date
of determination, and including such applicable date of determination, the Equity Conditions have not been satisfied (or waived in writing
by the applicable Holder).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(cc)&nbsp;&ldquo;<B>Event
Market Price</B>&rdquo; means, with respect to any Stock Combination Event Date, the lowest VWAP of the Common Stock on any Trading Day
during the fifteen (15) consecutive Trading Day period ending and including the Trading Day immediately preceding the sixteenth (16th)
Trading Day after such Stock Combination Event Date (such period, the &ldquo;<B>Stock Combination Measuring Period</B>&rdquo;). All such
determinations to be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction
that proportionately decreases or increases the Common Stock during such applicable Stock Combination Measuring Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(dd)&nbsp; &ldquo;<B>Excluded
Securities</B>&rdquo; means (i) shares of Common Stock, restricted stock units or standard options to purchase Common Stock issued to
directors, officers or employees of the Company for services rendered to the Company in their capacity as such pursuant to an Approved
Stock Plan (as defined above), provided that (A) all such issuances (taking into account the shares of Common Stock issuable upon exercise
of such options) after the Subscription Date pursuant to this clause (i) do not, in the aggregate, exceed more than 5% of the Common Stock
issued and outstanding immediately prior to the Subscription Date and (B) the exercise price of any such options is not lowered, none
of such options are amended to increase the number of shares issuable thereunder and none of the terms or conditions of any such options
are otherwise materially changed in any manner that adversely affects any of the Holders; (ii) shares of Common Stock issued upon the
conversion or exercise, as applicable, of Convertible Securities or Options (other than standard options to purchase Common Stock issued
pursuant to an Approved Stock Plan that are covered by clause (i) above) issued prior to the Subscription Date, provided that the conversion
price or exercise price, as applicable, of any such Convertible Securities or Options (other than standard options to purchase Common
Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) is not lowered, none of such Convertible Securities
or Options (other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause
(i) above) are amended to increase the number of shares issuable thereunder and none of the terms or conditions of any such Convertible
Securities or Options (other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered
by clause (i) above) are otherwise materially changed in any manner that adversely affects any of the Holders; (iii) the shares of Common
Stock issuable upon conversion of the Preferred Shares or otherwise pursuant to the terms of this Certificate of Designations; provided,
that the terms of this Certificate of Designations are not amended, modified or changed on or after the Subscription Date (other than
antidilution adjustments pursuant to the terms thereof in effect as of the Subscription Date); (iv) the shares of Common Stock issuable
upon exercise of the Warrants; provided, that the terms of the Warrants are not amended, modified or changed on or after the Subscription
Date (other than antidilution adjustments pursuant to the terms thereof in effect as of the Subscription Date) and (v) shares of Common
Stock issued pursuant to the Permitted Equity Line.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ee)&nbsp;&ldquo;<B>FATCA</B>&rdquo;
means Sections 1471 through 1474 of the Code, as of the date of this Certificate of Designation (or any amended or successor version that
is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations
thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code and any fiscal or regulatory legislation, rules or practices
adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities and implementing such Sections
of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ff)&nbsp;&ldquo;<B>Fiscal
Quarter</B>&rdquo; means each of the fiscal quarters adopted by the Company for financial reporting purposes that correspond to the Company&rsquo;s
fiscal year as of the date hereof that ends on December 31.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(gg)&nbsp; &ldquo;<B>Floor
Price</B>&rdquo; means $0.7715 (or such lower amount as permitted, from time to time, by the Principal Market), subject to adjustment
for stock splits, stock dividends, stock combinations, recapitalizations or other similar events; provided that (a) if on a Floor Adjustment
Date the Floor Price then in effect is higher than the Adjusted Floor Price with respect to such Floor Adjustment Date, on such Floor
Adjustment Date the Floor Price shall automatically lower to such applicable Adjusted Floor Price and (b) the Company may lower the Floor
Price to such price as the Company and the Required Holders may agree, from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hh)&nbsp;&ldquo;<B>Fundamental
Transaction</B>&rdquo; means (A) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise,
in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the surviving corporation) another
Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of
the Company or any of its &ldquo;significant subsidiaries&rdquo; (as defined in Rule 1-02 of Regulation S-X) to one or more Subject Entities,
or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject to or have its Common Stock be subject
to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is accepted by the holders of at least either
(x) 50% of the outstanding shares of Common Stock, (y) 50% of the outstanding shares of Common Stock calculated as if any shares of Common
Stock held by all Subject Entities making or party to, or Affiliated with any Subject Entities making or party to, such purchase, tender
or exchange offer were not outstanding; or (z) such number of shares of Common Stock such that all Subject Entities making or party to,
or Affiliated with any Subject Entity making or party to, such purchase, tender or exchange offer, become collectively the beneficial
owners (as defined in Rule 13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (iv) consummate a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire,
either (x) at least 50% of the outstanding shares of Common Stock, (y) at least 50% of the outstanding shares of Common Stock calculated
as if any shares of Common Stock held by all the Subject Entities making or party to, or Affiliated with any Subject Entity making or
party to, such stock purchase agreement or other business combination were not outstanding; or (z) such number of shares of Common Stock
such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of at least 50%
of the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify its Common Stock, (B) that the Company shall,
directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions, allow any Subject
Entity individually or the Subject Entities in the aggregate to be or become the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3
under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance, tender, tender offer, exchange,
reduction in outstanding shares of Common Stock, merger, consolidation, business combination, reorganization, recapitalization, spin-off,
scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever, of either (x) at least
50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock, (y) at least 50% of the aggregate ordinary
voting power represented by issued and outstanding Common Stock not held by all such Subject Entities as of the date of this Certificate
of Designations calculated as if any shares of Common Stock held by all such Subject Entities were not outstanding, or (z) a percentage
of the aggregate ordinary voting power represented by issued and outstanding shares of Common Stock or other equity securities of the
Company sufficient to allow such Subject Entities to effect a statutory short form merger or other transaction requiring other stockholders
of the Company to surrender their shares of Common Stock without approval of the stockholders of the Company or (C) directly or indirectly,
including through subsidiaries, Affiliates or otherwise, in one or more related transactions, the issuance of or the entering into any
other instrument or transaction structured in a manner to circumvent, or that circumvents, the intent of this definition in which case
this definition shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this definition to
the extent necessary to correct this definition or any portion of this definition which may be defective or inconsistent with the intended
treatment of such instrument or transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&ldquo;<B>GAAP</B>&rdquo;
means United States generally accepted accounting principles, consistently applied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jj)&nbsp;&ldquo;<B>Going
Private Transaction</B>&rdquo; means any Change of Control (i) pursuant to which, the Company (and the Successor Entity, if applicable)
ceases to have any securities registered under the 1934 Act or (ii) that results in the purchase and/or cancellation of all of the Common
Stock of the Company solely for cash (and not in whole, or in part, for any other securities of any Person).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kk)&nbsp;&ldquo;<B>Group</B>&rdquo;
means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5 thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ll)&nbsp;&ldquo;<B>Governmental
Authority</B>&rdquo; means any federal, foreign, state, county, municipal, provincial, or local governmental authority, court, judicial
body, arbitration tribunal, government or self-regulatory organization, commission, tribunal or organization, or any regulatory, administrative,
or other agency, or any political or other subdivision, department, commission, board, bureau, branch, division, ministry, or instrumentality
of any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(mm)&nbsp;&ldquo;<B>Indebtedness</B>&rdquo;
means of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed
as the deferred purchase price of property or services, including, without limitation, &ldquo;capital leases&rdquo; in accordance with
United States generally accepted accounting principles consistently applied for the periods covered thereby (other than trade payables
entered into in the ordinary course of business consistent with past practice), (C) all reimbursement or payment obligations with respect
to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures or similar
instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets or businesses, (E) all
indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case
with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights and remedies of the seller
or bank under such agreement in the event of default are limited to repossession or sale of such property), (F) all monetary obligations
under any leasing or similar arrangement which, in connection with United States generally accepted accounting principles, consistently
applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F)
above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage,
deed of trust, lien, pledge, charge, security interest or other encumbrance of any nature whatsoever in or upon any property or assets
(including accounts and contract rights) with respect to any asset or property owned by any Person, even though the Person which owns
such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in respect
of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(nn)&nbsp;&ldquo;<B>Intellectual
Property Rights</B>&rdquo; means, with respect to the Company and its Subsidiaries, all of their rights or licenses to use all trademarks,
trade names, service marks, service mark registrations, service names, original works of authorship, patents, patent rights, copyrights,
inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications
and registrations therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(oo)&nbsp;&ldquo;<B>Investment</B>&rdquo;
means any beneficial ownership (including stock, partnership or limited liability company interests) of or in any Person, or any loan,
advance or capital contribution to any Person or the acquisition of all, or substantially all, of the assets of another Person or the
purchase of any assets of another Person for greater than the fair market value of such assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(pp)&nbsp;&ldquo;<B>Liquidation
Event</B>&rdquo; means, whether in a single transaction or series of transactions, the voluntary or involuntary liquidation, dissolution
or winding up of the Company or such Subsidiaries the assets of which constitute all or substantially all of the assets of the business
of the Company and its Subsidiaries, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(qq)&nbsp;&ldquo;<B>Market
Price</B>&rdquo; means, with respect to any Adjustment Date, the greater of (x) the Floor Price and (y) the lowest Nasdaq closing price
of the Common Stock on any Trading Day during the five (5) Trading Day period ended on, and including, the Trading Day ended immediately
prior to such applicable Adjustment Date (each, a &ldquo;<B>Market Price Measuring Period</B>&rdquo;). All such determinations to be appropriately
adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases
or increases the Common Stock during such applicable Market Price Measuring Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(rr)&nbsp;&ldquo;<B>Material
Adverse Effect</B>&rdquo; means any material adverse effect on the business, properties, assets, liabilities, operations, results of operations,
condition (financial or otherwise) or prospects of the Company and its Subsidiaries, if any, individually or taken as a whole, or on the
transactions contemplated hereby or on the other Transaction Documents, or by the agreements and instruments to be entered into in connection
therewith or on the authority or ability of the Company to perform its obligations under the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ss)&nbsp;&ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(tt)&nbsp;&ldquo;<B>Parent
Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent
equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent
Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(uu)&nbsp;&ldquo;<B>Permitted
Indebtedness</B>&rdquo; means (i) Indebtedness set forth on Schedule 3(s) to the Securities Purchase Agreement, as in effect as of the
Subscription Date and (ii) Indebtedness secured by Permitted Liens or unsecured but as described in clauses (iv) and (v) of the definition
of Permitted Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vv)&nbsp;&ldquo;<B>Permitted
Liens</B>&rdquo; means (i) any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate proceedings for
which adequate reserves have been established in accordance with GAAP, (ii) any statutory Lien arising in the ordinary course of business
by operation of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation of law, such as
materialmen&rsquo;s liens, mechanics&rsquo; liens and other similar liens, arising in the ordinary course of business with respect to
a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv) Liens (A) upon
or in any equipment acquired or held by the Company or any of its Subsidiaries to secure the purchase price of such equipment or Indebtedness
incurred solely for the purpose of financing the acquisition or lease of such equipment, or (B) existing on such equipment at the time
of its acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon, and the proceeds of
such equipment, in either case, with respect to Indebtedness in an aggregate amount not to exceed $500,000, (v)&nbsp;Liens incurred in
connection with the extension, renewal or refinancing of the Indebtedness secured by Liens of the type described in clause (iv) above,
provided that any extension, renewal or replacement Lien shall be limited to the property encumbered by the existing Lien and the principal
amount of the Indebtedness being extended, renewed or refinanced does not increase and (vi) Liens in favor of customs and revenue authorities
arising as a matter of law to secure payments of custom duties in connection with the importation of goods, and Liens arising from judgments,
decrees or attachments in circumstances not constituting a Triggering Event under Section 5(a)(xi).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ww)&nbsp;&ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xx)&nbsp;<B>&ldquo;Price
Failure</B>&rdquo; means, with respect to a particular date of determination, the VWAP of the Common Stock on any Trading Day during the
twenty (20) Trading Day period ending on the Trading Day immediately preceding such date of determination fails to exceed the Floor Price
(as adjusted for stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions occurring after the
Subscription Date). All such determinations to be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations
or other similar transactions during any such measuring period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(yy)&nbsp;&ldquo;<B>Principal
Market</B>&rdquo; means, as of any time of determination, the principal trading market, if any, in which the shares of Common Stock then
trade.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(zz)&nbsp;&ldquo;<B>Registration
Rights Agreement</B>&rdquo; means that certain registration rights agreement, dated as of the Closing Date, by and among the Company and
the initial holders of the Preferred Shares relating to, among other things, the registration of the resale of the Common Stock issuable
upon conversion of the Preferred Shares or otherwise pursuant to the terms of this Certificate of Designations and exercise of the Warrants,
as may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aaa)&nbsp;&ldquo;<B>Required
Premium</B>&rdquo; means 125%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bbb)&nbsp;&ldquo;<B>SEC</B>&rdquo;
means the United States Securities and Exchange Commission or the successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ccc)&nbsp;&ldquo;<B>Securities
Purchase Agreement</B>&rdquo; means that certain securities purchase agreement by and among the Company and the initial holders of Preferred
Shares, dated as of the Subscription Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ddd)&nbsp;&ldquo;<B>Series
C Preferred Stock</B>&rdquo; means convertible preferred stock of the Company designated as Series C Convertible Preferred Stock, $0.00001
par value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(eee)&nbsp;&ldquo;<B>Series
D Preferred Stock</B>&rdquo; means convertible preferred stock of the Company designated as Series D Convertible Preferred Stock, $0.00001
par value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(fff)&nbsp;&ldquo;<B>Stated
Value</B>&rdquo; shall mean $1,000 per share, subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations,
reclassifications, combinations, subdivisions or other similar events occurring after the Initial Issuance Date with respect to the Preferred
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ggg)&nbsp;&ldquo;<B>Subscription
Date</B>&rdquo; means October 1, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hhh)&nbsp;<B>&ldquo;Subsequent
Placement&rdquo; </B>means any direct, or indirect, issuance, offer, sale, grant of any option or right to purchase, or otherwise disposal
of (or announcement of any issuance, offer, sale, grant of any option or right to purchase or other disposition of) any equity security
or any equity-linked or related security (including, without limitation, any &ldquo;equity security&rdquo; (as that term is defined under
Rule 405 promulgated under the 1933 Act), any Convertible Securities, any debt, any preferred stock or any purchase rights) by the Company
or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;<B>&ldquo;Subject
Entity</B>&rdquo; means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jjj)&nbsp; &ldquo;<B>Subsidiary</B>&rdquo;
shall have the meaning set forth in the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kkk)&nbsp;&ldquo;<B>Successor
Entity</B>&rdquo; means the Person (or, if so elected by the Required Holders, the Parent Entity) formed by, resulting from or surviving
any Fundamental Transaction or the Person (or, if so elected by the Required Holders, the Parent Entity) with which such Fundamental Transaction
shall have been entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(lll)&nbsp;&ldquo;<B>Trading
Day</B>&rdquo; means, as applicable, (x) with respect to all price or trading volume determinations relating to the Common Stock, any
day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for the
Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded, provided that &ldquo;Trading
Day&rdquo; shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours
or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange
or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00
p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the applicable Holder or (y) with respect
to all determinations other than price determinations relating to the Common Stock, any day on which The New York Stock Exchange (or any
successor thereto) is open for trading of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(mmm)&nbsp;&ldquo;<B>Transaction
Documents</B>&rdquo; means the Securities Purchase Agreement, the Registration Rights Agreement, this Certificate of Designations, the
Warrants and each of the other agreements and instruments entered into or delivered by the Company or any of the Holders in connection
with the transactions contemplated by the Securities Purchase Agreement, all as may be amended from time to time in accordance with the
terms thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(nnn)&nbsp;&ldquo;<B>Volume
Failure</B>&rdquo; means, with respect to a particular date of determination, the aggregate daily dollar trading volume (as reported on
Bloomberg) of the Common Stock on the Principal Market on any Trading Day during the twenty (20) Trading Day period ending on the Trading
Day immediately preceding such date of determination, is less than $20,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ooo)&nbsp;&ldquo;<B>VWAP</B>&rdquo;
means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market (or, if the
Principal Market is not the principal trading market for such security, then on the principal securities exchange or securities market
on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time,
as reported by Bloomberg through its &ldquo;VAP&rdquo; function (set to 09:30 start time and 16:00 end time) or, if the foregoing does
not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for
such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg,
or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing
bid price and the lowest closing ask price of any of the market makers for such security as reported in The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be calculated for such security on such date
on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as mutually determined by the Company
and the Required Holders. If the Company and the Required Holders are unable to agree upon the fair market value of such security, then
such dispute shall be resolved in accordance with the procedures in Section 23. All such determinations shall be appropriately adjusted
for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ppp)&nbsp;&ldquo;<B>Warrants</B>&rdquo;
has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include all warrants issued in exchange therefor
or replacement thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(qqq)&nbsp;&ldquo;<B>Warrant
Shares</B>&rdquo; means, collectively, the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">33.&nbsp;<U>Disclosure</U>.
Upon receipt or delivery by the Company of any notice in accordance with the terms of this Certificate of Designations, unless the Company
has in good faith determined that the matters relating to such notice do not constitute material, non-public information relating to the
Company or any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York city time on the Business Day immediately following
such notice delivery date, publicly disclose such material, non-public information on a Current Report on Form 8-K or otherwise. In the
event that the Company believes that a notice contains material, non-public information relating to the Company or any of its Subsidiaries,
the Company so shall indicate to the applicable Holder explicitly in writing in such notice (or promptly (but no later than the next Business
Day) following receipt of notice from such Holder, as applicable), and in the absence of any such written indication in such notice (or
notification from the Company promptly (but no later than the next Business Day) following receipt of notice from such Holder), such Holder
shall be entitled to presume that information contained in the notice does not constitute material, non-public information relating to
the Company or any of its Subsidiaries. Nothing contained in this Section 33 shall limit any obligations of the Company, or any rights
of any Holder, under Section 4(i) of the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">34.&nbsp;<U>Absence
of Trading and Disclosure Restrictions</U>. The Company acknowledges and agrees that no Holder is a fiduciary or agent of the Company
and that each Holder shall have no obligation to (a) maintain the confidentiality of any information provided by the Company or (b) refrain
from trading any securities while in possession of such information in the absence of a written non-disclosure agreement signed by an
officer of such Holder that explicitly provides for such confidentiality and trading restrictions. In the absence of such an executed,
written non-disclosure agreement, the Company acknowledges that each Holder may freely trade in any securities issued by the Company,
may possess and use any information provided by the Company in connection with such trading activity, and may disclose any such information
to any third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[The remainder of the page is intentionally left
blank]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Certificate of Designations of the Series E Convertible Preferred Stock of Onconetix, Inc. to be signed by its Interim
Chief Executive Officer on this 1st day of October, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ONCONETIX, INC.</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U STYLE="text-decoration: none">/s/ Karina M. Fedasz</U></I></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD></TD>
    <TD>Name:</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Karina M. Fedasz</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD></TD>
    <TD>Title:</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Interim Chief Executive Officer and</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Interim Chief Financial Officer</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ONCONETIX</B>, <B>INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONVERSION NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is made to the Certificate
of Designations of the Certificate of Incorporation of Onconetix, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;) establishing
the terms, preferences and rights of the Series E Convertible Preferred Stock, $0.00001 par value (the &ldquo;<B>Preferred Shares</B>&rdquo;)
of the Company (the &ldquo;<B>Certificate of Designations</B>&rdquo;). In accordance with and pursuant to the Certificate of Designations,
the undersigned hereby elects to convert the number of Preferred Shares indicated below into shares of common stock, $0.00001 value per
share (the &ldquo;<B>Common Stock</B>&rdquo;), of the Company, as of the date specified below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 0.5in">Date of Conversion:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 0.5in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in">Aggregate number of Preferred Shares to be converted:</P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-indent: 0in; padding-right: 5.4pt; padding-left: 0.875in; text-align: justify">Aggregate Stated Value of such Preferred Shares to be converted:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-indent: 0in; padding-right: 5.4pt; padding-left: 0.875in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 0.875in; text-align: justify">Aggregate accrued and unpaid Dividends with respect to such Preferred Shares to be converted:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 0.875in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 0.5in">AGGREGATE CONVERSION AMOUNT TO BE CONVERTED:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 0.5in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 0.5in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify">Please confirm the following information:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">Conversion Price:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">Number of shares of Common Stock to be issued:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Wingdings 2">&pound;</FONT>&nbsp;If
    this Conversion Notice is being delivered with respect to an Alternate Conversion, check here if Holder is electing to use the following
    Alternate Conversion Price:____________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in; text-align: justify">Please issue the Common Stock into which the applicable
    Preferred Shares are being converted to Holder, or for its benefit, as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#9744;
    &nbsp;Check here if requesting delivery as a certificate to the following name and to the following address:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">Issue to:</TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 1in; text-indent: -1in">&#9744; Check here if requesting delivery by
    Deposit/Withdrawal at Custodian as follows:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 1in; text-indent: -1in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">DTC Participant:</TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">DTC Number:</TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="padding-bottom: 1pt; padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">Account Number:</TD>
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0.5in; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 23%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 17%">&nbsp;</TD>
    <TD STYLE="width: 48%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">Date: _____________ __,________</TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>________________________________</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Name of Registered Holder</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U STYLE="text-decoration: none"></U></I></FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"></TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="font-size: 10pt; width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>Title:</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -18.45pt">Tax ID:_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -18.45pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; text-indent: 0.5in">E-mail Address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 52; Options: NewSection; Value: 52 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACKNOWLEDGMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby (a) acknowledges
this Conversion Notice, (b) certifies that the above indicated number of shares of Common Stock [are][are not] eligible to be resold by
the applicable Holder either (i) pursuant to Rule 144 (subject to such Holder&rsquo;s execution and delivery to the Company of a customary
144 representation letter) or (ii) an effective and available registration statement and (c) hereby directs _________________ to issue
the above indicated number of shares of Common Stock in accordance with the Transfer Agent Instructions dated _____________, 20__ from
the Company and acknowledged and agreed to by ________________________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ONCONETIX, INC.</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U STYLE="text-decoration: none"></U></I></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD></TD>
    <TD>Name:</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD></TD>
    <TD>Title:</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 53; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ea025986001ex4-1_onconetix.htm
<DESCRIPTION>FORM OF WARRANT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>Exhibit 4.1</B></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: normal; text-transform: uppercase">NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO
THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE
144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER
LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. THE NUMBER OF SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY
BE LESS THAN THE AMOUNTS SET FORTH ON THE FACE HEREOF PURSUANT TO SECTION</FONT> <FONT STYLE="font-variant: normal">1(a) <FONT STYLE="text-transform: uppercase">OF
THIS WARRANT.</FONT></FONT></P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Onconetix, Inc.</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Warrant To Purchase Common Stock</P>

<P STYLE="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Warrant No.: WD-[*]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date of Issuance: October 1, 2025 (&ldquo;<B>Issuance
Date</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Onconetix, Inc., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, ______, the registered holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is
entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect,
upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or
replacement hereof, the &ldquo;<B>Warrant</B>&rdquo;), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New
York time, on the Expiration Date (as defined below), ________ (subject to adjustment as provided herein) fully paid and non-assessable
shares of Common Stock (as defined below) (the &ldquo;<B>Warrant Shares</B>&rdquo;, and such number of Warrant Shares, the &ldquo;<B>Warrant
Number</B>&rdquo;). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set forth in Section&nbsp;19.
This Warrant is one of the Warrants to Purchase Common Stock (the &ldquo;<B>SPA Warrants</B>&rdquo;) issued pursuant to Section&nbsp;1
of that certain Securities Purchase Agreement, dated as of October 1, 2025 (the &ldquo;<B>Subscription Date</B>&rdquo;), by and among
the Company and the investors (the &ldquo;<B>Buyers</B>&rdquo;) referred to therein, as amended from time to time (the &ldquo;<B>Securities
Purchase Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><U>EXERCISE OF WARRANT.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Mechanics of
Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in
Section&nbsp;1(f)), this Warrant may be exercised by the Holder on any day on or after the Issuance Date (an &ldquo;<B>Exercise
Date</B>&rdquo;), in whole or in part, by delivery (whether via facsimile or otherwise) of a written notice, in the form attached
hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Exercise Notice</B>&rdquo;), of the Holder&rsquo;s election to exercise this
Warrant. Within one (1) Trading Day following an exercise of this Warrant as aforesaid, the Holder shall deliver payment to the
Company of an amount equal to the Exercise Price in effect on the date of such exercise multiplied by the number of Warrant Shares
as to which this Warrant was so exercised (the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;) in cash or via wire transfer of
immediately available funds if the Holder did not notify the Company in such Exercise Notice that such exercise was made pursuant to
a Cashless Exercise (as defined in Section&nbsp;1(d)). The Holder shall not be required to deliver the original of this Warrant in
order to effect an exercise hereunder. Execution and delivery of an Exercise Notice with respect to less than all of the Warrant
Shares shall have the same effect as cancellation of the original of this Warrant and issuance of a new Warrant evidencing the right
to purchase the remaining number of Warrant Shares. Execution and delivery of an Exercise Notice for all of the then-remaining
Warrant Shares shall have the same effect as cancellation of the original of this Warrant after delivery of the Warrant Shares in
accordance with the terms hereof. On the date on which the Company has received an Exercise Notice, the Company shall transmit by
facsimile or electronic mail an acknowledgment of confirmation of receipt of such Exercise Notice, in the form attached hereto as <B><U>Exhibit&nbsp;B</U></B>,
to the Holder and the Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;), which confirmation shall constitute
an instruction to the Transfer Agent to process such Exercise Notice in accordance with the terms herein. On or before the first
(1<SUP>st</SUP>) Trading Day following the date on which the Company has received such Exercise Notice (or such earlier date as
required pursuant to the 1934 Act or other applicable law, rule or regulation for the settlement of a trade of such Warrant Shares
initiated on the applicable Exercise Date), the Company shall (X) provided such Warrant Shares issuable pursuant to such Exercise
Notice are eligible for resale by such Holder pursuant to Rule 144 of the 1933 Act or pursuant to an effective Registration
Statement (the &ldquo;<B>Unrestricted Resale Conditions</B>&rdquo; that the Transfer Agent is participating in The Depository Trust
Company (&ldquo;<B>DTC</B>&rdquo;) Fast Automated Securities Transfer Program (&ldquo;<B>FAST</B>&rdquo;)), upon the request of the
Holder, credit such aggregate number of shares of Common Stock to which the Holder is entitled pursuant to such exercise to the
Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit/Withdrawal at Custodian system, or (Y) if the
Transfer Agent is not participating in the FAST or the Unrestricted Resale Conditions are not satisfied, upon the request of the
Holder, issue and deliver (via reputable overnight courier) to the address as specified in the Exercise Notice, a certificate,
registered in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder shall be entitled
pursuant to such exercise. Upon delivery of an Exercise Notice, the Holder shall be deemed for all corporate purposes to have become
the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date such
Warrant Shares are credited to the Holder&rsquo;s DTC account or the date of delivery of the certificates evidencing such Warrant
Shares (as the case may be); provided, that the Holder shall be deemed to have waived any voting rights of any such Warrant Shares
during the period commencing on such Exercise Date, through, and including, such applicable Share Delivery Date (as defined below)
(each, an &ldquo;<B>Exercise Period</B>&rdquo;), as necessary, such that the aggregate voting rights of any Common Stock (including
such Warrant Shares) beneficially owned by the Holder and/or any Attribution Parties, collectively, on any such date of
determination shall not exceed the Maximum Percentage (as defined below) as a result of any such exercise of this Warrant. If this
Warrant is submitted in connection with any exercise pursuant to this Section&nbsp;1(a) and the number of Warrant Shares represented
by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon an exercise and upon
surrender of this Warrant to the Company by the Holder, then, at the request of the Holder, the Company shall as soon as practicable
and in no event later than one (1) Business Day after any exercise and at its own expense, issue and deliver to the Holder (or its
designee) a new Warrant (in accordance with Section&nbsp;7(d)) representing the right to purchase the number of Warrant Shares
purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this
Warrant is exercised. No fractional shares of Common Stock are to be issued upon the exercise of this Warrant, but rather the number
of shares of Common Stock to be issued shall be rounded up to the nearest whole number. The Company shall pay any and all transfer,
stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees and expenses of the Transfer Agent) that
may be payable with respect to the issuance and delivery of Warrant Shares upon exercise of this Warrant. Notwithstanding the
foregoing, except in the case where an exercise of this Warrant is validly made pursuant to a Cashless Exercise, the Company&rsquo;s
failure to deliver Warrant Shares to the Holder on or prior to the later of (i) one (1) Trading Day after receipt of the applicable
Exercise Notice (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the
settlement of a trade of such Warrant Shares initiated on the applicable Exercise Date) and (ii) the date of the Company&rsquo;s
receipt of the Aggregate Exercise Price (or valid notice of a Cashless Exercise) (such later date, the &ldquo;<B>Share Delivery
Date</B>&rdquo;) shall not be deemed to be a breach of this Warrant. Notwithstanding anything to the contrary contained in this
Warrant or the Registration Rights Agreement, after the effective date of the Registration Statement (as defined in the Registration
Rights Agreement) and prior to the Holder&rsquo;s receipt of the notice of a Grace Period (as defined in the Registration Rights
Agreement), the Company shall cause the Transfer Agent to deliver unlegended shares of Common Stock to the Holder (or its designee)
in connection with any sale of Registrable Securities (as defined in the Registration Rights Agreement) with respect to which the
Holder has entered into a contract for sale, and delivered a copy of the prospectus included as part of the particular Registration
Statement to the extent applicable, and for which the Holder has not yet settled. From the Issuance Date through and including the
Expiration Date, the Company shall maintain a transfer agent that participates in FAST.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Exercise Price</U>. For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $3.8576 subject to adjustment as
provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Company&rsquo;s
Failure to Timely Deliver Securities</U>. If the Company shall fail, for any reason or for no reason, on or prior to the Share
Delivery Date, either (I) if the Transfer Agent is not participating in FAST or the Unrestricted Resale Conditions are not
satisfied, to issue and deliver to the Holder (or its designee) a certificate for the number of Warrant Shares to which the Holder
is entitled and register such Warrant Shares on the Company&rsquo;s share register or, (II) if the Transfer Agent is participating
in FAST and the Unrestricted Resale Conditions are satisfied, to credit the balance account of the Holder or the Holder&rsquo;s
designee with DTC for such number of Warrant Shares to which the Holder is entitled upon the Holder&rsquo;s exercise of this Warrant
(as the case may be) or (II) if a Registration Statement covering the resale of the Warrant Shares that are the subject of the
Exercise Notice (the &ldquo;<B>Unavailable Warrant Shares</B>&rdquo;) is not available for the resale of such Unavailable Warrant
Shares and the Company fails to promptly, but in no event later than as required pursuant to the Registration Rights Agreement (x)
so notify the Holder and (y) deliver the Warrant Shares electronically without any restrictive legend by crediting such aggregate
number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s
balance account with DTC through its Deposit/Withdrawal At Custodian system (the event described in the immediately foregoing clause
(II) is hereinafter referred as a &ldquo;<B>Notice Failure</B>&rdquo; and together with the event described in clause (I) above, a
&ldquo;<B>Delivery Failure</B>&rdquo;), then, in addition to all other remedies available to the Holder, (X) the Company shall pay
in cash to the Holder on each day after the Share Delivery Date and during such Delivery Failure an amount equal to 2% of the
product of (A) the sum of the number of shares of Common Stock not issued to the Holder on or prior to the Share Delivery Date and
to which the Holder is entitled, multiplied by (B) any trading price of the Common Stock selected by the Holder in writing as in
effect at any time during the period beginning on the applicable Exercise Date and ending on the applicable Share Delivery Date, and
(Y) the Holder, upon written notice to the Company, may void its Exercise Notice with respect to, and retain or have returned, as
the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that the voiding
of an Exercise Notice shall not affect the Company&rsquo;s obligations to make any payments which have accrued prior to the date of
such notice pursuant to this Section 1(c) or otherwise. In addition to the foregoing, if on or prior to the Share Delivery Date
either (I) the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program or the Unrestricted Resale
Conditions are not satisfied, the Company shall fail to issue and deliver to the Holder (or its designee) a certificate and register
such shares of Common Stock on the Company&rsquo;s share register or, if the Transfer Agent is participating in the DTC Fast
Automated Securities Transfer Program and the Unrestricted Resale Conditions are satisfied, the Transfer Agent shall fail to credit
the balance account of the Holder or the Holder&rsquo;s designee with DTC for the number of shares of Common Stock to which the
Holder is entitled upon the Holder&rsquo;s exercise hereunder or pursuant to the Company&rsquo;s obligation pursuant to clause (ii)
below or (II) a Notice Failure occurs, and if on or after such Share Delivery Date the Holder acquires (in an open market
transaction, stock loan or otherwise) shares of Common Stock corresponding to all or any portion of the number of shares of Common
Stock issuable upon such exercise that the Holder is entitled to receive from the Company and has not received from the Company in
connection with such Delivery Failure or Notice Failure, as applicable (a &ldquo;<B>Buy-In</B>&rdquo;), then, in addition to all
other remedies available to the Holder, the Company shall, within two (2) Business Days after the Holder&rsquo;s request and in the
Holder&rsquo;s discretion, either (i) pay cash to the Holder in an amount equal to the Holder&rsquo;s total purchase price
(including brokerage commissions, stock loan costs and other out-of-pocket expenses, if any) for the shares of Common Stock so
acquired (including, without limitation, by any other Person in respect, or on behalf, of the Holder) (the &ldquo;<B>Buy-In
Price</B>&rdquo;), at which point the Company&rsquo;s obligation to so issue and deliver such certificate (and to issue such shares
of Common Stock) or credit the balance account of such Holder or such Holder&rsquo;s designee, as applicable, with DTC for the
number of Warrant Shares to which the Holder is entitled upon the Holder&rsquo;s exercise hereunder (as the case may be) (and to
issue such Warrant Shares) shall terminate, or (ii) promptly honor its obligation to so issue and deliver to the Holder a
certificate or certificates representing such Warrant Shares or credit the balance account of such Holder or such Holder&rsquo;s
designee, as applicable, with DTC for the number of Warrant Shares to which the Holder is entitled upon the Holder&rsquo;s exercise
hereunder (as the case may be) and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the
product of (A) such number of Warrant Shares multiplied by (B) the lowest Closing Sale Price of the Common Stock on any Trading Day
during the period commencing on the date of the applicable Exercise Notice and ending on the date of such issuance and payment under
this clause (ii) (the &ldquo;<B>Buy-In Payment Amount</B>&rdquo;). Nothing shall limit the Holder&rsquo;s right to pursue any other
remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver certificates representing shares of Common Stock (or
to electronically deliver such shares of Common Stock) upon the exercise of this Warrant as required pursuant to the terms hereof.
While this Warrant is outstanding, the Company shall cause its transfer agent to participate in FAST. In addition to the foregoing
rights, (i) if the Company fails to deliver the applicable number of Warrant Shares upon an exercise pursuant to Section 1 by the
applicable Share Delivery Date, then the Holder shall have the right to rescind such exercise in whole or in part and retain and/or
have the Company return, as the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise
Notice; provided that the rescission of an exercise shall not affect the Company&rsquo;s obligation to make any payments that have
accrued prior to the date of such notice pursuant to this Section 1(c) or otherwise, and (ii) if a registration statement covering
the issuance or resale of the Warrant Shares that are subject to an Exercise Notice is not available for the issuance or resale, as
applicable, of such Warrant Shares and the Holder has submitted an Exercise Notice prior to receiving notice of the non-availability
of such registration statement and the Company has not already delivered the Warrant Shares underlying such Exercise Notice
electronically without any restrictive legend by crediting such aggregate number of Warrant Shares to which the Holder is entitled
pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At
Custodian system, the Holder shall have the option, by delivery of notice to the Company, to (x) rescind such Exercise Notice in
whole or in part and retain or have returned, as the case may be, any portion of this Warrant that has not been exercised pursuant
to such Exercise Notice; provided that the rescission of an Exercise Notice shall not affect the Company&rsquo;s obligation to make
any payments that have accrued prior to the date of such notice pursuant to this Section 1(c) or otherwise, and/or (y) switch some
or all of such Exercise Notice from a cash exercise to a Cashless Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Cashless Exercise</U>. Notwithstanding anything contained herein to the contrary (other than Section&nbsp;1(f) below), if at
any time or times of exercise on or after the six month and one day anniversary of the Issuance Date hereof a Registration Statement (as
defined in the Registration Rights Agreement) is not effective (or the prospectus contained therein is not available for use) for the
resale by the Holder of all of the Warrant Shares, then the Holder may, in its sole discretion, exercise this Warrant in whole or in part
and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Aggregate
Exercise Price, elect instead to receive upon such exercise the &ldquo;Net Number&rdquo; of Warrant Shares determined according to the
following formula (a &ldquo;<B>Cashless Exercise</B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Net Number = <U>(A x B) - (A x C)<BR>
</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">For purposes of the foregoing
formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">A= the total number of shares with respect
to which this Warrant is then being exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">B = as elected by the Holder: (i) the
VWAP of the shares of Common Stock on the Trading Day immediately preceding the date of the applicable Exercise Notice if such Exercise
Notice is (1) both executed and delivered pursuant to Section 1(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 1(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in
Rule 600(b)(88) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Exercise Notice or (z) the Bid Price of the shares
of Common Stock as of the time of the Holder&rsquo;s execution of the applicable Exercise Notice if such Exercise Notice is executed during
&ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter pursuant to Section&nbsp;1(a) hereof,
or (iii) the Closing Sale Price of the Common Stock on the date of the applicable Exercise Notice if the date of such Exercise Notice
is a Trading Day and such Exercise Notice is both executed and delivered pursuant to Section&nbsp;1(a) hereof after the close of &ldquo;regular
trading hours&rdquo; on such Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.8pt; text-align: justify; text-indent: -2.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.8pt; text-align: justify; text-indent: -2.8pt">C = the Exercise
Price then in effect for the applicable Warrant Shares at the time of such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">If the Warrant Shares are issued
in a Cashless Exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the 1933 Act, the Warrant Shares
take on the registered characteristics of the Warrants being exercised. For purposes of Rule 144(d) promulgated under the 1933 Act, as
in effect on the Subscription Date, it is intended that the Warrant Shares issued in a Cashless Exercise shall be deemed to have been
acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was
originally issued pursuant to the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Disputes</U>. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number
of Warrant Shares to be issued pursuant to the terms hereof, the Company shall promptly issue to the Holder the number of Warrant Shares
that are not disputed and resolve such dispute in accordance with Section&nbsp;15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Limitations on
Exercises</U>. The Company shall not effect the exercise of any portion of this Warrant, and the Holder shall not have the right to
exercise any portion of this Warrant, pursuant to the terms and conditions of this Warrant and any such exercise shall be null and
void and treated as if never made, to the extent that after giving effect to such exercise, the Holder together with the other
Attribution Parties collectively would beneficially own in excess of 4.99% (the &ldquo;<B>Maximum Percentage</B>&rdquo;) of the
shares of Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the
aggregate number of shares of Common Stock beneficially owned by the Holder and the other Attribution Parties shall include the
number of shares of Common Stock held by the Holder and all other Attribution Parties plus the number of shares of Common Stock
issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude
shares of Common Stock which would be issuable upon (A) exercise of the remaining, unexercised portion of this Warrant beneficially
owned by the Holder or any of the other Attribution Parties and (B) exercise or conversion of the unexercised or unconverted portion
of any other securities of the Company (including, without limitation, any convertible notes or convertible preferred stock or
warrants, including other SPA Warrants) beneficially owned by the Holder or any other Attribution Party subject to a limitation on
conversion or exercise analogous to the limitation contained in this Section 1(f). For purposes of this Section 1(f), beneficial
ownership shall be calculated in accordance with Section 13(d) of the 1934 Act. For purposes of determining the number of
outstanding shares of Common Stock the Holder may acquire upon the exercise of this Warrant without exceeding the Maximum
Percentage, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (x) the Company&rsquo;s most
recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the SEC, as
the case may be, (y) a more recent public announcement by the Company or (z) any other written notice by the Company or the Transfer
Agent, if any, setting forth the number of shares of Common Stock outstanding (the &ldquo;<B>Reported Outstanding Share
Number</B>&rdquo;). If the Company receives an Exercise Notice from the Holder at a time when the actual number of outstanding
shares of Common Stock is less than the Reported Outstanding Share Number, the Company shall (i) notify the Holder in writing of the
number of shares of Common Stock then outstanding and, to the extent that such Exercise Notice would otherwise cause the
Holder&rsquo;s beneficial ownership, as determined pursuant to this Section 1(f), to exceed the Maximum Percentage, the Holder must
notify the Company of a reduced number of Warrant Shares to be acquired pursuant to such Exercise Notice (the number of shares by
which such purchase is reduced, the &ldquo;<B>Reduction Shares</B>&rdquo;) and (ii) as soon as reasonably practicable, the Company
shall return to the Holder any exercise price paid by the Holder for the Reduction Shares. For any reason at any time, upon the
written or oral request of the Holder, the Company shall within one (1) Business Day confirm orally and in writing or by electronic
mail to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common
Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by
the Holder and any other Attribution Party since the date as of which the Reported Outstanding Share Number was reported. In the
event that the issuance of shares of Common Stock to the Holder upon exercise of this Warrant results in the Holder and the other
Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of
outstanding shares of Common Stock (as determined under Section 13(d) of the 1934 Act), the number of shares so issued by which the
Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate beneficial ownership exceeds the Maximum Percentage (the
&ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall be cancelled ab initio, and the Holder shall not have
the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares has
been deemed null and void, the Company shall return to the Holder the exercise price paid by the Holder for the Excess Shares. Upon
delivery of a written notice to the Company, the Holder may from time to time increase (with such increase not effective until the
sixty-first (61<SUP>st</SUP>) day after delivery of such notice) or decrease the Maximum Percentage to any other percentage not in
excess of 9.99% as specified in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective
until the sixty-first (61<SUP>st</SUP>) day after such notice is delivered to the Company and (ii) any such increase or decrease
will apply only to the Holder and the other Attribution Parties and not to any other holder of SPA Warrants that is not an
Attribution Party of the Holder. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of this Warrant
in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for
purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. No prior inability to exercise this Warrant pursuant to this
paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent
determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 1(f) to the extent necessary to correct this paragraph or any portion of this
paragraph which may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 1(f) or
to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this
paragraph may not be waived, modified or amended and shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Reservation of Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT><U>Required Reserve Amount</U>. So long as this Warrant remains outstanding, the Company shall at all times keep reserved for issuance
under this Warrant a number of shares of Common Stock at least equal to 150% of the maximum number of shares of Common Stock as shall
be necessary to satisfy the Company&rsquo;s obligation to issue shares of Common Stock under the SPA Warrants then outstanding (without
regard to any limitations on exercise) (the &ldquo;<B>Required Reserve Amount</B>&rdquo;); provided that at no time shall the number of
shares of Common Stock reserved pursuant to this Section 1(g)(i) be reduced other than proportionally in connection with any exercise
or redemption of SPA Warrants or such other event covered by Section 2(a) or Section 2(e) below. The Required Reserve Amount (including,
without limitation, each increase in the number of shares so reserved) shall be allocated pro rata among the holders of the SPA Warrants
based on number of shares of Common Stock issuable upon exercise of SPA Warrants held by each holder on the Closing Date (without regard
to any limitations on exercise) or increase in the number of reserved shares, as the case may be (the &ldquo;<B>Authorized Share Allocation</B>&rdquo;).
In the event that a holder shall sell or otherwise transfer any of such holder&rsquo;s SPA Warrants, each transferee shall be allocated
a pro rata portion of such holder&rsquo;s Authorized Share Allocation. Any shares of Common Stock reserved and allocated to any Person
which ceases to hold any SPA Warrants shall be allocated to the remaining holders of SPA Warrants, pro rata based on the number of shares
of Common Stock issuable upon exercise of the SPA Warrants then held by such holders (without regard to any limitations on exercise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <U>Insufficient
Authorized Shares</U>. If, notwithstanding Section 1(g)(i) above, and not in limitation thereof, at any time while any of the SPA
Warrants remain outstanding, the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to
satisfy its obligation to reserve the Required Reserve Amount (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company
shall immediately take all action necessary to increase the Company&rsquo;s authorized shares of Common Stock to an amount
sufficient to allow the Company to reserve the Required Reserve Amount for all the SPA Warrants then outstanding. Without limiting
the generality of the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure,
but in no event later than sixty (60) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting
of its stockholders for the approval of an increase in the number of authorized shares of Common Stock. In connection with such
meeting, the Company shall provide each stockholder with a proxy statement and shall use its best efforts to solicit its
stockholders&rsquo; approval of such increase in authorized shares of Common Stock and to cause its board of directors to recommend
to the stockholders that they approve such proposal. Notwithstanding the foregoing, if any such time of an Authorized Share Failure,
the Company is able to obtain the written consent of a majority of the shares of its issued and outstanding shares of Common Stock
to approve the increase in the number of authorized shares of Common Stock, the Company may satisfy this obligation by obtaining
such consent and submitting for filing with the SEC an Information Statement on Schedule 14C. In the event that the Company is
prohibited from issuing shares of Common Stock upon an exercise of this Warrant due to the failure by the Company to have sufficient
shares of Common Stock available out of the authorized but unissued shares of Common Stock (such unavailable number of shares of
Common Stock, the &ldquo;<B>Authorization Failure Shares</B>&rdquo;), in lieu of delivering such Authorization Failure Shares to the
Holder, the Company shall pay cash in exchange for the cancellation of such portion of this Warrant exercisable into such
Authorization Failure Shares at a price equal to the sum of (i) the product of (x) such number of Authorization Failure Shares and
(y) the greatest Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date the Holder
delivers the applicable Exercise Notice with respect to such Authorization Failure Shares to the Company and ending on the date of
such issuance and payment under this Section 1(g); and (ii) to the extent the Holder purchases (in an open market transaction or
otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of Authorization Failure Shares, any Buy-In
Payment Amount, brokerage commissions and other out-of-pocket expenses, if any, of the Holder incurred in connection therewith.
Nothing contained in this Section 1(g) shall limit any obligations of the Company under any provision of the Securities Purchase
Agreement.</P>

<P STYLE="margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-left: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">2.</FONT>
<U>ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U><FONT STYLE="font-size: 10pt">. </FONT>The Exercise Price and number
of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth in this Section&nbsp;2.</P>

<P STYLE="margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0pt; margin-left: 0in; text-indent: 0.5in; text-align: justify">(a) <U>Stock Dividends
and Splits</U>. Without limiting any provision of Section&nbsp;2(b), Section 3 or Section&nbsp;4, if the Company, at any time on or
after the Subscription Date, (i) pays a stock dividend on one or more classes of its then outstanding shares of Common Stock or
otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides (by any
stock split, stock dividend, recapitalization or otherwise) one or more classes of its then outstanding shares of Common Stock into
a larger number of shares or (iii) combines (by combination, reverse stock split or otherwise) one or more classes of its then
outstanding shares of Common Stock into a smaller number of shares, then in each such case the Exercise Price shall be multiplied by
a fraction of which the numerator shall be the number of shares of Common Stock outstanding immediately before such event and of
which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made
pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of
stockholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this
paragraph shall become effective immediately after the effective date of such subdivision or combination. If any event requiring an
adjustment under this paragraph occurs during the period that an Exercise Price is calculated hereunder, then the calculation of
such Exercise Price shall be adjusted appropriately to reflect such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Adjustment Upon Issuance of Shares of Common Stock</U>. If and whenever on or after the Subscription Date, the Company grants,
issues or sells (or enters into any agreement to grant, issue or sell), or in accordance with this Section&nbsp;2 is deemed to have granted,
issued or sold, any shares of Common Stock (including the issuance or sale of shares of Common Stock owned or held by or for the account
of the Company, but excluding any Excluded Securities granted issued or sold or deemed to have been granted issued or sold) for a consideration
per share (the &ldquo;<B>New Issuance Price</B>&rdquo;) less than a price equal to the Exercise Price in effect immediately prior to such
granting, issuance or sale or deemed granting, issuance or sale (such Exercise Price then in effect is referred to herein as the &ldquo;<B>Applicable
Price</B>&rdquo;) (the foregoing a &ldquo;<B>Dilutive Issuance</B>&rdquo;), then immediately after such Dilutive Issuance, the Exercise
Price then in effect shall be reduced to an amount equal to the New Issuance Price. For all purposes of the foregoing (including, without
limitation, determining the adjusted Exercise Price and the New Issuance Price under this Section&nbsp;2(b)), the following shall be applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <U>Issuance
of Options</U>. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell) any
Options and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such
Option or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise
pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding
and to have been issued and sold by the Company at the time of the granting, issuance or sale (or the time of execution of such
agreement to grant, issue or sell, as applicable) of such Option for such price per share. For purposes of this
Section&nbsp;2(b)(i), the &ldquo;lowest price per share for which one share of Common Stock is at any time issuable upon the
exercise of any such Options or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any
such Option or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1) the lower of (x) the sum of the lowest amounts
of consideration (if any) received or receivable by the Company with respect to any one share of Common Stock upon the granting,
issuance or sale (or pursuant to the agreement to grant, issue or sell, as applicable) of such Option, upon exercise of such Option
and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant to
the terms thereof and (y) the lowest exercise price set forth in such Option for which one share of Common Stock is issuable (or may
become issuable assuming all possible market conditions) upon the exercise of any such Options or upon conversion, exercise or
exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof minus
(2) the sum of all amounts paid or payable to the holder of such Option (or any other Person) upon the granting, issuance or sale
(or the agreement to grant, issue or sell, as applicable) of such Option, upon exercise of such Option and upon conversion, exercise
or exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof plus the
value of any other consideration received or receivable by, or benefit conferred on, the holder of such Option (or any other
Person). Except as contemplated below, no further adjustment of the Exercise Price shall be made upon the actual issuance of such
shares of Common Stock or of such Convertible Securities upon the exercise of such Options or otherwise pursuant to the terms of or
upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Issuance of Convertible Securities</U>. If the Company in any manner issues or sells (or enters into any agreement to issue
or sell) any Convertible Securities and the lowest price per share for which one share of Common Stock is at any time issuable upon the
conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share
of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale
(or the time of execution of such agreement to issue or sell, as applicable) of such Convertible Securities for such price per share.
For the purposes of this Section&nbsp;2(b)(ii), the &ldquo;lowest price per share for which one share of Common Stock is at any time issuable
upon the conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1) the lower of
(x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to one share of Common
Stock upon the issuance or sale (or pursuant to the agreement to issue or sell, as applicable) of the Convertible Security and upon conversion,
exercise or exchange of such Convertible Security or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth
in such Convertible Security for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions)
upon conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable
to the holder of such Convertible Security (or any other Person) upon the issuance or sale (or the agreement to issue or sell, as applicable)
of such Convertible Security plus the value of any other consideration received or receivable by, or benefit conferred on, the holder
of such Convertible Security (or any other Person). Except as contemplated below, no further adjustment of the Exercise Price shall be
made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities or otherwise
pursuant to the terms thereof, and if any such issuance or sale of such Convertible Securities is made upon exercise of any Options for
which adjustment of this Warrant has been or is to be made pursuant to other provisions of this Section&nbsp;2(b), except as contemplated
below, no further adjustment of the Exercise Price shall be made by reason of such issuance or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii) <U>Change
in Option Price or Rate of Conversion</U>. If the purchase or exercise price provided for in any Options, the additional
consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which
any Convertible Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases at
any time (other than proportional changes in conversion or exercise prices, as applicable, in connection with an event referred to
in Section 2(a)), the Exercise Price in effect at the time of such increase or decrease shall be adjusted to the Exercise Price
which would have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased
purchase price, additional consideration or increased or decreased conversion rate, as the case may be, at the time initially
granted, issued or sold. For purposes of this Section&nbsp;2(b)(i), if the terms of any Option or Convertible Security (including,
without limitation, any Option or Convertible Security that was outstanding as of the Subscription Date) are increased or decreased
in the manner described in the immediately preceding sentence, then such Option or Convertible Security and the shares of Common
Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date of such
increase or decrease. No adjustment pursuant to this Section&nbsp;2(b) shall be made if such adjustment would result in an increase
of the Exercise Price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv) <U>Calculation
of Consideration Received</U>. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection with the
issuance or sale or deemed issuance or sale of any other securities of the Company (as determined by the Holder, the
&ldquo;<B>Primary Security</B>&rdquo;, and such Option and/or Convertible Security and/or Adjustment Right, the &ldquo;<B>Secondary
Securities</B>&rdquo;), together comprising one integrated transaction, (or one or more transactions if such issuances or sales or
deemed issuances or sales of securities of the Company either (A) have at least one investor or purchaser in common, (B) are
consummated in reasonable proximity to each other and/or (C) are consummated under the same plan of financing) the aggregate
consideration per share of Common Stock with respect to such Primary Security shall be deemed to be equal to the difference of (x)
the lowest price per share for which one share of Common Stock was issued (or was deemed to be issued pursuant to Section 2(b)(i) or
2(b)(ii) above, as applicable) in such integrated transaction solely with respect to such Primary Security, minus (y) with respect
to such Secondary Securities, the sum of (I) the Black Scholes Consideration Value of each such Option, if any, (II) the fair market
value (as determined by the Holder in good faith) or the Black Scholes Consideration Value, as applicable, of such Adjustment Right,
if any, and (III) the fair market value (as determined by the Holder) of such Convertible Security, if any, in each case, as
determined on a per share basis in accordance with this Section 2(b)(iv). If any shares of Common Stock, Options or Convertible
Securities are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor (for the purpose
of determining the consideration paid for such Common Stock, Option or Convertible Security, but not for the purpose of the
calculation of the Black Scholes Consideration Value) will be deemed to be the net amount of consideration received by the Company
therefor. If any shares of Common Stock, Options or Convertible Securities are issued or sold for a consideration other than cash,
the amount of such consideration received by the Company (for the purpose of determining the consideration paid for such Common
Stock, Option or Convertible Security, but not for the purpose of the calculation of the Black Scholes Consideration Value) will be
the fair value of such consideration, except where such consideration consists of publicly traded securities, in which case the
amount of consideration received by the Company for such securities will be the arithmetic average of the VWAPs of such security for
each of the five (5) Trading Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Convertible
Securities are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving
entity, the amount of consideration therefor (for the purpose of determining the consideration paid for such Common Stock, Option or
Convertible Security, but not for the purpose of the calculation of the Black Scholes Consideration Value) will be deemed to be the
fair value of such portion of the net assets and business of the non-surviving entity as is attributable to such shares of Common
Stock, Options or Convertible Securities (as the case may be). The fair value of any consideration other than cash or publicly
traded securities will be determined jointly by the Company and the Holder. If such parties are unable to reach agreement within ten
(10) days after the occurrence of an event requiring valuation (the &ldquo;<B>Valuation Event</B>&rdquo;), the fair value of such
consideration will be determined within five (5) Trading Days after the tenth (10<SUP>th</SUP>) day following such Valuation Event
by an independent, reputable appraiser jointly selected by the Company and the Holder. The determination of such appraiser shall be
final and binding upon all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Record Date</U>. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A)&nbsp;to
receive a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B)&nbsp;to subscribe
for or purchase shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the
issuance or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making
of such other distribution or the date of the granting of such right of subscription or purchase (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Number of Warrant Shares</U>. Simultaneously with any adjustment to the Exercise Price pursuant to Section&nbsp;2(a) or Section
2(e), the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately,
so that after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same
as the aggregate Exercise Price in effect immediately prior to such adjustment (without regard to any limitations on exercise contained
herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Holder&rsquo;s
Right of Alternative Exercise Price Following Issuance of Certain Options or Convertible Securities</U>. In addition to and not in
limitation of the other provisions of this Section&nbsp;2, if the Company in any manner issues or sells or enters into any agreement
to issue or sell, any Common Stock, Options or Convertible Securities (other than with respect to a Permitted Equity Line (as
defined in the Securities Purchase Agreement)) (any such securities, &ldquo;<B>Variable Price Securities</B>&rdquo;) after the
Subscription Date that are issuable pursuant to such agreement or convertible into or exchangeable or exercisable for shares of
Common Stock at a price which varies or may vary with the market price of the shares of Common Stock, including by way of one or
more reset(s) to a fixed price, but exclusive of such formulations reflecting customary anti-dilution provisions (such as share
splits, share combinations, share dividends and similar transactions) (each of the formulations for such variable price being herein
referred to as, the &ldquo;<B>Variable Price</B>&rdquo;), the Company shall provide written notice thereof via facsimile and
overnight courier to the Holder on the date of such agreement and the issuance of such Convertible Securities or Options. From and
after the date the Company enters into such agreement or issues any such Variable Price Securities, the Holder shall have the right,
but not the obligation, in its sole discretion to substitute the Variable Price for the Exercise Price upon exercise of this Warrant
by designating in the Exercise Notice delivered upon any exercise of this Warrant that solely for purposes of such exercise the
Holder is relying on the Variable Price rather than the Exercise Price then in effect. The Holder&rsquo;s election to rely on a
Variable Price for a particular exercise of this Warrant shall not obligate the Holder to rely on a Variable Price for any future
exercises of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Stock Combination Event Adjustment</U>. If at any time and from time to time on or after the Issuance Date there occurs any
stock split, stock dividend, stock combination recapitalization or other similar transaction involving the Common Stock (each, a &ldquo;<B>Stock
Combination Event</B>&rdquo;, and such date thereof, each a &ldquo;<B>Stock Combination Event Date</B>&rdquo;) and the Event Market Price
is less than the Exercise Price then in effect (after giving effect to the adjustment in clause 2(a) above), then on the sixteenth (16th)
Trading Day immediately following such Stock Combination Event (each, a &ldquo;<B>Stock Combination Adjustment Date</B>&rdquo;), the Exercise
Price then in effect on such sixteenth (16th) Trading Day (after giving effect to the adjustment in clause 2(a) above) shall be reduced
(but in no event increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in the immediately preceding sentence
would otherwise result in an increase in the Exercise Price hereunder, no adjustment shall be made. Notwithstanding the foregoing, if
the Holder requests to exercise this Warrant in whole or in part on any given date during a Stock Combination Measuring Period, solely
with respect to such portion of this Warrant being exercised on such applicable Exercise Date, (a) such applicable Stock Combination Adjustment
Date shall be deemed to mean such Exercise Date, (b) such applicable Stock Combination Measuring Period shall be deemed to have ended
on the Trading Day immediately prior to such Exercise Date and (c) the applicable Event Market Price for such exercised Warrants shall
be calculated pursuant to this Section 2(e). For the avoidance of doubt, following the calculation of the Event Market Price pursuant
to this Section 2(e), the Company&rsquo;s obligations with regard to such exercised Warrants shall be deemed satisfied and no additional
Event Market Price shall apply to such exercised Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Other Events</U>. In the event that the Company (or any Subsidiary (as defined in the Securities Purchase Agreement)) shall
take any action to which the provisions hereof are not strictly applicable, or, if applicable, would not operate to protect the Holder
from dilution or if any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided for by such
provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity
features), then the Company&rsquo;s board of directors shall in good faith determine and implement an appropriate adjustment in the Exercise
Price and the number of Warrant Shares (if applicable) so as to protect the rights of the Holder, provided that no such adjustment pursuant
to this Section 2(f) will increase the Exercise Price or decrease the number of Warrant Shares as otherwise determined pursuant to this
Section 2, provided further that if the Holder does not accept such adjustments as appropriately protecting its interests hereunder against
such dilution, then the Company&rsquo;s board of directors and the Holder shall agree, in good faith, upon an independent investment bank
of nationally recognized standing to make such appropriate adjustments, whose determination shall be final and binding absent manifest
error and whose fees and expenses shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Calculations</U>.
All calculations under this Section&nbsp;2 shall be made by rounding to the nearest cent or the nearest 1/100<SUP>th</SUP> of a
share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by
or for the account of the Company, and the disposition of any such shares shall be considered an issuance or sale of Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Voluntary Adjustment By Company</U>. Subject to the rules and regulations of the Principal Market and Section 2(j) below, the
Company may at any time during the term of this Warrant, with the prior written consent of the Required Holders (as defined in the Securities
Purchase Agreement), reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of
directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Adjustments</U>. If on any Trading Day during the period commencing on the later of (I) the Stockholder Approval Date (as defined
in the Securities Purchase Agreement) and (II) the Applicable Date (as defined in the Securities Purchase Agreement) through, and including,
the one hundred and eightieth (180th) calendar day after the later of (x) the Applicable Date and (y) the Stockholder Approval Date, as
applicable (any Trading Day during such period, each, &ldquo;<B>Adjustment Date</B>&rdquo;), the Exercise Price then in effect is greater
than the Market Price then in effect (each, an &ldquo;<B>Adjustment Price</B>&rdquo;), on any such applicable Adjustment Date the Exercise
Price shall automatically lower to the applicable Adjustment Price. Notwithstanding the foregoing, if a Holder requests to exercise this
Warrant in whole or in part on any given date during a Market Price Measuring Period, solely with respect to such portion of this Warrant
being exercised on such applicable Exercise Date (each, an &ldquo;<B>Exercised Warrant</B>&rdquo;), (a) such applicable Adjustment Date
shall be deemed to mean such Exercise Date, (b) such applicable Market Price Measuring Period shall be deemed to have ended on the Trading
Day immediately prior to such Exercise Date and (c) the applicable Adjustment Price for such Exercised Warrant shall be calculated pursuant
to this Section 2(i). For the avoidance of doubt, following the calculation of the Adjustment Price pursuant to this Section 2(i), the
Company&rsquo;s obligations with regard to such Exercised Warrant shall be deemed satisfied and no additional Adjustment Price shall apply
to such Exercised Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Exercise Floor Price</U>. Prior to the Stockholder Approval Date (as defined in the Securities Purchase Agreement), no adjustment
pursuant to this Section 2 shall cause the Exercise Price to be less than $3.8576 (as adjusted for any stock dividend, stock split, stock
combination, reclassification or similar transaction occurring after the date of the Securities Purchase Agreement) (the &ldquo;<B>Exercise
Floor Price</B>&rdquo;). As of the Stockholder Approval Date, any Dilutive Issuances or other events that would have resulted in an adjustment
to the Exercise Price prior to the Stockholder Approval Date, but for the application of this Section 2(j), shall adjust the Exercise
Price hereunder as if such Dilutive Issuances and/or other events, as applicable, occurred on the Stockholder Approval Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">3.</FONT>
<U>RIGHTS UPON DISTRIBUTION OF ASSETS</U> In addition to any adjustments pursuant to Section&nbsp;2 above or Section 4 below, if the
Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares
of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities,
property, options, evidence of indebtedness or any other assets by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations or restrictions on exercise of this Warrant, including without limitation, the Maximum Percentage) immediately
before the date on which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, that to the extent that
the Holder&rsquo;s right to participate in any such Distribution would result in the Holder and the other Attribution Parties exceeding
the Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution to the extent of the Maximum Percentage
(and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution (and beneficial ownership)
to the extent of any such excess) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until
such time or times, if ever, as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum
Percentage, at which time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial
Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="text-transform: none">4.</FONT>
<U>PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Purchase Rights</U>. In addition to any adjustments pursuant to Sections&nbsp;2 or 3 above, if at any time the Company grants,
issues or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the
record holders of any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon
the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held
the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions
on exercise of this Warrant, including without limitation, the Maximum Percentage) immediately before the date on which a record is taken
for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issuance or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to
the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder and the other Attribution
Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such Purchase Right to the extent of
the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Purchase
Right (and beneficial ownership) to the extent of any such excess) and such Purchase Right to such extent shall be held in abeyance for
the benefit of the Holder until such time or times, if ever, as its right thereto would not result in the Holder and the other Attribution
Parties exceeding the Maximum Percentage, at which time or times the Holder shall be granted such right (and any Purchase Right granted,
issued or sold on such initial Purchase Right or on any subsequent Purchase Right held similarly in abeyance) to the same extent as if
there had been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Fundamental
Transactions</U>. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity assumes
in writing all of the obligations of the Company under this Warrant and the other Transaction Documents (as defined in the
Securities Purchase Agreement) in accordance with the provisions of this Section&nbsp;4(a) pursuant to written agreements in form
and substance reasonably satisfactory to the Holder and approved by the Holder prior to such Fundamental Transaction, including
agreements to deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written
instrument substantially similar in form and substance to this Warrant, including, without limitation, which is exercisable for a
corresponding number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable upon exercise of
this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an
exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such
adjustments to the number of shares of capital stock and such exercise price being for the purpose of protecting the economic value
of this Warrant immediately prior to the consummation of such Fundamental Transaction) and (ii) the Successor Entity (including its
Parent Entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an Eligible Market. Upon
the consummation of each Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and
after the date of the applicable Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents
referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the
Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same
effect as if such Successor Entity had been named as the Company herein. Upon consummation of each Fundamental Transaction, the
Successor Entity shall deliver to the Holder confirmation that there shall be issued upon exercise of this Warrant at any time after
the consummation of the applicable Fundamental Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets
or other property (except such items still issuable under Sections&nbsp;3 and 4(a) above, which shall continue to be receivable
thereafter)) issuable upon the exercise of this Warrant prior to the applicable Fundamental Transaction, such shares of publicly
traded common stock (or its equivalent) of the Successor Entity (including its Parent Entity) which the Holder would have been
entitled to receive upon the happening of the applicable Fundamental Transaction had this Warrant been exercised immediately prior
to the applicable Fundamental Transaction (without regard to any limitations on the exercise of this Warrant), as adjusted in
accordance with the provisions of this Warrant. Notwithstanding the foregoing, and without limiting Section 1(f) hereof, the Holder
may elect, at its sole option, by delivery of written notice to the Company to waive this Section&nbsp;4(a) to permit the
Fundamental Transaction without the assumption of this Warrant. In addition to and not in substitution for any other rights
hereunder, prior to the consummation of each Fundamental Transaction pursuant to which holders of shares of Common Stock are
entitled to receive securities or other assets with respect to or in exchange for shares of Common Stock (a &ldquo;<B>Corporate
Event</B>&rdquo;), the Company shall make appropriate provision to insure that the Holder will thereafter have the right to receive
upon an exercise of this Warrant at any time after the consummation of the applicable Fundamental Transaction but prior to the
Expiration Date, in lieu of the shares of the Common Stock (or other securities, cash, assets or other property (except such items
still issuable under Sections&nbsp;3 and 4(a) above, which shall continue to be receivable thereafter)) issuable upon the exercise
of the Warrant prior to such Fundamental Transaction, such shares of stock, securities, cash, assets or any other property
whatsoever (including warrants or other purchase or subscription rights) which the Holder would have been entitled to receive upon
the happening of the applicable Fundamental Transaction had this Warrant been exercised immediately prior to the applicable
Fundamental Transaction (without regard to any limitations on the exercise of this Warrant). Provision made pursuant to the
preceding sentence shall be in a form and substance reasonably satisfactory to the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Black Scholes Value</U>. Notwithstanding the foregoing and the provisions of Section&nbsp;4(b) above, at the request of the
Holder delivered at any time commencing on the earliest to occur of (x) the public disclosure of any Fundamental Transaction, (y) the
consummation of any Fundamental Transaction and (z) the Holder first becoming aware of any Fundamental Transaction through the date that
is ninety (90) days after the public disclosure of the consummation of such Fundamental Transaction by the Company pursuant to a Current
Report on Form 8-K filed with the SEC, the Company or the Successor Entity (as the case may be) shall purchase this Warrant from the Holder
on the date of such request by paying to the Holder cash in an amount equal to the Black Scholes Value. Payment of such amounts shall
be made by the Company (or at the Company&rsquo;s direction) to the Holder on or prior to the later of (x) the second (2<SUP>nd</SUP>)
Trading Day after the date of such request and (y) the date of consummation of such Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Application</U>. The provisions of this Section&nbsp;4 shall apply similarly and equally to successive Fundamental Transactions
and Corporate Events and shall be applied as if this Warrant (and any such subsequent warrants) were fully exercisable and without regard
to any limitations on the exercise of this Warrant (provided that the Holder shall continue to be entitled to the benefit of the Maximum
Percentage, applied however with respect to shares of capital stock registered under the 1934 Act and thereafter receivable upon exercise
of this Warrant (or any such other warrant)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">5.</FONT>
<U>NONCIRCUMVENTION</U>. The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation
(as defined in the Securities Purchase Agreement), Bylaws (as defined in the Securities Purchase Agreement) or through any reorganization,
transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issuance or sale of securities, or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith
carry out all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting
the generality of the foregoing, the Company (a) shall not increase the par value of any shares of Common Stock receivable upon the exercise
of this Warrant above the Exercise Price then in effect, and (b) shall take all such actions as may be necessary or appropriate in order
that the Company may validly and legally issue fully paid and non-assessable shares of Common Stock upon the exercise of this Warrant.
Notwithstanding anything herein to the contrary, if after the sixty (60) calendar day anniversary of the Issuance Date, the Holder is
not permitted to exercise this Warrant in full for any reason (other than pursuant to restrictions set forth in Section 1(f) hereof),
the Company shall use its best efforts to promptly remedy such failure, including, without limitation, obtaining such consents or approvals
as necessary to permit such exercise into shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">6.</FONT>
<U>WARRANT HOLDER NOT DEEMED A STOCKHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in its capacity
as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company
for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder
of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action
(whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice
of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which
it is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed
as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder
of the Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section&nbsp;6,
the Company shall provide the Holder with copies of the same notices and other information given to the stockholders of the Company generally,
contemporaneously with the giving thereof to the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><U>REISSUANCE OF WARRANTS.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Transfer of Warrant</U>. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon
the Company will forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section&nbsp;7(d)), registered
as the Holder may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less
than the total number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section&nbsp;7(d))
to the Holder representing the right to purchase the number of Warrant Shares not being transferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Lost, Stolen or Mutilated Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the
loss, theft, destruction or mutilation of this Warrant (as to which a written certification and the indemnification contemplated below
shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the
Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company
shall execute and deliver to the Holder a new Warrant (in accordance with Section&nbsp;7(d)) representing the right to purchase the Warrant
Shares then underlying this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Exchangeable for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal
office of the Company, for a new Warrant or Warrants (in accordance with Section&nbsp;7(d)) representing in the aggregate the right to
purchase the number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such
portion of such Warrant Shares as is designated by the Holder at the time of such surrender; provided, however, no warrants for fractional
shares of Common Stock shall be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Issuance of New
Warrants</U>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i)
shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase
the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section&nbsp;7(a) or
Section 7(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the
other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this
Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date,
and (iv) shall have the same rights and conditions as this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">8.</FONT>
<U>NOTICES</U>. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given
in accordance with Section&nbsp;9(f) of the Securities Purchase Agreement. The Company shall provide the Holder with prompt written notice
of all actions taken pursuant to this Warrant (other than the issuance of shares of Common Stock upon exercise in accordance with the
terms hereof), including in reasonable detail a description of such action and the reason therefor. Without limiting the generality of
the foregoing, the Company will give written notice to the Holder (i) promptly upon each adjustment of the Exercise Price and the number
of Warrant Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s), (ii) at least fifteen (15)
days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon
the shares of Common Stock, (B) with respect to any grants, issuances or sales of any Options, Convertible Securities or rights to purchase
stock, warrants, securities or other property to holders of shares of Common Stock or (C) for determining rights to vote with respect
to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall be made known to the public
prior to or in conjunction with such notice being provided to the Holder, and (iii) at least ten (10) Trading Days prior to the consummation
of any Fundamental Transaction. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information
regarding the Company or any of its Subsidiaries (as defined in the Securities Purchase Agreement), the Company shall simultaneously
file such notice with the SEC (as defined in the Securities Purchase Agreement) pursuant to a Current Report on Form 8-K. If the Company
or any of its Subsidiaries provides material non-public information to the Holder that is not simultaneously filed in a Current Report
on Form 8-K and the Holder has not agreed to receive such material non-public information, the Company hereby covenants and agrees that
the Holder shall not have any duty of confidentiality to the Company, any of its Subsidiaries or any of their respective officers, directors,
employees, affiliates or agents with respect to, or a duty to any of the foregoing not to trade on the basis of, such material non-public
information. It is expressly understood and agreed that the time of execution specified by the Holder in each Exercise Notice shall be
definitive and may not be disputed or challenged by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">9.</FONT>
<U>DISCLOSURE</U>. Upon delivery by the Company to the Holder (or receipt by the Company from the Holder) of any notice in accordance
with the terms of this Warrant, unless the Company has in good faith determined that the matters relating to such notice do not constitute
material, non-public information relating to the Company or any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York
city time on the Business Day immediately following such notice delivery date, publicly disclose such material, non-public information
on a Current Report on Form 8-K or otherwise. In the event that the Company believes that a notice contains material, non-public information
relating to the Company or any of its Subsidiaries, the Company so shall indicate to the Holder explicitly in writing in such notice
(or immediately upon receipt of notice from the Holder, as applicable), and in the absence of any such written indication in such notice
(or notification from the Company immediately upon receipt of notice from the Holder), the Holder shall be entitled to presume that information
contained in the notice does not constitute material, non-public information relating to the Company or any of its Subsidiaries. Nothing
contained in this Section 9 shall limit any obligations of the Company, or any rights of the Holder, under Section 4(i) of the Securities
Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>ABSENCE OF TRADING AND DISCLOSURE RESTRICTIONS</U>. The Company acknowledges and agrees that the Holder is not a fiduciary or
agent of the Company and that the Holder shall have no obligation to (a) maintain the confidentiality of any information provided by the
Company or (b) refrain from trading any securities while in possession of such information in the absence of a written non-disclosure
agreement signed by an officer of the Holder that explicitly provides for such confidentiality and trading restrictions. In the absence
of such an executed, written non-disclosure agreement, the Company acknowledges that the Holder may freely trade in any securities issued
by the Company, may possess and use any information provided by the Company in connection with such trading activity, and may disclose
any such information to any third party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">11.</FONT>
<U>AMENDMENT AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Warrant (other than Section&nbsp;1(f) and this
Section 11, which may not be amended or waived hereunder) may be amended and the Company may take any action herein prohibited, or omit
to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Holder. No waiver
shall be effective unless it is in writing and signed by an authorized representative of the waiving party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">12.</FONT>
<U>SEVERABILITY</U>. If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by
a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall
not affect the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or
the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith
negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as
close as possible to that of the prohibited, invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">13.</FONT>
<U>GOVERNING LAW</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the
construction, validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of Delaware,
without giving effect to any provision or rule (whether of the State of Delaware or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of Delaware. The Company hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to the Company at the address set
forth in Section 9(f) of the Securities Purchase Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in Wilmington, Delaware, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient
forum or that the venue of such suit, action or proceeding is improper. Nothing contained herein shall be deemed to limit in any way
any right to serve process in any manner permitted by law. Nothing contained herein shall be deemed or operate to preclude the Holder
from bringing suit or taking other legal action against the Company in any other jurisdiction to collect on the Company&rsquo;s obligations
to the Holder, to realize on any collateral or any other security for such obligations, or to enforce a judgment or other court ruling
in favor of the Holder. <B>THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR
THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">14.</FONT>
<U>CONSTRUCTION; HEADINGS</U>. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed
against any Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or
affect the interpretation of, this Warrant. Terms used in this Warrant but defined in the other Transaction Documents shall have the
meanings ascribed to such terms on the Closing Date (as defined in the Securities Purchase Agreement) in such other Transaction Documents
unless otherwise consented to in writing by the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><U>DISPUTE RESOLUTION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Submission to Dispute Resolution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>In the case of a dispute relating to the Exercise Price, the Closing Sale Price, the Bid Price, Black Scholes Consideration Value,
Black Scholes Value or fair market value or the arithmetic calculation of the number of Warrant Shares (as the case may be) (including,
without limitation, a dispute relating to the determination of any of the foregoing), the Company or the Holder (as the case may be) shall
submit the dispute to the other party via facsimile (A) if by the Company, within two (2) Business Days after the occurrence of the circumstances
giving rise to such dispute or (B) if by the Holder, at any time after the Holder learned of the circumstances giving rise to such dispute.
If the Holder and the Company are unable to promptly resolve such dispute relating to such Exercise Price, such Closing Sale Price, such
Bid Price, such Black Scholes Consideration Value, such Black Scholes Value or such fair market value or such arithmetic calculation of
the number of Warrant Shares (as the case may be), at any time after the second (2<SUP>nd</SUP>) Business Day following such initial notice
by the Company or the Holder (as the case may be) of such dispute to the Company or the Holder (as the case may be), then the Holder may,
at its sole option, select an independent, reputable investment bank to resolve such dispute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) The
Holder and the Company shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in
accordance with the first sentence of this Section&nbsp;15 and (B) written documentation supporting its position with respect to
such dispute, in each case, no later than 5:00 p.m. (New York time) by the fifth (5<SUP>th</SUP>) Business Day immediately following
the date on which the Holder selected such investment bank (the &ldquo;<B>Dispute Submission Deadline</B>&rdquo;) (the documents
referred to in the immediately preceding clauses (A) and (B) are collectively referred to herein as the &ldquo;<B>Required Dispute
Documentation</B>&rdquo;) (it being understood and agreed that if either the Holder or the Company fails to so deliver all of the
Required Dispute Documentation by the Dispute Submission Deadline, then the party who fails to so submit all of the Required Dispute
Documentation shall no longer be entitled to (and hereby waives its right to) deliver or submit any written documentation or other
support to such investment bank with respect to such dispute and such investment bank shall resolve such dispute based solely on the
Required Dispute Documentation that was delivered to such investment bank prior to the Dispute Submission Deadline). Unless
otherwise agreed to in writing by both the Company and the Holder or otherwise requested by such investment bank, neither the
Company nor the Holder shall be entitled to deliver or submit any written documentation or other support to such investment bank in
connection with such dispute (other than the Required Dispute Documentation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company and the Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company
and the Holder of such resolution no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees
and expenses of such investment bank shall be borne solely by the Company, and such investment bank&rsquo;s resolution of such dispute
shall be final and binding upon all parties absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Miscellaneous</U>.
The Company expressly acknowledges and agrees that (i) this Section&nbsp;15 constitutes an agreement to arbitrate between the
Company and the Holder (and constitutes an arbitration agreement) under the rules then in effect under the Delaware Rapid
Arbitration Act, as amended, (ii) a dispute relating to the Exercise Price includes, without limitation, disputes as to (A) whether
an issuance or sale or deemed issuance or sale of Common Stock occurred under Section 2(b), (B) the consideration per share at which
an issuance or deemed issuance of Common Stock occurred, (C) whether any issuance or sale or deemed issuance or sale of Common Stock
was an issuance or sale or deemed issuance or sale of Excluded Securities, (D) whether an agreement, instrument, security or the
like constitutes and Option or Convertible Security and (E) whether a Dilutive Issuance occurred, (iii) the terms of this Warrant
and each other applicable Transaction Document shall serve as the basis for the selected investment bank&rsquo;s resolution of the
applicable dispute, such investment bank shall be entitled (and is hereby expressly authorized) to make all findings, determinations
and the like that such investment bank determines are required to be made by such investment bank in connection with its resolution
of such dispute (including, without limitation, determining (A) whether an issuance or sale or deemed issuance or sale of Common
Stock occurred under Section 2(b), (B) the consideration per share at which an issuance or deemed issuance of Common Stock occurred,
(C) whether any issuance or sale or deemed issuance or sale of Common Stock was an issuance or sale or deemed issuance or sale of
Excluded Securities, (D) whether an agreement, instrument, security or the like constitutes and Option or Convertible Security and
(E) whether a Dilutive Issuance occurred) and in resolving such dispute such investment bank shall apply such findings,
determinations and the like to the terms of this Warrant and any other applicable Transaction Documents, (iv) the Holder (and only
the Holder), in its sole discretion, shall have the right to submit any dispute described in this Section&nbsp;15 to any state or
federal court sitting in Wilmington, Delaware in lieu of utilizing the procedures set forth in this Section&nbsp;15 and (iv) nothing
in this Section&nbsp;15 shall limit the Holder from obtaining any injunctive relief or other equitable remedies (including, without
limitation, with respect to any matters described in this Section&nbsp;15).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">16.</FONT>
<U>REMEDIES, CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be
cumulative and in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity
(including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to
pursue actual and consequential damages for any failure by the Company to comply with the terms of this Warrant. The Company covenants
to the Holder that there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set
forth or provided for herein with respect to payments, exercises and the like (and the computation thereof) shall be the amounts to be
received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the
performance thereof). The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder
and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach
or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available remedies, to specific performance
and/or temporary, preliminary and permanent injunctive or other equitable relief from any court of competent jurisdiction in any such
case without the necessity of proving actual damages and without posting a bond or other security. The Company shall provide all information
and documentation to the Holder that is requested by the Holder to enable the Holder to confirm the Company&rsquo;s compliance with the
terms and conditions of this Warrant (including, without limitation, compliance with Section&nbsp;2 hereof). The issuance of shares and
certificates for shares as contemplated hereby upon the exercise of this Warrant shall be made without charge to the Holder or such shares
for any issuance tax or other costs in respect thereof, provided that the Company shall not be required to pay any tax which may be payable
in respect of any transfer involved in the issuance and delivery of any certificate in a name other than the Holder or its agent on its
behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><U>PAYMENT OF COLLECTION, ENFORCEMENT AND OTHER COSTS</U><FONT STYLE="text-transform: none">. If (a) this Warrant is placed
in the hands of an attorney for collection or enforcement or is collected or enforced through any legal proceeding or the Holder otherwise
takes action to collect amounts due under this Warrant or to enforce the provisions of this Warrant or (b) there occurs any bankruptcy,
reorganization, receivership of the company or other proceedings affecting company creditors&rsquo; rights and involving a claim under
this Warrant, then the Company shall pay the costs incurred by the Holder for such collection, enforcement or action or in connection
with such bankruptcy, reorganization, receivership or other proceeding, including, without limitation, attorneys&rsquo; fees and disbursements.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">18.</FONT>
<U>TRANSFER</U>. This Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company, except as may
otherwise be required by Section 2(g) of the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="text-transform: none">19.</FONT>
<U>CERTAIN DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>1933 Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>1934 Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Adjustment Right</B>&rdquo; means any right granted with respect to any securities issued in connection with, or with
respect to, any issuance or sale (or deemed issuance or sale in accordance with Section&nbsp;2) of shares of Common Stock (other than
rights of the type described in Section&nbsp;3 and 4 hereof) that could result in a decrease in the net consideration received by the
Company in connection with, or with respect to, such securities (including, without limitation, any cash settlement rights, cash adjustment
or other similar rights).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Affiliate</B>&rdquo; means, with respect to any Person, any other Person that directly or indirectly controls, is controlled
by, or is under common control with, such Person, it being understood for purposes of this definition that &ldquo;control&rdquo; of a
Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of
directors of such Person or direct or cause the direction of the management and policies of such Person whether by contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Approved Stock Plan</B>&rdquo; means any employee benefit plan which has been approved by the board of directors of the
Company prior to or subsequent to the date hereof pursuant to which shares of Common Stock and standard options to purchase Common Stock
may be issued to any employee, officer or director for services provided to the Company in their capacity as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Attribution Parties</B>&rdquo; means, collectively, the following Persons and entities: (i) any investment vehicle, including,
any funds, feeder funds or managed accounts, currently, or from time to time after the Issuance Date, directly or indirectly managed or
advised by the Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the
Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or any
of the foregoing and (iv) any other Persons whose beneficial ownership of the Company&rsquo;s Common Stock would or could be aggregated
with the Holder&rsquo;s and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of the
foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) &ldquo;<B>Bid
Price</B>&rdquo; means, for any security as of the particular time of determination, the bid price for such security on the
Principal Market as reported by Bloomberg as of such time of determination, or, if the Principal Market is not the principal
securities exchange or trading market for such security, the bid price of such security on the principal securities exchange or
trading market where such security is listed or traded as reported by Bloomberg as of such time of determination, or if the
foregoing does not apply, the bid price of such security in the over-the-counter market on the electronic bulletin board for such
security as reported by Bloomberg as of such time of determination, or, if no bid price is reported for such security by Bloomberg
as of such time of determination, the average of the bid prices of any market makers for such security as reported in The Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices) as of such time of determination. If
the Bid Price cannot be calculated for a security as of the particular time of determination on any of the foregoing bases, the Bid
Price of such security as of such time of determination shall be the fair market value as mutually determined by the Company and the
Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be
resolved in accordance with the procedures in Section&nbsp;15. All such determinations shall be appropriately adjusted for any stock
dividend, stock split, stock combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Black Scholes Consideration Value</B>&rdquo; means the value of the applicable Option, Convertible Security or Adjustment
Right (as the case may be) as of the date of issuance thereof calculated using the Black Scholes Option Pricing Model obtained from the
&ldquo;OV&rdquo; function on Bloomberg utilizing (i) an underlying price per share equal to the Closing Sale Price of the Common Stock
on the Trading Day immediately preceding the public announcement of the execution of definitive documents with respect to the issuance
of such Option or Convertible Security (as the case may be), (ii) a risk-free interest rate corresponding to the U.S. Treasury rate for
a period equal to the remaining term of such Option, Convertible Security or Adjustment Right (as the case may be) as of the date of issuance
of such Option, Convertible Security or Adjustment Right (as the case may be), (iii) a zero cost of borrow and (iv) an expected volatility
equal to the greater of 100% and the 30 day volatility obtained from the &ldquo;HVT&rdquo; function on Bloomberg (determined utilizing
a 365 day annualization factor) as of&nbsp;the Trading Day immediately following the date of issuance of such Option, Convertible Security
or Adjustment Right (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) &ldquo;<B>Black
Scholes Value</B>&rdquo; means the value of the unexercised portion of this Warrant remaining on the date of the Holder&rsquo;s
request pursuant to Section 4(b), which value is calculated using the Black Scholes Option Pricing Model obtained from the
&ldquo;OV&rdquo; function on Bloomberg utilizing (i) an underlying price per share equal to the greater of (1) the highest Closing
Sale Price of the Common Stock during the period beginning on the Trading Day immediately preceding the announcement of the
applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the
Trading Day of the Holder&rsquo;s request pursuant to Section 4(b) and (2) the sum of the price per share being offered in cash in
the applicable Fundamental Transaction (if any) plus the value of the non-cash consideration being offered in the applicable
Fundamental Transaction (if any), (ii) a strike price equal to the Exercise Price in effect on the date of the Holder&rsquo;s
request pursuant to Section 4(b), (iii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the
greater of (1) the remaining term of this Warrant as of the date of the Holder&rsquo;s request pursuant to Section 4(b) and (2) the
remaining term of this Warrant as of the date of consummation of the applicable Fundamental Transaction or as of the date of the
Holder&rsquo;s request pursuant to Section 4(b) if such request is prior to the date of the consummation of the applicable
Fundamental Transaction, (iv) a zero cost of borrow and (v) an expected volatility equal to the greater of 100% and the 30 day
volatility obtained from the &ldquo;HVT&rdquo; function on Bloomberg (determined utilizing a 365 day annualization factor) as of the
Trading Day immediately following the earliest to occur of (A) the public disclosure of the applicable Fundamental Transaction and
(B) the date of the Holder&rsquo;s request pursuant to Section 4(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Bloomberg</B>&rdquo; means Bloomberg, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City
of New York are authorized or required by law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>, <U>however</U>,
for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;,
&ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure
of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including
for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Certificate of Designations</B>&rdquo; has the meaning ascribed to such term in the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Closing Bid Price</B>&rdquo; and &ldquo;<B>Closing Sale Price</B>&rdquo; means, for any security as of any date, the
last closing bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg,
or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade
price (as the case may be) then the last bid price or last trade price, respectively, of such security prior to 4:00:00 p.m., New York
time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security,
the last closing bid price or last trade price, respectively, of such security on the principal securities exchange or trading market
where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last
trade price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as reported
by Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of
the bid prices, or the ask prices, respectively, of any market makers for such security as reported in The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices). If the Closing Bid Price or the Closing Sale Price cannot be
calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price (as the
case may be) of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the
Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance
with the procedures in Section&nbsp;15. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock
combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Common Stock</B>&rdquo; means (i)&nbsp;the Company&rsquo;s shares of common stock, $0.00001 par value per share, and
(ii) any capital stock into which such common stock shall have been changed or any share capital resulting from a reclassification of
such common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)
&ldquo;<B>Convertible Securities</B>&rdquo; means any stock or other security (other than Options) that is at any time and under any
circumstances, directly or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder
thereof to acquire, any shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Eligible Market</B>&rdquo; means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the
Nasdaq Global Market or the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Event Market Price</B>&rdquo; means, with respect to any Stock Combination Event Date, the lowest VWAP of the Common
Stock on any Trading Day during the fifteen (15) consecutive Trading Day period ending and including the Trading Day immediately preceding
the sixteenth (16<SUP>th</SUP>) Trading Day after such Stock Combination Event Date (such period, the &ldquo;<B>Stock Combination Measuring
Period</B>&rdquo;). All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification
or similar transaction that proportionately decreases or increases the Common Stock during such applicable Stock Combination Measuring
Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Excluded Securities</B>&rdquo; means (i) shares of Common Stock or standard options to purchase Common Stock issued to
directors, officers or employees of the Company for services rendered to the Company in their capacity as such pursuant to an Approved
Stock Plan (as defined above), provided that (A) all such issuances (taking into account the shares of Common Stock issuable upon exercise
of such options) after the Subscription Date pursuant to this clause (i) do not, in the aggregate, exceed more than 5% of the Common Stock
issued and outstanding immediately prior to the Subscription Date and (B) the exercise price of any such options is not lowered, none
of such options are amended to increase the number of shares issuable thereunder and none of the terms or conditions of any such options
are otherwise materially changed in any manner that adversely affects any of the Buyers; (ii) shares of Common Stock issued upon the conversion
or exercise of Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan
that are covered by clause (i) above) issued prior to the Subscription Date, provided that the conversion price of any such Convertible
Securities (other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause
(i) above) is not lowered, none of such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to
an Approved Stock Plan that are covered by clause (i) above) are amended to increase the number of shares issuable thereunder and none
of the terms or conditions of any such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to
an Approved Stock Plan that are covered by clause (i) above) are otherwise materially changed in any manner that adversely affects any
of the Buyers; (iii) the shares of Common Stock issuable upon conversion of the Preferred Shares or otherwise pursuant to the terms of
the Certificate of Designations; provided, that the terms of the Certificate of Designations are not amended, modified or changed on or
after the Subscription Date (other than antidilution adjustments pursuant to the terms thereof in effect as of the Subscription Date),
(iv) shares of Common Stock issued (or issuable) pursuant to a Permitted Equity Line, (v) the shares of Common Stock issuable upon exercise
of the SPA Warrants; provided, that the terms of the SPA Warrant are not amended, modified or changed on or after the Subscription Date
(other than antidilution adjustments pursuant to the terms thereof in effect as of the Subscription Date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> &ldquo;<B>Expiration Date</B>&rdquo; means the date that is the third (3<SUP>rd</SUP>) anniversary of the Issuance Date or, if
such date falls on a day other than a Trading Day or on which trading does not take place on the Principal Market (a &ldquo;<B>Holiday</B>&rdquo;),
the next date that is not a Holiday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t)
&ldquo;<B>Fundamental Transaction</B>&rdquo; means (A) that the Company shall, directly or indirectly, including through
subsidiaries, Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not
the Company is the surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all
or substantially all of the properties or assets of the Company or any of its &ldquo;significant subsidiaries&rdquo; (as defined in
Rule 1-02 of Regulation S-X) to one or more Subject Entities, or (iii) make, or allow one or more Subject Entities to make, or allow
the Company to be subject to or have its Common Stock be subject to or party to one or more Subject Entities making, a purchase,
tender or exchange offer that is accepted by the holders of at least either (x) 50% of the outstanding shares of Common Stock, (y)
50% of the outstanding shares of Common Stock calculated as if any shares of Common Stock held by all Subject Entities making or
party to, or Affiliated with any Subject Entities making or party to, such purchase, tender or exchange offer were not outstanding;
or (z) such number of shares of Common Stock such that all Subject Entities making or party to, or Affiliated with any Subject
Entity making or party to, such purchase, tender or exchange offer, become collectively the beneficial owners (as defined in Rule
13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (iv) consummate a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of
arrangement) with one or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire, either
(x) at least 50% of the outstanding shares of Common Stock, (y) at least 50% of the outstanding shares of Common Stock calculated as
if any shares of Common Stock held by all the Subject Entities making or party to, or Affiliated with any Subject Entity making or
party to, such stock purchase agreement or other business combination were not outstanding; or (z) such number of shares of Common
Stock such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of at
least 50% of the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify its Common Stock, (B) that the
Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions,
allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the &ldquo;beneficial owner&rdquo;
(as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment,
conveyance, tender, tender offer, exchange, reduction in outstanding shares of Common Stock, merger, consolidation, business
combination, reorganization, recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification
or otherwise in any manner whatsoever, of either (x) at least 50% of the aggregate ordinary voting power represented by issued and
outstanding Common Stock, (y) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock
not held by all such Subject Entities as of the date of this Warrant calculated as if any shares of Common Stock held by all such
Subject Entities were not outstanding, or (z) a percentage of the aggregate ordinary voting power represented by issued and
outstanding shares of Common Stock or other equity securities of the Company sufficient to allow such Subject Entities to effect a
statutory short form merger or other transaction requiring other shareholders of the Company to surrender their shares of Common
Stock without approval of the shareholders of the Company or (C) directly or indirectly, including through subsidiaries, Affiliates
or otherwise, in one or more related transactions, the issuance of or the entering into any other instrument or transaction
structured in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition shall be
construed and implemented in a manner otherwise than in strict conformity with the terms of this definition to the extent necessary
to correct this definition or any portion of this definition which may be defective or inconsistent with the intended treatment of
such instrument or transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Group</B>&rdquo; means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in
Rule 13d-5 thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Market Price</B>&rdquo; means, with respect to any Adjustment Date, the greater of (x) the Floor Price (as defined in
the Certificate of Designations) and (y) the lowest Closing Bid Price of the Common Stock on any Trading Day during the five (5) Trading
Day period ended on, and including, the Trading Day ended immediately prior to such applicable Adjustment Date (each, a &ldquo;<B>Market
Price Measuring Period</B>&rdquo;). All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination,
reclassification or similar transaction that proportionately decreases or increases the Common Stock during such applicable Market Price
Measuring Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> &ldquo;<B>Options</B>&rdquo; means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Parent Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person and
whose common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person
or Parent Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental
Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Person</B>&rdquo; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a
trust, an unincorporated organization, any other entity or a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Preferred Shares</B>&rdquo; has the meaning ascribed to such term in the Securities Purchase Agreement and shall include
all shares of preferred stock issued in exchange therefor or replacement thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> &ldquo;<B>Principal Market</B>&rdquo; means the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Registration Rights Agreement</B>&rdquo; means that certain registration rights agreement, dated as of the Closing Date,
by and among the Company and the initial holders of the Preferred Shares relating to, among other things, the registration of the resale
of the Common Stock issuable upon conversion of the Preferred Shares or otherwise pursuant to the terms of the Certificate of Designations
and exercise of the SPA Warrants, as may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> &ldquo;<B>SEC</B>&rdquo; means the United States Securities and Exchange Commission or the successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><B>&ldquo;Subject Entity</B>&rdquo; means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons
or Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Successor Entity</B>&rdquo; means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting
from or surviving any Fundamental Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental
Transaction shall have been entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>Trading Day</B>&rdquo; means, as applicable, (x) with respect to all price or trading volume determinations relating
to the Common Stock, any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal
trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then
traded, provided that &ldquo;Trading Day&rdquo; shall not include any day on which the Common Stock is scheduled to trade on such exchange
or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such
exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market,
then during the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the
Holder or (y) with respect to all determinations other than price or trading volume determinations relating to the Common Stock, any day
on which The New York Stock Exchange (or any successor thereto) is open for trading of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(gg)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&ldquo;<B>VWAP</B>&rdquo; means, for any security as of any date, the dollar volume-weighted average price for such security on
the Principal Market (or, if the Principal Market is not the principal trading market for such security, then on the principal securities
exchange or securities market on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending
at 4:00 p.m., New York time, as reported by Bloomberg through its &ldquo;VAP&rdquo; function (set to 09:30 start time and 16:00 end time)
or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic
bulletin board for such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported
by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of
the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in The Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be calculated for such
security on such date on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as mutually
determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security,
then such dispute shall be resolved in accordance with the procedures in Section&nbsp;15. All such determinations shall be appropriately
adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>signature page follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B>
the Company has caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>ONCONETIX, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 33%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Options: NewSection; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">EXHIBIT A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXERCISE NOTICE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">TO BE EXECUTED
BY THE REGISTERED HOLDER TO EXERCISE THIS<BR>
WARRANT TO PURCHASE COMMON STOCK</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">ONCONETIX,
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned holder hereby
elects to exercise the Warrant to Purchase Common Stock No.&nbsp;_______ (the &ldquo;<B>Warrant</B>&rdquo;) of Onconetix, Inc., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;) as specified below. Capitalized terms used herein and not otherwise defined shall have
the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.   <U>Form
of Exercise Price</U>. The Holder intends that payment of the Aggregate Exercise Price shall be made as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a &ldquo;<U>Cash Exercise</U>&rdquo; with respect to _________________ Warrant
Shares; and/or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to _______________
Warrant Shares.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the Holder
has elected a Cashless Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto, the Holder hereby represents
and warrants that (i) this Exercise Notice was executed by the Holder at __________ [a.m.][p.m.] on the date set forth below and (ii)
if applicable, the Bid Price as of such time of execution of this Exercise Notice was $________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.   <U>Payment
of Exercise Price</U>. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be
issued pursuant hereto, the Holder shall pay the Aggregate Exercise </FONT>Price <FONT STYLE="font-size: 10pt">in the sum of $___________________
to the Company in accordance with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">3.   <U>Delivery
of Warrant Shares</U>. The Company shall deliver to Holder, or its designee or agent as specified below, __________ </FONT>shares of Common
Stock <FONT STYLE="font-size: 10pt">in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit,
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9744;   Check
here if requesting delivery as a certificate to the following name and to the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 21%; text-align: right">Issue to:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 79%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9744;</TD><TD>Check here if requesting delivery by Deposit/Withdrawal at Custodian as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC Participant:</FONT></TD>
    <TD STYLE="width: 72%; border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC Number:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account Number:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 56%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax ID:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>E-mailAddress:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">EXHIBIT B</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">ACKNOWLEDGMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
Company hereby acknowledges this Exercise Notice and hereby directs ______________ to issue the above </FONT>indicated <FONT STYLE="font-size: 10pt">number
of shares of Common Stock in accordance with the Transfer Agent Instructions dated _________, 202_, from the Company and acknowledged
and agreed to by _______________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="text-transform: uppercase"><B>Onconetix, Inc. </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 33%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">29</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in; text-indent: -0.25in">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ea025986001ex10-1_onconetix.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT DATED OCTOBER 1, 2025 RELATING TO THE SALE OF THE SERIES E PREFERRED STOCK AND WARRANTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SECURITIES PURCHASE
AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>SECURITIES PURCHASE
AGREEMENT</B> (the &ldquo;<B>Agreement</B>&rdquo;), dated as of October 1, 2025, is by and among Onconetix, Inc., a Delaware corporation
with offices located at 201 E. Fifth Street, Suite 1900 Cincinnati, OH 45202 (the &ldquo;<B>Company</B>&rdquo;), and each of the investors
listed on the Schedule of Buyers attached hereto (individually, a &ldquo;<B>Buyer</B>&rdquo; and collectively, the &ldquo;<B>Buyers</B>&rdquo;).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>RECITALS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;The
Company and each Buyer is executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;<B>1933 Act</B>&rdquo;), and Rule 506(b) of Regulation D (&ldquo;<B>Regulation&nbsp;D</B>&rdquo;)
as promulgated by the United States Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) under the 1933 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;The
Company has authorized a new series of convertible preferred stock of the Company designated as Series E Convertible Preferred Stock,
$0.00001 par value, the terms of which are set forth in the certificate of designation for such series of Preferred Stock (the &ldquo;<B>Certificate
of Designations</B>&rdquo;) in the form attached hereto as <B><U>Exhibit A</U></B> (together with any convertible preferred shares issued
in replacement thereof in accordance with the terms thereof, the &ldquo;<B>Series E Preferred Stock</B>&rdquo;), which Series E Preferred
Stock shall be convertible into shares of Common Stock (as defined below) (such shares of Common Stock issuable pursuant to the terms
of the Certificate of Designations, including, without limitation, upon conversion or otherwise, collectively, the &ldquo;<B>Conversion
Shares</B>&rdquo;), in accordance with the terms of the Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.&nbsp;Each
Buyer wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement, (i) the aggregate number
of shares of Series E Preferred Stock (the &ldquo;<B>Preferred Shares</B>&rdquo;) set forth opposite such Buyer&rsquo;s name in column
(3) on the Schedule of Buyers, and (ii) a warrant to initially acquire up to that aggregate number of additional shares of Common Stock
(as defined below) set forth opposite such Buyer&rsquo;s name in column (4) on the Schedule of Buyers, substantially in the form attached
hereto as <B><U>Exhibit B</U></B> (the &ldquo;<B>Warrants</B>&rdquo;) (as exercised, collectively, the &ldquo;<B>Warrant Shares</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E.&nbsp;At
the Closing (as defined below), the parties hereto shall execute and deliver a Registration Rights Agreement, in the form attached hereto
as <B><U>Exhibit C</U></B> (the &ldquo;<B>Registration Rights Agreement</B>&rdquo;), pursuant to which the Company has agreed to provide
certain registration rights with respect to the Registrable Securities (as defined in the Registration Rights Agreement), under the 1933
Act and the rules and regulations promulgated thereunder, and applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">F.&nbsp;The
Preferred Shares (as defined below), the Conversion Shares, the Warrants (as defined below) and the Warrant Shares (as defined below)
are collectively referred to herein as the &ldquo;<B>Securities</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the Company and each Buyer hereby agree as follows:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1.&nbsp;PURCHASE
AND SALE OF PREFERRED SHARES AND WARRANTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Purchase
of Preferred Shares and Warrants</U><FONT STYLE="font-size: 10pt"></FONT>. Subject to the satisfaction (or waiver) of the conditions
set forth in Sections 6 and 7 below, the Company shall issue and sell to each Buyer, and each Buyer severally, but not jointly, agrees
to purchase from the Company on the Closing Date (as defined below) the aggregate number of Preferred Shares as is set forth opposite
such Buyer&rsquo;s name in column (3) on the Schedule of Buyers, along with Warrants to initially acquire up to that aggregate number
of Warrant Shares as is set forth opposite such Buyer&rsquo;s name in column (4) on the Schedule of Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Closing</U><FONT STYLE="font-size: 10pt"></FONT>.
The closing (the &ldquo;<B>Closing</B>&rdquo;) of the purchase of the Preferred Shares and the Warrants by the Buyers shall occur at
the offices of Kelley Drye &amp; Warren LLP, 3 World Trade Center, 175 Greenwich Street, New York, NY 10007. The date and time of the
Closing (the &ldquo;<B>Closing Date</B>&rdquo;) shall be 10:00 a.m., New York time, on the first (1st) Business Day on which the conditions
to the Closing set forth in Sections 6 and 7 below are satisfied or waived (or such other date as is mutually agreed to by the Company
and each Buyer). As used herein &ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial
banks in The City of New York are authorized or required by law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>,
<U>however</U>, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay
at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp; or any other similar orders or restrictions
or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer
systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Purchase Price</U><FONT STYLE="font-size: 10pt"></FONT>.
The aggregate purchase price for the Preferred Shares and the Warrants to be purchased by each Buyer (the &ldquo;<B>Purchase Price</B>&rdquo;)
shall be the amount set forth opposite such Buyer&rsquo;s name in column (5) on the Schedule of Buyers, which may be satisfied in cash,
in exchange for other securities and/or by the cancellation of amounts owed by the Company to any such Buyer (with such aggregate amounts
owed credited against the Purchase Price on a dollar-for-dollar basis), as the Company and such applicable Buyer shall mutually agree.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Form of Payment</U><FONT STYLE="font-size: 10pt"></FONT>.
On the Closing Date, (i) each Buyer shall pay its respective Purchase Price (less, in the case of any Buyer, the amounts withheld pursuant
to Section&nbsp;4(g)) to the Company for the Preferred Shares and the Warrants to be issued and sold to such Buyer at the Closing, and,
to the extent all, or any part, of such Buyer&rsquo;s Purchase Price is being satisfied in cash, such portion to be satisfied in cash
by wire transfer of immediately available funds in accordance with the Flow of Funds Letter (as defined below) and (ii)&nbsp;the Company
shall deliver to each Buyer (A) the aggregate number of Preferred Shares as is set forth opposite such Buyer&rsquo;s name in column (3)
of the Schedule of Buyers, and (B) a Warrant pursuant to which such Buyer shall have the right to initially acquire up to such aggregate
number of Warrant Shares as is set forth opposite such Buyer&rsquo;s name in column (4) of the Schedule of Buyers, in each case, duly
executed on behalf of the Company and registered in the name of such Buyer or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.&nbsp;BUYER&rsquo;S
REPRESENTATIONS AND WARRANTIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Buyer, severally and
not jointly, represents and warrants to the Company with respect to only itself that, as of the date hereof and as of the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Organization;
Authority</U>. Such Buyer is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its
organization with the requisite power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
(as defined below) to which it is a party and otherwise to carry out its obligations hereunder and thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>No Public Sale
or Distribution</U><FONT STYLE="font-size: 10pt"></FONT>. Such Buyer (i) is acquiring its Preferred Shares and Warrants, (ii) upon
conversion of its Preferred Shares will acquire the Conversion Shares issuable upon conversion thereof, and (iii)&nbsp;upon exercise
of its Warrants (other than pursuant to a Cashless Exercise (as defined in the Warrants)) will acquire the Warrant Shares issuable upon
exercise thereof, in each case, for its own account and not with a view towards, or for resale in connection with, the public sale or
distribution thereof in violation of applicable securities laws, except pursuant to sales registered or exempted under the 1933 Act;
provided, however, by making the representations herein, such Buyer does not agree, or make any representation or warranty, to hold any
of the Securities for any minimum or other specific term and reserves the right to dispose of the Securities at any time in accordance
with or pursuant to a registration statement or an exemption from registration under the 1933 Act. Such Buyer does not presently have
any agreement or understanding, directly or indirectly, with any Person to distribute any of the Securities in violation of applicable
securities laws. For purposes of this Agreement, &ldquo;<B>Person</B>&rdquo; means an individual, a limited liability company, a partnership,
a joint venture, a corporation, a trust, an unincorporated organization, any other entity and any Governmental Entity (as defined below)
or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Accredited Investor
Status</U><FONT STYLE="font-size: 10pt"></FONT>. Such Buyer is an &ldquo;accredited investor&rdquo; as that term is defined in
Rule 501(a) of Regulation D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Reliance on Exemptions</U><FONT STYLE="font-size: 10pt"></FONT>.
Such Buyer understands that the Securities are being offered and sold to it in reliance on specific exemptions from the registration
requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of,
and such Buyer&rsquo;s compliance with, the representations, warranties, agreements, acknowledgments and understandings of such Buyer
set forth herein in order to determine the availability of such exemptions and the eligibility of such Buyer to acquire the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Information</U><FONT STYLE="font-size: 10pt"></FONT>.
Such Buyer and its advisors, if any, have been furnished with all materials relating to the business, finances and operations of the
Company and materials relating to the offer and sale of the Securities that have been requested by such Buyer. Such Buyer and its advisors,
if any, have been afforded the opportunity to ask questions of the Company. Neither such inquiries nor any other due diligence investigations
conducted by such Buyer or its advisors, if any, or its representatives shall modify, amend or affect such Buyer&rsquo;s right to rely
on the Company&rsquo;s representations and warranties contained herein. Such Buyer understands that its investment in the Securities
involves a high degree of risk. Such Buyer has sought such accounting, legal and tax advice as it has considered necessary to make an
informed investment decision with respect to its acquisition of the Securities. Such Buyer has determined based on its own independent
review and such professional advice as it deems appropriate that its purchase of the Securities and participation in the transactions
contemplated by this Agreement (i) are fully consistent with its financial needs, objectives and condition, (ii) comply and are fully
consistent with all investment policies, guidelines and other restrictions applicable to it, (iii) have been duly authorized and approved
by all necessary action, (iv) do not and will not violate or constitute a default under its charter, by-laws or other constituent document
or under any law, rule, regulation, agreement or other obligation by which it is bound and (v) are a fit, proper and suitable investment
for such Buyer, notwithstanding the substantial risks inherent in investing in or holding the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>No Governmental
Review</U><FONT STYLE="font-size: 10pt"></FONT>. Such Buyer understands that no United States federal or state agency or any other
government or governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability
of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Transfer or Resale</U><FONT STYLE="font-size: 10pt"></FONT>.
Such Buyer understands that except as provided in the Registration Rights Agreement and Section 4(h) hereof: (i) the Securities have
not been and are not being registered under the 1933 Act or any state securities laws, and may not be offered for sale, sold, assigned
or transferred unless (A) subsequently registered thereunder, (B) such Buyer shall have delivered to the Company (if requested by the
Company) an opinion of counsel, in a form reasonably acceptable to the Company, to the effect that such Securities to be sold, assigned
or transferred may be sold, assigned or transferred pursuant to an exemption from such registration, or (C) such Buyer provides the Company
with reasonable assurance that such Securities can be sold, assigned or transferred pursuant to Rule 144 or Rule 144A promulgated under
the 1933 Act (or a successor rule thereto) (collectively, &ldquo;<B>Rule 144</B>&rdquo;); (ii) any sale of the Securities made in reliance
on Rule 144 may be made only in accordance with the terms of Rule 144, and further, if Rule 144 is not applicable, any resale of the
Securities under circumstances in which the seller (or the Person through whom the sale is made) may be deemed to be an underwriter (as
that term is defined in the 1933 Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations
of the SEC promulgated thereunder; and (iii) neither the Company nor any other Person is under any obligation to register the Securities
under the 1933 Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder. Notwithstanding
the foregoing, the Securities may be pledged in connection with a bona fide margin account or other loan or financing arrangement secured
by the Securities and such pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities hereunder,
and no Buyer effecting a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise make any
delivery to the Company pursuant to this Agreement or any other Transaction Document, including, without limitation, this Section 2(g).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Validity; Enforcement</U><FONT STYLE="font-size: 10pt"></FONT>.
This Agreement and the Registration Rights Agreement have been duly and validly authorized, executed and delivered on behalf of such
Buyer and shall constitute the legal, valid and binding obligations of such Buyer enforceable against such Buyer in accordance with their
respective terms, except as such enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors&rsquo;
rights and remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>No Conflicts</U><FONT STYLE="font-size: 10pt"></FONT>.
The execution, delivery and performance by such Buyer of this Agreement and the Registration Rights Agreement and the consummation by
such Buyer of the transactions contemplated hereby and thereby will not (i) result in a violation of the organizational documents of
such Buyer, or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument
to which such Buyer is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal
and state securities laws) applicable to such Buyer, except in the case of clauses (ii) and (iii) above, for such conflicts, defaults,
rights or violations which could not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the
ability of such Buyer to perform its obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Residency</U>.
Such Buyer is a resident of that jurisdiction specified below as its address on the Schedule of Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.&nbsp;REPRESENTATIONS
AND WARRANTIES OF THE COMPANY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company represents and
warrants to each of the Buyers that, as of the date hereof and as of the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Organization
and Qualification</U><FONT STYLE="font-size: 10pt"></FONT>. Each of the Company and each of its Subsidiaries are entities duly
organized and validly existing and in good standing under the laws of the jurisdiction in which they are formed, and have the requisite
power and authority to own their properties and to carry on their business as now being conducted and as presently proposed to be conducted.
Each of the Company and each of its Subsidiaries is duly qualified as a foreign entity to do business and is in good standing in every
jurisdiction in which its ownership of property or the nature of the business conducted by it makes such qualification necessary, except
to the extent that the failure to be so qualified or be in good standing would not reasonably be expected to have a Material Adverse
Effect (as defined below). As used in this Agreement, &ldquo;<B>Material Adverse Effect</B>&rdquo; means any material adverse effect
on (i) the business, properties, assets, liabilities, operations (including results thereof), condition (financial or otherwise) or prospects
of the Company or any Subsidiary, taken as a whole, (ii) the transactions contemplated hereby or in any of the other Transaction Documents
or any other agreements or instruments to be entered into in connection herewith or therewith or (iii) the authority or ability of the
Company or any of its Subsidiaries to perform any of their respective obligations under any of the Transaction Documents. Other than
the Persons (as defined below) set forth on <U>Schedule&nbsp;3(a)</U>, the Company has no Subsidiaries. &ldquo;<B>Subsidiaries</B>&rdquo;
means any Person in which the Company, directly or indirectly, (I) owns any of the outstanding capital stock or holds any equity or similar
interest of such Person or (II) controls or operates all or any part of the business, operations or administration of such Person, and
each of the foregoing, is individually referred to herein as a &ldquo;<B>Subsidiary</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Authorization;
Enforcement; Validity</U><FONT STYLE="font-size: 10pt"></FONT>. The Company has the requisite power and authority to enter into
and perform its obligations under this Agreement and the other Transaction Documents and to issue the Securities in accordance with the
terms hereof and thereof. The execution and delivery of this Agreement and the other Transaction Documents by the Company, and the consummation
by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Preferred Shares
and the reservation for issuance and issuance of the Conversion Shares issuable upon conversion of the Preferred Shares and the issuance
of the Warrants and the reservation for issuance and issuance of the Warrant Shares issuable upon exercise of the Warrants) have been
duly authorized by the Company&rsquo;s board of directors or other governing body, as applicable, and (other than the filing with the
SEC of one or more Registration Statements (as defined in the Registration Rights Agreement) in accordance with the requirements of the
Registration Rights Agreement, a Form D with the SEC and any other filings as may be required by any state securities agencies) no further
filing, consent or authorization is required by the Company, its Subsidiaries, their respective boards of directors or their stockholders
or other governing body. This Agreement has been, and the other Transaction Documents to which it is a party will be prior to the Closing,
duly executed and delivered by the Company, and each constitutes the legal, valid and binding obligations of the Company, enforceable
against the Company in accordance with its respective terms, except as such enforceability may be limited by general principles of equity
or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the
enforcement of applicable creditors&rsquo; rights and remedies and except as rights to indemnification and to contribution may be limited
by federal or state securities law. The Certificate of Designations in the form attached hereto as Exhibit A has been filed with the
Secretary of State of the State of Delaware and is in full force and effect, enforceable against the Company in accordance with its terms
and has not have been amended. &ldquo;<B>Transaction Documents</B>&rdquo; means, collectively, this Agreement, the Preferred Shares,
the Warrants, the Certificate of Designations, the Registration Rights Agreement, the Irrevocable Transfer Agent Instructions (as defined
below) and each of the other agreements and instruments entered into or delivered by any of the parties hereto in connection with the
transactions contemplated hereby and thereby, as may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Issuance
of Securities</U>. The issuance of the Preferred Shares and the Warrants are duly authorized and upon issuance in accordance with the
terms of the Transaction Documents shall be validly issued, fully paid and non-assessable and free from all preemptive or similar rights,
mortgages, defects, claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other encumbrances
(collectively &ldquo;<B>Liens</B>&rdquo;) with respect to the issuance thereof. As of the Closing, the Company shall have reserved from
its duly authorized capital stock not less than 150% of the sum of (i) the maximum number of Conversion Shares issuable upon conversion
of the Preferred Shares (assuming for purposes hereof that (x) the Preferred Shares are convertible at the Alternate Conversion Price
(as defined in the Certificate of Designations) then in effect assuming an Alternate Conversion Date (as defined in the Certificate of
Designations) as of the date hereof and (y) any such conversion shall not take into account any limitations on the conversion of the Series
E Preferred Stock set forth in the Certificate of Designations), and (ii) the maximum number of Warrant Shares initially issuable upon
exercise of the Warrants (without taking into account any limitations on the exercise of the Warrants set forth therein). Upon issuance
or conversion in accordance with the Certificate of Designations or exercise in accordance with the Warrants (as the case may be), the
Conversion Shares and the Warrant Shares, respectively, when issued, will be validly issued, fully paid and nonassessable and free from
all preemptive or similar rights or Liens with respect to the issue thereof, with the holders being entitled to all rights accorded to
a holder of Common Stock. Subject to the accuracy of the representations and warranties of the Buyers in this Agreement, the offer and
issuance by the Company of the Securities is exempt from registration under the 1933 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>No Conflicts</U><FONT STYLE="font-size: 10pt"></FONT>.
The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company of the transactions
contemplated hereby and thereby (including, without limitation, the issuance of the Preferred Shares, the Warrants, the Conversion Shares
and the Warrant Shares and the reservation for issuance of the Conversion Shares and the Warrant Shares) will not (i) result in a violation
of the Certificate of Incorporation (as defined below) (including, without limitation, any certificate of designation contained therein),
Bylaws (as defined below), certificate of formation, memorandum of association, articles of association, bylaws or other organizational
documents of the Company or any of its Subsidiaries, or any capital stock or other securities of the Company or any of its Subsidiaries,
(ii) except as set forth in <U>Schedule 3(d)</U>, conflict with, or constitute a default (or an event which with notice or lapse of time
or both would become a default) in any respect under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party, or (iii) result in a violation
of any law, rule, regulation, order, judgment or decree (including, without limitation, foreign, federal and state securities laws and
regulations and the rules and regulations of the Nasdaq Capital Market (the <B>&ldquo;Principal Market</B>&rdquo;) and including all
applicable foreign, federal and state laws, rules and regulations) applicable to the Company or any of its Subsidiaries or by which any
property or asset of the Company or any of its Subsidiaries is bound or affected, except in the case of clauses (ii) and (iii) above,
for such conflicts, defaults, rights or violations which could not, individually or in the aggregate, reasonably be expected to have
a material adverse effect on the ability of the Company to perform its obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Consents</U><FONT STYLE="font-size: 10pt"></FONT>.
Neither the Company nor any Subsidiary is required to obtain any consent from, authorization or order of, or make any filing or registration
with (other than the filing with the SEC of one or more Registration Statements in accordance with the requirements of the Registration
Rights Agreement, a Form D with the SEC and any other filings as may be required by any state securities agencies), any Governmental
Entity (as defined below) or any regulatory or self-regulatory agency or, except as set forth on <U>Schedule 3(e)</U>, any other Person
in order for it to execute, deliver or perform any of its respective obligations under or contemplated by the Transaction Documents,
in each case, in accordance with the terms hereof or thereof. All consents, authorizations, orders, filings and registrations which the
Company or any Subsidiary is required to obtain pursuant to the preceding sentence have been or will be obtained or effected on or prior
to the Closing Date, and neither the Company nor any of its Subsidiaries are aware of any facts or circumstances which might prevent
the Company or any of its Subsidiaries from obtaining or effecting any of the registration, application or filings contemplated by the
Transaction Documents. Except as set forth the SEC Documents, the Company is not in violation of the requirements of the Principal Market
and has no knowledge of any facts or circumstances which could reasonably lead to delisting or suspension of the Common Stock in the
foreseeable future. &ldquo;<B>Governmental Entity</B>&rdquo; means any nation, state, county, city, town, village, district, or other
political jurisdiction of any nature, federal, state, local, municipal, foreign, or other government, governmental or quasi-governmental
authority of any nature (including any governmental agency, branch, department, official, or entity and any court or other tribunal),
multi-national organization or body; or body exercising, or entitled to exercise, any administrative, executive, judicial, legislative,
police, regulatory, or taxing authority or power of any nature or instrumentality of any of the foregoing, including any entity or enterprise
owned or controlled by a government or a public international organization or any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Acknowledgment
Regarding Buyer&rsquo;s Purchase of Securities</U><FONT STYLE="font-size: 10pt"></FONT>. The Company acknowledges and agrees that
each Buyer is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions
contemplated hereby and thereby and that no Buyer is (i) an officer or director of the Company or any of its Subsidiaries, (ii) an &ldquo;affiliate&rdquo;
(as defined in Rule 144) of the Company or any of its Subsidiaries or (iii) to its knowledge, a &ldquo;beneficial owner&rdquo; of more
than 10% of the shares of Common Stock (as defined for purposes of Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the
&ldquo;<B>1934 Act</B>&rdquo;)). The Company further acknowledges that no Buyer is acting as a financial advisor or fiduciary of the
Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated
hereby and thereby, and any advice given by a Buyer or any of its representatives or agents in connection with the Transaction Documents
and the transactions contemplated hereby and thereby is merely incidental to such Buyer&rsquo;s purchase of the Securities. The Company
further represents to each Buyer that the Company&rsquo;s decision to enter into the Transaction Documents to which it is a party has
been based solely on the independent evaluation by the Company and its respective representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>No General Solicitation;
Placement Agent&rsquo;s Fees</U><FONT STYLE="font-size: 10pt"></FONT>. Neither the Company, nor any of its Subsidiaries or affiliates,
nor any Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning
of Regulation D) in connection with the offer or sale of the Securities. The Company shall be responsible for the payment of any placement
agent&rsquo;s fees, financial advisory fees, or brokers&rsquo; commissions (other than for Persons engaged by any Buyer or its investment
advisor) relating to or arising out of the transactions contemplated hereby. The Company shall pay, and hold each Buyer harmless against,
any liability, loss or expense (including, without limitation, attorney&rsquo;s fees and out-of-pocket expenses) arising in connection
with any such claim. Neither the Company nor any of its Subsidiaries has engaged any placement agent or other agent in connection with
the offer or sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>No Integrated
Offering</U><FONT STYLE="font-size: 10pt"></FONT>. None of the Company, its Subsidiaries or any of their affiliates, nor any Person
acting on their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would require registration of the issuance of any of the Securities under the 1933 Act, whether through integration
with prior offerings or otherwise, or cause this offering of the Securities to require approval of stockholders of the Company for purposes
of the 1933 Act or under any applicable stockholder approval provisions, including, without limitation, under the rules and regulations
of any exchange or automated quotation system on which any of the securities of the Company are listed or designated for quotation. None
of the Company, its Subsidiaries, their affiliates nor any Person acting on their behalf will take any action or steps that would require
registration of the issuance of any of the Securities under the 1933 Act or cause the offering of any of the Securities to be integrated
with other offerings of securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Dilutive Effect</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company understands and acknowledges that the number of Conversion Shares and Warrant Shares will increase in certain circumstances.
The Company further acknowledges that its obligation to issue the Conversion Shares pursuant to the terms of the Certificate of Designations
in accordance with this Agreement and the Certificate of Designations and the Warrant Shares upon exercise of the Warrants in accordance
with this Agreement and the Warrants is, in each case, absolute and unconditional regardless of the dilutive effect that such issuance
may have on the ownership interests of other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Application of
Takeover Protections; Rights Agreement</U><FONT STYLE="font-size: 10pt"></FONT>. The Company and its board of directors have taken
all necessary action, if any, in order to render inapplicable any control share acquisition, interested stockholder, business combination,
poison pill (including, without limitation, any distribution under a rights agreement), stockholder rights plan or other similar anti-takeover
provision under the Certificate of Incorporation, Bylaws or other organizational documents or the laws of the jurisdiction of its incorporation
or otherwise which is or could become applicable to any Buyer as a result of the transactions contemplated by this Agreement, including,
without limitation, the Company&rsquo;s issuance of the Securities and any Buyer&rsquo;s ownership of the Securities. The Company and
its board of directors have taken all necessary action, if any, in order to render inapplicable any stockholder rights plan or similar
arrangement relating to accumulations of beneficial ownership of shares of Common Stock or a change in control of the Company or any
of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>SEC Documents;
Financial Statements</U><FONT STYLE="font-size: 10pt"></FONT>. Except as set forth on <U>Schedule 3(k)</U>, during the two (2)
years prior to the date hereof, the Company has timely filed all reports, schedules, forms, proxy statements, statements and other documents
required to be filed by it with the SEC pursuant to the reporting requirements of the 1934 Act (all of the foregoing filed prior to the
date hereof and all exhibits and appendices included therein and financial statements, notes and schedules thereto and documents incorporated
by reference therein being hereinafter referred to as the &ldquo;<B>SEC Documents</B>&rdquo;). The Company has delivered or has made
available to the Buyers or their respective representatives true, correct and complete copies of each of the SEC Documents not available
on the EDGAR system. As of their respective dates, the SEC Documents complied in all material respects with the requirements of the 1934
Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at
the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. As of their respective dates, the financial statements of the Company included in the SEC Documents complied in all material
respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto as in effect
as of the time of filing. Such financial statements have been prepared in accordance with generally accepted accounting principles (&ldquo;<B>GAAP</B>&rdquo;),
consistently applied, during the periods involved (except (i) as may be otherwise indicated in such financial statements or the notes
thereto, or (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary
statements) and fairly present in all material respects the financial position of the Company as of the dates thereof and the results
of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments
which will not be material, either individually or in the aggregate). The reserves, if any, established by the Company or the lack of
reserves, if applicable, are reasonable based upon facts and circumstances known by the Company on the date hereof and there are no loss
contingencies that are required to be accrued by the Statement of Financial Accounting Standard No. 5 of the Financial Accounting Standards
Board which are not provided for by the Company in its financial statements or otherwise. No other information provided by or on behalf
of the Company to any of the Buyers which is not included in the SEC Documents (including, without limitation, information referred to
in Section&nbsp;2(e) of this Agreement or in the disclosure schedules to this Agreement) contains any untrue statement of a material
fact or omits to state any material fact necessary in order to make the statements therein not misleading, in the light of the circumstance
under which they are or were made. The Company is not currently contemplating to amend or restate any of the financial statements (including,
without limitation, any notes or any letter of the independent accountants of the Company with respect thereto) included in the SEC Documents
(the &ldquo;<B>Financial Statements</B>&rdquo;), nor is the Company currently aware of facts or circumstances which would require the
Company to amend or restate any of the Financial Statements, in each case, in order for any of the Financials Statements to be in compliance
with GAAP and the rules and regulations of the SEC. The Company has not been informed by its independent accountants that they recommend
that the Company amend or restate any of the Financial Statements or that there is any need for the Company to amend or restate any of
the Financial Statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Absence of Certain
Changes</U><FONT STYLE="font-size: 10pt"></FONT>. Since the date of the Company&rsquo;s most recent audited financial statements
contained in a Form 10-K, there has been no material adverse change and no material adverse development in the business, assets, liabilities,
properties, operations (including results thereof), condition (financial or otherwise) or prospects of the Company or any of its Subsidiaries,
except as set forth in the SEC Documents or <U>Schedule 3(l)</U>. Since the date of the Company&rsquo;s most recent audited financial
statements contained in a Form 10-K, neither the Company nor any of its Subsidiaries has (i) declared or paid any dividends, (ii) sold
any assets, individually or in the aggregate, outside of the ordinary course of business or (iii) made any capital expenditures, individually
or in the aggregate, outside of the ordinary course of business, except as set forth in the SEC Documents or <U>Schedule 3(l)</U>. Neither
the Company nor any of its Subsidiaries has taken any steps to seek protection pursuant to any law or statute relating to bankruptcy,
insolvency, reorganization, receivership, liquidation or winding up, nor does the Company or any Subsidiary have any knowledge or reason
to believe that any of their respective creditors intend to initiate involuntary bankruptcy proceedings or any actual knowledge of any
fact which would reasonably lead a creditor to do so. The Company and its Subsidiaries, individually and on a consolidated basis, after
giving effect to the transactions contemplated hereby to occur at the Closing, will not be Insolvent (as defined below). For purposes
of this Section 3(l), &ldquo;<B>Insolvent</B>&rdquo; means, (i) with respect to the Company and its Subsidiaries, on a consolidated basis,
(A) the present fair saleable value of the Company&rsquo;s and its Subsidiaries&rsquo; assets is less than the amount required to pay
the Company&rsquo;s and its Subsidiaries&rsquo; total Indebtedness (as defined below), (B) the Company and its Subsidiaries are unable
to pay their debts and liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured
or (C) the Company and its Subsidiaries intend to incur or believe that they will incur debts that would be beyond their ability to pay
as such debts mature; and (ii) with respect to the Company and each Subsidiary, individually, (A) the present fair saleable value of
the Company&rsquo;s or such Subsidiary&rsquo;s (as the case may be) assets is less than the amount required to pay its respective total
Indebtedness, (B) the Company or such Subsidiary (as the case may be) is unable to pay its respective debts and liabilities, subordinated,
contingent or otherwise, as such debts and liabilities become absolute and matured or (C) the Company or such Subsidiary (as the case
may be) intends to incur or believes that it will incur debts that would be beyond its respective ability to pay as such debts mature.
Neither the Company nor any of its Subsidiaries has engaged in any business or in any transaction, and is not about to engage in any
business or in any transaction, for which the Company&rsquo;s or such Subsidiary&rsquo;s remaining assets constitute unreasonably small
capital with which to conduct the business in which it is engaged as such business is now conducted and is proposed to be conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>No Undisclosed
Events, Liabilities, Developments or Circumstances</U><FONT STYLE="font-size: 10pt"></FONT>. Except as set forth on <U>Schedule
3(m)</U> or as set forth in the SEC Documents, to the Company&rsquo;s knowledge, no event, liability, development or circumstance has
occurred or exists, or is reasonably expected to exist or occur with respect to the Company, any of its Subsidiaries or any of their
respective businesses, properties, liabilities, prospects, operations (including results thereof) or condition (financial or otherwise),
that (i) would be required to be disclosed by the Company under applicable securities laws on a registration statement on Form S-1 filed
with the SEC relating to an issuance and sale by the Company of its Common Stock and which has not been publicly announced, (ii) could
have a material adverse effect on any Buyer&rsquo;s investment hereunder or (iii) could have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Conduct of Business;
Regulatory Permits</U><FONT STYLE="font-size: 10pt"></FONT>. Neither the Company nor any of its Subsidiaries is in violation of
any term of or in default under its Certificate of Incorporation, any certificate of designation, preferences or rights of any other
outstanding series of preferred stock of the Company or any of its Subsidiaries or Bylaws or their organizational charter, certificate
of formation, memorandum of association, articles of association, Certificate of Incorporation or certificate of incorporation or bylaws,
respectively. Neither the Company nor any of its Subsidiaries is in violation of any judgment, decree or order or any statute, ordinance,
rule or regulation applicable to the Company or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries will conduct
its business in violation of any of the foregoing, except in all cases for possible violations which could not, individually or in the
aggregate, have a Material Adverse Effect. Except as set forth in the SEC Documents, without limiting the generality of the foregoing,
the Company is not in violation of any of the rules, regulations or requirements of the Principal Market and has no knowledge of any
facts or circumstances that could reasonably lead to delisting or suspension of the Common Stock by the Principal Market in the foreseeable
future. Except as set forth in the SEC Documents, during the two years prior to the date hereof, (i) the Common Stock has been listed
or designated for quotation on the Principal Market, (ii) trading in the Common Stock has not been suspended by the SEC or the Principal
Market and (iii) the Company has received no communication, written or oral, from the SEC or the Principal Market regarding the suspension
or delisting of the Common Stock from the Principal Market. The Company and each of its Subsidiaries possess all certificates, authorizations
and permits issued by the appropriate regulatory authorities necessary to conduct their respective businesses, except where the failure
to possess such certificates, authorizations or permits would not have, individually or in the aggregate, a Material Adverse Effect,
and neither the Company nor any such Subsidiary has received any notice of proceedings relating to the revocation or modification of
any such certificate, authorization or permit. There is no agreement, commitment, judgment, injunction, order or decree binding upon
the Company or any of its Subsidiaries or to which the Company or any of its Subsidiaries is a party which has or would reasonably be
expected to have the effect of prohibiting or materially impairing any business practice of the Company or any of its Subsidiaries, any
acquisition of property by the Company or any of its Subsidiaries or the conduct of business by the Company or any of its Subsidiaries
as currently conducted other than such effects, individually or in the aggregate, which have not had and would not reasonably be expected
to have a Material Adverse Effect on the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)<U>&nbsp;Foreign Corrupt
Practices</U>. Neither the Company, the Company&rsquo;s subsidiary or any director, officer, agent, employee, nor any other person acting
for or on behalf of the foregoing (individually and collectively, a &ldquo;<B>Company Affiliate</B>&rdquo;) have violated the U.S. Foreign
Corrupt Practices Act (the &ldquo;<B>FCPA</B>&rdquo;) or any other applicable anti-bribery or anti-corruption laws, nor has any Company
Affiliate offered, paid, promised to pay, or authorized the payment of any money, or offered, given, promised to give, or authorized
the giving of anything of value, to any officer, employee or any other person acting in an official capacity for any Governmental Entity
to any political party or official thereof or to any candidate for political office (individually and collectively, a &ldquo;<B>Government
Official</B>&rdquo;) or to any person under circumstances where such Company Affiliate knew or was aware of a high probability that all
or a portion of such money or thing of value would be offered, given or promised, directly or indirectly, to any Government Official,
for the purpose of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;(A)
influencing any act or decision of such Government Official in his/her official capacity, (B) inducing such Government Official to do
or omit to do any act in violation of his/her lawful duty, (C) securing any improper advantage, or (D) inducing such Government Official
to influence or affect any act or decision of any Governmental Entity, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii)&nbsp;assisting
the Company or its Subsidiaries in obtaining or retaining business for or with, or directing business to, the Company or its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Sarbanes-Oxley
Act</U><FONT STYLE="font-size: 10pt"></FONT>. The Company and each Subsidiary is in compliance with any and all applicable requirements
of the Sarbanes-Oxley Act of 2002, as amended, and any and all applicable rules and regulations promulgated by the SEC thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;<U>Transactions
With Affiliates</U><FONT STYLE="font-size: 10pt"></FONT>. Except as disclosed in the SEC Documents, as would not require disclosure
pursuant to Item 404(a) of Regulation S-K or as set forth on <U>Schedule 3(q)</U>, no current or former employee, partner, director,
officer or stockholder (direct or indirect) of the Company or its Subsidiaries, or any associate, or, to the knowledge of the Company,
any affiliate of any thereof, or any relative with a relationship no more remote than first cousin of any of the foregoing, is presently,
or has ever been, (i) a party to any transaction with the Company or its Subsidiaries (including any contract, agreement or other arrangement
providing for the furnishing of services by, or rental of real or personal property from, or otherwise requiring payments to, any such
director, officer or stockholder or such associate or affiliate or relative Subsidiaries (other than for ordinary course services as
employees, officers or directors of the Company or any of its Subsidiaries)) or (ii) the direct or indirect owner of an interest in any
corporation, firm, association or business organization which is a competitor, supplier or customer of the Company or its Subsidiaries
(except for a passive investment (direct or indirect) in less than 5% of the common stock of a company whose securities are traded on
or quoted through an Eligible Market (as defined below)), nor does any such Person receive income from any source other than the Company
or its Subsidiaries which relates to the business of the Company or its Subsidiaries or should properly accrue to the Company or its
Subsidiaries. No employee, officer, stockholder or director of the Company or any of its Subsidiaries or member of his or her immediate
family is indebted to the Company or its Subsidiaries, as the case may be, nor is the Company or any of its Subsidiaries indebted (or
committed to make loans or extend or guarantee credit) to any of them, other than (i) for payment of salary for services rendered, (ii)
reimbursement for reasonable expenses incurred on behalf of the Company, and (iii) for other standard employee benefits made generally
available to all employees or executives (including stock option agreements outstanding under any stock option plan approved by the Board
of Directors of the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)&nbsp;<U>Equity
Capitalization.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Definitions</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(A)&nbsp;&ldquo;<B>Common
Stock</B>&rdquo; means (x)&nbsp;the Company&rsquo;s shares of common stock, $0.00001 par value per share, and (y) any capital stock into
which such common stock shall have been changed or any share capital resulting from a reclassification of such common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(B)&nbsp;&ldquo;<B>Preferred
Stock</B>&rdquo; means (x) the Company&rsquo;s blank check preferred stock, $0.00001 par value per share, the terms of which may be designated
by the board of directors of the Company in a certificate of designations and (y) any capital stock into which such preferred stock shall
have been changed or any share capital resulting from a reclassification of such preferred stock (other than a conversion of such preferred
stock into Common Stock in accordance with the terms of such certificate of designations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Authorized
and Outstanding Capital Stock</U>. As of the date hereof, the authorized capital stock of the Company consists of (A) 250,000,000 shares
of Common Stock, of which, 1,550,132 shares are issued and outstanding and 15,991,564 shares are reserved for issuance pursuant to Convertible
Securities (as defined below) (other than the Preferred Shares and the Warrants) exercisable or exchangeable for, or convertible into,
shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, of which, 1,150,000 shares have been designated as Series Seed Preferred
Stock, none of which are issued and outstanding, 10,000 shares have been designated as Series A Preferred Stock, none of which shares
are issued and outstanding, 2,700,000 shares have been designated as Series B Preferred Stock, none of which shares are issued and outstanding,
10,000 shares have been designated as Series C Preferred Stock, 7 of which are issued and outstanding, and 32,000 shares have been designated
as Series D Preferred Stock, 16,343 of which are issued and outstanding. 152 shares of Common Stock are held in the treasury of the Company.
&ldquo;<B>Convertible Securities</B>&rdquo; means any capital stock or other security of the Company or any of its Subsidiaries that is
at any time and under any circumstances directly or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles
the holder thereof to acquire, any capital stock or other security of the Company (including, without limitation, Common Stock) or any
of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;<U>Valid
Issuance; Available Shares; Affiliates</U>. All of such outstanding shares are duly authorized and have been, or upon issuance will be,
validly issued and are fully paid and nonassessable. <U>Schedule 3(r)(iii)</U> sets forth the number of shares of Common Stock that are
(A) reserved for issuance pursuant to Convertible Securities (other than the Preferred Shares and the Warrants and shares to be issued
under the Company&rsquo;s Stock Option and Incentive Plan) and (B) that are, as of the date hereof, owned by Persons who are &ldquo;affiliates&rdquo;
(as defined in Rule 405 of the 1933 Act and calculated based on the assumption that only officers, directors and holders of at least 10%
of the Company&rsquo;s issued and outstanding Common Stock are &ldquo;affiliates&rdquo; without conceding that any such Persons are &ldquo;affiliates&rdquo;
for purposes of federal securities laws) of the Company or any of its Subsidiaries. To the Company&rsquo;s knowledge, except as set forth
on <U>Schedule 3(r)(iii)</U>, no Person owns 10% or more of the Company&rsquo;s issued and outstanding shares of Common Stock (calculated
based on the assumption that all Convertible Securities, whether or not presently exercisable or convertible, have been fully exercised&nbsp;or
converted&nbsp;(as the case may be) taking account of any limitations on exercise or conversion (including &ldquo;blockers&rdquo;) contained
therein without conceding that such identified Person is a 10% stockholder for purposes of federal securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;<U>Existing
Securities; Obligations</U>. Except as disclosed in the SEC Documents or <U>Schedule 3(r)(iv)</U>: (A) none of the Company&rsquo;s or
any Subsidiary&rsquo;s shares, interests or capital stock is subject to preemptive rights or any other similar rights or Liens suffered
or permitted by the Company or any Subsidiary; (B) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any
shares, interests or capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements
by which the Company or any of its Subsidiaries is or may become bound to issue additional shares, interests or capital stock of the Company
or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities or rights convertible into, or exercisable or exchangeable for, any shares, interests or capital stock of the Company
or any of its Subsidiaries; (C) there are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated
to register the sale of any of their securities under the 1933 Act (except pursuant to the Registration Rights Agreement); (D) there are
no outstanding securities or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions,
and there are no contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become
bound to redeem a security of the Company or any of its Subsidiaries; (E) there are no securities or instruments containing anti-dilution
or similar provisions that will be triggered by the issuance of the Securities; and (F) neither the Company nor any Subsidiary has any
stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Organizational
Documents</U>. The Company has furnished to the Buyers true, correct and complete copies of the Company&rsquo;s Certificate of Incorporation,
as amended and as in effect on the date hereof (the &ldquo;<B>Certificate of Incorporation</B>&rdquo;), and the Company&rsquo;s bylaws,
as amended and as in effect on the date hereof (the &ldquo;<B>Bylaws</B>&rdquo;), and the terms of all Convertible Securities and the
material rights of the holders thereof in respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)&nbsp;<U>Indebtedness
and Other Contracts</U><FONT STYLE="font-size: 10pt"></FONT>. Except as disclosed in the SEC Documents or on <U>Schedule&nbsp;3(s)</U>,
neither the Company nor any of its Subsidiaries, (i) has any outstanding debt securities, notes, credit agreements, credit facilities
or other agreements, documents or instruments evidencing Indebtedness of the Company or any of its Subsidiaries or by which the Company
or any of its Subsidiaries is or may become bound, (ii) is a party to any contract, agreement or instrument, the violation of which,
or default under which, by the other party(ies) to such contract, agreement or instrument could reasonably be expected to result in a
Material Adverse Effect, (iii) has any financing statements securing obligations in any amounts filed in connection with the Company
or any of its Subsidiaries; (iv) is in violation of any term of, or in default under, any contract, agreement or instrument relating
to any Indebtedness, except where such violations and defaults would not result, individually or in the aggregate, in a Material Adverse
Effect, or (v) is a party to any contract, agreement or instrument relating to any Indebtedness, the performance of which, in the judgment
of the Company&rsquo;s officers, has or is expected to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries
have any liabilities or obligations required to be disclosed in the SEC Documents which are not so disclosed in the SEC Documents, other
than those incurred in the ordinary course of the Company&rsquo;s or its Subsidiaries&rsquo; respective businesses and which, individually
or in the aggregate, do not or could not have a Material Adverse Effect. For purposes of this Agreement: (x) &ldquo;<B>Indebtedness</B>&rdquo;
of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed as
the deferred purchase price of property or services (including, without limitation, &ldquo;capital leases&rdquo; in accordance with GAAP)
(other than trade payables entered into in the ordinary course of business consistent with past practice), (C) all reimbursement or payment
obligations with respect to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds,
debentures or similar instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets
or businesses, (E) all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as
financing, in either case with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights
and remedies of the seller or bank under such agreement in the event of default are limited to repossession or sale of such property),
(F) all monetary obligations under any leasing or similar arrangement which, in connection with GAAP, consistently applied for the periods
covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above secured by (or for
which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien upon or in any property
or assets (including accounts and contract rights) owned by any Person, even though the Person which owns such assets or property has
not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in respect of indebtedness or obligations
of others of the kinds referred to in clauses (A) through (G) above; and (y) &ldquo;<B>Contingent Obligation</B>&rdquo; means, as to
any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect to any Indebtedness, lease, dividend
or other obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the primary effect
thereof, is to provide assurance to the obligee of such liability that such liability will be paid or discharged, or that any agreements
relating thereto will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with
respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t)&nbsp;<U>Litigation</U><FONT STYLE="font-size: 10pt"></FONT>.
There is no action, suit, arbitration, proceeding, inquiry or investigation before or by the Principal Market, any court, public board,
other Governmental Entity, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting
the Company or any of its Subsidiaries, the Common Stock or any of the Company&rsquo;s or its Subsidiaries&rsquo; officers or directors,
whether of a civil or criminal nature or otherwise, in their capacities as such, except as set forth in <U>Schedule 3(t)</U>. No director,
officer or employee of the Company or any of its subsidiaries has willfully violated 18 U.S.C. &sect;1519 or engaged in spoliation in
reasonable anticipation of litigation. Without limitation of the foregoing, there has not been, and to the knowledge of the Company,
there is not pending or contemplated, any investigation by the SEC involving the Company, any of its Subsidiaries or any current or former
director or officer of the Company or any of its Subsidiaries. The SEC has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Company under the 1933 Act or the 1934 Act. After reasonable inquiry of its employees, the
Company is not aware of any fact which might result in or form the basis for any such action, suit, arbitration, investigation, inquiry
or other proceeding. Neither the Company nor any of its Subsidiaries is subject to any order, writ, judgment, injunction, decree, determination
or award of any Governmental Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u)&nbsp;<U>Insurance</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and its
Subsidiaries are engaged. Neither the Company nor any such Subsidiary has been refused any insurance coverage sought or applied for,
and neither the Company nor any such Subsidiary has any reason to believe that it will be unable to renew its existing insurance coverage
as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at
a cost that would not have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Employee Relations</U><FONT STYLE="font-size: 10pt"></FONT>.
Neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement or employs any member of a union. The
Company and its Subsidiaries believe that their relations with their employees are good. No executive officer (as defined in Rule 501(f)
promulgated under the 1933 Act) or other key employee of the Company or any of its Subsidiaries has notified the Company or any such
Subsidiary that such officer intends to leave the Company or any such Subsidiary or otherwise terminate such officer&rsquo;s employment
with the Company or any such Subsidiary. No current (or former) executive officer or other key employee of the Company or any of its
Subsidiaries is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure
or proprietary information agreement, non-competition agreement, or any other contract or agreement or any restrictive covenant, and
the continued employment of each such executive officer or other key employee (as the case may be) does not subject the Company or any
of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance
with all federal, state, local and foreign laws and regulations respecting labor, employment and employment practices and benefits, terms
and conditions of employment and wages and hours, except where failure to be in compliance would not, either individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w)&nbsp;<U>Title</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Real
Property</U>. Each of the Company and its Subsidiaries holds good title to all real property, leases in real property, facilities or other
interests in real property owned or held by the Company or any of its Subsidiaries (the &ldquo;<B>Real Property</B>&rdquo;) owned by the
Company or any of its Subsidiaries (as applicable). The Real Property is free and clear of all Liens and is not subject to any rights
of way, building use restrictions, exceptions, variances, reservations, or limitations of any nature except for (a) Liens for current
taxes not yet due and (b) zoning laws and other land use restrictions that do not impair the present or anticipated use of the property
subject thereto. Any Real Property held under lease by the Company or any of its Subsidiaries are held by them under valid, subsisting
and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such
property and buildings by the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Fixtures
and Equipment</U>. Each of the Company and its Subsidiaries (as applicable) has good title to, or a valid leasehold interest in, the tangible
personal property, equipment, improvements, fixtures, and other personal property and appurtenances that are used by the Company or its
Subsidiary in connection with the conduct of its business (the &ldquo;<B>Fixtures and Equipment</B>&rdquo;). The Fixtures and Equipment
are structurally sound, are in good operating condition and repair, are adequate for the uses to which they are being put, are not in
need of maintenance or repairs except for ordinary, routine maintenance and repairs and are sufficient for the conduct of the Company&rsquo;s
and/or its Subsidiaries&rsquo; businesses (as applicable) in the manner as conducted prior to the Closing. Each of the Company and its
Subsidiaries owns all of its Fixtures and Equipment free and clear of all Liens except for (a) liens for current taxes not yet due and
(b) zoning laws and other land use restrictions that do not impair the present or anticipated use of the property subject thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x)&nbsp;<U>Intellectual
Property Rights</U><FONT STYLE="font-size: 10pt"></FONT>. The Company and its Subsidiaries own or possess adequate rights or licenses
to use all trademarks, trade names, service marks, service mark registrations, service names, original works of authorship, patents,
patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property
rights and all applications and registrations therefor (&ldquo;<B>Intellectual Property Rights</B>&rdquo;) necessary to conduct their
respective businesses as now conducted and presently proposed to be conducted. Each of patents owned by the Company or any of its Subsidiaries
is listed on <U>Schedule 3(x)(i).</U> Except as set forth in <U>Schedule 3(x)(ii)</U>, none of the Company&rsquo;s Intellectual Property
Rights have expired or terminated or have been abandoned or are expected to expire or terminate or are expected to be abandoned, within
three years from the date of this Agreement. The Company does not have any knowledge of any infringement by the Company or its Subsidiaries
of Intellectual Property Rights of others. There is no claim, action or proceeding being made or brought, or to the knowledge of the
Company or any of its Subsidiaries, being threatened, against the Company or any of its Subsidiaries regarding its Intellectual Property
Rights. Neither the Company nor any of its Subsidiaries is aware of any facts or circumstances which might give rise to any of the foregoing
infringements or claims, actions or proceedings. The Company and its Subsidiaries have taken reasonable security measures to protect
the secrecy, confidentiality and value of all of their Intellectual Property Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y)&nbsp;<U>Environmental
Laws</U>. (i) The Company and its Subsidiaries (A) are in compliance with any and all Environmental Laws (as defined below), (B) have
received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses
and (C) are in compliance with all terms and conditions of any such permit, license or approval where, in each of the foregoing clauses
(A), (B) and (C), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse
Effect. The term &ldquo;<B>Environmental Laws</B>&rdquo; means all federal, state, local or foreign laws relating to pollution or protection
of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface
strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<B>Hazardous Materials</B>&rdquo;) into the environment,
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous
Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice
letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)&nbsp;<U>No
Hazardous Materials</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.8pt; text-align: justify; text-indent: 71.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.8pt; text-align: justify; text-indent: 71.2pt">(A)&nbsp;have
been disposed of or otherwise released from any Real Property of the Company or any of its Subsidiaries in violation of any Environmental
Laws; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.8pt; text-align: justify; text-indent: 71.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72.8pt; text-align: justify; text-indent: 71.2pt">(B)&nbsp;are
present on, over, beneath, in or upon any Real Property or any portion thereof in quantities that would constitute a violation of any
Environmental Laws. No prior use by the Company or any of its Subsidiaries of any Real Property has occurred that violates any Environmental
Laws, which violation would have a material adverse effect on the business of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;Neither
the Company nor any of its Subsidiaries knows of any other person who or entity which has stored, treated, recycled, disposed of or otherwise
located on any Real Property any Hazardous Materials, including, without limitation, such substances as asbestos and polychlorinated biphenyls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;None
of the Real Properties are on any federal or state &ldquo;Superfund&rdquo; list or Liability Information System (&ldquo;<B>CERCLIS</B>&rdquo;)
list or any state environmental agency list of sites under consideration for CERCLIS, nor subject to any environmental related Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z)&nbsp;<U>Subsidiary Rights</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company or one of its Subsidiaries has the unrestricted right to vote, and (subject to limitations imposed by applicable law) to
receive dividends and distributions on, all capital securities of its Subsidiaries as owned by the Company or such Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa) <U>Tax Status</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company and each of its Subsidiaries (i) has timely made or filed all foreign, federal and state income and all other tax returns,
reports and declarations required by any jurisdiction to which it is subject, (ii) has timely paid all taxes and other governmental assessments
and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being
contested in good faith and (iii) has set aside on its books provision reasonably adequate for the payment of all taxes for periods subsequent
to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due
by the taxing authority of any jurisdiction, and the officers of the Company and its Subsidiaries know of no basis for any such claim.
The Company is not operated in such a manner as to qualify as a passive foreign investment company, as defined in Section 1297 of the
Internal Revenue Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;). The net operating loss carryforwards (&ldquo;<B>NOLs</B>&rdquo;)
for United States federal income tax purposes of the consolidated group of which the Company is the common parent, if any, shall not
be adversely effected by the transactions contemplated hereby. The transactions contemplated hereby do not constitute an &ldquo;ownership
change&rdquo; within the meaning of Section 382 of the Code, thereby preserving the Company&rsquo;s ability to utilize such NOLs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb) <U>Internal Accounting
and Disclosure Controls</U><FONT STYLE="font-size: 10pt"></FONT>. The Company and each of its Subsidiaries maintains internal control
over financial reporting (as such term is defined in Rule 13a-15(f) under the 1934 Act) that is effective to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles, including that (i) transactions are executed in accordance with management&rsquo;s general
or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in accordance
with management&rsquo;s general or specific authorization and (iv) the recorded accountability for assets and liabilities is compared
with the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any difference. The
Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the 1934 Act) that are effective
in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the 1934 Act is recorded,
processed, summarized and reported, within the time periods specified in the rules and forms of the SEC, including, without limitation,
controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits
under the 1934 Act is accumulated and communicated to the Company&rsquo;s management, including its principal executive officer or officers
and its principal financial officer or officers, as appropriate, to allow timely decisions regarding required disclosure. Neither the
Company nor any of its Subsidiaries has received any notice or correspondence from any accountant, Governmental Entity or other Person
relating to any potential material weakness or significant deficiency in any part of the internal controls over financial reporting of
the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc) <U>Off Balance Sheet
Arrangements</U><FONT STYLE="font-size: 10pt"></FONT>. There is no transaction, arrangement, or other relationship between the
Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company
in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd) <U>Investment Company
Status</U><FONT STYLE="font-size: 10pt"></FONT>. The Company is not, and upon consummation of the sale of the Securities will not
be, an &ldquo;investment company,&rdquo; an affiliate of an &ldquo;investment company,&rdquo; a company controlled by an &ldquo;investment
company&rdquo; or an &ldquo;affiliated person&rdquo; of, or &ldquo;promoter&rdquo; or &ldquo;principal underwriter&rdquo; for, an &ldquo;investment
company&rdquo; as such terms are defined in the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee) <U>Acknowledgement Regarding
Buyers&rsquo; Trading Activity</U><FONT STYLE="font-size: 10pt"></FONT>. It is understood and acknowledged by the Company that
(i) following the public disclosure of the transactions contemplated by the Transaction Documents, in accordance with the terms thereof,
none of the Buyers have been asked by the Company or any of its Subsidiaries to agree, nor has any Buyer agreed with the Company or any
of its Subsidiaries, to desist from effecting any transactions in or with respect to (including, without limitation, purchasing or selling,
long and/or short) any securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or
to hold any of the Securities for any specified term; (ii) any Buyer, and counterparties in &ldquo;derivative&rdquo; transactions to
which any such Buyer is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock which
was established prior to such Buyer&rsquo;s knowledge of the transactions contemplated by the Transaction Documents; (iii) each Buyer
shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counterparty in any &ldquo;derivative&rdquo;
transaction; and (iv) each Buyer may rely on the Company&rsquo;s obligation to timely deliver shares of Common Stock upon conversion,
exercise or exchange, as applicable, of the Securities as and when required pursuant to the Transaction Documents for purposes of effecting
trading in the Common Stock of the Company. The Company further understands and acknowledges that following the public disclosure of
the transactions contemplated by the Transaction Documents pursuant to the 8-K Filing (as defined below) one or more Buyers may engage
in hedging and/or trading activities (including, without limitation, the location and/or reservation of borrowable shares of Common Stock)
at various times during the period that the Securities are outstanding, including, without limitation, during the periods that the value
and/or number of the Warrant Shares or Conversion Shares, as applicable, deliverable with respect to the Securities are being determined
and such hedging and/or trading activities (including, without limitation, the location and/or reservation of borrowable shares of Common
Stock), if any, can reduce the value of the existing stockholders&rsquo; equity interest in the Company both at and after the time the
hedging and/or trading activities are being conducted. The Company acknowledges that such aforementioned hedging and/or trading activities
do not constitute a breach of this Agreement, the Certificate of Designations, the Warrants or any other Transaction Document or any
of the documents executed in connection herewith or therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff) <U>Manipulation of Price</U><FONT STYLE="font-size: 10pt"></FONT>.
Neither the Company nor any of its Subsidiaries has, and, to the knowledge of the Company, no Person acting on their behalf has, directly
or indirectly, (i) taken any action designed to cause or to result in the stabilization or manipulation of the price of any security
of the Company or any of its Subsidiaries to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or
paid any compensation for soliciting purchases of, any of the Securities, (iii) paid or agreed to pay to any Person any compensation
for soliciting another to purchase any other securities of the Company or any of its Subsidiaries or (iv) paid or agreed to pay any Person
for research services with respect to any securities of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(gg) <U>U.S. Real Property
Holding Corporation</U><FONT STYLE="font-size: 10pt"></FONT>. Neither the Company nor any of its Subsidiaries is, or has ever been,
and so long as any of the Securities are held by any of the Buyers, shall become, a U.S. real property holding corporation within the
meaning of Section&nbsp;897 of the Code, and the Company and each Subsidiary shall so certify upon any Buyer&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(hh) <U>Registration Eligibility</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company is eligible to register the Registrable Securities (defined in the Registration Rights Agreement) for resale by the Buyers
using Form S-3 promulgated under the 1933 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Transfer Taxes</U><FONT STYLE="font-size: 10pt"></FONT>.
On the Closing Date, all stock transfer or other taxes (other than income or similar taxes) which are required to be paid in connection
with the issuance, sale and transfer of the Securities to be sold to each Buyer hereunder will be, or will have been, fully paid or provided
for by the Company, and all laws imposing such taxes will be or will have been complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(jj) <U>Bank Holding Company
Act</U><FONT STYLE="font-size: 10pt"></FONT>. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<B>BHCA</B>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<B>Federal Reserve</B>&rdquo;). Neither the Company nor any of its Subsidiaries or affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total
equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its
Subsidiaries or affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject
to the BHCA and to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(kk) <U>Shell Company Status</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ll) <U>Illegal or Unauthorized
Payments; Political Contributions</U><FONT STYLE="font-size: 10pt"></FONT>. Neither the Company nor any of its Subsidiaries nor,
to the best of the Company&rsquo;s knowledge (after reasonable inquiry of its officers and directors), any of the officers, directors,
employees, agents or other representatives of the Company or any of its Subsidiaries or any other business entity or enterprise with
which the Company or any Subsidiary is or has been affiliated or associated, has, directly or indirectly, made or authorized any payment,
contribution or gift of money, property, or services, whether or not in contravention of applicable law, (i) as a kickback or bribe to
any Person or (ii) to any political organization, or the holder of or any aspirant to any elective or appointive public office except
for personal political contributions not involving the direct or indirect use of funds of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(mm) <U>Money Laundering</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company and its Subsidiaries are in compliance with, and have not previously violated, the USA Patriot Act of 2001 and all other
applicable U.S. and non-U.S. anti-money laundering laws and regulations, including, without limitation, the laws, regulations and Executive
Orders and sanctions programs administered by the U.S. Office of Foreign Assets Control, including, but not limited, to (i) Executive
Order 13224 of September 23, 2001 entitled, &ldquo;Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to
Commit, or Support Terrorism&rdquo; (66 Fed. Reg. 49079 (2001)); and (ii) any regulations contained in 31 CFR, Subtitle B, Chapter V.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(nn) <U>Management</U><FONT STYLE="font-size: 10pt"></FONT>.
During the past five year period, no current or former officer or director or, to the knowledge of the Company, no current ten percent
(10%) or greater stockholder of the Company or any of its Subsidiaries has been the subject of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;a
petition under bankruptcy laws or any other insolvency or moratorium law or the appointment by a court of a receiver, fiscal agent or
similar officer for such Person, or any partnership in which such person was a general partner at or within two years before the filing
of such petition or such appointment, or any corporation or business association of which such person was an executive officer at or within
two years before the time of the filing of such petition or such appointment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;a
conviction in a criminal proceeding or a named subject of a pending criminal proceeding (excluding traffic violations that do not relate
to driving while intoxicated or driving under the influence);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;any
order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily
enjoining any such person from, or otherwise limiting, the following activities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(1)&nbsp;Acting
as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction
merchant, any other person regulated by the United States Commodity Futures Trading Commission or an associated person of any of the foregoing,
or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment
company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with
such activity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(2)&nbsp;Engaging
in any particular type of business practice; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(3)&nbsp;Engaging
in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of securities
laws or commodities laws;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;any
order, judgment or decree, not subsequently reversed, suspended or vacated, of any authority barring, suspending or otherwise limiting
for more than sixty (60) days the right of any such person to engage in any activity described in the preceding sub paragraph, or to be
associated with persons engaged in any such activity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;a
finding by a court of competent jurisdiction in a civil action or by the SEC or other authority to have violated any securities law, regulation
or decree and the judgment in such civil action or finding by the SEC or any other authority has not been subsequently reversed, suspended
or vacated; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;a
finding by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any federal
commodities law, and the judgment in such civil action or finding has not been subsequently reversed, suspended or vacated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(oo)&nbsp;<U>Stock Option
Plans</U><FONT STYLE="font-size: 10pt"></FONT>. Each stock option granted by the Company was granted (i) in accordance with the
terms of the applicable stock option plan of the Company and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no policy or
practice of the Company to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with,
the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results
or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(pp) <U>No Disagreements
with Accountants and Lawyers</U><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;.
There are no material disagreements of any kind presently existing, or reasonably anticipated by the Company to arise, between the Company
and the accountants and lawyers formerly or presently employed by the Company and the Company is current with respect to any fees owed
to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations under any of the Transaction
Documents. In addition, on or prior to the date hereof, the Company had discussions with its accountants about its financial statements
previously filed with the SEC. Based on those discussions, the Company has no reason to believe that it will need to restate any such
financial statements or any part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(qq) <U>No Disqualification
Events</U><FONT STYLE="font-size: 10pt"></FONT>. With respect to Securities to be offered and sold hereunder in reliance
on Rule 506(b) under the 1933 Act (&ldquo;<B>Regulation D Securities</B>&rdquo;), none of the Company, any of its predecessors, any affiliated
issuer, any director, executive officer, other officer of the Company participating in the offering contemplated hereby, any beneficial
owner of 20% or more of the Company&rsquo;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter
(as that term is defined in Rule 405 under the 1933 Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<B>Issuer
Covered Person</B>&rdquo; and, together, &ldquo;<B>Issuer Covered Persons</B>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo;
disqualifications described in Rule 506(d)(1)(i) to (viii) under the 1933 Act (a &ldquo;<B>Disqualification Event</B>&rdquo;), except
for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any
Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure
obligations under Rule 506(e), and has furnished to the Buyers a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(rr) <U>Other Covered Persons</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company is not aware of any Person that has been or will be paid (directly or indirectly) remuneration for solicitation of Buyers
or potential purchasers in connection with the sale of any Regulation D Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ss) <U>No Additional Agreements</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company does not have any agreement or understanding with any Buyer with respect to the transactions contemplated by the Transaction
Documents other than as specified in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(tt) <U>Public Utility Holding
Act</U><FONT STYLE="font-size: 10pt"></FONT>. None of the Company nor any of its Subsidiaries is a &ldquo;holding company,&rdquo;
or an &ldquo;affiliate&rdquo; of a &ldquo;holding company,&rdquo; as such terms are defined in the Public Utility Holding Act of 2005.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(uu) <U>Federal Power Act</U><FONT STYLE="font-size: 10pt"></FONT>.
None of the Company nor any of its Subsidiaries is subject to regulation as a &ldquo;public utility&rdquo; under the Federal Power Act,
as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vv) <U>Potential Products;
FDA; EMEA.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;The
Company possesses all certificates, authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities
necessary to conduct its business as currently conducted, including without limitation all such certificates, authorizations and permits
required by the United States Food and Drug Administration (the &ldquo;<B>FDA</B>&rdquo;) or any other federal, state or foreign agencies
or bodies engaged in the regulation of pharmaceuticals or biohazardous materials, except where the failure to so possess such certificates,
authorizations and permits, individually or in the aggregate, would not result in a Material Adverse Effect. The Company has not received
any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit which, individually
or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;The
Company has not received any written notices or statements from the FDA, the European Medicines Agency (the &ldquo;<B>EMEA</B>&rdquo;)
or any other governmental agency, and otherwise has no knowledge or reason to believe, that (i) any drug candidate of the Company (each
a &ldquo;<B>Potential Product</B>&rdquo;) may or will be rejected or determined to be non-approvable; (ii) a delay in time for review
and/or approval of a marketing authorization application or marketing approval application in any jurisdiction for any Potential Product
is or may be required, requested or being implemented; (iii) one or more clinical studies for any Potential Product shall or may be requested
or required in addition to the clinical studies submitted to the FDA prior to the date hereof as a precondition to or condition of issuance
or maintenance of a marketing approval for any Potential Product; (iv) any license, approval, permit or authorization to conduct any clinical
trial of or market any product or Potential Product of the Company has been, will be or may be suspended, revoked, modified or limited,
except in the cases of clauses (i), (ii), (iii) and (iv) where such rejections, determinations, delays, requests, suspensions, revocations,
modifications or limitations might not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;To
the Company&rsquo;s knowledge, the preclinical and clinical testing, application for marketing approval of, manufacture, distribution,
promotion and sale of the products and Potential Products of the Company is in compliance, in all material respects, with all laws, rules
and regulations applicable to such activities, including without limitation applicable good laboratory practices, good clinical practices
and good manufacturing practices, except for such non-compliance as would not, individually or in the aggregate, have a Material Adverse
Effect. The Company is not aware of any studies, tests or trial the results of which reasonably call into question the results of the
tests and trials conducted by or on behalf of the Company. The Company has not received notice of adverse finding, warning letter or clinical
hold notice from the FDA or any non-U.S. counterpart of any of the foregoing, or any untitled letter or other correspondence or notice
from the FDA or any other governmental authority or agency or any institutional or ethical review board alleging or asserting noncompliance
with any law, rule or regulation applicable in any jurisdiction, except notices, letters, and correspondences and non-U.S. counterparts
thereof alleging or asserting such noncompliance as would not, individually or in the aggregate, have a Material Adverse Effect. The Company
has not, either voluntarily or involuntarily, initiated, conducted or issued, or caused to be initiated, conducted or issued, any recall,
field correction, market withdrawal or replacement, safety alert, warning, &ldquo;dear doctor&rdquo; letter, investigator notice, or other
notice or action relating to an alleged or potential lack of safety or efficacy of any product or Potential Product of the Company, any
alleged product defect of any product or Potential Product of the Company, or any violation of any material applicable law, rule, regulation
or any clinical trial or marketing license, approval, permit or authorization for any product or potential product of the Company, and
the Company is not aware of any facts or information that would cause it to initiate any such notice or action and has no knowledge or
reason to believe that the FDA, the EMEA or any other governmental agency or authority or any institutional or ethical review board or
other non-governmental authority intends to impose, require, request or suggest such notice or action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ww) <U>Cybersecurity</U>.
The Company and its Subsidiaries&rsquo; information technology assets and equipment, computers, systems, networks, hardware, software,
websites, applications, and databases (collectively, &ldquo;<B>IT Systems</B>&rdquo;) are adequate for, and operate and perform in all
material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted,
free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants that would reasonably be
expected to have a Material Adverse Effect on the Company&rsquo;s business. The Company and its Subsidiaries have implemented and maintained
commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards to maintain and protect
their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data, including
&ldquo;Personal Data,&rdquo; used in connection with their businesses. &ldquo;<B>Personal Data</B>&rdquo; means (i) a natural person&rsquo;s
name, street address, telephone number, e-mail address, photograph, social security number or tax identification number, driver&rsquo;s
license number, passport number, credit card number, bank information, or customer or account number; (ii) any information which would
qualify as &ldquo;personally identifying information&rdquo; under the Federal Trade Commission Act, as amended; (iii) &ldquo;personal
data&rdquo; as defined by the European Union General Data Protection Regulation (&ldquo;<B>GDPR</B>&rdquo;) (EU 2016/679); (iv) any information
which would qualify as &ldquo;protected health information&rdquo; under the Health Insurance Portability and Accountability Act of 1996,
as amended by the Health Information Technology for Economic and Clinical Health Act (collectively, &ldquo;<B>HIPAA</B>&rdquo;); and (v)
any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection
or analysis of any data related to an identified person&rsquo;s health or sexual orientation. There have been no breaches, violations,
outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the
duty to notify any other person or such, nor any incidents under internal review or investigations relating to the same except in each
case, where such would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. The
Company and its Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations
of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy
and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access,
misappropriation or modification except in each case, where such would not, either individually or in the aggregate, reasonably be expected
to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xx)&nbsp;<U>Compliance
with Data Privacy Laws</U>. The Company and its Subsidiaries are, and at all prior times were, in compliance with all applicable state
and federal data privacy and security laws and regulations, including without limitation HIPAA, and the Company and its Subsidiaries have
taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, have been and currently are in compliance with,
the GDPR (EU 2016/679) (collectively, the &ldquo;<B>Privacy Laws</B>&rdquo;) except in each case, where such would not, either individually
or in the aggregate, reasonably be expected to result in a Material Adverse Effect. To ensure compliance with the Privacy Laws, the Company
and its Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to ensure compliance in all material respects
with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis
of Personal Data (the &ldquo;<B>Policies</B>&rdquo;). The Company and its Subsidiaries have at all times made all disclosures to users
or customers required by applicable laws and regulatory rules or requirements, and none of such disclosures made or contained in any Policy
have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in
any material respect. The Company further certifies that neither it nor any Subsidiary: (i) has received notice of any actual or potential
liability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition
that would reasonably be expected to result in any such notice; (ii) is currently conducting or paying for, in whole or in part, any investigation,
remediation, or other corrective action pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement that imposes
any obligation or liability under any Privacy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(yy) <U>Disclosure</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company confirms that neither it nor any other Person acting on its behalf has provided any of the Buyers or their agents or counsel
with any information that constitutes or could reasonably be expected to constitute material, non-public information concerning the Company
or any of its Subsidiaries, other than the existence of the transactions contemplated by this Agreement and the other Transaction Documents.
The Company understands and confirms that each of the Buyers will rely on the foregoing representations in effecting transactions in
securities of the Company. All disclosure provided to the Buyers regarding the Company and its Subsidiaries, their businesses and the
transactions contemplated hereby, including the schedules to this Agreement, furnished by or on behalf of the Company or any of its Subsidiaries
is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order
to make the statements made therein, in the light of the circumstances under which they were made, not misleading. All of the written
information furnished after the date hereof by or on behalf of the Company or any of its Subsidiaries to each Buyer pursuant to or in
connection with this Agreement and the other Transaction Documents, taken as a whole, will be true and correct in all material respects
as of the date on which such information is so provided and will not contain any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made,
not misleading. Each press release issued by the Company or any of its Subsidiaries during the twelve (12) months preceding the date
of this Agreement did not at the time of release contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they are made,
not misleading. To the Company&rsquo;s knowledge, no event or circumstance has occurred or information exists with respect to the Company
or any of its Subsidiaries or its or their business, properties, liabilities, prospects, operations (including results thereof) or conditions
(financial or otherwise), which, under applicable law, rule or regulation, requires public disclosure at or before the date hereof or
announcement by the Company but which has not been so publicly disclosed. All financial projections and forecasts that have been prepared
by or on behalf of the Company or any of its Subsidiaries and made available to you have been prepared in good faith based upon reasonable
assumptions and represented, at the time each such financial projection or forecast was delivered to each Buyer, the Company&rsquo;s
best estimate of future financial performance (it being recognized that such financial projections or forecasts are not to be viewed
as facts and that the actual results during the period or periods covered by any such financial projections or forecasts may differ from
the projected or forecasted results). The Company acknowledges and agrees that no Buyer makes or has made any representations or warranties
with respect to the transactions contemplated hereby other than those specifically set forth in Section&nbsp;2.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.&nbsp;COVENANTS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Best Efforts</U><FONT STYLE="font-size: 10pt"></FONT>.
Each Buyer shall use its best efforts to timely satisfy each of the covenants hereunder and conditions to be satisfied by it as provided
in Section 6 of this Agreement. The Company shall use its best efforts to timely satisfy each of the covenants hereunder and conditions
to be satisfied by it as provided in Section 7 of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Form D and Blue
Sky</U><FONT STYLE="font-size: 10pt"></FONT>. The Company shall file a Form D with respect to the Securities as required under
Regulation D and to provide a copy thereof to each Buyer promptly after such filing. The Company shall, on or before the Closing Date,
take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to, qualify the Securities
for sale to the Buyers at the Closing pursuant to this Agreement under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states
of the United States (or to obtain an exemption from such qualification), and shall provide evidence of any such action so taken to the
Buyers on or prior to the Closing Date. Without limiting any other obligation of the Company under this Agreement, the Company shall
timely make all filings and reports relating to the offer and sale of the Securities required under all applicable securities laws (including,
without limitation, all applicable federal securities laws and all applicable &ldquo;Blue Sky&rdquo; laws), and the Company shall comply
with all applicable foreign, federal, state and local laws, statutes, rules, regulations and the like relating to the offering and sale
of the Securities to the Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Reporting Status</U><FONT STYLE="font-size: 10pt"></FONT>.
Until the date on which the Buyers shall have sold all of the Registrable Securities (the &ldquo;<B>Reporting Period</B>&rdquo;), the
Company shall timely file all reports required to be filed with the SEC pursuant to the 1934 Act, and the Company shall not terminate
its status as an issuer required to file reports under the 1934 Act even if the 1934 Act or the rules and regulations thereunder would
no longer require or otherwise permit such termination. From the time Form S-3 is available to the Company for the registration of the
Registrable Securities, the Company shall take all actions necessary to maintain its eligibility to register the Registrable Securities
for resale by the Buyers on Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Use of Proceeds</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company will use the proceeds from the sale of the Securities for general corporate purposes, but not, directly or indirectly, for
(i) except as set forth on <U>Schedule 4(d)</U>, the satisfaction of any indebtedness of the Company or any of its Subsidiaries, (ii)
the redemption or repurchase of any securities of the Company or any of its Subsidiaries, or (iii) the settlement of any outstanding
litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Financial Information</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company agrees to send the following to each Investor (as defined in the Registration Rights Agreement) during the Reporting Period
(i) unless the following are filed with the SEC through EDGAR and are available to the public through the EDGAR system, within one (1)
Business Day after the filing thereof with the SEC, a copy of its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, any
interim reports or any consolidated balance sheets, income statements, stockholders&rsquo; equity statements and/or cash flow statements
for any period other than annual, any Current Reports on Form 8-K and any registration statements (other than on Form S-8) or amendments
filed pursuant to the 1933 Act, (ii) unless the following are either filed with the SEC through EDGAR or are otherwise widely disseminated
via a recognized news release service (such as PR Newswire), on the same day as the release thereof, e-mail copies of all press releases
issued by the Company or any of its Subsidiaries and (iii) unless the following are filed with the SEC through EDGAR, copies of any notices
and other information made available or given to the stockholders of the Company generally, contemporaneously with the making available
or giving thereof to the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Listing</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company shall promptly secure the listing or designation for quotation (as the case may be) of all of the Registrable Securities
upon each national securities exchange and automated quotation system, if any, upon which the Common Stock is then listed or designated
for quotation (as the case may be) (subject to official notice of issuance) and shall maintain such listing or designation for quotation
(as the case may be) of all Registrable Securities from time to time issuable under the terms of the Transaction Documents on such national
securities exchange or automated quotation system. The Company shall maintain the Common Stock&rsquo;s listing or authorization for quotation
(as the case may be) on the Principal Market, The New York Stock Exchange, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global
Market or the Nasdaq Global Select Market (each, an &ldquo;<B>Eligible Market</B>&rdquo;). Neither the Company nor any of its Subsidiaries
shall take any action which could be reasonably expected to result in the delisting or suspension of the Common Stock on an Eligible
Market. The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section 4(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Fees</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company shall reimburse the lead Buyer a non-accountable amount of $10,000 for all costs and expenses incurred by it or its affiliates
in connection with the structuring, documentation, negotiation and closing of the transactions contemplated by the Transaction Documents
and certain prior transactions with the Company (including, without limitation, as applicable, all reasonable legal fees of outside counsel
and disbursements of Kelley Drye &amp; Warren LLP, counsel to the lead Buyer, any other reasonable fees and expenses in connection with
the structuring, documentation, negotiation and closing of the transactions contemplated by the Transaction Documents and due diligence
and regulatory filings in connection therewith) at the Closing (the &ldquo;<B>Transaction Expenses</B>&rdquo;), which shall be withheld
by the lead Buyer from its Purchase Price at the Closing; provided, that the Company shall promptly reimburse Kelley Drye &amp; Warren
LLP on demand for all Transaction Expenses not so reimbursed through such withholding at the Closing. The Company shall be responsible
for the payment of any placement agent&rsquo;s fees, financial advisory fees, transfer agent fees, DTC (as defined below) fees or broker&rsquo;s
commissions (other than for Persons engaged by any Buyer) relating to or arising out of the transactions contemplated hereby. The Company
shall pay, and hold each Buyer harmless against, any liability, loss or expense (including, without limitation, reasonable attorneys&rsquo;
fees and out-of-pocket expenses) arising in connection with any claim relating to any such payment. Except as otherwise set forth in
the Transaction Documents, each party to this Agreement shall bear its own expenses in connection with the sale of the Securities to
the Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Pledge of Securities</U><FONT STYLE="font-size: 10pt"></FONT>.
Notwithstanding anything to the contrary contained in this Agreement, the Company acknowledges and agrees that the Securities may be
pledged by an Investor in connection with a bona fide margin agreement or other loan or financing arrangement that is secured by the
Securities. The pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities hereunder, and no Investor
effecting a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise make any delivery to the
Company pursuant to this Agreement or any other Transaction Document, including, without limitation, Section 2(g) hereof; <U>provided</U>
that an Investor and its pledgee shall be required to comply with the provisions of Section 2(g) hereof in order to effect a sale, transfer
or assignment of Securities to such pledgee. The Company hereby agrees to execute and deliver such documentation as a pledgee of the
Securities may reasonably request in connection with a pledge of the Securities to such pledgee by a Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Disclosure of
Transactions and Other Material Information</U><FONT STYLE="font-size: 10pt"></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Disclosure
of Transaction</U>. On or before 9:30 a.m., New York time, on the first (1<SUP>st</SUP>) Business Day after the date of this Agreement,
the Company shall file a Current Report on Form 8-K describing all the material terms of the transactions contemplated by the Transaction
Documents in the form required by the 1934 Act and attaching all the material Transaction Documents (including, without limitation, this
Agreement (and all schedules to this Agreement), the form of the Warrants, the form of Certificate of Designations and the form of the
Registration Rights Agreement) (including all attachments, the &ldquo;<B>8-K Filing</B>&rdquo;). From and after the filing of the 8-K
Filing, the Company shall have disclosed all material, non-public information (if any) provided to any of the Buyers by the Company or
any of its Subsidiaries or any of their respective officers, directors, employees or agents in connection with the transactions contemplated
by the Transaction Documents. In addition, effective upon the filing of the 8-K Filing, the Company acknowledges and agrees that any and
all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries
or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and any of the Buyers or any of their
affiliates, on the other hand, shall terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Limitations
on Disclosure</U>. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their respective officers,
directors, employees and agents not to, provide any Buyer with any material, non-public information regarding the Company or any of its
Subsidiaries from and after the date hereof without the express prior written consent of such Buyer (which may be granted or withheld
in such Buyer&rsquo;s sole discretion). In the event of a breach of any of the foregoing covenants, including, without limitation, Section&nbsp;4(o)
of this Agreement, or any of the covenants or agreements contained in any other Transaction Document, by the Company, any of its Subsidiaries,
or any of its or their respective officers, directors, employees and agents (as determined in the reasonable good faith judgment of such
Buyer), in addition to any other remedy provided herein or in the Transaction Documents, as long as such Buyers has given the Company
at least two (2) Business Days prior written notice such Buyer shall have the right to make a public disclosure, in the form of a press
release, public advertisement or otherwise, of such breach or such material, non-public information, as applicable, without the prior
approval by the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees or agents. No Buyer
shall have any liability to the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees, affiliates,
stockholders or agents, for any such disclosure. To the extent that the Company delivers any material, non-public information to a Buyer
without such Buyer&rsquo;s consent, the Company hereby covenants and agrees that such Buyer shall not have any duty of confidentiality
with respect to, or a duty not to trade on the basis of, such material, non-public information. Subject to the foregoing, neither the
Company, its Subsidiaries nor any Buyer shall issue any press releases or any other public statements with respect to the transactions
contemplated hereby; provided, however, the Company shall be entitled, without the prior approval of any Buyer, to make any press release
or other public disclosure with respect to such transactions (i) in substantial conformity with the 8-K Filing and contemporaneously therewith
and (ii) as is required by applicable law and regulations (provided that in the case of clause (i) each Buyer shall be consulted by the
Company in connection with any such press release or other public disclosure prior to its release). Without the prior written consent
of the applicable Buyer (which may be granted or withheld in such Buyer&rsquo;s sole discretion), the Company shall not (and shall cause
each of its Subsidiaries and affiliates to not) disclose the name of such Buyer in any filing, announcement, release or otherwise. Notwithstanding
anything contained in this Agreement to the contrary and without implication that the contrary would otherwise be true, the Company expressly
acknowledges and agrees that no Buyer shall have (unless expressly agreed to by a particular Buyer after the date hereof in a written
definitive and binding agreement executed by the Company and such particular Buyer (it being understood and agreed that no Buyer may bind
any other Buyer with respect thereto)), any duty of confidentiality with respect to, or a duty not to trade on the basis of, any material,
non-public information regarding the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Additional Registration
Statements</U><FONT STYLE="font-size: 10pt"></FONT>. Until the Applicable Date (as defined below) and at any time thereafter while
any Registration Statement is not effective or the prospectus contained therein is not available for use or any Current Public Information
Failure (as defined in the Registration Rights Agreement) exists, the Company shall not file a registration statement or an offering
statement under the 1933 Act relating to securities that are not the Registrable Securities (other than (i) a registration statement
on Form S-8; (ii) a registration statement on Form S-1 or Form S-3, as applicable, covering the resale of shares sold pursuant to a Permitted
Equity Line (as defined below), or (iii) such supplements or amendments to registration statements that are outstanding and have been
declared effective by the SEC as of the date hereof (solely to the extent necessary to keep such registration statements effective and
available and not with respect to any Subsequent Placement (as defined below))). &ldquo;<B>Applicable Date</B>&rdquo; means the later
of (x) the Stockholder Approval Date (as defined below) and (y) the earlier to occur of (I) the first date on which the resale by the
Buyers of all the Registrable Securities required to be filed on the initial Registration Statement pursuant to the Registration Rights
Agreement is declared effective by the SEC (and each prospectus contained therein is available for use on such date) or (II) the first
date on which all of the Registrable Securities are eligible to be resold by the Buyers pursuant to Rule 144 (or, if a Current Public
Information Failure has occurred and is continuing, such later date after which the Company has cured such Current Public Information
Failure).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Additional Issuance
of Securities</U><FONT STYLE="font-size: 10pt"></FONT>. So long as any Buyer beneficially owns any Securities, the Company will
not, without the prior written consent of the Required Holders (as defined below), issue any Preferred Shares (other than to the Buyers
as contemplated hereby) and the Company shall not issue any other securities that would cause a breach or default under the Certificate
of Designations or the Warrants. The Company agrees that for the period commencing on the date hereof and ending on the date immediately
following the 90<SUP>th</SUP> Trading Day after the Applicable Date (provided that such period shall be extended by the number of calendar
days during such period and any extension thereof contemplated by this proviso on which any Registration Statement is not effective or
any prospectus contained therein is not available for use or any Current Public Information Failure exists) (the &ldquo;<B>Restricted
Period</B>&rdquo;), neither the Company nor any of its Subsidiaries shall directly or indirectly issue, offer, sell, grant any option
or right to purchase, or otherwise dispose of (or announce any issuance, offer, sale, grant of any option or right to purchase or other
disposition of) any equity security or any equity-linked or related security (including, without limitation, any &ldquo;equity security&rdquo;
(as that term is defined under Rule 405 promulgated under the 1933 Act), any Convertible Securities, any debt, any preferred stock or
any purchase rights) (any such issuance, offer, sale, grant, disposition or announcement (whether occurring during the Restricted Period
or at any time thereafter) is referred to as a &ldquo;<B>Subsequent Placement</B>&rdquo;). Notwithstanding the foregoing, this Section
4(k) shall not apply in respect of the issuance of (i) shares of Common Stock or standard options to purchase Common Stock to directors,
officers or employees of the Company in their capacity as such pursuant to an Approved Stock Plan (as defined below), provided that (1)
all such issuances (taking into account the shares of Common Stock issuable upon exercise of such options) after the date hereof pursuant
to this clause (i) do not, in the aggregate, exceed more than 5% of the Common Stock issued and outstanding immediately prior to the
date hereof and (2) the exercise price of any such options is not lowered, none of such options are amended to increase the number of
shares issuable thereunder and none of the terms or conditions of any such options are otherwise materially changed in any manner that
adversely affects any of the Buyers; (ii) shares of Common Stock issued upon the conversion or exercise of Convertible Securities (other
than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) issued
prior to the date hereof, provided that the conversion, exercise or other method of issuance (as the case may be) of any such Convertible
Security is made solely pursuant to the conversion, exercise or other method of issuance (as the case may be) provisions of such Convertible
Security that were in effect on the date immediately prior to the date of this Agreement, the conversion, exercise or issuance price
of any such Convertible Securities (other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan that
are covered by clause (i) above) is not lowered, none of such Convertible Securities (other than standard options to purchase Common
Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) are amended to increase the number of shares issuable
thereunder and none of the terms or conditions of any such Convertible Securities (other than standard options to purchase Common Stock
issued pursuant to an Approved Stock Plan that are covered by clause (i) above) are otherwise materially changed in any manner that adversely
affects any of the Buyers and (iii) the Conversion Shares, (iv) the Warrant Shares and (v) the shares of Common Stock issued (or issuable)
pursuant to a Permitted Equity Line (each of the foregoing in clauses (i) through (v), collectively the &ldquo;<B>Excluded Securities</B>&rdquo;).
&ldquo;<B>Approved Stock Plan</B>&rdquo; means any employee benefit plan which has been approved by the board of directors of the Company
prior to or subsequent to the date hereof pursuant to which shares of Common Stock and standard options to purchase Common Stock may
be issued to any employee, officer or director for services provided to the Company in their capacity as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Reservation of
Shares</U><FONT STYLE="font-size: 10pt"></FONT>. So long as any of the Preferred Shares or Warrants remain outstanding, the Company
shall take all action necessary to at all times have authorized, and reserved for the purpose of issuance, no less than 150% of the sum
of (i) the maximum number of Conversion Shares issuable upon conversion of the Preferred Shares (assuming for purposes hereof that (x)
the Preferred Shares are convertible at the Alternate Conversion Price (as defined in the Certificate of Designations) then in effect
assuming an Alternate Conversion Date (as defined in the Certificate of Designations) as of such applicable date of determination and
(y) any such conversion shall not take into account any limitations on the conversion of the Series E Preferred Stock set forth in the
Certificate of Designations), and (ii) the maximum number of Warrant Shares issuable upon exercise of all the Warrants then outstanding
(without regard to any limitations on the exercise of the Warrants set forth therein) (collectively, the &ldquo;<B>Required Reserve Amount</B>&rdquo;);
provided that at no time shall the number of shares of Common Stock reserved pursuant to this Section 4(l) be reduced other than proportionally
in connection with any conversion, exercise and/or redemption, as applicable of Preferred Shares and Warrants. If at any time the number
of shares of Common Stock authorized and reserved for issuance is not sufficient to meet the Required Reserve Amount, the Company will
promptly take all corporate action necessary to authorize and reserve a sufficient number of shares, including, without limitation, calling
a special meeting of stockholders to authorize additional shares to meet the Company&rsquo;s obligations pursuant to the Transaction
Documents, in the case of an insufficient number of authorized shares, obtain stockholder approval of an increase in such authorized
number of shares, and voting the management shares of the Company in favor of an increase in the authorized shares of the Company to
ensure that the number of authorized shares is sufficient to meet the Required Reserve Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Conduct of Business</U><FONT STYLE="font-size: 10pt"></FONT>.
The business of the Company and its Subsidiaries shall not be conducted in violation of any law, ordinance or regulation of any Governmental
Entity, except where such violations would not reasonably be expected to result, either individually or in the aggregate, in a Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Other Preferred
Shares; Variable Securities</U><FONT STYLE="font-size: 10pt"></FONT>. So long as any Preferred Shares remain outstanding, the Company
and each Subsidiary shall be prohibited from effecting or entering into an agreement to effect any Subsequent Placement involving a Variable
Rate Transaction (other than a Permitted Equity Line). &ldquo;<B>Variable Rate Transaction</B>&rdquo; means a transaction in which the
Company or any Subsidiary (i) issues or sells any Convertible Securities either (A) at a conversion, exercise or exchange rate or other
price that is based upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the
initial issuance of such Convertible Securities, or (B) with a conversion, exercise or exchange price that is subject to being reset
at some future date after the initial issuance of such Convertible Securities or upon the occurrence of specified or contingent events
directly or indirectly related to the business of the Company or the market for the Common Stock, other than pursuant to a customary
&ldquo;weighted average&rdquo; anti-dilution provision or (ii) enters into any agreement (including, without limitation, any other equity
line of credit or an &ldquo;at-the-market&rdquo; offering) whereby the Company or any Subsidiary may sell securities at a future determined
price (other than standard and customary &ldquo;preemptive&rdquo; or &ldquo;participation&rdquo; rights). Each Buyer shall be entitled
to obtain injunctive relief against the Company and its Subsidiaries to preclude any such issuance, which remedy shall be in addition
to any right to collect damages. &ldquo;<B>Permitted Equity Line</B>&rdquo; means any equity line of credit by and between the Company
and [LEAD BUYER] or any of its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>Participation
Right</U><FONT STYLE="font-size: 10pt"></FONT>. At any time after October 2, 2026 and on or prior to the second (2<SUP>nd</SUP>)
anniversary of the Closing Date, neither the Company nor any of its Subsidiaries shall, directly or indirectly, effect any Subsequent
Placement unless the Company shall have first complied with this Section&nbsp;4(o). The Company acknowledges and agrees that the right
set forth in this Section&nbsp;4(o) is a right granted by the Company, separately, to each Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;At
least five (5) Trading Days prior to any proposed or intended Subsequent Placement, the Company shall deliver to each Buyer a written
notice (each such notice, a &ldquo;<B>Pre-Notice</B>&rdquo;), which Pre-Notice shall not contain any information (including, without limitation,
material, non-public information) other than: (A) if the proposed Offer Notice (as defined below) constitutes or contains material, non-public
information, a statement asking whether the Investor is willing to accept material non-public information or (B) if the proposed Offer
Notice does not constitute or contain material, non-public information, (x) a statement that the Company proposes or intends to effect
a Subsequent Placement, (y) a statement that the statement in clause (x) above does not constitute material, non-public information and
(z) a statement informing such Buyer that it is entitled to receive an Offer Notice with respect to such Subsequent Placement upon its
written request. Upon the written request of a Buyer within three (3) Trading Days after the Company&rsquo;s delivery to such Buyer of
such Pre-Notice, and only upon a written request by such Buyer, the Company shall promptly, but no later than one (1) Trading Day after
such request, deliver to such Buyer an irrevocable written notice (the &ldquo;<B>Offer Notice</B>&rdquo;) of any proposed or intended
issuance or sale or exchange (the &ldquo;<B>Offer</B>&rdquo;) of the securities being offered (the &ldquo;<B>Offered Securities</B>&rdquo;)
in a Subsequent Placement, which Offer Notice shall (A) identify and describe the Offered Securities, (B) describe the price and other
terms upon which they are to be issued, sold or exchanged, and the number or amount of the Offered Securities to be issued, sold or exchanged,
(C) identify the Persons (if known) to which or with which the Offered Securities are to be offered, issued, sold or exchanged and (D)
offer to issue and sell to or exchange with such Buyer in accordance with the terms of the Offer such Buyer&rsquo;s pro rata portion of
one hundred percent (100%) of the Offered Securities, provided that the number of Offered Securities which such Buyer shall have the right
to subscribe for under this Section 4(o) shall be (x) based on such Buyer&rsquo;s pro rata portion of the aggregate number of the Preferred
Shares purchased hereunder by all Buyers (the &ldquo;<B>Basic Amount</B>&rdquo;), and (y) with respect to each Buyer that elects to purchase
its Basic Amount, any additional portion of the Offered Securities attributable to the Basic Amounts of other Buyers as such Buyer shall
indicate it will purchase or acquire should the other Buyers subscribe for less than their Basic Amounts (the &ldquo;<B>Undersubscription
Amount</B>&rdquo;), which process shall be repeated until each Buyer shall have an opportunity to subscribe for any remaining Undersubscription
Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;To
accept an Offer, in whole or in part, such Buyer must deliver a written notice to the Company prior to the end of the fifth (5<SUP>th</SUP>)
Business Day after such Buyer&rsquo;s receipt of the Offer Notice (the &ldquo;<B>Offer Period</B>&rdquo;), setting forth the portion of
such Buyer&rsquo;s Basic Amount that such Buyer elects to purchase and, if such Buyer shall elect to purchase all of its Basic Amount,
the Undersubscription Amount, if any, that such Buyer elects to purchase (in either case, the &ldquo;<B>Notice of Acceptance</B>&rdquo;).
If the Basic Amounts subscribed for by all Buyers are less than the total of all of the Basic Amounts, then each Buyer who has set forth
an Undersubscription Amount in its Notice of Acceptance shall be entitled to purchase, in addition to the Basic Amounts subscribed for,
the Undersubscription Amount it has subscribed for; provided, however, if the Undersubscription Amounts subscribed for exceed the difference
between the total of all the Basic Amounts and the Basic Amounts subscribed for (the &ldquo;<B>Available Undersubscription Amount</B>&rdquo;),
each Buyer who has subscribed for any Undersubscription Amount shall be entitled to purchase only that portion of the Available Undersubscription
Amount as the Basic Amount of such Buyer bears to the total Basic Amounts of all Buyers that have subscribed for Undersubscription Amounts,
subject to rounding by the Company to the extent it deems reasonably necessary. Notwithstanding the foregoing, if the Company desires
to modify or amend the terms and conditions of the Offer prior to the expiration of the Offer Period, the Company may deliver to each
Buyer a new Offer Notice and the Offer Period shall expire on the fifth (5<SUP>th</SUP>) Business Day after such Buyer&rsquo;s receipt
of such new Offer Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;The
Company shall have five (5) Business Days from the expiration of the Offer Period above (A) to offer, issue, sell or exchange all or any
part of such Offered Securities as to which a Notice of Acceptance has not been given by a Buyer (the &ldquo;<B>Refused Securities</B>&rdquo;)
pursuant to a definitive agreement(s) (the &ldquo;<B>Subsequent Placement Agreement</B>&rdquo;), but only to the offerees described in
the Offer Notice (if so described therein) and only upon terms and conditions (including, without limitation, unit prices and interest
rates) that are not more favorable to the acquiring Person or Persons or less favorable to the Company than those set forth in the Offer
Notice and (B) to publicly announce (x) the execution of such Subsequent Placement Agreement, and (y) either (I) the consummation of the
transactions contemplated by such Subsequent Placement Agreement or (II) the termination of such Subsequent Placement Agreement, which
shall be filed with the SEC on a Current Report on Form 8-K with such Subsequent Placement Agreement and any documents contemplated therein
filed as exhibits thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;In
the event the Company shall propose to sell less than all the Refused Securities (any such sale to be in the manner and on the terms specified
in Section&nbsp;4(o)(iii) above), then each Buyer may, at its sole option and in its sole discretion, withdraw its Notice of Acceptance
or reduce the number or amount of the Offered Securities specified in its Notice of Acceptance to an amount that shall be not less than
the number or amount of the Offered Securities that such Buyer elected to purchase pursuant to Section&nbsp;4(o)(ii) above multiplied
by a fraction, (i) the numerator of which shall be the number or amount of Offered Securities the Company actually proposes to issue,
sell or exchange (including Offered Securities to be issued or sold to Buyers pursuant to this Section&nbsp;4(o) prior to such reduction)
and (ii) the denominator of which shall be the original amount of the Offered Securities. In the event that any Buyer so elects to reduce
the number or amount of Offered Securities specified in its Notice of Acceptance, the Company may not issue, sell or exchange more than
the reduced number or amount of the Offered Securities unless and until such securities have again been offered to the Buyers in accordance
with Section&nbsp;4(o)(i) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;Upon
the closing of the issuance, sale or exchange of all or less than all of the Refused Securities, such Buyer shall acquire from the Company,
and the Company shall issue to such Buyer, the number or amount of Offered Securities specified in its Notice of Acceptance, as reduced
pursuant to Section&nbsp;4(o)(iv) above if such Buyer has so elected, upon the terms and conditions specified in the Offer. The purchase
by such Buyer of any Offered Securities is subject in all cases to the preparation, execution and delivery by the Company and such Buyer
of a separate purchase agreement relating to such Offered Securities reasonably satisfactory in form and substance to such Buyer and its
counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;Any
Offered Securities not acquired by a Buyer or other Persons in accordance with this Section&nbsp;4(o) may not be issued, sold or exchanged
until they are again offered to such Buyer under the procedures specified in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vii)&nbsp;The
Company and each Buyer agree that if any Buyer elects to participate in the Offer, (x) neither the Subsequent Placement Agreement with
respect to such Offer nor any other transaction documents related thereto (collectively, the &ldquo;<B>Subsequent Placement Documents</B>&rdquo;)
shall include any term or provision whereby such Buyer shall be required to agree to any restrictions on trading as to any securities
of the Company or be required to consent to any amendment to or termination of, or grant any waiver, release or the like under or in connection
with, any agreement previously entered into with the Company or any instrument received from the Company, and (y) any registration rights
set forth in such Subsequent Placement Documents shall be similar in all material respects to the registration rights contained in the
Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(viii)&nbsp;Notwithstanding
anything to the contrary in this Section 4(o) and unless otherwise agreed to by such Buyer, the Company shall either confirm in writing
to such Buyer that the transaction with respect to the Subsequent Placement has been abandoned or shall publicly disclose its intention
to issue the Offered Securities, in either case, in such a manner such that such Buyer will not be in possession of any material, non-public
information, by the fifth (5<SUP>th</SUP>) Business Day following delivery of the Offer Notice. If by such fifth (5<SUP>th</SUP>) Business
Day, no public disclosure regarding a transaction with respect to the Offered Securities has been made, and no notice regarding the abandonment
of such transaction has been received by such Buyer, such transaction shall be deemed to have been abandoned and such Buyer shall not
be in possession of any material, non-public information with respect to the Company or any of its Subsidiaries. Should the Company decide
to pursue such transaction with respect to the Offered Securities, the Company shall provide such Buyer with another Offer Notice and
such Buyer will again have the right of participation set forth in this Section 4(o). The Company shall not be permitted to deliver more
than one such Offer Notice to such Buyer in any sixty (60) day period, except as expressly contemplated by the last sentence of Section
4(o)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ix)&nbsp;The
restrictions contained in this Section 4(o) shall not apply in connection with the issuance of any Excluded Securities. The Company shall
not circumvent the provisions of this Section 4(o) by providing terms or conditions to one Buyer that are not provided to all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Dilutive Issuances</U><FONT STYLE="font-size: 10pt"></FONT>.
For so long as any Preferred Shares or Warrants remain outstanding, the Company shall not, in any manner, enter into or affect any Dilutive
Issuance (as defined in the Certificate of Designations) if the effect of such Dilutive Issuance is to cause the Company to be required
to issue upon conversion of any Preferred Shares or exercise of any Warrant any shares of Common Stock in excess of that number of shares
of Common Stock which the Company may issue upon conversion of the Preferred Shares and exercise of the Warrants without breaching the
Company&rsquo;s obligations under the rules or regulations of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;<U>Passive Foreign
Investment Company</U><FONT STYLE="font-size: 10pt"></FONT>. The Company shall conduct its business, and shall cause its Subsidiaries
to conduct their respective businesses, in such a manner as will ensure that the Company will not be deemed to constitute a passive foreign
investment company within the meaning of Section 1297 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)&nbsp;<U>Restriction on
Redemption and Cash Dividends</U><FONT STYLE="font-size: 10pt"></FONT>. So long as any Preferred Shares are outstanding, the Company
shall not, directly or indirectly, redeem, or declare or pay any cash dividend or distribution on, any securities of the Company without
the prior express written consent of the Buyers (other than as required by the Certificate of Designations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)&nbsp;<U>Corporate Existence</U><FONT STYLE="font-size: 10pt"></FONT>.
So long as any Buyer beneficially owns any Preferred Shares or Warrants, the Company shall not be party to any Fundamental Transaction
(as defined in the Certificate of Designations) unless the Company is in compliance with the applicable provisions governing Fundamental
Transactions set forth in the Certificate of Designations and the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t)&nbsp;<U>Stock Splits</U><FONT STYLE="font-size: 10pt"></FONT>.
Until the Preferred Shares and all preferred shares issued pursuant to the Certificate of Designations and the Warrants are no longer
outstanding, the Company shall not effect any stock combination, reverse stock split or other similar transaction (or make any public
announcement or disclosure with respect to any of the foregoing) without the prior written consent of the Required Holders; provided,
however, that the Company may effect one (1) stock combination, reverse stock split or other similar transaction as necessary to comply
with the requirements of the Principal Market without the prior written consent of the Required Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u)&nbsp;<U>Conversion
and Exercise Procedures</U>. Each of the form of Exercise Notice (as defined in the Warrants) included in the Warrants and the form of
Conversion Notice (as defined in the Certificate of Designations) included in the Certificate of Designations set forth the totality of
the procedures required of the Buyers in order to exercise the Warrants or convert the Preferred Shares. Except as provided in Section
5(d), no additional legal opinion, other information or instructions shall be required of the Buyers to exercise their Warrants or convert
their Preferred Shares. The Company shall honor exercises of the Warrants and conversions of the Preferred Shares and shall deliver the
Conversion Shares and Warrant Shares in accordance with the terms, conditions and time periods set forth in the Certificate of Designations
and Warrants. Without limiting the preceding sentences, no ink-original Conversion Notice or Exercise Notice shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Conversion Notice or Exercise Notice form be required in order
to convert the Preferred Shares or exercise the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Regulation M</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company will not take any action prohibited by Regulation M under the 1934 Act, in connection with the distribution of the Securities
contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>(w)&nbsp;General Solicitation</U>.
None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933 Act) or any person acting on behalf of the Company
or such affiliate will solicit any offer to buy or offer or sell the Securities by means of any form of general solicitation or general
advertising within the meaning of Regulation&nbsp;D, including: (i) any advertisement, article, notice or other communication published
in any newspaper, magazine or similar medium or broadcast over television or radio; and (ii) any seminar or meeting whose attendees have
been invited by any general solicitation or general advertising.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>(x)&nbsp;Integration</U>.
None of the Company, any of its affiliates (as defined in Rule 501(b) under the 1933 Act), or any person acting on behalf of the Company
or such affiliate will sell, offer for sale, or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
the 1933 Act) which will be integrated with the sale of the Securities in a manner which would require the registration of the Securities
under the 1933 Act or require stockholder approval under the rules and regulations of the Principal Market and the Company will take
all action that is appropriate or necessary to assure that its offerings of other securities will not be integrated for purposes of the
1933 Act or the rules and regulations of the Principal Market, with the issuance of Securities contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y)&nbsp;<U>Notice of Disqualification
Events</U><FONT STYLE="font-size: 10pt"></FONT>. The Company will notify the Buyers in writing, prior to the Closing Date of (i)
any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification
Event relating to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>(z)&nbsp;Stockholder Approval</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company shall either (x) if the Company shall have obtained the prior written consent of the requisite stockholders (the &ldquo;<B>Stockholder
Consent</B>&rdquo;) to obtain the Stockholder Approval (as defined below), inform the stockholders of the Company of the receipt of the
Stockholder Consent by preparing and filing with the SEC, as promptly as practicable after the date hereof, but prior to the forty-fifth
(45<SUP>th</SUP>) calendar day after the Closing Date (or, if such filing is delayed by a court or regulatory agency, in no event later
than ninety (90) calendar days after the Closing), an information statement with respect thereto or (y) provide each stockholder entitled
to vote at a special meeting of stockholders of the Company (the &ldquo;<B>Stockholder Meeting</B>&rdquo;), which shall be promptly called
and held not later than the ninetieth (90<SUP>th</SUP>) calendar day after the Closing Date (the &ldquo;<B>Stockholder Meeting Deadline</B>&rdquo;),
a proxy statement, in each case, in a form reasonably acceptable to the Buyers and Kelley Drye &amp; Warren LLP, at the expense of the
Company, with the Company obligated to reimburse the expenses of Kelley Drye &amp; Warren LLP incurred in connection therewith in an
amount not exceed $2,500. The proxy statement, if any, shall solicit each of the Company&rsquo;s stockholder&rsquo;s affirmative vote
at the Stockholder Meeting for approval of resolutions (&ldquo;<B>Stockholder Resolutions</B>&rdquo;) providing for the approval of the
issuance of all of the Securities in compliance with the rules and regulations of the Principal Market (without regard to any limitations
on conversion or exercise set forth in the Certificate of Designations or the Warrants, respectively) (such affirmative approval being
referred to herein as the &ldquo;<B>Stockholder Approval</B>&rdquo;, and the date such Stockholder Approval is obtained, the &ldquo;<B>Stockholder
Approval Date</B>&rdquo;), and the Company shall use its reasonable best efforts to solicit its stockholders&rsquo; approval of such
resolutions and to cause the Board of Directors of the Company to recommend to the stockholders that they approve such resolutions. The
Company shall be obligated to seek to obtain the Stockholder Approval by the Stockholder Meeting Deadline. If, despite the Company&rsquo;s
reasonable best efforts the Stockholder Approval is not obtained on or prior to the Stockholder Meeting Deadline, the Company shall cause
an additional Stockholder Meeting to be held on or prior to the one hundred and sixtieth (160<SUP>th</SUP>) calendar day following the
failure to obtain Stockholder Approval. If, despite the Company&rsquo;s reasonable best efforts the Stockholder Approval is not obtained
after such subsequent stockholder meetings, the Company shall cause an additional Stockholder Meeting to be held every semi-annually
thereafter until such Stockholder Approval is obtained. Until the Company shall have obtained the Stockholder Approval (or, if earlier,
such date as no Preferred Shares remain outstanding), the Company shall not consummate any Subsequent Placement at a New Issuance Price
(as defined in the Certificate of Designations) less than the Conversion Floor Price (as defined in the Certificate of Designations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa) <U>Closing Documents</U><FONT STYLE="font-size: 10pt"></FONT>.
On or prior to fourteen (14) calendar days after the Closing Date, the Company agrees to deliver, or cause to be delivered, to each Buyer
and Kelley Drye &amp; Warren LLP a complete closing set of the executed Transaction Documents, Securities and any other document required
to be delivered to any party pursuant to Section&nbsp;7 hereof or otherwise.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.&nbsp;REGISTER;
TRANSFER AGENT INSTRUCTIONS; LEGEND.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Register</U><FONT STYLE="font-size: 10pt"></FONT>.
The Company shall maintain at its principal executive offices (or such other office or agency of the Company as it may designate by notice
to each holder of Securities), a register for the Preferred Shares and the Warrants in which the Company shall record the name and address
of the Person in whose name the Preferred Shares and the Warrants have been issued (including the name and address of each transferee),
the aggregate number of the Preferred Shares held by such Person, the number of Conversion Shares issuable pursuant to the terms of the
Certificate of Designations and the number of Warrant Shares issuable upon exercise of the Warrants held by such Person. The Company
shall keep the register open and available at all times during business hours for inspection of any Buyer or its legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Transfer Agent
Instructions</U><FONT STYLE="font-size: 10pt"></FONT>. The Company shall issue irrevocable instructions to its transfer agent and
any subsequent transfer agent (as applicable, the &ldquo;<B>Transfer Agent</B>&rdquo;) in a form acceptable to each of the Buyers (the
&ldquo;<B>Irrevocable Transfer Agent Instructions</B>&rdquo;) to issue certificates or credit shares to the applicable balance accounts
at The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;), registered in the name of each Buyer or its respective nominee(s), for the
Conversion Shares and the Warrant Shares in such amounts as specified from time to time by each Buyer to the Company upon conversion
of the Preferred Shares or the exercise of the Warrants (as the case may be). The Company represents and warrants that no instruction
other than the Irrevocable Transfer Agent Instructions referred to in this Section&nbsp;5(b), and stop transfer instructions to give
effect to Section 2(g) hereof, will be given by the Company to the Transfer Agent with respect to the Securities, and that the Securities
shall otherwise be freely transferable on the books and records of the Company, as applicable, to the extent provided in this Agreement
and the other Transaction Documents. If a Buyer effects a sale, assignment or transfer of the Securities in accordance with Section 2(g),
the Company shall permit the transfer and shall promptly instruct the Transfer Agent to issue one or more certificates or credit shares
to the applicable balance accounts at DTC in such name and in such denominations as specified by such Buyer to effect such sale, transfer
or assignment. In the event that such sale, assignment or transfer involves Conversion Shares or Warrant Shares sold, assigned or transferred
pursuant to an effective registration statement or in compliance with Rule 144, the Transfer Agent shall issue such shares to such Buyer,
assignee or transferee (as the case may be) without any restrictive legend in accordance with Section&nbsp;5(d) below. The Company acknowledges
that a breach by it of its obligations hereunder will cause irreparable harm to a Buyer. Accordingly, the Company acknowledges that the
remedy at law for a breach of its obligations under this Section&nbsp;5(b) will be inadequate and agrees, in the event of a breach or
threatened breach by the Company of the provisions of this Section&nbsp;5(b), that a Buyer shall be entitled, in addition to all other
available remedies, to an order and/or injunction restraining any breach and requiring immediate issuance and transfer, without the necessity
of showing economic loss and without any bond or other security being required. The Company shall cause its counsel to issue the legal
opinion referred to in the Irrevocable Transfer Agent Instructions to the Transfer Agent on each Effective Date (as defined in the Registration
Rights Agreement). Any fees (with respect to the Transfer Agent, counsel to the Company or otherwise) associated with the issuance of
such opinion or the removal of any legends on any of the Securities shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Legends</U><FONT STYLE="font-size: 10pt"></FONT>.
Each Buyer understands that the Securities have been issued (or will be issued in the case of the Conversion Shares and the Warrant Shares)
pursuant to an exemption from registration or qualification under the 1933 Act and applicable state securities laws, and except as set
forth below, the Securities shall bear any legend as required by the &ldquo;blue sky&rdquo; laws of any state and a restrictive legend
in substantially the following form (and a stop-transfer order may be placed against transfer of such stock certificates):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify">[NEITHER THE ISSUANCE AND SALE OF THE
SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE [CONVERTIBLE] [EXERCISABLE] HAVE BEEN][THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY
THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR
ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN
CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Removal of Legends</U><FONT STYLE="font-size: 10pt"></FONT>.
Certificates evidencing Securities shall not be required to contain the legend set forth in Section&nbsp;5(c) above or any other legend
(i) while a registration statement (including a Registration Statement) covering the resale of such Securities is effective under the
1933 Act, (ii) following any sale of such Securities pursuant to Rule 144 (assuming the transferor is not an affiliate of the Company),
(iii) if such Securities are eligible to be sold, assigned or transferred under Rule 144 (provided that a Buyer provides the Company
with reasonable assurances that such Securities are eligible for sale, assignment or transfer under Rule 144 which shall not include
an opinion of Buyer&rsquo;s counsel), (iv) in connection with a sale, assignment or other transfer (other than under Rule 144), provided
that such Buyer provides the Company with an opinion of counsel to such Buyer, in a generally acceptable form, to the effect that such
sale, assignment or transfer of the Securities may be made without registration under the applicable requirements of the 1933 Act or
(v) if such legend is not required under applicable requirements of the 1933 Act (including, without limitation, controlling judicial
interpretations and pronouncements issued by the SEC). If a legend is not required pursuant to the foregoing, the Company shall no later
than one (1) Trading Day (or such earlier date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the
settlement of a trade initiated on the date such Buyer delivers such legended certificate representing such Securities to the Company)
following the delivery by a Buyer to the Company or the Transfer Agent (with notice to the Company) of a legended certificate representing
such Securities (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect the reissuance
and/or transfer, if applicable), together with any other deliveries from such Buyer as may be required above in this Section&nbsp;5(d),
as directed by such Buyer, either: (A) provided that the Transfer Agent is participating in the DTC Fast Automated Securities Transfer
Program (&ldquo;<B>FAST</B>&rdquo;) and such Securities are Conversion Shares or Warrant Shares, credit the aggregate number of shares
of Common Stock to which such Buyer shall be entitled to such Buyer&rsquo;s or its designee&rsquo;s balance account with DTC through
its Deposit/Withdrawal at Custodian system or (B) if the Transfer Agent is not participating in FAST, issue and deliver (via reputable
overnight courier) to such Buyer, a certificate representing such Securities that is free from all restrictive and other legends, registered
in the name of such Buyer or its designee (the date by which such credit is so required to be made to the balance account of such Buyer&rsquo;s
or such Buyer&rsquo;s designee with DTC or such certificate is required to be delivered to such Buyer pursuant to the foregoing is referred
to herein as the &ldquo;<B>Required Delivery Date</B>&rdquo;, and the date such shares of Common Stock are actually delivered without
restrictive legend to such Buyer or such Buyer&rsquo;s designee with DTC, as applicable, the &ldquo;<B>Share Delivery Date</B>&rdquo;).
The Company shall be responsible for any Transfer Agent fees or DTC fees with respect to any issuance of Securities or the removal of
any legends with respect to any Securities in accordance herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Failure to Timely
Deliver; Buy-In</U><FONT STYLE="font-size: 10pt"></FONT>. If the Company fails, for any reason or for no reason, to issue and deliver
(or cause to be delivered) to a Buyer (or its designee) by the Required Delivery Date, either (I) if the Transfer Agent is not participating
in FAST, a certificate for the number of Conversion Shares or Warrant Shares (as the case may be) to which such Buyer is entitled and
register such Conversion Shares or Warrant Shares (as the case may be) on the Company&rsquo;s share register or, if the Transfer Agent
is participating in FAST, to credit the balance account of such Buyer or such Buyer&rsquo;s designee with DTC for such number of Conversion
Shares or Warrant Shares (as the case may be) submitted for legend removal by such Buyer pursuant to Section 5(d) above or (II) if the
Registration Statement covering the resale of the Conversion Shares or Warrant Shares (as the case may be) submitted for legend removal
by such Buyer pursuant to Section 5(d) above (the &ldquo;<B>Unavailable Shares</B>&rdquo;) is not available for the resale of such Unavailable
Shares and the Company fails to promptly, but in no event later than as required pursuant to the Registration Rights Agreement (x) so
notify such Buyer and (y) deliver the Conversion Shares or Warrant Shares, as applicable, electronically without any restrictive legend
by crediting such aggregate number of Conversion Shares or Warrant Shares (as the case may be) submitted for legend removal by such Buyer
pursuant to Section 5(d) above to such Buyer&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit/Withdrawal
At Custodian system (the event described in the immediately foregoing clause (II) is hereinafter referred as a &ldquo;<B>Notice Failure</B>&rdquo;
and together with the event described in clause (I) above, a &ldquo;<B>Delivery Failure</B>&rdquo;), then, in addition to all other remedies
available to such Buyer, the Company shall pay in cash to such Buyer on each day after the Share Delivery Date and during such Delivery
Failure an amount equal to 2% of the product of (A) the sum of the number of shares of Common Stock not issued to such Buyer on or prior
to the Required Delivery Date and to which such Buyer is entitled, and (B) any trading price of the Common Stock selected by such Buyer
in writing as in effect at any time during the period beginning on the date of the delivery by such Buyer to the Company of the applicable
Conversion Shares or Warrant Shares (as the case may be) and ending on the applicable Share Delivery Date. In addition to the foregoing,
if on or prior to the Required Delivery Date either (I) if the Transfer Agent is not participating in FAST, the Company shall fail to
issue and deliver a certificate to a Buyer and register such shares of Common Stock on the Company&rsquo;s share register or, if the
Transfer Agent is participating in FAST, credit the balance account of such Buyer or such Buyer&rsquo;s designee with DTC for the number
of shares of Common Stock to which such Buyer submitted for legend removal by such Buyer pursuant to Section 5(d) above (ii) below or
(II) a Notice Failure occurs, and if on or after such Trading Day such Buyer acquires (in an open market transaction, stock loan or otherwise)
shares of Common Stock corresponding to all or any portion of the number of shares of Common Stock submitted for legend removal by such
Buyer pursuant to Section 5(d) above (a &ldquo;<B>Buy-In</B>&rdquo;), then the Company shall, within one (1) Trading Day after such Buyer&rsquo;s
request and in such Buyer&rsquo;s discretion, either (i) pay cash to such Buyer in an amount equal to such Buyer&rsquo;s total purchase
price (including brokerage commissions, stock loan costs and other out-of-pocket expenses, if any) (the &ldquo;<B>Buy-In Price</B>&rdquo;),
at which point the Company&rsquo;s obligation to so deliver such certificate or credit such Buyer&rsquo;s balance account shall terminate
and such shares shall be cancelled, or (ii) promptly honor its obligation to so deliver to such Buyer a certificate or certificates or
credit the balance account of such Buyer or such Buyer&rsquo;s designee with DTC representing such number of shares of Common Stock that
would have been so delivered if the Company timely complied with its obligations hereunder and pay cash to such Buyer in an amount equal
to the excess (if any) of the Buy-In Price over the product of (A) such number of shares of Conversion Shares or Warrant Shares (as the
case may be) that the Company was required to deliver to such Buyer by the Required Delivery Date multiplied by (B) the lowest Closing
Sale Price (as defined in the Certificate of Designations) of the Common Stock on any Trading Day during the period commencing on the
date of the delivery by such Buyer to the Company of the applicable Conversion Shares or Warrant Shares (as the case may be) and ending
on the date of such delivery and payment under this clause (ii). Nothing shall limit such Buyer&rsquo;s right to pursue any other remedies
available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief
with respect to the Company&rsquo;s failure to timely deliver certificates representing shares of Common Stock (or to electronically
deliver such shares of Common Stock) as required pursuant to the terms hereof. <FONT STYLE="background-color: white">Notwithstanding
anything herein to the contrary, with respect to any given Notice Failure and/or Delivery Failure, this Section 5(e) shall not apply
to the applicable Buyer the extent the Company has already paid such amounts in full to such Buyer with respect to such Notice Failure
and/or Delivery Failure, as applicable, pursuant to the analogous sections of the Certificate of Designations </FONT>or Warrant, as applicable,
with respect to the Preferred Shares or Warrants, as applicable, then held by such Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>FAST
Compliance</U>. While any Warrants remain outstanding, the Company shall maintain a transfer agent that participates in FAST.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">6.&nbsp;CONDITIONS
TO THE COMPANY&rsquo;S OBLIGATION TO SELL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligation of the Company
hereunder to issue and sell the Preferred Shares and the related Warrants to each Buyer at the Closing is subject to the satisfaction,
at or before the Closing Date, of each of the following conditions, provided that these conditions are for the Company&rsquo;s sole benefit
and may be waived by the Company at any time in its sole discretion by providing each Buyer with prior written notice thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;Such
Buyer shall have executed each of the other Transaction Documents to which it is a party and delivered the same to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;Such
Buyer and each other Buyer shall have delivered to the Company the Purchase Price (less, in the case of any Buyer, the amounts withheld
pursuant to Section&nbsp;4(g)) for the Preferred Shares and the related Warrants being purchased by such Buyer at the Closing and, to
the extent all, or any part, or any such Buyer&rsquo;s Purchase Price is being satisfied in cash, such portion shall have been satisfied
in cash by wire transfer of immediately available funds in accordance with the Flow of Funds Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;The
representations and warranties of such Buyer shall be true and correct in all material respects as of the date when made and as of the
Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific date, which
shall be true and correct as of such specific date), and such Buyer shall have performed, satisfied and complied in all material respects
with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by such Buyer at
or prior to the Closing Date.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">7.&nbsp;CONDITIONS
TO EACH BUYER&rsquo;S OBLIGATION TO PURCHASE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligation of each Buyer
hereunder to purchase its Preferred Shares and its related Warrants at the Closing is subject to the satisfaction, at or before the Closing
Date, of each of the following conditions, provided that these conditions are for each Buyer&rsquo;s sole benefit and may be waived by
such Buyer at any time in its sole discretion by providing the Company with prior written notice thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The
Company shall have duly executed and delivered to such Buyer each of the Transaction Documents to which it is a party and the Company
shall have duly executed and delivered to such Buyer (A) such aggregate number of Preferred Shares as set forth across from such Buyer&rsquo;s
name in column (3) of the Schedule of Buyers, and (B) Warrants initially exercisable for such aggregate number of Warrant Shares as is
set forth across from such Buyer&rsquo;s name in column (4) of the Schedule of Buyers, in each case, as being purchased by such Buyer
at the Closing pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;Such
Buyer shall have received the opinion of Ellenoff Grossman &amp; Schole LLP, the Company&rsquo;s counsel, dated as of the Closing Date,
in the form acceptable to such Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;The
Company shall have delivered to such Buyer a copy of the Irrevocable Transfer Agent Instructions, in the form acceptable to such Buyer,
which instructions shall have been delivered to and acknowledged in writing by the Transfer Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;The
Company shall have delivered to such Buyer a certificate evidencing the formation and good standing of the Company in Delaware issued
by the Delaware Secretary of State as of a date within ten (10) days of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;The
Company shall have delivered to such Buyer a certificate evidencing the Company&rsquo;s qualification as a foreign corporation and good
standing issued by the Secretary of State (or comparable office) of each jurisdiction in which the Company conducts business and is required
to so qualify, as of a date within ten (10) days of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;The
Company shall have delivered to such Buyer a certified copy of the Certificate of Incorporation and the Certificate of Designations as
certified by the Delaware Secretary of State within ten (10) days of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;The
Company shall have delivered to such Buyer a certificate, in the form acceptable to such Buyer, executed by the Secretary of the Company
and dated as of the Closing Date, as to (i) the resolutions consistent with Section&nbsp;3(b) as adopted by the Company&rsquo;s board
of directors in a form reasonably acceptable to such Buyer, (ii) the Certificate of Incorporation of the Company and (iii)&nbsp;the Bylaws
of the Company, each as in effect at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;Each
and every representation and warranty of the Company shall be true and correct as of the date when made and as of the Closing Date as
though originally made at that time (except for representations and warranties that speak as of a specific date, which shall be true and
correct as of such specific date) and the Company shall have performed, satisfied and complied in all respects with the covenants, agreements
and conditions required to be performed, satisfied or complied with by the Company at or prior to the Closing Date. Such Buyer shall have
received a certificate, duly executed by the Chief Executive Officer of the Company, dated as of the Closing Date, to the foregoing effect
and as to such other matters as may be reasonably requested by such Buyer in the form acceptable to such Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;The
Company shall have delivered to such Buyer a letter from the Transfer Agent certifying the number of shares of Common Stock outstanding
on the Closing Date immediately prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;The
Common Stock (A) shall be designated for quotation or listed (as applicable) on the Principal Market and (B) shall not have been suspended,
as of the Closing Date, by the SEC or the Principal Market from trading on the Principal Market nor shall suspension by the SEC or the
Principal Market have been threatened, as of the Closing Date, either (I) in writing by the SEC or the Principal Market or (II) by falling
below the minimum maintenance requirements of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;The
Company shall have obtained all governmental, regulatory or third party consents and approvals, if any, necessary for the sale of the
Securities, including without limitation, those required by the Principal Market, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;No
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by
any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by
the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;Since
the date of execution of this Agreement, no event or series of events shall have occurred that reasonably would have or result in a Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;The
Company shall have obtained approval of the Principal Market to list or designate for quotation (as the case may be) the Conversion Shares
and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;Such
Buyer shall have received a letter on the letterhead of the Company, duly executed by the Chief Executive Officer of the Company, setting
forth the wire amounts of each Buyer and the wire transfer instructions of the Company (the &ldquo;<B>Flow of Funds Letter</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;Neither
the Company, nor any of its Subsidiaries shall have any oral or written agreement with any Person with respect to any Fundamental Transaction
or other acquisition, merger or asset purchase outstanding as of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;The
Company and its Subsidiaries shall have delivered to such Buyer such other documents, instruments or certificates relating to the transactions
contemplated by this Agreement as such Buyer or its counsel may reasonably request.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">8.&nbsp;TERMINATION.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the Closing
shall not have occurred with respect to a Buyer within five (5) days of the date hereof, then such Buyer shall have the right to terminate
its obligations under this Agreement with respect to itself at any time on or after the close of business on such date without liability
of such Buyer to any other party; provided, however, (i) the right to terminate this Agreement under this Section&nbsp;8 shall not be
available to such Buyer if the failure of the transactions contemplated by this Agreement to have been consummated by such date is the
result of such Buyer&rsquo;s breach of this Agreement and (ii) the abandonment of the sale and purchase of the Preferred Shares and the
Warrants shall be applicable only to such Buyer providing such written notice, provided further that no such termination shall affect
any obligation of the Company under this Agreement to reimburse such Buyer for the expenses described in Section&nbsp;4(g) above. Nothing
contained in this Section&nbsp;8 shall be deemed to release any party from any liability for any breach by such party of the terms and
provisions of this Agreement or the other Transaction Documents or to impair the right of any party to compel specific performance by
any other party of its obligations under this Agreement or the other Transaction Documents.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">9.&nbsp;MISCELLANEOUS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Governing Law;
Jurisdiction; Jury Trial</U><FONT STYLE="font-size: 10pt"></FONT>. All questions concerning the construction, validity, enforcement
and interpretation of this Agreement shall be governed by the internal laws of the State of Delaware, without giving effect to any provision
or rule (whether of the State of Delaware or any other jurisdictions) that would cause the application of the laws of any jurisdictions
other than the State of Delaware. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in Wilmington, Delaware, for the adjudication of any dispute hereunder or in connection herewith or under any of the other Transaction
Documents or with any transaction contemplated hereby or thereby, and hereby irrevocably waives, and agrees not to assert in any suit,
action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding
is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to
such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. Nothing contained herein shall be deemed or operate to preclude any Buyer from bringing suit or taking other
legal action against the Company in any other jurisdiction to collect on the Company&rsquo;s obligations to such Buyer or to enforce
a judgment or other court ruling in favor of such Buyer. <B>EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES
NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR UNDER ANY OTHER TRANSACTION DOCUMENT OR IN CONNECTION WITH
OR ARISING OUT OF THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Counterparts</U><FONT STYLE="font-size: 10pt"></FONT>.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature
is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature
page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Headings; Gender</U><FONT STYLE="font-size: 10pt"></FONT>.
The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement.
Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular
and plural forms thereof. The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall
be construed broadly as if followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo;
&ldquo;hereof&rdquo; and words of like import refer to this entire Agreement instead of just the provision in which they are found.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Severability;
Maximum Payment Amounts</U><FONT STYLE="font-size: 10pt"></FONT>. If any provision of this Agreement is prohibited by law or otherwise
determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid
or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or
unenforceability of such provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement
as so modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof
and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective
expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred
upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s)
with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).
Notwithstanding anything to the contrary contained in this Agreement or any other Transaction Document (and without implication that
the following is required or applicable), it is the intention of the parties that in no event shall amounts and value paid by the Company
and/or any of its Subsidiaries (as the case may be), or payable to or received by any of the Buyers, under the Transaction Documents
(including without limitation, any amounts that would be characterized as &ldquo;interest&rdquo; under applicable law) exceed amounts
permitted under any applicable law. Accordingly, if any obligation to pay, payment made to any Buyer, or collection by any Buyer pursuant
the Transaction Documents is finally judicially determined to be contrary to any such applicable law, such obligation to pay, payment
or collection shall be deemed to have been made by mutual mistake of such Buyer, the Company and its Subsidiaries and such amount shall
be deemed to have been adjusted with retroactive effect to the maximum amount or rate of interest, as the case may be, as would not be
so prohibited by the applicable law. Such adjustment shall be effected, to the extent necessary, by reducing or refunding, at the option
of such Buyer, the amount of interest or any other amounts which would constitute unlawful amounts required to be paid or actually paid
to such Buyer under the Transaction Documents. For greater certainty, to the extent that any interest, charges, fees, expenses or other
amounts required to be paid to or received by such Buyer under any of the Transaction Documents or related thereto are held to be within
the meaning of &ldquo;interest&rdquo; or another applicable term to otherwise be violative of applicable law, such amounts shall be pro-rated
over the period of time to which they relate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Entire Agreement;
Amendments</U><FONT STYLE="font-size: 10pt"></FONT>. This Agreement, the other Transaction Documents and the schedules and exhibits
attached hereto and thereto and the instruments referenced herein and therein supersede all other prior oral or written agreements between
the Buyers, the Company, its Subsidiaries, their affiliates and Persons acting on their behalf, including, without limitation, any transactions
by any Buyer with respect to Common Stock or the Securities, and the other matters contained herein and therein, and this Agreement,
the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced herein and therein
contain the entire understanding of the parties solely with respect to the matters covered herein and therein; provided, however, nothing
contained in this Agreement or any other Transaction Document shall (or shall be deemed to) (i) have any effect on any agreements any
Buyer has entered into with, or any instruments any Buyer has received from, the Company or any of its Subsidiaries prior to the date
hereof with respect to any prior investment made by such Buyer in the Company or (ii) waive, alter, modify or amend in any respect any
obligations of the Company or any of its Subsidiaries, or any rights of or benefits to any Buyer or any other Person, in any agreement
entered into prior to the date hereof between or among the Company and/or any of its Subsidiaries and any Buyer, or any instruments any
Buyer received from the Company and/or any of its Subsidiaries prior to the date hereof, and all such agreements and instruments shall
continue in full force and effect. Except as specifically set forth herein or therein, neither the Company nor any Buyer makes any representation,
warranty, covenant or undertaking with respect to such matters. For clarification purposes, the Recitals are part of this Agreement.
No provision of this Agreement may be amended other than by an instrument in writing signed by the Company and the Required Holders,
and any amendment to any provision of this Agreement made in conformity with the provisions of this Section&nbsp;9(e) shall be binding
on all Buyers and holders of Securities, as applicable; provided that no such amendment shall be effective to the extent that it (A)
applies to less than all of the holders of the Securities then outstanding or (B) imposes any obligation or liability on any Buyer without
such Buyer&rsquo;s prior written consent (which may be granted or withheld in such Buyer&rsquo;s sole discretion). No waiver shall be
effective unless it is in writing and signed by an authorized representative of the waiving party, provided that the Required Holders
may waive any provision of this Agreement, and any waiver of any provision of this Agreement made in conformity with the provisions of
this Section&nbsp;9(e) shall be binding on all Buyers and holders of Securities, as applicable, provided that no such waiver shall be
effective to the extent that it (1) applies to less than all of the holders of the Securities then outstanding (unless a party gives
a waiver as to itself only) or (2) imposes any obligation or liability on any Buyer without such Buyer&rsquo;s prior written consent
(which may be granted or withheld in such Buyer&rsquo;s sole discretion). No consideration (other than reimbursement of legal fees) shall
be offered or paid to any Person to amend or consent to a waiver or modification of any provision of any of the Transaction Documents
unless the same consideration also is offered to all of the parties to the Transaction Documents, all holders of the Preferred Shares
or all holders of the Warrants (as the case may be). From the date hereof and while any Preferred Shares or Warrants are outstanding,
the Company shall not be permitted to receive any consideration from a Buyer or a holder of Preferred Shares or Warrants that is not
otherwise contemplated by the Transaction Documents in order to, directly or indirectly, induce the Company or any Subsidiary (i) to
treat such Buyer or holder of Preferred Shares or Warrants in a manner that is more favorable than to other similarly situated Buyers
or holders of Preferred Shares or Warrants, as applicable, or (ii) to treat any Buyer(s) or holder(s) of Preferred Shares or Warrants
in a manner that is less favorable than the Buyer or holder of Preferred Shares or Warrants that is paying such consideration; provided,
however, that the determination of whether a Buyer has been treated more or less favorably than another Buyer shall disregard any securities
of the Company purchased or sold by any Buyer. The Company has not, directly or indirectly, made any agreements with any Buyers relating
to the terms or conditions of the transactions contemplated by the Transaction Documents except as set forth in the Transaction Documents.
Without limiting the foregoing, the Company confirms that, except as set forth in this Agreement, no Buyer has made any commitment or
promise or has any other obligation to provide any financing to the Company, any Subsidiary or otherwise. As a material inducement for
each Buyer to enter into this Agreement, the Company expressly acknowledges and agrees that (x) no due diligence or other investigation
or inquiry conducted by a Buyer, any of its advisors or any of its representatives shall affect such Buyer&rsquo;s right to rely on,
or shall modify or qualify in any manner or be an exception to any of, the Company&rsquo;s representations and warranties contained in
this Agreement or any other Transaction Document and (y) unless a provision of this Agreement or any other Transaction Document is expressly
preceded by the phrase &ldquo;except as disclosed in the SEC Documents,&rdquo; nothing contained in any of the SEC Documents shall affect
such Buyer&rsquo;s right to rely on, or shall modify or qualify in any manner or be an exception to any of, the Company&rsquo;s representations
and warranties contained in this Agreement or any other Transaction Document. &ldquo;<B>Required Holders</B>&rdquo; means (I) prior to
the Closing Date, each Buyer entitled to purchase Preferred Shares at the Closing and (II) on or after the Closing Date, holders of a
majority of the Registrable Securities as of such time (excluding any Registrable Securities held by the Company or any of its Subsidiaries
as of such time) issued or issuable hereunder or pursuant to the Certificate of Designations and/or the Warrants (or the Buyers, with
respect to any waiver or amendment of Section 4(o)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Notices</U><FONT STYLE="font-size: 10pt"></FONT>.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in
writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by electronic
mail (provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the sending party
does not receive an automatically generated message from the recipient&rsquo;s email server that such e-mail could not be delivered to
such recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each
case, properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Onconetix, Inc.<BR>
201 E. Fifth Street, Suite 1900</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Cincinnati, Ohio<BR>
Telephone: (513) 620-4101<BR>
Attention: Interim Chief Financial Officer<BR>
E-Mail: KFedasz@Onconetix.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">With a copy (for informational purposes only) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Ellenoff Grossman &amp; Schole LLP<BR>
1345&nbsp;Avenue&nbsp;of&nbsp;the&nbsp;Americas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">11<SUP>th</SUP> Floor<BR>
New York, NY 10105<BR>
Telephone: (212) 370-1300<BR>
Attention: Barry I. Grossman, Esq.<BR>
E-Mail: bigrossman@egsllp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">If to the Transfer Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">1 State Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">30<SUP>th</SUP> Floor<BR>
New York 10004-1571<BR>
Telephone: (800) 509-5586<BR>
Attention: Vincent Amodeo<BR>
E-Mail: cstmail@continentalstock.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If to a Buyer, to its mailing address and e-mail
address set forth on the Schedule of Buyers, with copies to such Buyer&rsquo;s representatives as set forth on the Schedule of Buyers,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">with a copy (for informational purposes only) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Kelley Drye &amp; Warren LLP<BR>
3 World Trade Center<BR>
175 Greenwich Street<BR>
New York, NY 10007<BR>
Telephone: (212) 808-7540<BR>
Attention: Michael A. Adelstein, Esq.<BR>
E-mail: madelstein@kelleydrye.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or to such other mailing address and/or e-mail
address and/or to the attention of such other Person as the recipient party has specified by written notice given to each other party
five (5) days prior to the effectiveness of such change, provided that Kelley Drye &amp; Warren LLP shall only be provided copies of notices
sent to the lead Buyer. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication,
(B) mechanically or electronically generated by the sender&rsquo;s e-mail containing the time, date and recipient&rsquo;s e-mail or (C)
provided by an overnight courier service shall be rebuttable evidence of personal service, receipt by e-mail or receipt from an overnight
courier service in accordance with clause (i), (ii) or (iii) above, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Successors and
Assigns</U><FONT STYLE="font-size: 10pt"></FONT>. This Agreement shall be binding upon and inure to the benefit of the parties
and their respective successors and assigns, including any purchasers of any of the Preferred Shares and Warrants. The Company shall
not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Required Holders, including,
without limitation, by way of a Fundamental Transaction (as defined in the Warrants) (unless the Company is in compliance with the applicable
provisions governing Fundamental Transactions set forth in the Warrants) or a Fundamental Transaction (as defined in the Certificate
of Designations) (unless the Company is in compliance with the applicable provisions governing Fundamental Transactions set forth in
the Certificate of Designations). A Buyer may assign some or all of its rights hereunder in connection with any transfer of any of its
Securities without the consent of the Company, in which event such assignee shall be deemed to be a Buyer hereunder with respect to such
assigned rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>No Third Party
Beneficiaries</U><FONT STYLE="font-size: 10pt"></FONT>. This Agreement is intended for the benefit of the parties hereto and their
respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person,
other than the Indemnitees (as defined below) referred to in Section&nbsp;9(k).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Survival</U><FONT STYLE="font-size: 10pt"></FONT>.
The representations, warranties, agreements and covenants shall survive the Closing. Each Buyer shall be responsible only for its own
representations, warranties, agreements and covenants hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Further Assurances</U><FONT STYLE="font-size: 10pt"></FONT>.
Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents, as any other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Indemnification</U><FONT STYLE="font-size: 10pt"></FONT>.
In consideration of each Buyer&rsquo;s execution and delivery of the Transaction Documents and acquiring the Securities thereunder and
in addition to all of the Company&rsquo;s other obligations under the Transaction Documents, the Company shall defend, protect, indemnify
and hold harmless each Buyer and each holder of any Securities and all of their stockholders, partners, members, officers, directors,
employees and direct or indirect investors and any of the foregoing Persons&rsquo; agents or other representatives (including, without
limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively, the &ldquo;<B>Indemnitees</B>&rdquo;)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses
in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is
sought), and including reasonable attorneys&rsquo; fees and disbursements (the &ldquo;<B>Indemnified Liabilities</B>&rdquo;), incurred
by any Indemnitee as a result of, or arising out of, or relating to (i) any misrepresentation or breach of any representation or warranty
made by the Company or any Subsidiary in any of the Transaction Documents, (ii) any breach of any covenant, agreement or obligation of
the Company or any Subsidiary contained in any of the Transaction Documents or (iii) any cause of action, suit, proceeding or claim brought
or made against such Indemnitee by a third party (including for these purposes a derivative action brought on behalf of the Company or
any Subsidiary) or which otherwise involves such Indemnitee that arises out of or results from (A) the execution, delivery, performance
or enforcement of any of the Transaction Documents, (B) any transaction financed or to be financed in whole or in part, directly or indirectly,
with the proceeds of the issuance of the Securities, (C) any disclosure properly made by such Buyer pursuant to Section&nbsp;4(i), or
(D) the status of such Buyer or holder of the Securities either as an investor in the Company pursuant to the transactions contemplated
by the Transaction Documents or as a party to this Agreement (including, without limitation, as a party in interest or otherwise in any
action or proceeding for injunctive or other equitable relief). To the extent that the foregoing undertaking by the Company may be unenforceable
for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities
which is permissible under applicable law. Except as otherwise set forth herein, the mechanics and procedures with respect to the rights
and obligations under this Section&nbsp;9(k) shall be the same as those set forth in Section&nbsp;6 of the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Construction</U><FONT STYLE="font-size: 10pt"></FONT>.
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules
of strict construction will be applied against any party. No specific representation or warranty shall limit the generality or applicability
of a more general representation or warranty. Each and every reference to share prices, shares of Common Stock and any other numbers
in this Agreement that relate to the Common Stock shall be automatically adjusted for any stock splits, stock dividends, stock combinations,
recapitalizations or other similar transactions that occur with respect to the Common Stock after the date of this Agreement. Notwithstanding
anything in this Agreement to the contrary, for the avoidance of doubt, nothing contained herein shall constitute a representation or
warranty against, or a prohibition of, any actions with respect to the borrowing of, arrangement to borrow, identification of the availability
of, and/or securing of, securities of the Company in order for such Buyer (or its broker or other financial representative) to effect
short sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Remedies</U><FONT STYLE="font-size: 10pt"></FONT>.
Each Buyer and in the event of assignment by Buyer of its rights and obligations hereunder, each holder of Securities, shall have all
rights and remedies set forth in the Transaction Documents and all rights and remedies which such holders have been granted at any time
under any other agreement or contract and all of the rights which such holders have under any law. Any Person having any rights under
any provision of this Agreement shall be entitled to enforce such rights specifically (without posting a bond or other security), to
recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights granted by law. Furthermore,
the Company recognizes that in the event that it or any Subsidiary fails to perform, observe, or discharge any or all of its or such
Subsidiary&rsquo;s (as the case may be) obligations under the Transaction Documents, any remedy at law would inadequate relief to the
Buyers. The Company therefore agrees that the Buyers shall be entitled to specific performance and/or temporary, preliminary and permanent
injunctive or other equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual
damages and without posting a bond or other security. The remedies provided in this Agreement and the other Transaction Documents shall
be cumulative and in addition to all other remedies available under this Agreement and the other Transaction Documents, at law or in
equity (including a decree of specific performance and/or other injunctive relief).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Withdrawal Right</U><FONT STYLE="font-size: 10pt"></FONT>.
Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction Documents, whenever
any Buyer exercises a right, election, demand or option under a Transaction Document and the Company or any Subsidiary does not timely
perform its related obligations within the periods therein provided, then such Buyer may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company or such Subsidiary (as the case may be), any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>Payment Set Aside;
Currency</U><FONT STYLE="font-size: 10pt"></FONT>. To the extent that the Company makes a payment or payments to any Buyer hereunder
or pursuant to any of the other Transaction Documents or any of the Buyers enforce or exercise their rights hereunder or thereunder,
and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared
to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored
to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, foreign, state
or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally
intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement
or setoff had not occurred. Unless otherwise expressly indicated, all dollar amounts referred to in this Agreement and the other Transaction
Documents are in United States Dollars (&ldquo;<B>U.S. Dollars</B>&rdquo;), and all amounts owing under this Agreement and all other
Transaction Documents shall be paid in U.S. Dollars. All amounts denominated in other currencies (if any) shall be converted into the
U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. &ldquo;<B>Exchange Rate</B>&rdquo; means,
in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Agreement, the U.S. Dollar exchange rate as
published in the Wall Street Journal on the relevant date of calculation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Judgment Currency</U><FONT STYLE="font-size: 10pt"></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;If
for the purpose of obtaining or enforcing judgment against the Company in connection with this Agreement or any other Transaction Document
in any court in any jurisdiction it becomes necessary to convert into any other currency (such other currency being hereinafter in this
Section&nbsp;9(p) referred to as the &ldquo;<B>Judgment Currency</B>&rdquo;) an amount due in US Dollars under this Agreement, the conversion
shall be made at the Exchange Rate prevailing on the Trading Day immediately preceding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(1)&nbsp;the
date actual payment of the amount due, in the case of any proceeding in the courts of Delaware or in the courts of any other jurisdiction
that will give effect to such conversion being made on such date: or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">(2)&nbsp;the
date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of which
such conversion is made pursuant to this Section&nbsp;9(p)(i)(2) being hereinafter referred to as the &ldquo;<B>Judgment Conversion Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;If
in the case of any proceeding in the court of any jurisdiction referred to in Section&nbsp;9(p)(i)(2) above, there is a change in the
Exchange Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable party shall
pay such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange Rate
prevailing on the date of payment, will produce the amount of US Dollars which could have been purchased with the amount of Judgment Currency
stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;Any
amount due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained
for any other amounts due under or in respect of this Agreement or any other Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;<U>Independent Nature
of Buyers&rsquo; Obligations and Rights</U><FONT STYLE="font-size: 10pt"></FONT>. The obligations of each Buyer under the Transaction
Documents are several and not joint with the obligations of any other Buyer, and no Buyer shall be responsible in any way for the performance
of the obligations of any other Buyer under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Buyer pursuant hereto or thereto, shall be deemed to constitute the Buyers as, and the Company acknowledges
that the Buyers do not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create
a presumption that the Buyers are in any way acting in concert or as a group or entity, and the Company shall not assert any such claim
with respect to such obligations or the transactions contemplated by the Transaction Documents or any matters, and the Company acknowledges
that the Buyers are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or the transactions contemplated by the Transaction Documents. The decision of each Buyer to purchase Securities pursuant to the Transaction
Documents has been made by such Buyer independently of any other Buyer. Each Buyer acknowledges that no other Buyer has acted as agent
for such Buyer in connection with such Buyer making its investment hereunder and that no other Buyer will be acting as agent of such
Buyer in connection with monitoring such Buyer&rsquo;s investment in the Securities or enforcing its rights under the Transaction Documents.
The Company and each Buyer confirms that each Buyer has independently participated with the Company and its Subsidiaries in the negotiation
of the transaction contemplated hereby with the advice of its own counsel and advisors. Each Buyer shall be entitled to independently
protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of any other Transaction
Documents, and it shall not be necessary for any other Buyer to be joined as an additional party in any proceeding for such purpose.
The use of a single agreement to effectuate the purchase and sale of the Securities contemplated hereby was solely in the control of
the Company, not the action or decision of any Buyer, and was done solely for the convenience of the Company and its Subsidiaries and
not because it was required or requested to do so by any Buyer. It is expressly understood and agreed that each provision contained in
this Agreement and in each other Transaction Document is between the Company, each Subsidiary and a Buyer, solely, and not between the
Company, its Subsidiaries and the Buyers collectively and not between and among the Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>signature pages follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B>
each Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><B>COMPANY:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><B>ONCONETIX, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:</TD>
    <TD STYLE="text-align: justify">Karina M. Fedasz</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Interim Chief Executive Officer and Interim Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 221.4pt; text-indent: -25.9pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 221.4pt; text-indent: -25.9pt"></P>

<!-- Field: Page; Sequence: 50; Options: NewSection; Value: 51 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 221.4pt; text-indent: -25.9pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B>
each Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>BUYER:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase"><B>[lead buyer]</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name: [__]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title: [__]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 51; Value: 51 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B>
each Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>BUYER:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase"><B>[OTHER BUYERS]</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-weight: normal"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">53&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ea025986001ex10-2_onconetix.htm
<DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT DATED AS OF OCTOBER 1, 2025 RELATING TO THE RESALE OF THE SHARES OF COMMON STOCK UNDERLYING THE SERIES E PREFERRED STOCK AND WARRANTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REGISTRATION RIGHTS AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>REGISTRATION RIGHTS
AGREEMENT</B> (this &ldquo;<B>Agreement</B>&rdquo;), dated as of October 1, 2025, is by and among Onconetix, Inc., a Delaware corporation
with offices located at 201 E. Fifth Street, Suite 1900 Cincinnati, OH 45202 (the &ldquo;<B>Company</B>&rdquo;), and the undersigned buyers
(each, a &ldquo;<B>Buyer</B>,&rdquo; and collectively, the &ldquo;<B>Buyers</B>&rdquo;).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>RECITALS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;In
connection with the Securities Purchase Agreement by and among the parties hereto, dated as of October 1, 2025 (the &ldquo;<B>Securities
Purchase Agreement</B>&rdquo;), the Company has agreed, upon the terms and subject to the conditions of the Securities Purchase Agreement,
to issue and sell to each Buyer (i) shares of the Company&rsquo;s Series E Convertible Preferred Stock, par value $0.00001 per share (the
&ldquo;<B>Series E Preferred Stock</B>&rdquo;), which will be convertible into shares (the &ldquo;<B>Conversion Shares</B>&rdquo;) of
common stock of the Company, $0.00001 par value per share (the &ldquo;<B>Common Stock</B>&rdquo;) in accordance with the terms of the
Certificate of Designations (as defined in the Securities Purchase Agreement) and (ii) the Warrants (as defined in the Securities Purchase
Agreement) which will be exercisable to purchase Warrant Shares (as defined in the Securities Purchase Agreement) in accordance with the
terms of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;To
induce the Buyers to consummate the transactions contemplated by the Securities Purchase Agreement, the Company has agreed to provide
certain registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor
statute (collectively, the &ldquo;<B>1933 Act</B>&rdquo;), and applicable state securities laws.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>AGREEMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE,</B> in
consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and each of the Buyers hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1.&nbsp;<U>Definitions.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Capitalized terms used herein
and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement. As used in this Agreement,
the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>, <U>however</U>, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo;&nbsp; or any other similar orders or restrictions or the closure of any physical branch locations
at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&ldquo;<B>Closing
Date</B>&rdquo; shall have the meaning set forth in the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&ldquo;<B>Effective
Date</B>&rdquo; means the date that the applicable Registration Statement has been declared effective by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&ldquo;<B>Effectiveness
Deadline</B>&rdquo; means (i) with respect to the initial Registration Statement required to be filed pursuant to Section&nbsp;2(a), the
earlier of the (A) 90<SUP>th</SUP> calendar day (or the 120<SUP>th</SUP> calendar day if subject to a full review by the SEC) after the
applicable Closing Date and (B) 3rd Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by
the SEC that such Registration Statement will not be reviewed or will not be subject to further review and (ii) with respect to any additional
Registration Statements that may be required to be filed by the Company pursuant to this Agreement, the earlier of the (A) 90<SUP>th</SUP>
calendar day (or the 120<SUP>th</SUP> calendar day if subject to a full review by the SEC) following the date on which the Company was
required to file such additional Registration Statement and (B) 3rd Business Day after the date the Company is notified (orally or in
writing, whichever is earlier) by the SEC that such Registration Statement will not be reviewed or will not be subject to further review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&ldquo;<B>Filing
Deadline</B>&rdquo; means (i) with respect to the initial Registration Statement required to be filed pursuant to Section&nbsp;2(a), the
45<SUP>th</SUP> calendar day after the applicable Closing Date and (ii)&nbsp;with respect to any additional Registration Statements that
may be required to be filed by the Company pursuant to this Agreement, the date on which the Company was required to file such additional
Registration Statement pursuant to the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&ldquo;<B>Investor</B>&rdquo;
means a Buyer or any transferee or assignee of any Registrable Securities or Series E Preferred Stock or Warrants, as applicable, to whom
a Buyer assigns its rights under this Agreement and who agrees to become bound by the provisions of this Agreement in accordance with
Section&nbsp;9 and any transferee or assignee thereof to whom a transferee or assignee of any Registrable Securities or Series E Preferred
Stock or Warrants, as applicable, assigns its rights under this Agreement and who agrees to become bound by the provisions of this Agreement
in accordance with Section&nbsp;9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization
or a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&ldquo;<B>register</B>,&rdquo;
&ldquo;<B>registered</B>,&rdquo; and &ldquo;<B>registration</B>&rdquo; refer to a registration effected by preparing and filing one or
more Registration Statements in compliance with the 1933 Act and pursuant to Rule 415 and the declaration of effectiveness of such Registration
Statement(s) by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&ldquo;<B>Registrable
Securities</B>&rdquo; means (i) the Conversion Shares, (ii) the Warrant Shares and (iii) any capital stock of the Company issued or issuable
with respect to the Conversion Shares, the Warrant Shares, the Series E Preferred Stock or the Warrants, including, without limitation,
(1) as a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise and (2) shares of capital
stock of the Company into which the shares of Common Stock (as defined in the Certificate of Designations) are converted or exchanged
and shares of capital stock of a Successor Entity (as defined in the Warrants) into which the shares of Common Stock are converted or
exchanged, in each case, without regard to any limitations on conversion of the Series E Preferred Stock or exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;&ldquo;<B>Registration
Statement</B>&rdquo; means a registration statement or registration statements of the Company filed under the 1933 Act covering Registrable
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;&ldquo;<B>Required
Holders</B>&rdquo; shall have the meaning as set forth in the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;&ldquo;<B>Required
Registration Amount</B>&rdquo; means, as of any time of determination, 150% of the sum of (i) the maximum number of shares of Common Stock
issuable upon conversion of all the Series E Preferred Stock (assuming for purposes hereof that (x) the shares of Series E Preferred Stock
are convertible at the Alternate Conversion Price (as defined in the Certificate of Designations) then in effect assuming an Alternate
Conversion Date (as defined in the Certificate of Designations) as of such applicable date of determination and (y) any such conversion
shall not take into account any limitations on the conversion of the Series E Preferred Stock set forth in the Certificate of Designations
and (ii) the maximum number of Warrant Shares issuable upon exercise of the Warrants (without taking into account any limitations on the
exercise of the Warrants set forth therein), all subject to adjustment as provided in Section&nbsp;2(d) and/or Section 2(f)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;&ldquo;<B>Rule
144</B>&rdquo; means Rule 144 promulgated by the SEC under the 1933 Act, as such rule may be amended from time to time, or any other similar
or successor rule or regulation of the SEC that may at any time permit the Investors to sell securities of the Company to the public without
registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;&ldquo;<B>Rule
415</B>&rdquo; means Rule 415 promulgated by the SEC under the 1933 Act, as such rule may be amended from time to time, or any other similar
or successor rule or regulation of the SEC providing for offering securities on a continuous or delayed basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;&ldquo;<B>SEC</B>&rdquo;
means the United States Securities and Exchange Commission or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.&nbsp;<U>Registration.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Mandatory
Registration</U>. The Company shall prepare and, as soon as practicable, but in no event later than the Filing Deadline, file with the
SEC an initial Registration Statement on Form S-3 covering the resale of all of the Registrable Securities, provided that such initial
Registration Statement shall register for resale at least the number of shares of Common Stock equal to the Required Registration Amount
as of the date such Registration Statement is initially filed with the SEC; provided further that if Form S-3 is unavailable for such
a registration, the Company shall use such other form as is required by Section 2(c). Such initial Registration Statement, and each other
Registration Statement required to be filed pursuant to the terms of this Agreement, shall contain (except if otherwise directed by the
Required Holders) the &ldquo;<U>Selling Stockholders</U>&rdquo; and &ldquo;<U>Plan of Distribution</U>&rdquo; sections in substantially
the form attached hereto as <B>Exhibit B</B>. The Company shall use its best efforts to have such initial Registration Statement, and
each other Registration Statement required to be filed pursuant to the terms of this Agreement, declared effective by the SEC as soon
as practicable, but in no event later than the applicable Effectiveness Deadline for such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Legal
Counsel</U>. Subject to Section&nbsp;5 hereof, Kelley Drye &amp; Warren LLP, counsel solely to the lead Investor (&ldquo;<B>Legal Counsel</B>&rdquo;)
shall review and oversee any registration, solely on behalf of the lead Investor, pursuant to this Section&nbsp;2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Ineligibility
to Use Form S-3</U>. In the event that Form S-3 is not available for the registration of the resale of Registrable Securities hereunder,
the Company shall (i) register the resale of the Registrable Securities on Form S-1 or another appropriate form reasonably acceptable
to the Required Holders and (ii) undertake to register the resale of the Registrable Securities on Form&nbsp;S-3 as soon as such form
is available, provided that the Company shall maintain the effectiveness of all Registration Statements then in effect until such time
as a Registration Statement on Form S-3 covering the resale of all the Registrable Securities has been declared effective by the SEC and
the prospectus contained therein is available for use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Sufficient
Number of Shares Registered</U>. In the event the number of shares available under any Registration Statement is insufficient to cover
all of the Registrable Securities required to be covered by such Registration Statement or an Investor&rsquo;s allocated portion of the
Registrable Securities pursuant to Section&nbsp;2(h), the Company shall amend such Registration Statement (if permissible), or file with
the SEC a new Registration Statement (on the short form available therefor, if applicable), or both, so as to cover at least the Required
Registration Amount as of the Trading Day (as defined in the Certificate of Designations) immediately preceding the date of the filing
of such amendment or new Registration Statement, in each case, as soon as practicable, but in any event not later than fifteen (15) Trading
Days (or twenty (20) Trading Days with respect to financial statement comments) after the necessity therefor arises (but taking account
of any Staff (as defined below) position with respect to the date on which the Staff will permit such amendment to the Registration Statement
and/or such new Registration Statement (as the case may be) to be filed with the SEC). The Company shall use its best efforts to cause
such amendment to such Registration Statement and/or such new Registration Statement (as the case may be) to become effective as soon
as practicable following the filing thereof with the SEC, but in no event later than the applicable Effectiveness Deadline for such Registration
Statement. For purposes of the foregoing provision, the number of shares available under a Registration Statement shall be deemed &ldquo;insufficient
to cover all of the Registrable Securities&rdquo; if at any time the number of shares of Common Stock available for resale under the applicable
Registration Statement is less than the product determined by multiplying (i) the Required Registration Amount as of such time by (ii)
0.90. The calculation set forth in the foregoing sentence shall be made without regard to any limitations on conversion, amortization
and/or redemption of the Series E Preferred Stock or exercise of the Warrants (and such calculation shall assume (A) that the shares of
Series E Preferred Stock are then convertible in full into shares of Common Stock at the Alternate Conversion Price (as defined in the
Certificate of Designations) then in effect assuming an Alternate Conversion Date (as defined in the Certificate of Designations) as of
such applicable date of determination, (B) all shares of the Series E Preferred Stock oustanding as of such time of determination remain
outstanding through the scheduled Maturity Date (as defined in the Certificate of Designations) and no redemptions of the Series E Preferred
Stock occur prior to the scheduled Maturity Date and (C) the Warrants are then exercisable in full into shares of Common Stock at the
then prevailing Exercise Price (as defined in the Warrants)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Effect
of Failure to File and Obtain and Maintain Effectiveness of any Registration Statement</U>. If (i) a Registration Statement covering the
resale of all of the Registrable Securities required to be covered thereby (disregarding any reduction pursuant to Section&nbsp;2(f))
and required to be filed by the Company pursuant to this Agreement is (A) not filed with the SEC on or before the Filing Deadline for
such Registration Statement (a &ldquo;<B>Filing Failure</B>&rdquo;) (it being understood that if the Company files a Registration Statement
without affording each Investor and Legal Counsel the opportunity to review and comment on the same as required by Section&nbsp;3(c) hereof,
the Company shall be deemed to not have satisfied this clause&nbsp;(i)(A) and such event shall be deemed to be a Filing Failure) or (B)
not declared effective by the SEC on or before the Effectiveness Deadline for such Registration Statement (an &ldquo;<B>Effectiveness
Failure</B>&rdquo;) (it being understood that if on the Business Day immediately following the Effective Date for such Registration Statement
the Company shall not have filed a &ldquo;final&rdquo; prospectus for such Registration Statement with the SEC under Rule 424(b) in accordance
with Section&nbsp;3(b) (whether or not such a prospectus is technically required by such rule), the Company shall be deemed to not have
satisfied this clause (i)(B) and such event shall be deemed to be an Effectiveness Failure), (ii) other than during an Allowable Grace
Period (as defined below), on any day after the Effective Date of a Registration Statement sales of all of the Registrable Securities
required to be included on such Registration Statement (disregarding any reduction pursuant to Section&nbsp;2(f)) cannot be made pursuant
to such Registration Statement (including, without limitation, because of a failure to keep such Registration Statement effective, a failure
to disclose such information as is necessary for sales to be made pursuant to such Registration Statement, a suspension or delisting of
(or a failure to timely list) the shares of Common Stock on the Principal Market (as defined in the Securities Purchase Agreement) or
any other limitations imposed by the Principal Market, or a failure to register a sufficient number of shares of Common Stock or by reason
of a stop order) or the prospectus contained therein is not available for use for any reason (a &ldquo;<B>Maintenance Failure</B>&rdquo;),
or (iii) if a Registration Statement is not effective for any reason or the prospectus contained therein is not available for use for
any reason, and either (x) the Company fails for any reason to satisfy the requirements of Rule 144(c)(1), including, without limitation,
the failure to satisfy the current public information requirement under Rule 144(c) or (y) the Company has ever been an issuer described
in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2)
(a &ldquo;<B>Current Public Information Failure</B>&rdquo;) as a result of which any of the Investors are unable to sell Registrable Securities
without restriction under Rule&nbsp;144 (including, without limitation, volume restrictions), then, as partial relief for the damages
to any holder by reason of any such delay in, or reduction of, its ability to sell the underlying shares of Common Stock (which remedy
shall not be exclusive of any other remedies available at law or in equity, including, without limitation, specific performance), the
Company shall pay to each holder of Registrable Securities relating to such Registration Statement an amount in cash equal to one percent
(1%) of such Investor&rsquo;s Purchase Price (as defined in the Securities Purchase Agreement) (1) on the date of such Filing Failure,
Effectiveness Failure, Maintenance Failure or Current Public Information Failure, as applicable, and (2) on every thirty (30) day anniversary
of (I) a Filing Failure until such Filing Failure is cured; (II) an Effectiveness Failure until such Effectiveness Failure is cured; (III)&nbsp;a
Maintenance Failure until such Maintenance Failure is cured; and (IV) a Current Public Information Failure until the earlier of (i) the
date such Current Public Information Failure is cured and (ii) such time that such public information is no longer required pursuant to
Rule&nbsp;144 (in each case, pro rated for periods totaling less than thirty (30) days). The payments to which a holder of Registrable
Securities shall be entitled pursuant to this Section&nbsp;2(e) are referred to herein as &ldquo;<B>Registration Delay Payments</B>.&rdquo;
Following the initial Registration Delay Payment for any particular event or failure (which shall be paid on the date of such event or
failure, as set forth above), without limiting the foregoing, if an event or failure giving rise to the Registration Delay Payments is
cured prior to any thirty (30) day anniversary of such event or failure, then such Registration Delay Payment shall be made on the third
(3<SUP>rd</SUP>) Business Day after such cure. In the event the Company fails to make Registration Delay Payments in a timely manner in
accordance with the foregoing, such Registration Delay Payments shall bear interest at the rate of two percent (2%) per month (prorated
for partial months) until paid in full. Notwithstanding the foregoing, no Registration Delay Payments shall be owed to an Investor (other
than with respect to a Maintenance Failure resulting from a suspension or delisting of (or a failure to timely list) the shares of Common
Stock on the Principal Market) with respect to any period during which all of such Investor&rsquo;s Registrable Securities may be sold
by such Investor without restriction under Rule 144 (including, without limitation, volume restrictions) and without the need for current
public information required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Offering</U>.
Notwithstanding anything to the contrary contained in this Agreement, but subject to the payment of the Registration Delay Payments pursuant
to Section&nbsp;2(e), in the event the staff of the SEC (the &ldquo;<B>Staff</B>&rdquo;) or the SEC seeks to characterize any&nbsp;offering
pursuant to a Registration Statement filed pursuant to this Agreement as constituting an&nbsp;offering of securities by, or on behalf
of, the Company, or in any other manner, such that&nbsp;the Staff or&nbsp;the SEC do not&nbsp;permit such Registration Statement to become
effective and used for resales in a manner that does not constitute such an offering and that permits the continuous resale at the market
by the Investors participating&nbsp;therein&nbsp;(or as otherwise may be acceptable to each Investor) without being named therein as an
&ldquo;underwriter,&rdquo; then the Company shall reduce the number of shares to be included in such Registration Statement by all Investors
until such time as the Staff&nbsp;and the SEC shall so permit such Registration Statement to become effective as aforesaid. In making
such reduction, the Company shall reduce the number of shares to be included by all Investors on a pro rata basis (based upon the number
of Registrable Securities otherwise required to be included for each Investor) unless the inclusion of shares by a particular Investor
or a particular set of Investors are resulting in the Staff or the SEC&rsquo;s &ldquo;by or on behalf of the Company&rdquo; offering position,
in which event the shares held by such Investor or set of Investors shall be the only shares subject to reduction (and if by a set of
Investors on a pro rata basis by such Investors or on such other basis as would result in the exclusion of the least number of shares
by all such Investors); provided, that, with respect to such pro rata portion allocated to any Investor, such Investor may elect the allocation
of such pro rata portion among the Registrable Securities of such Investor. In addition, in the event that the Staff or the SEC requires
any Investor seeking to&nbsp;sell securities under a Registration Statement filed pursuant to this Agreement&nbsp;to be specifically identified
as an &ldquo;underwriter&rdquo; in order to permit such Registration Statement to become effective, and such Investor does not consent
to being so named as an underwriter in such Registration Statement,&nbsp;then, in each such case, the Company&nbsp;shall reduce the total
number of Registrable Securities to be registered on behalf of&nbsp;such&nbsp;Investor,&nbsp;until such time as the Staff or the SEC does
not require such identification or until such Investor accepts such identification and the manner thereof. Any reduction pursuant to this
paragraph will&nbsp;first reduce all Registrable Securities other than those issued pursuant to the Securities Purchase Agreement.&nbsp;&nbsp;In
the event of any&nbsp;reduction in Registrable Securities pursuant to this paragraph,&nbsp;an affected Investor shall have the right to
require, upon delivery of a written request to the Company signed by such Investor, the Company to file a registration statement within
twenty (20) days of such request (subject to any restrictions imposed by Rule 415 or required&nbsp;by the&nbsp;Staff or the SEC) for resale
by such Investor in a manner acceptable to such Investor, and the Company shall following such request&nbsp;cause to be and keep effective
such registration statement in the same manner as otherwise contemplated&nbsp;in this Agreement for&nbsp;registration statements hereunder,
in each case until such time as: (i) all Registrable Securities held by such Investor&nbsp;have been registered and sold pursuant to an
effective Registration Statement in a manner acceptable to such Investor&nbsp;or (ii) all Registrable Securities may be resold by such
Investor&nbsp;without restriction (including, without limitation, volume limitations) pursuant to Rule 144 (taking account of any Staff
position with respect to &ldquo;affiliate&rdquo; status) and without the need for current public information required by Rule 144(c)(1)
(or Rule 144(i)(2), if applicable) or (iii) such Investor agrees to be named as an underwriter in any such Registration Statement in a
manner acceptable to such Investor as to all Registrable Securities held by such Investor and that have not theretofore been included
in a Registration Statement under this Agreement (it being understood that the special demand right under this sentence may be exercised
by an Investor multiple times and with respect to limited amounts of Registrable Securities in order to permit the resale thereof by such
Investor as contemplated above).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Piggyback
Registrations</U>. Without limiting any obligation of the Company hereunder or under the Securities Purchase Agreement if there is not
an effective Registration Statement covering all of the Registrable Securities or the prospectus contained therein is not available for
use and the Company shall determine to prepare and file with the SEC a registration statement or offering statement relating to an offering
for its own account or the account of others under the 1933 Act of any of its equity securities (other than on Form S-4 or Form S-8 (each
as promulgated under the 1933 Act) or their then equivalents relating to equity securities to be issued solely in connection with any
acquisition of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock option or other employee
benefit plans), then the Company shall deliver to each Investor a written notice of such determination and, if within fifteen&nbsp;(15)
days after the date of the delivery of such notice, any such Investor shall so request in writing, the Company shall include in such registration
statement or offering statement all or any part of such Registrable Securities such Investor requests to be registered; provided, however,
the Company shall not be required to register any Registrable Securities pursuant to this Section&nbsp;2(g) that are eligible for resale
pursuant to Rule 144 without restriction (including, without limitation, volume restrictions) and without the need for current public
information required by Rule 144(c)(1) (or Rule&nbsp;144(i)(2), if applicable) or that are the subject of a then-effective Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Allocation
of Registrable Securities</U>. The initial number of Registrable Securities included in any Registration Statement and any increase in
the number of Registrable Securities included therein shall be allocated pro rata among the Investors based on the number of Registrable
Securities held by each Investor at the time such Registration Statement covering such initial number of Registrable Securities or increase
thereof is declared effective by the SEC. In the event that an Investor sells or otherwise transfers any of such Investor&rsquo;s Registrable
Securities, each transferee or assignee (as the case may be) that becomes an Investor shall be allocated a pro rata portion of the then-remaining
number of Registrable Securities included in such Registration Statement for such transferor or assignee (as the case may be). Any shares
of Common Stock included in a Registration Statement and which remain allocated to any Person which ceases to hold any Registrable Securities
covered by such Registration Statement shall be allocated to the remaining Investors, pro rata based on the number of Registrable Securities
then held by such Investors which are covered by such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>No
Inclusion of Other Securities</U>. Except for such securities as set forth on <U>Schedule 2(i)</U>, the Company shall in no event include
any securities other than Registrable Securities on any Registration Statement filed in accordance herewith without the prior written
consent of the Required Holders; provided, that, in the event of any reduction in the aggregate number of securities included on the applicable
Registration Statement required by the SEC (or as necessary to prevent one or more Investors being deemed an underwriter under such applicable
Registration Statement), the aggregate number of securities as set forth on <U>Schedule 2(i)</U> shall be reduced on such Registration
Statement, pro rata, prior to any reduction of any of the Registrable Securities included in such Registration Statement. Until the Applicable
Date (as defined in the Securities Purchase Agreement), the Company shall not enter into any agreement providing any registration rights
to any of its security holders, except as otherwise permitted under the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.&nbsp;<U>Related
Obligations.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company shall use its
best efforts to effect the registration of the Registrable Securities in accordance with the intended method of disposition thereof, and,
pursuant thereto, the Company shall have the following obligations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The
Company shall promptly prepare and file with the SEC a Registration Statement with respect to all the Registrable Securities (but in no
event later than the applicable Filing Deadline) and use its best efforts to cause such Registration Statement to become effective as
soon as practicable after such filing (but in no event later than the Effectiveness Deadline). Subject to Allowable Grace Periods, the
Company shall keep each Registration Statement effective (and the prospectus contained therein available for use) pursuant to Rule 415
for resales by the Investors on a delayed or continuous basis at then-prevailing market prices (and not fixed prices) at all times until
the earlier of (i) the date as of which all of the Investors may sell all of the Registrable Securities required to be covered by such
Registration Statement (disregarding any reduction pursuant to Section&nbsp;2(f)) without restriction pursuant to Rule 144 (including,
without limitation, volume restrictions) and without the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2),
if applicable) or (ii) the date on which the Investors shall have sold all of the Registrable Securities covered by such Registration
Statement (the &ldquo;<B>Registration Period</B>&rdquo;). Notwithstanding anything to the contrary contained in this Agreement, the Company
shall ensure that, when filed and at all times while effective, each Registration Statement (including, without limitation, all amendments
and supplements thereto) and the prospectus (including, without limitation, all amendments and supplements thereto) used in connection
with such Registration Statement (1) shall not contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light of the circumstances in which
they were made) not misleading and (2) will disclose (whether directly or through incorporation by reference to other SEC filings to the
extent permitted) all material information regarding the Company and its securities. The Company shall submit to the SEC, as promptly
as practicable after the later of the date that (i) the Company learns that no review of a particular Registration Statement will be made
by the Staff or that the Staff has no further comments on a particular Registration Statement (as the case may be) and (ii) the consent
of Legal Counsel is obtained pursuant to Section&nbsp;3(c) (which consent shall be immediately sought), a request for acceleration of
effectiveness of such Registration Statement to a time and date not later than forty-eight&nbsp;(48) hours after the submission of such
request. The Company shall respond in writing to comments made by the SEC in respect of a Registration Statement as soon as practicable,
but in no event later than fifteen (15) Trading Days (or twenty (20) Trading Days with respect to financial statement comments) after
the receipt of comments by or notice from the SEC that an amendment is required in order for a Registration Statement to be declared effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;Subject
to Section&nbsp;3(r) of this Agreement, the Company shall prepare and file with the SEC such amendments (including, without limitation,
post-effective amendments) and supplements to each Registration Statement and the prospectus used in connection with each such Registration
Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the 1933 Act, as may be necessary to keep each such
Registration Statement effective at all times during the Registration Period for such Registration Statement, and, during such period,
comply with the provisions of the 1933 Act with respect to the disposition of all Registrable Securities of the Company required to be
covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance
with the intended methods of disposition by the seller or sellers thereof as set forth in such Registration Statement; provided, however,
by 8:30 a.m. (New York time) on the Business Day immediately following each Effective Date, the Company shall file with the SEC in accordance
with Rule 424(b) under the 1933 Act the final prospectus to be used in connection with sales pursuant to the applicable Registration Statement
(whether or not such a prospectus is technically required by such rule). In the case of amendments and supplements to any Registration
Statement which are required to be filed pursuant to this Agreement (including, without limitation, pursuant to this Section&nbsp;3(b))
by reason of the Company filing a report on Form 8-K, Form 10-Q or Form 10-K or any analogous report under the Securities Exchange Act
of 1934, as amended (the &ldquo;<B>1934 Act</B>&rdquo;), the Company shall, if permitted under the applicable rules and regulations of
the SEC, have incorporated such report by reference into such Registration Statement, if applicable, or shall file such amendments or
supplements with the SEC on the same day on which the 1934 Act report is filed which created the requirement for the Company to amend
or supplement such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;The
Company shall (A) permit Legal Counsel and legal counsel for each other Investor to review and comment upon (i) each Registration Statement
at least five (5) Business Days prior to its filing with the SEC and (ii) all amendments and supplements to each Registration Statement
(including, without limitation, the prospectus contained therein) (except for Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q,
Current Reports on Form 8-K, and any similar or successor reports) within a reasonable number of days prior to their filing with the SEC,
and (B) not file any Registration Statement or amendment or supplement thereto in a form to which Legal Counsel or any legal counsel for
any other Investor reasonably objects. The Company shall not submit a request for acceleration of the effectiveness of a Registration
Statement or any amendment or supplement thereto or to any prospectus contained therein without the prior consent of Legal Counsel, which
consent shall not be unreasonably withheld. The Company shall promptly furnish to Legal Counsel and legal counsel for each other Investor,
without charge, (i) copies of any correspondence from the SEC or the Staff to the Company or its representatives relating to each Registration
Statement, provided that such correspondence shall not contain any material, non-public information regarding the Company or any of its
Subsidiaries (as defined in the Securities Purchase Agreement), (ii)&nbsp;after the same is prepared and filed with the SEC, one (1) copy
of each Registration Statement and any amendment(s) and supplement(s) thereto, including, without limitation, financial statements and
schedules, all documents incorporated therein by reference, if requested by an Investor, and all exhibits and (iii)&nbsp;upon the effectiveness
of each Registration Statement, one (1) copy of the prospectus included in such Registration Statement and all amendments and supplements
thereto. The Company shall reasonably cooperate with Legal Counsel and legal counsel for each other Investor in performing the Company&rsquo;s
obligations pursuant to this Section 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;The
Company shall promptly furnish to each Investor whose Registrable Securities are included in any Registration Statement, without charge,
(i) after the same is prepared and filed with the SEC, at least one (1) copy of each Registration Statement and any amendment(s) and supplement(s)
thereto, including, without limitation, financial statements and schedules, all documents incorporated therein by reference, if requested
by an Investor, all exhibits and each preliminary prospectus, (ii) upon the effectiveness of each Registration Statement, ten&nbsp;(10)
copies of the prospectus included in such Registration Statement and all amendments and supplements thereto (or such other number of copies
as such Investor may reasonably request from time to time) and (iii) such other documents, including, without limitation, copies of any
preliminary or final prospectus, as such Investor may reasonably request from time to time in order to facilitate the disposition of the
Registrable Securities owned by such Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;The
Company shall use its best efforts to (i) register and qualify, unless an exemption from registration and qualification applies, the resale
by Investors of the Registrable Securities covered by a Registration Statement under such other securities or &ldquo;blue sky&rdquo; laws
of all applicable jurisdictions in the United States, (ii) prepare and file in those jurisdictions, such amendments (including, without
limitation, post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain the effectiveness
thereof during the Registration Period, (iii) take such other actions as may be necessary to maintain such registrations and qualifications
in effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary or advisable to qualify the
Registrable Securities for sale in such jurisdictions; provided, however, the Company shall not be required in connection therewith or
as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this
Section&nbsp;3(e), (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to service of process
in any such jurisdiction. The Company shall promptly notify Legal Counsel, legal counsel for each other Investor and each Investor who
holds Registrable Securities of the receipt by the Company of any notification with respect to the suspension of the registration or qualification
of any of the Registrable Securities for sale under the securities or &ldquo;blue sky&rdquo; laws of any jurisdiction in the United States
or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Options: NewSection; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;The
Company shall notify Legal Counsel, legal counsel for each other Investor and each Investor in writing of the happening of any event,
as promptly as practicable after becoming aware of such event, as a result of which the prospectus included in a Registration Statement,
as then in effect, may include an untrue statement of a material fact or omission to state a material fact required to be stated therein
or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading (provided that
in no event shall such notice contain any material, non-public information regarding the Company or any of its Subsidiaries), and, subject
to Section&nbsp;3(r), promptly prepare a supplement or amendment to such Registration Statement and such prospectus contained therein
to correct such untrue statement or omission and deliver ten (10) copies of such supplement or amendment to Legal Counsel, legal counsel
for each other Investor and each Investor (or such other number of copies as Legal Counsel, legal counsel for each other Investor or such
Investor may reasonably request). The Company shall also promptly notify Legal Counsel, legal counsel for each other Investor and each
Investor in writing (i) when a prospectus or any prospectus supplement or post-effective amendment has been filed, when a Registration
Statement or any post-effective amendment has become effective (notification of such effectiveness shall be delivered to Legal Counsel,
legal counsel for each other Investor and each Investor by e-mail on the same day of such effectiveness and by overnight mail), and when
the Company receives written notice from the SEC that a Registration Statement or any post-effective amendment will be reviewed by the
SEC, (ii) of any request by the SEC for amendments or supplements to a Registration Statement or related prospectus or related information,
(iii) of the Company&rsquo;s reasonable determination that a post-effective amendment to a Registration Statement would be appropriate;
and (iv) of the receipt of any request by the SEC or any other federal or state governmental authority for any additional information
relating to the Registration Statement or any amendment or supplement thereto or any related prospectus. The Company shall respond as
promptly as practicable to any comments received from the SEC with respect to each Registration Statement or any amendment thereto (it
being understood and agreed that the Company&rsquo;s response to any such comments shall be delivered to the SEC no later than fifteen&nbsp;(15)
Business Days after the receipt thereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;The
Company shall (i) use its best efforts to prevent the issuance of any stop order or other suspension of effectiveness of each Registration
Statement or the use of any prospectus contained therein, or the suspension of the qualification, or the loss of an exemption from qualification,
of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is issued, to obtain the withdrawal
of such order or suspension at the earliest possible moment and (ii) notify Legal Counsel, legal counsel for each other Investor and each
Investor who holds Registrable Securities of the issuance of such order and the resolution thereof or its receipt of actual notice of
the initiation or threat of any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;If
any Investor may be required under applicable securities law to be described in any Registration Statement as an underwriter and such
Investor consents to so being named an underwriter, at the request of any Investor, the Company shall furnish to such Investor, on the
date of the effectiveness of such Registration Statement and thereafter from time to time on such dates as an Investor may reasonably
request (i) a letter, dated such date, from the Company&rsquo;s independent certified public accountants in form and substance as is customarily
given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the Investors, and
(ii) an opinion, dated as of such date, of counsel representing the Company for purposes of such Registration Statement, in form, scope
and substance as is customarily given in an underwritten public offering, addressed to the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;If
any Investor may be required under applicable securities law to be described in any Registration Statement as an underwriter and such
Investor consents to so being named an underwriter, upon the written request of such Investor, the Company shall make available for inspection
by (i) such Investor, (ii) legal counsel for such Investor and (iii) one (1) firm of accountants or other agents retained by such Investor
(collectively, the &ldquo;<B>Inspectors</B>&rdquo;), all pertinent financial and other records, and pertinent corporate documents and
properties of the Company (collectively, the &ldquo;<B>Records</B>&rdquo;), as shall be reasonably deemed necessary by each Inspector,
and cause the Company&rsquo;s officers, directors and employees to supply all information which any Inspector may reasonably request;
provided, however, each Inspector shall agree in writing to hold in strict confidence and not to make any disclosure (except to such Investor)
or use of any Record or other information which the Company&rsquo;s board of directors determines in good faith to be confidential, and
of which determination the Inspectors are so notified, unless (1) the disclosure of such Records is necessary to avoid or correct a misstatement
or omission in any Registration Statement or is otherwise required under the 1933 Act, (2) the release of such Records is ordered pursuant
to a final, non-appealable subpoena or order from a court or government body of competent jurisdiction, or (3) the information in such
Records has been made generally available to the public other than by disclosure in violation of this Agreement or any other Transaction
Document (as defined in the Securities Purchase Agreement). Such Investor agrees that it shall, upon learning that disclosure of such
Records is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt notice to the Company
and allow the Company, at its expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for,
the Records deemed confidential. Nothing herein (or in any other confidentiality agreement between the Company and such Investor, if any)
shall be deemed to limit any Investor&rsquo;s ability to sell Registrable Securities in a manner which is otherwise consistent with applicable
laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;The
Company shall hold in confidence and not make any disclosure of information concerning an Investor provided to the Company unless (i)
disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is
necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed in such
Registration Statement pursuant to the 1933 Act, (iii) the release of such information is ordered pursuant to a subpoena or other final,
non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made generally available
to the public other than by disclosure in violation of this Agreement or any other Transaction Document. The Company agrees that it shall,
upon learning that disclosure of such information concerning an Investor is sought in or by a court or governmental body of competent
jurisdiction or through other means, give prompt written notice to such Investor and allow such Investor, at such Investor&rsquo;s expense,
to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;Without
limiting any obligation of the Company under the Securities Purchase Agreement, the Company shall use its best efforts either to (i) cause
all of the Registrable Securities covered by each Registration Statement to be listed on each securities exchange on which securities
of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted
under the rules of such exchange, (ii)&nbsp;secure designation and quotation of all of the Registrable Securities covered by each Registration
Statement on an Eligible Market (as defined in the Securities Purchase Agreement), or (iii) if, despite the Company&rsquo;s best efforts
to satisfy the preceding clauses&nbsp;(i) or (ii) the Company is unsuccessful in satisfying the preceding clauses (i) or (ii), without
limiting the generality of the foregoing, to use its best efforts to arrange for at least two market makers to register with the Financial
Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;) as such with respect to such Registrable Securities. In addition, the Company
shall cooperate with each Investor and any broker or dealer through which any such Investor proposes to sell its Registrable Securities
in effecting a filing with FINRA pursuant to FINRA Rule 5110 as requested by such Investor. The Company shall pay all fees and expenses
in connection with satisfying its obligations under this Section&nbsp;3(k).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;The
Company shall cooperate with the Investors who hold Registrable Securities being offered and, to the extent applicable, facilitate the
timely preparation and delivery of certificates (not bearing any restrictive legend) representing the Registrable Securities to be offered
pursuant to a Registration Statement and enable such certificates to be in such denominations or amounts (as the case may be) as the Investors
may reasonably request from time to time and registered in such names as the Investors may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;If
requested by an Investor, the Company shall as soon as practicable after receipt of notice from such Investor and subject to Section&nbsp;3(r)
hereof, (i) incorporate in a prospectus supplement or post-effective amendment such information as an Investor reasonably requests to
be included therein relating to the sale and distribution of Registrable Securities, including, without limitation, information with respect
to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other terms of the offering
of the Registrable Securities to be sold in such offering; (ii) make all required filings of such prospectus supplement or post-effective
amendment after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment; and (iii)
supplement or make amendments to any Registration Statement or prospectus contained therein if reasonably requested by an Investor holding
any Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;The
Company shall use its best efforts to cause the Registrable Securities covered by a Registration Statement to be registered with or approved
by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;The
Company shall make generally available to its security holders as soon as practical, but not later than ninety (90) days after the close
of the period covered thereby, an earnings statement (in form complying with, and in the manner provided by, the provisions of Rule&nbsp;158
under the 1933 Act) covering a twelve-month period beginning not later than the first day of the Company&rsquo;s fiscal quarter next following
the applicable Effective Date of each Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;The
Company shall otherwise use its best efforts to comply with all applicable rules and regulations of the SEC in connection with any registration
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;Within
one (1) Business Day after a Registration Statement which covers Registrable Securities is declared effective by the SEC, the Company
shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities (with copies
to the Investors whose Registrable Securities are included in such Registration Statement) confirmation that such Registration Statement
has been declared effective by the SEC in the form attached hereto as <B>Exhibit A</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)&nbsp;Notwithstanding
anything to the contrary herein (but subject to the last sentence of this Section&nbsp;3(r)), at any time after the Effective Date of
a particular Registration Statement, the Company may delay the disclosure of material, non-public information concerning the Company or
any of its Subsidiaries the disclosure of which at the time is not, in the good faith opinion of the board of directors of the Company,
in the best interest of the Company and, in the opinion of counsel to the Company, otherwise required (a &ldquo;<B>Grace Period</B>&rdquo;),
provided that the Company shall promptly notify the Investors in writing of the (i) existence of material, non-public information giving
rise to a Grace Period (provided that in each such notice the Company shall not disclose the content of such material, non-public information
to any of the Investors) and the date on which such Grace Period will begin and (ii)&nbsp;date on which such Grace Period ends, provided
further that (I) no Grace Period shall exceed ten (10) consecutive days and during any three hundred sixty five (365) day period all such
Grace Periods shall not exceed an aggregate of sixty (60) days, (II) the first day of any Grace Period must be at least five&nbsp;(5)
Trading Days after the last day of any prior Grace Period and (III) no Grace Period may exist during the forty (40) Trading Day period
immediately following the Effective Date of such Registration Statement (provided that such forty (40) Trading Day period shall be extended
by the number of Trading Days during such period and any extension thereof contemplated by this proviso during which such Registration
Statement is not effective or the prospectus contained therein is not available for use) (each, an &ldquo;<B>Allowable Grace Period</B>&rdquo;).
For purposes of determining the length of a Grace Period above, such Grace Period shall begin on and include the date the Investors receive
the notice referred to in clause (i) above and shall end on and include the later of the date the Investors receive the notice referred
to in clause (ii) above and the date referred to in such notice. The provisions of Section&nbsp;3(g) hereof shall not be applicable during
the period of any Allowable Grace Period. Upon expiration of each Grace Period, the Company shall again be bound by the first sentence
of Section&nbsp;3(f) with respect to the information giving rise thereto unless such material, non-public information is no longer applicable.
Notwithstanding anything to the contrary contained in this Section&nbsp;3(r), the Company shall cause its transfer agent to deliver unlegended
shares of Common Stock to a transferee of an Investor in accordance with the terms of the Securities Purchase Agreement in connection
with any sale of Registrable Securities with respect to which such Investor has entered into a contract for sale, and delivered a copy
of the prospectus included as part of the particular Registration Statement to the extent applicable, prior to such Investor&rsquo;s receipt
of the notice of a Grace Period and for which the Investor has not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)&nbsp;The
Company shall take all other reasonable actions necessary to expedite and facilitate disposition by each Investors of its Registrable
Securities pursuant to each Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t)&nbsp;Neither
the Company nor any Subsidiary or affiliate thereof shall identify any Investor as an underwriter in any public disclosure or filing with
the SEC, the Principal Market or any Eligible Market (as defined in the Securities Purchase Agreement) and any Buyer being deemed an underwriter
by the SEC shall not relieve the Company of any obligations it has under this Agreement or any other Transaction Document; provided, however,
that the foregoing shall not prohibit the Company from including the disclosure found in the &ldquo;Plan of Distribution&rdquo; section
attached hereto as Exhibit B in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u)&nbsp;Neither
the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after
the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights
granted to the Buyers in this Agreement or otherwise conflicts with the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.&nbsp;<U>Obligations
of the Investors.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;At
least five (5) Business Days prior to the first anticipated filing date of each Registration Statement, the Company shall notify each
Investor in writing of the information the Company requires from each such Investor with respect to such Registration Statement. It shall
be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the
Registrable Securities of a particular Investor that such Investor shall furnish to the Company such information regarding itself, the
Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it, as shall be reasonably
required to effect and maintain the effectiveness of the registration of such Registrable Securities and shall execute such documents
in connection with such registration as the Company may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;Each
Investor, by such Investor&rsquo;s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested
by the Company in connection with the preparation and filing of each Registration Statement hereunder, unless such Investor has notified
the Company in writing of such Investor&rsquo;s election to exclude all of such Investor&rsquo;s Registrable Securities from such Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;Each
Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section&nbsp;3(g)
or the first sentence of Section 3(f), such Investor will immediately discontinue disposition of Registrable Securities pursuant to any
Registration Statement(s) covering such Registrable Securities until such Investor&rsquo;s receipt of the copies of the supplemented or
amended prospectus contemplated by Section&nbsp;3(g) or the first sentence of Section&nbsp;3(f) or receipt of notice that no supplement
or amendment is required. Notwithstanding anything to the contrary in this Section&nbsp;4(c), the Company shall cause its transfer agent
to deliver unlegended shares of Common Stock to a transferee of an Investor in accordance with the terms of the Securities Purchase Agreement
in connection with any sale of Registrable Securities with respect to which such Investor has entered into a contract for sale prior to
the Investor&rsquo;s receipt of a notice from the Company of the happening of any event of the kind described in Section&nbsp;3(g) or
the first sentence of Section&nbsp;3(f) and for which such Investor has not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.&nbsp;<U>Expenses
of Registration.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All reasonable expenses, other
than underwriting discounts and commissions, incurred in connection with registrations, filings or qualifications pursuant to Sections&nbsp;2
and 3, including, without limitation, all registration, listing and qualifications fees, printers and accounting fees, FINRA filing fees
(if any) and fees and disbursements of counsel for the Company shall be paid by the Company. The Company shall reimburse Legal Counsel
for its fees and disbursements in connection with registration, filing or qualification pursuant to Sections&nbsp;2 and 3 of this Agreement
which amount shall be limited to $10,000 for each such registration, filing or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">6.&nbsp;<U>Indemnification.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;To
the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend each Investor and each of
its directors, officers, shareholders, members, partners, employees, agents, advisors, representatives (and any other Persons with a functionally
equivalent role of a Person holding such titles notwithstanding the lack of such title or any other title) and each Person, if any, who
controls such Investor within the meaning of the 1933 Act or the 1934 Act and each of the directors, officers, shareholders, members,
partners, employees, agents, advisors, representatives (and any other Persons with a functionally equivalent role of a Person holding
such titles notwithstanding the lack of such title or any other title) of such controlling Persons (each, an &ldquo;<B>Indemnified Person</B>&rdquo;),
against any losses, obligations, claims, damages, liabilities, contingencies, judgments, fines, penalties, charges, costs (including,
without limitation, court costs, reasonable attorneys&rsquo; fees and costs of defense and investigation), amounts paid in settlement
or expenses, joint or several, (collectively, &ldquo;<B>Claims</B>&rdquo;) incurred in investigating, preparing or defending any action,
claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental, administrative
or other regulatory agency, body or the SEC, whether pending or threatened, whether or not an Indemnified Person is or may be a party
thereto (&ldquo;<B>Indemnified Damages</B>&rdquo;), to which any of them may become subject insofar as such Claims (or actions or proceedings,
whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement
of a material fact in a Registration Statement or any post-effective amendment thereto or in any filing made in connection with the qualification
of the offering under the securities or other &ldquo;blue sky&rdquo; laws of any jurisdiction in which Registrable Securities are offered
(&ldquo;<B>Blue Sky Filing</B>&rdquo;), or the omission or alleged omission to state a material fact required to be stated therein or
necessary to make the statements therein not misleading, (ii) any untrue statement or alleged untrue statement of a material fact contained
in any preliminary prospectus if used prior to the effective date of such Registration Statement, or contained in the final prospectus
(as amended or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the omission or alleged
omission to state therein any material fact necessary to make the statements made therein, in light of the circumstances under which the
statements therein were made, not misleading or (iii) any violation or alleged violation by the Company of the 1933 Act, the 1934 Act,
any other law, including, without limitation, any state securities law, or any rule or regulation thereunder relating to the offer or
sale of the Registrable Securities pursuant to a Registration Statement or (iv) any violation of this Agreement (the matters in the foregoing
clauses (i) through (iv) being, collectively, &ldquo;<B>Violations</B>&rdquo;). Subject to Section&nbsp;6(c), the Company shall reimburse
the Indemnified Persons, promptly as such expenses are incurred and are due and payable, for any legal fees or other reasonable expenses
incurred by them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein,
the indemnification agreement contained in this Section&nbsp;6(a): (i) shall not apply to a Claim by an Indemnified Person arising out
of or based upon a Violation which occurs in reliance upon and in conformity with information furnished in writing to the Company by such
Indemnified Person for such Indemnified Person expressly for use in connection with the preparation of such Registration Statement or
any such amendment thereof or supplement thereto, if such prospectus was timely made available by the Company pursuant to Section 3(d);
and (ii) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of
the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer of any of the Registrable Securities
by any of the Investors pursuant to Section&nbsp;9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;In
connection with any Registration Statement in which an Investor is participating, such Investor agrees to severally and not jointly indemnify,
hold harmless and defend, to the same extent and in the same manner as is set forth in Section&nbsp;6(a), the Company, each of its directors,
each of its officers who signs the Registration Statement and each Person, if any, who controls the Company within the meaning of the
1933 Act or the 1934 Act (each, an &ldquo;<B>Indemnified Party</B>&rdquo;), against any Claim or Indemnified Damages to which any of them
may become subject, under the 1933 Act, the 1934 Act or otherwise, insofar as such Claim or Indemnified Damages arise out of or are based
upon any Violation, in each case, to the extent, and only to the extent, that such Violation occurs in reliance upon and in conformity
with written information furnished to the Company by such Investor expressly for use in connection with such Registration Statement; and,
subject to Section&nbsp;6(c) and the below provisos in this Section&nbsp;6(b), such Investor will reimburse an Indemnified Party any legal
or other expenses reasonably incurred by such Indemnified Party in connection with investigating or defending any such Claim; provided,
however, the indemnity agreement contained in this Section&nbsp;6(b) and the agreement with respect to contribution contained in Section&nbsp;7
shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of such Investor,
which consent shall not be unreasonably withheld or delayed, provided further that such Investor shall be liable under this Section&nbsp;6(b)
for only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to such Investor as a result of the applicable
sale of Registrable Securities pursuant to such Registration Statement. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of any of the Registrable Securities
by any of the Investors pursuant to Section&nbsp;9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;Promptly
after receipt by an Indemnified Person or Indemnified Party (as the case may be) under this Section&nbsp;6 of notice of the commencement
of any action or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Indemnified
Person or Indemnified Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under
this Section&nbsp;6, deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall
have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly
noticed, to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Indemnified Person
or the Indemnified Party (as the case may be); provided, however, an Indemnified Person or Indemnified Party (as the case may be) shall
have the right to retain its own counsel with the fees and expenses of such counsel to be paid by the indemnifying party if: (i) the indemnifying
party has agreed in writing to pay such fees and expenses; (ii) the indemnifying party shall have failed promptly to assume the defense
of such Claim and to employ counsel reasonably satisfactory to such Indemnified Person or Indemnified Party (as the case may be) in any
such Claim; or (iii) the named parties to any such Claim (including, without limitation, any impleaded parties) include both such Indemnified
Person or Indemnified Party (as the case may be) and the indemnifying party, and such Indemnified Person or such Indemnified Party (as
the case may be) shall have been advised by counsel that a conflict of interest is likely to exist if the same counsel were to represent
such Indemnified Person or such Indemnified Party and the indemnifying party (in which case, if such Indemnified Person or such Indemnified
Party (as the case may be) notifies the indemnifying party in writing that it elects to employ separate counsel at the expense of the
indemnifying party, then the indemnifying party shall not have the right to assume the defense thereof and such counsel shall be at the
expense of the indemnifying party, provided further that in the case of clause (iii) above the indemnifying party shall not be responsible
for the reasonable fees and expenses of more than one (1) separate legal counsel for such Indemnified Person or Indemnified Party (as
the case may be)). The Indemnified Party or Indemnified Person (as the case may be) shall reasonably cooperate with the indemnifying party
in connection with any negotiation or defense of any such action or Claim by the indemnifying party and shall furnish to the indemnifying
party all information reasonably available to the Indemnified Party or Indemnified Person (as the case may be) which relates to such action
or Claim. The indemnifying party shall keep the Indemnified Party or Indemnified Person (as the case may be) reasonably apprised at all
times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any
settlement of any action, claim or proceeding effected without its prior written consent; provided, however, the indemnifying party shall
not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent of the Indemnified
Party or Indemnified Person (as the case may be), consent to entry of any judgment or enter into any settlement or other compromise which
does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party or Indemnified Person
(as the case may be) of a release from all liability in respect to such Claim or litigation, and such settlement shall not include any
admission as to fault on the part of the Indemnified Party. Following indemnification as provided for hereunder, the indemnifying party
shall be subrogated to all rights of the Indemnified Party or Indemnified Person (as the case may be) with respect to all third parties,
firms or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying
party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the
Indemnified Person or Indemnified Party (as the case may be) under this Section&nbsp;6, except to the extent that the indemnifying party
is materially and adversely prejudiced in its ability to defend such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;The
indemnification required by this Section&nbsp;6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;The
indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified
Party or Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to
pursuant to the law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">7.&nbsp;<U>Contribution.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent any indemnification
by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect
to any amounts for which it would otherwise be liable under Section&nbsp;6 to the fullest extent permitted by law; provided, however:
(i) no contribution shall be made under circumstances where the maker would not have been liable for indemnification under the fault standards
set forth in Section&nbsp;6 of this Agreement, (ii) no Person involved in the sale of Registrable Securities which Person is guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) in connection with such sale shall be entitled to contribution
from any Person involved in such sale of Registrable Securities who was not guilty of fraudulent misrepresentation; and (iii)&nbsp;contribution
by any seller of Registrable Securities shall be limited in amount to the amount of net proceeds received by such seller from the applicable
sale of such Registrable Securities pursuant to such Registration Statement. Notwithstanding the provisions of this Section&nbsp;7, no
Investor shall be required to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds actually received
by such Investor from the applicable sale of the Registrable Securities subject to the Claim exceeds the amount of any damages that such
Investor has otherwise been required to pay, or would otherwise be required to pay under Section&nbsp;6(b), by reason of such untrue or
alleged untrue statement or omission or alleged omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">8.&nbsp;<U>Reports
Under the 1934 Act.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With a view to making available
to the Investors the benefits of Rule 144, the Company agrees to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;make
and keep public information available, as those terms are understood and defined in Rule 144;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;file
with the SEC in a timely manner all reports and other documents required of the Company under the 1933 Act and the 1934 Act so long as
the Company remains subject to such requirements (it being understood and agreed that nothing herein shall limit any obligations of the
Company under the Securities Purchase Agreement) and the filing of such reports and other documents is required for the applicable provisions
of Rule 144; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;furnish
to each Investor so long as such Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company,
if true, that it has complied with the reporting, submission and posting requirements of Rule 144, the 1933 Act and the 1934 Act, (ii)
a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company with
the SEC if such reports are not publicly available via EDGAR, and (iii)&nbsp;such other information as may be reasonably requested to
permit the Investors to sell such securities pursuant to Rule 144 without registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">9.&nbsp;<U>Assignment
of Registration Rights.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All or any portion of the
rights under this Agreement shall be automatically assignable by each Investor to any transferee or assignee (as the case may be) of all
or any portion of such Investor&rsquo;s Registrable Securities, Preferred Shares or Warrants if: (i) such Investor agrees in writing with
such transferee or assignee (as the case may be) to assign all or any portion of such rights, and a copy of such agreement is furnished
to the Company within a reasonable time after such transfer or assignment (as the case may be); (ii) the Company is, within a reasonable
time after such transfer or assignment (as the case may be), furnished with written notice of (a) the name and address of such transferee
or assignee (as the case may be), and (b) the securities with respect to which such registration rights are being transferred or assigned
(as the case may be); (iii)&nbsp;immediately following such transfer or assignment (as the case may be) the further disposition of such
securities by such transferee or assignee (as the case may be) is restricted under the 1933 Act or applicable state securities laws if
so required; (iv) at or before the time the Company receives the written notice contemplated by clause (ii) of this sentence such transferee
or assignee (as the case may be) agrees in writing with the Company to be bound by all of the provisions contained herein; (v) such transfer
or assignment (as the case may be) shall have been made in accordance with the applicable requirements of the Securities Purchase Agreement,
the Certificate of Designations and the Series E Preferred Stock and the Warrants (as the case may be); and (vi) such transfer or assignment
(as the case may be) shall have been conducted in accordance with all applicable federal and state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">10.&nbsp;<U>Amendment
of Registration Rights.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Provisions of this Agreement
may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively),
only with the written consent of the Company and the Required Holders; provided that any such amendment or waiver that complies with the
foregoing, but that disproportionately, materially and adversely affects the rights and obligations of any Investor relative to the comparable
rights and obligations of the other Investors shall require the prior written consent of such adversely affected Investor. Any amendment
or waiver effected in accordance with this Section 10 shall be binding upon each Investor and the Company, provided that no such amendment
shall be effective to the extent that it (1) applies to less than all of the holders of Registrable Securities or (2) imposes any obligation
or liability on any Investor without such Investor&rsquo;s prior written consent (which may be granted or withheld in such Investor&rsquo;s
sole discretion). No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving party.
No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement
unless the same consideration (other than the reimbursement of legal fees) also is offered to all of the parties to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">11.&nbsp;<U>Miscellaneous.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;Solely
for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns, or is deemed to
own, of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more Persons
with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received from
such record owner of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;Any
notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing
and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by electronic mail
(provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the sending party does not
receive an automatically generated message from the recipient&rsquo;s email server that such e-mail could not be delivered to such recipient);
or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each case, properly
addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Onconetix, Inc.<BR>
201 E. Fifth Street, Suite 1900</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Cincinnati, Ohio<BR>
Telephone: (513) 620-4101<BR>
Attention: Interim Chief Financial Officer<BR>
E-Mail: [_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">With a copy (for informational purposes only) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Ellenoff Grossman &amp; Schole LLP<BR>
1345&nbsp;Avenue&nbsp;of&nbsp;the&nbsp;Americas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">11<SUP>th</SUP> Floor<BR>
New York, NY 10105<BR>
Telephone: (212) 370-1300<BR>
Attention: Barry I. Grossman, Esq.<BR>
E-Mail: [_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">If to the Transfer Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">1 State Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">30<SUP>th</SUP> Floor<BR>
New York 10004-1571<BR>
Telephone: (800) 509-5586<BR>
Attention: Vincent Amodeo<BR>
E-Mail: [_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">If to Legal Counsel:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">Kelley Drye &amp; Warren LLP<BR>
3 World Trade Center<BR>
175 Greenwich Street<BR>
New York, NY 10007<BR>
Telephone: (212) 808-7540<BR>
Attention: Michael A. Adelstein, Esq.<BR>
E-mail: [_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If to a Buyer, to its mailing address and e-mail
address set forth on the Schedule of Buyers attached to the Securities Purchase Agreement, with copies to such Buyer&rsquo;s representatives
as set forth on the Schedule of Buyers, or to such other mailing address and/or e-mail address and/or to the attention of such other Person
as the recipient party has specified by written notice given to each other party five (5) days prior to the effectiveness of such change,
provided that Kelley Drye &amp; Warren LLP shall only be provided notices sent to the lead Investor. Written confirmation of receipt (A)&nbsp;given
by the recipient of such notice, consent, waiver or other communication, (B)&nbsp;mechanically or electronically generated by the sender&rsquo;s
e-mail containing the time, date and recipient&rsquo;s e-mail or (C) provided by a courier or overnight courier service shall be rebuttable
evidence of personal service, receipt by e-mail or receipt from a nationally recognized overnight delivery service in accordance with
clause&nbsp;(i), (ii) or (iii) above, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;Failure
of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy,
shall not operate as a waiver thereof. The Company and each Investor acknowledge and agree that irreparable damage would occur in the
event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached.
It is accordingly agreed that each party hereto shall be entitled to an injunction or injunctions to prevent or cure breaches of the provisions
of this Agreement by any other party hereto and to enforce specifically the terms and provisions hereof (without the necessity of showing
economic loss and without any bond or other security being required), this being in addition to any other remedy to which any party may
be entitled by law or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws
of the State of Delaware, without giving effect to any provision or rule (whether of the State of Delaware or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of Delaware. Each party hereby irrevocably submits
to the exclusive jurisdiction of the state and federal courts sitting in Wilmington, Delaware, for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not
to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such
suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each
party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any
right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO
REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY
TRANSACTION CONTEMPLATED HEREBY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;If
any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction,
the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that
it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining
provisions of this Agreement so long as this Agreement as so modified continues to express, without material change, the original intentions
of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question
does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the
benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited,
invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited,
invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;This
Agreement, the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced herein
and therein constitute the entire agreement among the parties hereto and thereto solely with respect to the subject matter hereof and
thereof. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein.
This Agreement, the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced
herein and therein supersede all prior agreements and understandings among the parties hereto solely with respect to the subject matter
hereof and thereof; provided, however, nothing contained in this Agreement or any other Transaction Document shall (or shall be deemed
to) (i) have any effect on any agreements any Investor has entered into with the Company or any of its Subsidiaries prior to the date
hereof with respect to any prior investment made by such Investor in the Company, (ii) waive, alter, modify or amend in any respect any
obligations of the Company or any of its Subsidiaries or any rights of or benefits to any Investor or any other Person in any agreement
entered into prior to the date hereof between or among the Company and/or any of its Subsidiaries and any Investor and all such agreements
shall continue in full force and effect or (iii) limit any obligations of the Company under any of the other Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;Subject
to compliance with Section&nbsp;9 (if applicable), this Agreement shall inure to the benefit of and be binding upon the permitted successors
and assigns of each of the parties hereto. This Agreement is not for the benefit of, nor may any provision hereof be enforced by, any
Person, other than the parties hereto, their respective permitted successors and assigns and the Persons referred to in Sections&nbsp;6
and 7 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;The
headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless the
context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural
forms thereof. The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall be construed
broadly as if followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo; &ldquo;hereof&rdquo;
and words of like import refer to this entire Agreement instead of just the provision in which they are found.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;This
Agreement may be executed in two or more identical counterparts, each of which shall be deemed an original, but all of which shall be
considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the
other party. In the event that any signature is delivered by facsimile transmission or by an email which contains a portable document
format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;Each
party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such
other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of
strict construction will be applied against any party. Notwithstanding anything to the contrary set forth in Section 10, terms used in
this Agreement but defined in the other Transaction Documents shall have the meanings ascribed to such terms on the Closing Date in such
other Transaction Documents unless otherwise consented to in writing by each Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;All
consents and other determinations required to be made by the Investors pursuant to this Agreement shall be made, unless otherwise specified
in this Agreement, by the Required Holders, determined as if all of the oustanding Series E Preferred Stock then held by the Investors
have been converted for Registrable Securities without regard to any limitations on redemption, amortization and/or conversion of the
Series E Preferred Stock and the outstanding Warrants then held by Investors have been exercised for Registrable Securities without regard
to any limitations on exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;This
Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the
benefit of, nor may any provision hereof be enforced by, any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;The
obligations of each Investor under this Agreement and the other Transaction Documents are several and not joint with the obligations of
any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under
this Agreement or any other Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by
any Investor pursuant hereto or thereto, shall be deemed to constitute the Investors as, and the Company acknowledges that the Investors
do not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that
the Investors are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated
by the Transaction Documents or any matters, and the Company acknowledges that the Investors are not acting in concert or as a group,
and the Company shall not assert any such claim, with respect to such obligations or the transactions contemplated by this Agreement or
any of the other the Transaction Documents. Each Investor shall be entitled to independently protect and enforce its rights, including,
without limitation, the rights arising out of this Agreement or out of any other Transaction Documents, and it shall not be necessary
for any other Investor to be joined as an additional party in any proceeding for such purpose. The use of a single agreement with respect
to the obligations of the Company contained herein was solely in the control of the Company, not the action or decision of any Investor,
and was done solely for the convenience of the Company and not because it was required or requested to do so by any Investor. It is expressly
understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and
an Investor, solely, and not between the Company and the Investors collectively and not between and among Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[signature page follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, each Buyer and the Company
have caused their respective signature page to this Registration Rights Agreement to be duly executed as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>COMPANY</B>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 31%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>ONCONETIX, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Options: NewSection; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, each Buyer and the Company
have caused their respective signature page to this Registration Rights Agreement to be duly executed as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>BUYERS</B>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 31%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>[LEAD INVESTOR]</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 24; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
each Buyer and the Company have caused their respective signature page to this Registration Rights Agreement to be duly executed as of
the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>[OTHER BUYERS]</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 31%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">EXHIBIT A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>FORM OF NOTICE OF EFFECTIVENESS<BR>
OF REGISTRATION STATEMENT</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">______________________<BR>
______________________<BR>
______________________<BR>
Attention: _____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>Re:&#9;</B>Onconetix, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">[We are][I am] counsel to Onconetix,
Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and have represented the Company in connection with that certain Securities
Purchase Agreement (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;) entered into by and among the Company and the buyers named
therein (collectively, the &ldquo;<B>Holders</B>&rdquo;) pursuant to which the Company issued to the Holders shares of the Company&rsquo;s
Series E Convertible Preferred Stock, par value $0.00001 per share (the &ldquo;<B>Series E Preferred Stock</B>&rdquo;), which will be
convertible into shares (the &ldquo;<B>Conversion Shares</B>&rdquo;) of the Company&rsquo;s shares of common stock, $0.00001 par value
per share (the &ldquo;<B>Common Stock</B>&rdquo;), and warrants exercisable for shares of Common Stock (the &ldquo;<B>Warrants</B>&rdquo;).
Pursuant to the Securities Purchase Agreement, the Company also has entered into a Registration Rights Agreement with the Holders (the
&ldquo;<B>Registration Rights Agreement</B>&rdquo;) pursuant to which the Company agreed, among other things, to register the Registrable
Securities (as defined in the Registration Rights Agreement), including the shares of Common Stock issuable upon conversion of the Series
E Preferred Stock and exercise of the Warrants, under the Securities Act of 1933, as amended (the &ldquo;<B>1933 Act</B>&rdquo;). In connection
with the Company&rsquo;s obligations under the Registration Rights Agreement, on ____________ ___, 20__, the Company filed a Registration
Statement on Form&nbsp;[S-1][S-3] (File No. 333-_____________) (the &ldquo;<B>Registration Statement</B>&rdquo;) with the Securities and
Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) relating to the Registrable Securities which names each of the Holders as a selling
stockholder thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">In connection with the foregoing,
[we][I] advise you that [a member of the SEC&rsquo;s staff has advised [us][me] by telephone that [the SEC has entered an order declaring
the Registration Statement effective under the 1933 Act at [ENTER TIME OF EFFECTIVENESS] on [ENTER DATE OF EFFECTIVENESS]] [an order declaring
the Registration Statement effective under the 1933 Act at [ENTER TIME OF EFFECTIVENESS] on [ENTER DATE OF EFFECTIVENESS]] has been posted
on the web site of the SEC at www.sec.gov] and [we][I] have no knowledge, after a review of information posted on the website of the SEC
at http://www.sec.gov/litigation/stoporders.shtml, that any stop order suspending its effectiveness has been issued or that any proceedings
for that purpose are pending before, or threatened by, the SEC and the Registrable Securities are available for resale under the 1933
Act pursuant to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2">Very truly yours,</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%">&nbsp;</TD>
  <TD STYLE="width: 4%">&nbsp;</TD>
  <TD STYLE="width: 36%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2">[ISSUER&rsquo;S COUNSEL]</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>By:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CC: [LEAD INVESTOR]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.25in; text-indent: 0.5in">[OTHER BUYERS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">EXHIBIT B</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SELLING STOCKHOLDERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The shares of common stock
being offered by the selling stockholders are those issuable to the selling stockholders upon conversion of the preferred shares and exercise
of the warrants. For additional information regarding the issuance of the preferred shares and the warrants, see &ldquo;Private Placement
of Preferred Shares&rdquo; above. We are registering the shares of common stock in order to permit the selling stockholders to offer the
shares for resale from time to time. Except for the ownership of the preferred shares and the warrants issued pursuant to the Securities
Purchase Agreement, the selling stockholders have not had any material relationship with us within the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
selling stockholders and other information regarding the beneficial ownership (as determined under Section 13(d) of the Securities Exchange
Act of 1934, as amended, and the rules and regulations thereunder) of the shares of common stock held by each of the selling stockholders.
The second column lists the number of shares of common stock beneficially owned by the selling stockholders, based on their respective
ownership of shares of common stock, preferred shares and warrants, as of ________, 20__, assuming conversion of the preferred shares
and exercise of the warrants held by each such selling stockholder on that date but taking account of any limitations on conversion and
exercise set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third column lists the
shares of common stock being offered by this prospectus by the selling stockholders and does not take in account any limitations on (i)
conversion of the preferred shares set forth therein or (ii) exercise of the warrants set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of a registration rights agreement with the holders of the preferred shares and the warrants, this prospectus generally covers the resale
of 250% of the sum of (i) the maximum number of shares of common stock issued or issuable pursuant to Certificate of Designations, including
payment of dividends on the preferred shares through [DATE], and (ii) the maximum number of shares of common stock issued or issuable
upon exercise of the warrants, in each case, determined as if the outstanding preferred shares (including dividends on the preferred shares
through [DATE]) and warrants were converted or exercised (as the case may be) in full (without regard to any limitations on conversion
or exercise contained therein solely for the purpose of such calculation) at a conversion price or exercise price (as the case may be)
calculated as of the trading day immediately preceding the date this registration statement was initially filed with the SEC. Because
the conversion price of the preferred shares and the exercise price of the warrants may be adjusted, the number of shares that will actually
be issued may be more or less than the number of shares being offered by this prospectus. The fourth column assumes the sale of all of
the shares offered by the selling stockholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the preferred
shares and the warrants, a selling stockholder may not convert the preferred shares or exercise the warrants to the extent (but only to
the extent) such selling stockholder or any of its affiliates would beneficially own a number of shares of our common stock which would
exceed 4.99% of the outstanding shares of the Company. The number of shares in the second column reflects these limitations. The selling
stockholders may sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in"><B>Name of Selling Stockholder</B></P></TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 19%; font-weight: bold; text-align: center">Number of Shares of Common Stock Owned Prior to Offering</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 19%; font-weight: bold; text-align: center">Maximum Number of Shares of Common Stock to be Sold Pursuant to this Prospectus</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 19%; font-weight: bold; text-align: center">Number of Shares of Common Stock of Owned After Offering</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">[LEAD INVESTOR] (1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">[OTHER BUYERS]</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">[ &nbsp;&nbsp;&nbsp;]</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PLAN OF DISTRIBUTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are registering the shares
of common stock issuable upon conversion of the preferred shares and exercise of the warrants to permit the resale of these shares of
common stock by the holders of the preferred shares and warrants from time to time after the date of this prospectus. We will not receive
any of the proceeds from the sale by the selling stockholders of the shares of common stock, although we will receive the exercise price
of any Warrants not exercised by the selling stockholders on a cashless exercise basis. We will bear all fees and expenses incident to
our obligation to register the shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders may
sell all or a portion of the shares of common stock held by them and offered hereby from time to time directly or through one or more
underwriters, broker-dealers or agents. If the shares of common stock are sold through underwriters or broker-dealers, the selling stockholders
will be responsible for underwriting discounts or commissions or agent&rsquo;s commissions. The shares of common stock may be sold in
one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the time
of sale or at negotiated prices. These sales may be effected in transactions, which may involve crosses or block transactions, pursuant
to one or more of the following methods:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">on any national securities exchange or quotation service on which the securities may be listed or quoted
at the time of sale;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">in the over-the-counter market;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">in transactions otherwise than on these exchanges or systems or in the over-the-counter market;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">through the writing or settlement of options, whether such options are listed on an options exchange or
otherwise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">block trades in which the broker-dealer will attempt to sell the shares as agent but may position and
resell a portion of the block as principal to facilitate the transaction;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">an exchange distribution in accordance with the rules of the applicable exchange;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">privately negotiated transactions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">short sales made after the date the Registration Statement is declared effective by the SEC;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">broker-dealers may agree with a selling security holder to sell a specified number of such shares at a
stipulated price per share;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 28; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">a combination of any such methods of sale; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">any other method permitted pursuant to applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders may
also sell shares of common stock under Rule 144 promulgated under the Securities Act of 1933, as amended, if available, rather than under
this prospectus. In addition, the selling stockholders may transfer the shares of common stock by other means not described in this prospectus.
If the selling stockholders effect such transactions by selling shares of common stock to or through underwriters, broker-dealers or agents,
such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from the selling
stockholders or commissions from purchasers of the shares of common stock for whom they may act as agent or to whom they may sell as principal
(which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may be in excess of those customary
in the types of transactions involved). In connection with sales of the shares of common stock or otherwise, the selling stockholders
may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the shares of common stock in the
course of hedging in positions they assume. The selling stockholders may also sell shares of common stock short and deliver shares of
common stock covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales.
The selling stockholders may also loan or pledge shares of common stock to broker-dealers that in turn may sell such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders may
pledge or grant a security interest in some or all of the preferred shares, warrants or shares of common stock owned by them and, if they
default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock
from time to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable provision of
the Securities Act amending, if necessary, the list of selling stockholders to include the pledgee, transferee or other successors in
interest as selling stockholders under this prospectus. The selling stockholders also may transfer and donate the shares of common stock
in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial
owners for purposes of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent required by
the Securities Act and the rules and regulations thereunder, the selling stockholders and any broker-dealer participating in the distribution
of the shares of common stock may be deemed to be &ldquo;underwriters&rdquo; within the meaning of the Securities Act, and any commission
paid, or any discounts or concessions allowed to, any such broker-dealer may be deemed to be underwriting commissions or discounts under
the Securities Act. At the time a particular offering of the shares of common stock is made, a prospectus supplement, if required, will
be distributed, which will set forth the aggregate amount of shares of common stock being offered and the terms of the offering, including
the name or names of any broker-dealers or agents, any discounts, commissions and other terms constituting compensation from the selling
stockholders and any discounts, commissions or concessions allowed or re-allowed or paid to broker-dealers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the securities laws
of some states, the shares of common stock may be sold in such states only through registered or licensed brokers or dealers. In addition,
in some states the shares of common stock may not be sold unless such shares have been registered or qualified for sale in such state
or an exemption from registration or qualification is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 29; Value: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There can be no assurance
that any selling stockholder will sell any or all of the shares of common stock registered pursuant to the registration statement, of
which this prospectus forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders and
any other person participating in such distribution will be subject to applicable provisions of the Securities Exchange Act of 1934, as
amended, and the rules and regulations thereunder, including, without limitation, to the extent applicable, Regulation M of the Exchange
Act, which may limit the timing of purchases and sales of any of the shares of common stock by the selling stockholders and any other
participating person. To the extent applicable, Regulation M may also restrict the ability of any person engaged in the distribution of
the shares of common stock to engage in market-making activities with respect to the shares of common stock. All of the foregoing may
affect the marketability of the shares of common stock and the ability of any person or entity to engage in market-making activities with
respect to the shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay all expenses of
the registration of the shares of common stock pursuant to the registration rights agreement, estimated to be $[ ] in total, including,
without limitation, Securities and Exchange Commission filing fees and expenses of compliance with state securities or &ldquo;blue sky&rdquo;
laws; provided, however, a selling stockholder will pay all underwriting discounts and selling commissions, if any. We will indemnify
the selling stockholders against liabilities, including some liabilities under the Securities Act in accordance with the registration
rights agreements or the selling stockholders will be entitled to contribution. We may be indemnified by the selling stockholders against
civil liabilities, including liabilities under the Securities Act that may arise from any written information furnished to us by the selling
stockholder specifically for use in this prospectus, in accordance with the related registration rights agreements or we may be entitled
to contribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Once sold under the registration
statement, of which this prospectus forms a part, the shares of common stock will be freely tradable in the hands of persons other than
our affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>onco-20251001.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWaqCSaPtyJ1x6YkxuG9+fak6DyMiRgbqwiPLz10GYRgK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ONCO="http://onconetix.com/20251001" elementFormDefault="qualified" targetNamespace="http://onconetix.com/20251001">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://onconetix.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="onco-20251001_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="onco-20251001_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>onco-20251001_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>onco-20251001_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="onco-20251001.xsd#Cover" roleURI="http://onconetix.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://onconetix.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  01,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Onconetix, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001782107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-2262816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">201 E. Fifth Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cincinnati<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">45202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">620-4101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ONCO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0259860-8k_onconetix.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onconetix.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0259860-8k_onconetix.htm">ea0259860-8k_onconetix.htm</File>
    <File>onco-20251001.xsd</File>
    <File>onco-20251001_lab.xml</File>
    <File>onco-20251001_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0259860-8k_onconetix.htm": {
   "nsprefix": "ONCO",
   "nsuri": "http://onconetix.com/20251001",
   "dts": {
    "inline": {
     "local": [
      "ea0259860-8k_onconetix.htm"
     ]
    },
    "schema": {
     "local": [
      "onco-20251001.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "onco-20251001_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "onco-20251001_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 24
   },
   "report": {
    "R1": {
     "role": "http://onconetix.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-10-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0259860-8k_onconetix.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-10-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0259860-8k_onconetix.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://onconetix.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001213900-25-095847-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-095847-xbrl.zip
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MK$\FKS]YM\>Q[490%U:PL+.^ 6/<JZR7=:#-=IP@DH^]T#VX4OU)%EPH]\,
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M!*A&%V/#6H,$D39(5#9%B]] 0&/'8!*&1%BX?(6!*() C)8^FI8>&]V^="
M[.W'XX Q)9<?@R"$&3WTT0V#'M: =]HKH!FLX3_K*QU:'GS4;<$*L%[<2.F8
MO75[3*FZN0,6!$H2:\ML+3!%B<IW"GL!)J\"8*U[WA@.,@1KSQ?TF:"WH3?)
M"'3:9<F/ R'!UH?>!5/9"*QNP$0XH!3/T-#/2 !9AX*.Q2MF8()U^NCCG'7X
M+<W_^XCA(P\.3=V=!_-F:O&#>K&PR"?8:>)%+U>#;Y>O_Q\C 0& ,_E3\ 2_
M>?#[644J\4+ QA6'$2XH-/&9(W6**@2)^ DPUX0Y%'P5I#@4:XV3,8[8:;=
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M*6PBTW^ IM0SNGZ"L;(TS;NQPSAI, I"+RGDH@G"QN*=X-G!Y$K0$4_V#AR
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M<(BRD92SS'2YKDE0L](C<(T$ =H'6];Y%F0<X-!2;5 9P+1U-9E6P %A_>G
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MFXYAIN]%CH'[A\T[#-!^K>.X0V?+K$.K%5#?E+;6"T=TPV-;H(8\"3GUP2
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MMOGHAX1'VX*QB<Y(B8WWFUK6R4;9YFDR9TKC7*H;2-W#L2ILZ-<&ST1[DV4
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M=$WUT+6O!5*%48S=>:H$K/"J2#?!O#)6<]W<*1=W5J#&TT;OAPD>><=@)TB
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MNH+:9+5$(YL[6:5,9!1R9V4UV)<SA'LTVH*S'.!L\3R"VX)>M0U@H>9'H<
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M*;W>FAH[*>MX:W)[TM2T;;_9DJLV\=SV)A4W!LX8MC!(:M/1-&A ?0Y..>7
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M^]&]QR?324\UIVUM\L:7'CPSC[0U*W%DV=%,]94[A+"CY\3P7A(WLN%_0C'
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M!^:DSW 9L%0X(D&2E47[)P+,K64GT&UK[_.C9XY S$+[,6QK,=0QLKSCF(C
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MYTRU */VK!=SILNL_18_UT#?;A*T:ZCZA:F*30 H0;$;,Q:L87<H68-#!UL
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M 1,\$-IORA@T84<Q@_5D.%T%-?"07E:8]^ALY[,216?G2I1586XND'FOV,*
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MV*.(K]4UU2]+V%BT@Z'HJFS+6Z*R**>$X%FV%;)DQ>_YW;G W=C7XC4-P?H
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MC3(NWM>2K&UK$4K8T!DWNSN/8&T]W$-SQA;BU&GKC]O.>$!\V-"-51T^XG(
M[SWH4.17IEN/A0>QVU5A3@R\;= MN<K/=G@9YC'VU*?2AD2=8+#_S;TB5(@7
M/F1 C@F9,Y@7-<X-84L0N),[;73/#C:@F?,SMB4\7J-(*%X5+AC?83FUGF3R
MA4A<:O3(0O7]>'-(M+R._[2_-#!!2 74F;J7>&'4JVSX_MJXQ;/1DV$Y*:MO
M0)TT^9_ )X79"V(6IF-HASE7QL_&LI*L$@C,($=#W:^!?<7K'?JDJ9=K-X8&
M!!%L01,<^/M8-R7?DAO;H*IORPUXVI,JST8 0E.,_.9HJ#M83 *]WYH'?N1/
MP98AM.<0Q&3"K<AFV:2\+A=01C_TX"67 4AP;-O=Z_ ]\:.ZG+VSG26<^0@3
MU#'XJ9)H7V^3:$$2[>MM$NWS3*+UQBJ591QHPO*D)F4B.?R)JG.-1+*@"&U4
MPE@$P<$-A6@<:#PY_YVRX/#V/R1PUA<,G'5T=GI\@N!8NSM^.P$K[(OD[.6;
MD]?43F"^<3%X\^8W+I;_W93*0R&(<LM"?A?GC7BY4\NPU0D"A2P)N2,V] 'M
M!&M;P/*@YFAQ]8O2:[493SWF< KZP$!IA1+.^R7E6@5PI12.42FK="R-:;M,
MK\X]%L?*Y9A: ;<2H5R!/ILA,+B8\"XSML$H;%37\5AS8Q&H&)[@HA>$Q"\H
MUVIA4,?[G 12UTG&W>,UI3W2K?]-L-TN5,A*8<E:7$.]^TN025SHD0K=,H8M
M5%%;!J:MLVE82KOMMUD)>:6W"5W/S"+CM?;.J^CSPB0@5S@4)_X[X.BF85^M
M12HCK2HF/UPA,'*C.4<:Y_/>=;^_&D.O)<0(2T'BA"$T2R#4S%-2S PHQP5C
MHQ+6-4?/_B/B1P=K4,CK2306G!/,ZIN4?BUA8K7&%)*2[V,"":-)4/B)?%:J
M)T*G.E76?0&U>1U4N*\PR#Y.7N&7WN1&7#VB,_$?=TND1_V20%<<GIYT93 F
M5D'.?ZRHNJE8 V.^8(@U#&1#FJ4O$*8/W4.$$)*@$]*RW6"F8L2-U@K44+-U
M8 @)$^C"*CRYYU^Q-8HZK<>=XF-LKU@Z#VK*F1O_A%^:N0#-"'4WRF,!N(I-
M,7.KX?U4@+S"9<*3S\$?[$^P]X6>RM'7KI53)/-04#-C3UJ*/"SWM-@-?L>[
M!LOB>K+H4,HJB .'H@0+J#N)LOZ0#L"7<0=@<'CT0_+RW<^#\P[[_^V[\Z,?
M#B\&6]&TOA>@P:<])T"4'UJU4<U)8(>!YMS,X$^Z[/W=G<<W^-U4H_9^$C/W
MN5W*ZOV-S'TO'?*9V?N?O&0XTTHR0A\Q6AB59.W^P'#W@KSZ@&SL#7A>\(->
M;Q-JL9*[]L6I57-X-JP X"OH87-Y<FSRP5;>R6(Z2WK/;,;J EKR%E0>27"K
MKO9((4(7C*3"<)ZVOK)SO$&N":J/:FRC7&O$23C@YTL'[--\92O,;DM*);+%
MC\=KA;Q5 !MY<.K8([G@+?O&JG%[,)GDLW(\3E[#_IL!,3.!V5:0@,BK%@NH
M<,-WBH:<LD?]N([M:HL "W^,],5_W*X.5PG3#MD%;!)SFXA>$][/^N=+=POR
M6"1S-3)@Z+,&]!(C#5TY4ERR$GGSA[4]$2N141YP(E3R4B&AR(:3Y0A;=5V6
M *^<<8VG7P-CMN[8V(9W8'Q1Y2U6J<-7[-\O()??0(\X-! V[)BB[TB^+-66
M-4C%LM\G!I:(_/A4><WG^]N\II_7?+Z_S6M^IGG-_&,(A%#=^R"%V!H!>VJ&
M!U&>.4M)*SV,92GB(T F:4N&'D=2& R9"%CZUD'\95$5]:@@RS]*A0(>X0(B
M9I89(R/$$X_RJ"YY$H2=_BF%T7^<3AK_VB,(N";*7@G*;$YFX1E;58N3&=_&
M/7H-];0]!+_Z$%P_AAQ:TP1U#GQ,KGBN/WKXRWP4C)F76(5.*2-'-0M,D]"A
M(0UJ7@KJ&<"E@R0<E7,UDE!R7@$[+393C"P][1K$UWJR6(V]\EZ$1%40- ",
M-1HMEA#? VJKI0BQ5!*$=1[T(ZEUVA[ZSD-_P\L+^,-TUHB'U4^JZ)Q*BU%L
M5=YD508H"1) D*[\%!F@]D2,#%Z5 >H@D=XL V139LOS/K0_L<3/AFF>H%)D
M:9HGN8AEMR![R/&80/SYX4EYV4V1CY.!Y:X[0QNI2L*+O%S.M0!VZ++3LF2.
M;X/2_<8?;! F3.%N65G%?3ZM!/HVVO.KI$GQ8!4ZP=0]DT>U>R+IB-U;WKY5
MK3&JX-&V'7AB1M<:Q [_=I,[-_F78)-5:\%AWPE12R])38#&F&!= AV!!=X]
MG^O-8G6\M6R7/U)CH^0/7*&^JBU9&-D)P(*$EA<5' Y5,K$%-\$KZ.!Q9TW7
M.*"+C,9 ;ZTYL>8_'-#R@A^ZX3J*F;13SND.X5:<<=DD!*7C"@ G$(1S=X?Z
M4.'KTV)63!=3JO8%[3*,@WV&C]U>A<ZK\'Z%O+-,\_"7:X3K@Z7.)JF @@+;
M'VYG48TX^0=&NRWSR)B2WO9MI@K 4LK'%,[*[HXF<W/MH[&>I0;I5$.^A'#[
MY<7;8]!Y#"9\#$Y+C!LU"[C%@/YJMYG:A1UW;X6-9M0RAE]%L>-1.H4)"7-C
M 9$A33"$"/\!_:V+R37AQ5:)14N]NB=<.P"%1*'P6IV\9 "0$/>$>3R=Y^@<
M>C$JJOFORIOB"BD\J?^J7DRGUD]3/8*JZ1S]S28WQF;6\# Z,]_;T]1YFJ:2
M""T0B]:Z3Q!0I!,DSK+.+*<.20BT%&'0PD]N499HH03( Y44I2BC6'42HU-5
M+R94WF<D 96H[>X<CJ --&>JK$^6WSC8YC>"_,;!-K_QF>8W9FL;":SKNPPQ
M<%' <H;;Z<C;?>,ZCK=W$VG@=D2J?FG-5C)W[F2Y9HF*=6=+X=Z ?]WDV:@=
M\?@UX1( D4<CGTJ@X#,LJI<^!*^*TD:J_+I[KP@BB.P%""&Q8GL/U7=[<KI.
MSEPL1/+M/.;@%/U*-JG XKI87-7%J,@J1^Z"YXO@]S-$Y9%231L==$CT;\TU
M%VJ-H%,>=BYC.U"995CIS1P&@"]4%V2P3O/JFB!,LAHJ[6SEK0JO='BQV[/0
M>1;^%=,'4K;<M?==D3,5\!R);9WRI6:OOH41 ?X(03R%!CP$O#T+/NPGR.H(
MKKMPIX"Z:<=8_Y"- E]QH\#EX/S'DU/L _@D-^+3F3UMWF^OB#X(Y5F?I"6U
M5%<J(&F .NR]\//;Z!U1K3HC3,0[<C [*M P"E-J";_TH2]>U<#,C_+)V*N\
MUQAN:(--2FH3M'4=I7"M2\J>0C+&I)]8IF4/E,<AUV!LZ%O;49 F-^4=I.I2
ME_AM32V<0Q=Q]E<>A5@G J>@20D8S1H1@$@_DHMHV*B"2L.,F'RAH0XU=$&C
M] Z*'SR4490XID7)KLP_RYD0[=AH&:(-674F]G:\"W-WQQ:NV^BVPH8I9Y/[
MD!/"=EK@'_V^"M46,EY4#;-:0729OBW;YX) F<USW7>WRL>/;0/8X\7T:@%.
MNQJAA X%%L['>6VUJA(8GP5@(CV1.32KKA.%>0# 7**!3')8;FD]O6>:$:!@
MD#M@(=0= 3NUEN+WY<0AU! F:"-4[&[R/,=E[=B4^"G,"A:5ND4<XZ*W(I/>
M=&XT7!392<)MZIZ*);=2JJP>X1]2?7[-ZO/'DXNCP9LWAZ>#LW=;MLG5+4O?
MO?N>8KT@>MYD=]_N[OQ5A7:_3<R_ $"NR"8;<!T<FHN,IIQ(^"&_04+#XD"F
MR:T9[@CQTO*9N2#$[D:1!I\$+G);K<2@1(ESA_&7,^.R"&<SYL$:6S='57$.
ME^VZN'75 :)%K:! 9P>IV7IW-P1YW?5(GPA3!\EKQA6DD"ES-]Q8M:#%LR::
M]AYA!B+"?Q9__UYRJ>0[6#AF10K;"W'/.*N6UBW_,)P84\/H5R^@+WK/LER/
M\Q$0&E*" +JHBD:@>7\J)D")V<!FNI45;9&-D-3/RP.,BGJ^8 .,9!P!YRF6
M1^'*@4\$6=(*\Y;LV]WQQ+/U:Y6=X9L9O# T1OA/ZCB+K!=V3W)#&GK.!+4,
M1\0XN!5%NQ$+H6@@GSR4A+4Y/<,\)_PD3*U,LF)*1Z!PB,WH>&.]4M!:&FZ'
MQ5O '4@3QUJ);TYB+T8FBBL$E^=Q0GH/HGJS HF1RFHQI45@8]M\LG! B]U/
MAO$;#5B59@)["3+1DQ;K7$&C=WFND&FX911Q?&)MV]-KZ7"4OS-XA/D!ES[)
M*BP9VA74?A43HI3%$MN&+'W$M5"F <\Y&XTJ>)?CT4";JV:4QZ@25J=!;03/
MBZ022KD"$GO47$)M_Q"6*U# =:R"WTCK\"N=]<0XAQ%KB= M>9GN +48*!;$
MQL=5M.^B;^WN&)TR QL$+,B&S6ISAS=X,02"S,\9+MR(:V1X=4 G9+)= >HH
MF;<%&3'9>\Q@4G!KDE\#'1[MI^6[]WMPXG*5;*T)8%-V08]KFZI%70883Z1X
MS.T%!M)KGTZ64J*<;P5_,KLM*]_!V$N^>_D]=O2_/3R__#GY87 ^>/ES<G)^
M/OC[V1&RB?]T>/)W8#,__3DY/WG]PV5R<HE,W,C^?GF6(IG]X>OSP>!B=P>H
MQ(']FRC+S6?)7]^=_YQ<GI\<OK'$Z8?'?WUW#!3R3'T.CSX^N7C[#CCES0"(
M)=Q\F?X#/B;F;B1T/R2Z[^.SHW=(V&V^=W*:!$3@NSM ^'Y^<@'TWF?OD(@=
M^>MQH/"[=(WGPC?T9^8EEX,?W[XY!#)V7BJ:$_SG'H2''S%':'9&C"WWW!6I
MPJ?;5&&0*GRZ315N?,C^&$$[VX1M'(DCR"$9B]UHUXT(ZR]]Y<JUMS;%!>&"
MNQ(D\A20-:!IJP$,8HPBR_M2(A\8AX79V,\PPC XX/I+1@NATC*MSQV:C_'<
M<\4DCS7H^E6ZE)#8V8W.S)T-U )8<#8K?@')08)()QHVPDF,=IM[ M;F#6NC
MW"<<.F,P?X0;@?<E^1,P>7CNK+$1&Z*LJ!Q9(OW<]IKT]N:C<3\9%Q-&)7/+
MK88!5Y:!NNQ?\1Z+C8.5B>8]Z,3AQ*\*;J%M!9UH<;@>Q7P#FN @Z80E95>Y
M>> X?!70T?"P^@KB"#</538!MG$#1VV)RX/!WN5$R2/= =:ZVH8'5C7AFUO]
M0XXEKO6WR6NHFJTVN]G@Y='O8W%71K.Q/@G9PQA4S1D"706:L<8>CE$"87L,
MG%LN[E:L( U>9D;S;@:0?!*#@'D;KPS8V\&\' E50\.\)]PDQ*SS2\QN*IDD
M;WZ:U4,P%<$#SJ%\%OYKEIL37 'I^ Q*^RJ*;LPG"_"H85*UL_<O;;"2L^@.
M19Z3YOX'9K/C?Y>_8F>+L41P_2?%>RAD![% ,X%J7PG(@*BIRFP$C5EXEPBA
MR$55Z#'\FG9YZ)Z\LC4'6KMPH X_W]**J4_*\<H9X#FQB"F@%<QY<J<+? @N
MH(##3D)(8CI>7^T]GT0SFJU,6 G#8&3"!>21./YNMNW'[ /6B;]E,H9#JB;9
MC!S5"[E%A 700G&)J753/:(B8"2@3(CM;RIFI)DPBL1N'NI#4)M2[=I5UIH&
M)T:%[^P[L8G*CBJ5%V+$T']C*#B@J&+$6"' (6"9RN$* B=(+K0!%#&B%YO?
M.UVK'N_XOGD$6+!K)(T:!&5+Q'-U\U)D!DZ>NH>0]B98<** 6Y(_J<MD4E*)
MA_\)MEJ83Z?E2)J?@7-B07&6_ .TX]4N(&L1#H<WV>R:R<*M_L9N!*_^" ''
M">1)L-DXGD9-79SL=15LZBB1J9#Z*Y?$%LX[#[T:FRTDS&U,+(X-FC=#J0O#
M5>E$$>6""VB&@RS:4+H/L79V6$!L!FIU5+@BF%XI%#@0*1DB *09\K\].XLA
MX.K.\VI67BCF%W,.F? +2/_(V^X*<R[@E&+(P\P5 UGC#.RP67Y=FAG:H$J5
MSXU_FP=KFW;?0+V.;-N)':D_HIUG$\^:]V"BXV93PMS\Q[RLB00>MS]KU'9M
M-A9C)P0<(XFE& FX19)V2M/+T[F 52Q/E_10L?&!+Z8N#4 L39@WMQB!"ML!
M'^UZH%*.)XL5- N-;MO0JKEC.4W,97\PDEL(>1 ;B=_P:5E%N@K.8A6D:)_-
MLWNI": CG@ORN(KF"X*:!%H[RO]W=WK+>U.P)HKGHXX^'/B;#"Z,$2C_IEY1
M:RE!6T3=B*'!B0:7IS<:IH_D5"BO\=$8Q^90J4M,^+_92PX1>-B,%&A["^Y^
M\(C$S-*DEKP(>Y4YZ\0-\&@58U23.\9</%6PXI;T2L!Y&',C-.9?2!:U]*,]
MR?QRPM+S)L/^7_?H4=>IL48L9.<PXTPA0K]H@-G..+)-]C[WPZD^WT2TS,UB
MZ#*=F+-E8R^%'!1V#W)%3F-4+/GV+N%'QCN9,?Q0.+*<7I.30L@)_E''O]%9
MDVJ8N@Q,%97HLV<$NZ1I:'XRDP:5CU*7I$-+P'9Q87NB$02+(?< &4-XP50=
MG-0HYUREV5Y8F9V;E2^K+"0Y2EI.5[IDQF)F1C]>.-D1MI1G)&'-"B_PT,$?
M"([&Q=U7W/6]Y)5YPC5&%Z@6$1H0[\,%L9$3MSUPU:_!V!WG\+^V5D7L1"/+
ME@R[+:=:8U:"J[,\1(!DT:F#FU7EQ&!$KZ+"-+J]TSR;,>)8AU#"O>&=<2<(
M[C$.5ROVVZ*$0LU;"NG$;K%,WIXU<TR?P"$'B]42[!$M',RR($(!Y2C1W#Y9
M%\^S;6@^",T_VX;F/\\NGL\ '\UXZH,@*F*\]4/P/%%8;>"@7P:M@ZNJY&R@
MG;%RZ2_Y!VH1!?S;)H./$I&1,R4OK2OK:M)M3-#FH>TOD'47J@MR2#M/A!Z>
M,!HZNQ^@N*"Y,^8!"6*Q0I7ID;;L#ORXP+BC\0DQ7 BCH/:)&M/7%@N@J#BH
MO9H(TJ]4J1%<TIE[81FQCUK!+/6J@UM6S\<T::7QU?+);[P=IF59LL7IDOU-
M'G5[;>TH*7\ZT:B.0\1.<7< RGQRWUHZ,O)D02B[TGY=M&1ZUEW&NHG/1XJW
M5U81,[F/==FV;T=\7BI\\+@<[J65#'@DN;D;C* 29VSY6?0"N_-T@Y2<;.)
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M38_@@*>:/89:^XNI\.9@8P>UXO#5"0\B=IHTZ.;1<50XA>PTU4KA9T:85L8
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M8#0)J\O<?(WWV)A8O#?&T *C'*\$&B[8>H48EA7;>#C054TN"_YT>7;9P,+
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M>K,:RS:)29%**V.R/CKTXRY%RO>LR9'B#G.'[L(GXX&5JZD]9]8R\RZQ#)+
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ML-! .62YJ$;,9;T[*\9%:[N'FQ6T5%#>*5^W,/XR&D6A'<@-,>=F>/VWE)0
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M$=K"-"2K+&9AU80FDZ1_E?^N=C L:>-D'29M^R?FW&I)+8.:[00/!/G&>,/
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MI=9<R',W(#@K^."J;@A*;.4@:WKHE\7XB1!XQ>DB\7A[M@H32)8F6-FW,T@
M22.<%/5DM4!BIHG.&Q-?FTW9TJQ /.#!]$\M(I&).GDW$&Y]J3B"*<.[2A>V
MT,TUL5J,&Z9F/(:O.O_GJN"[)2['&[+V#AB[U/2RO R2K&S,@"W4RAU+47"5
M:[.\W\- ^BG284Z%GD8(M+1U9.BY%9,T&M-,:A=Q!%([7F> (>UD,4V-"@F*
M IS5EB%$G0:3NAB /^W8J+V*@Z#(P+W+>ASAB'>3 X5=SK29:.C%UMD^G(Y
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MEWCN3ZNV7/1-V^$/^!<YZ?@LZ OV,++YC?W\?[<=_KK+GM!A5(NB+^&1QT?
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M61 ?H"PT)9V#D0;D(242O%2RA%$X?$EI/"<53T .*Y^JWHM3\H'6Q35CVJ(
M(.2Z/?Y9@5!_;<G[Y.*\!5X!JJX54^8S>N(_=[66\L+E7$FM9-2E$9_!RB<F
M1%:I<A\UU1/BYX3/) K\R9/&3/N9+VK<VZ[4348T+8K@>%G!\9$<<51>,&S
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M%NQ3LL0ZZ2 ;#$*R)IA$W])]\514OF' ,H$,$9O(U1EC:"<&B!AX.(O"U17
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MS8I!1<;TJ;V[[K90K1PX#PA&@K)5M2[CA*"H%8)L>!O^=.QT4J<U&-J$/K#
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M[\P#JA!T]2=]RIE(['.1V*U[ 0V2\&#Z[ $='\EZE]I>),N8Z=;0':@+&X;
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MT$BXTZP"+.NJ*)N+ZZN!(IB[]!@1;O;J+#M)(Y?IP!:F5@#*'N9Y/YZP_&.
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MX]G>A\A]PASZ0L=$3TP7-66K/!)=GD:CO=@/"9;APHZ'3)]S(R/-Z*_]&Q"
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M+KROM8YAG'(7T]1J2W%P5C('KJPQJA#@.'-QRKQ;M!6+[Z=:\#V:# !EAMD
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MN/;U1)!.$>A2[+-90#U?J3M2/7)8UHY\&T%:9.4B]\)'DM-:>4]MP0&/P.X
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MMC>RI#\^.@/B&3NW2Z8B$\ CS<ZQ =<*H['8DU&CU2SZN]//3A\\Z"D(7W#
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M.^U7Q7&%OZIW6<OP61/+VA_GY&/Q@4X;'9^6_N,;J'BV!24?5SN4D_N^=R:
M/%X(<$E2GBKPRS/IBK01PI&T40K5[PLPAN& !DS:^?=2O;Z+MOKPR*%:EUG
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M.1RTC947>]F<XO6-=#-1E A[3(D:2V#A1=^TG<R2H")69\0&]-=H\(TLIW0
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MYK-U<4U>N,K9+Z)!%I$ :1+20&!48.5F+L<@FB'G#7L%:<E>E^,A3C4E^"B
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M'F&\)2^Q$,V5YHY+Z:P$6"J$1V3Z$/9 9AF+0IOJLFB5V;6!11JRB;&NP^I
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MPC6,NCUN G/NI>VAJL9NUC/L'B*><N26OSXJ9X!A;Q2D8EE-S ER31V,"2P
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M4]H49KH6@"#[=:_(!2](T2*=$J$3%P@#VF)])EI6>'NGBF_-]>KCHQ4+LG7
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M-@B;%I0M0/)_I>4C:K+F2C!]17F-0=8K=$,,*:S,)(7(4+A>02C,2\QIR/Z
MP"?R21ESW\9*5U+Q&]3?HI<7A3+=$'8G6B([,X&#T1"22-3,46H7&#-5.Z8$
M!.X*0"//('%A)F:V)!$M&S"HQY@R.C'W4G3K7%&WSS0I1.&P,5:0TWC%=R0X
M(/#0SH$H(LDCP7C91M%?SK ):X?+[K#);C"D_0E[.IA.XQ.&"]SO_=]UT:R
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M:@(V0B4 TO(E4\!J8K;P) G+&C']7,)^I;-B)8YM3X W^894<3P@!U.HDE:
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M5" $VE9W-<Z84MW8GG+J%#<&UY.Y$=L2,S0PP9R%$>3N7P!YJ.F07U& ==Y
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M[+UK<QO'DC;X'1'X#[TG9B: #8@6)<OW401$0A9G)%)#4O9X-S;>:  -LFT
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MUL@MK/^/":Z-,=I/D5O8O())OPH8!FT"ZLURC>C1\Z)P2,H&M6;72'7K(ZL
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MTWZ+PG+K2@D,,,#(;2#Y#S!%G6,E=LT]X3;<' '^XZ!!#""V#1X*X]ZJ9BE
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ML=+ LJH .86\&E+@4YEST#P"]5>^?9]ZXC<;SGN7H^9J"U_V4-;PQIL4&S0
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MMD9@FN'(.%^]:;)S/O$/ W:LYCGXR%=-*&?3MF,?6U)PFGY264U-WJBQ]KB
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MG6Y]>2)]P"X<PW6T(+-!]61H(GS?'$P7W>)M@V?AS#:M"M+D@+OKNYW3#,M
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MK,0R0Q4F[#6GI@=7I<[]2<A_+(MKFTCG!ASLEA3^8#< [,'?U\O0.I8+PYZ
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M. P<&TI91FH]>BF"3YK_XJ/V=IJD]]@LG\5](ZU'3U%2!K9.0)\=NE#-C[J
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M<+,LG6LWB($'B"QM,9?,[B@#^/IP>=T.5058EVR!]7,YA=F,8R_3 N B+@T
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M KL" HC<$%?E8"B]@9--P EXP#7;K9@",%^EY<*%^FC<(:=.+CA^+*T>)G"
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M"D0T9ZW:7R!N.W7GZSG[X_]02P,$%     @ !4)#6V%8P)0I P  Y0L  !$
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M$6R.*7-+@-UDDX*F)B 2K,8 &@[:XIE2+T3,Q,C$<3JG,=G]0O9@NUHZMTP
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M8V]N971I>"YH=&U02P$"% ,4    "  %0D-;+8)832QZ  #WN0( 'P
M        @ &,(P$ 96$P,C4Y.#8P,#%E>#$P+3)?;VYC;VYE=&EX+FAT;5!+
M 0(4 Q0    (  5"0UOR.WH*M.,  -3F!  >              "  ?6= 0!E
M83 R-3DX-C P,65X,RTQ7V]N8V]N971I>"YH=&U02P$"% ,4    "  %0D-;
M!*TY[KJ#  !XV@( '@              @ 'E@0( 96$P,C4Y.#8P,#%E>#0M
M,5]O;F-O;F5T:7@N:'1M4$L! A0#%     @ !4)#6V%8P)0I P  Y0L  !$
M             ( !VP4# &]N8V\M,C R-3$P,#$N>'-D4$L! A0#%     @
M!4)#6ZRL0;+\"@  ?X8  !4              ( !,PD# &]N8V\M,C R-3$P
M,#%?;&%B+GAM;%!+ 0(4 Q0    (  5"0UON&=476 <  -97   5
M      "  6(4 P!O;F-O+3(P,C4Q,# Q7W!R92YX;6Q02P4&      @ "  _
) @  [1L#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ea0259860-8k_onconetix_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="onco-20251001.xsd" xlink:type="simple"/>
    <context id="AsOf2025-10-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001782107</identifier>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-10-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-10-01" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-10-01" id="Fact000004">0001782107</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-10-01" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-10-01" id="Fact000010">2025-10-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-10-01" id="Fact000011">Onconetix, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-10-01" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-10-01" id="Fact000013">001-41294</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-10-01" id="Fact000014">83-2262816</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-10-01" id="Fact000015">201 E. Fifth Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-10-01" id="Fact000016">Suite 1900</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-10-01" id="Fact000017">Cincinnati</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-10-01" id="Fact000018">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-10-01" id="Fact000019">45202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-10-01" id="Fact000020">513</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-10-01" id="Fact000021">620-4101</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-10-01" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-10-01" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-10-01" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-10-01" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-10-01" id="Fact000026">Common Stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-10-01" id="Fact000027">ONCO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-10-01" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-10-01" id="Fact000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-10-01" id="Fact000030">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
